Bibliographie - new - Stabilis 4.0

Last update :
26/09/2023

Filters

Authors :		Type :
Title :
Publication :		Année :
Research teams :
Pharmacological Class :
Galenic forms :

References

Reference

Type
Publication

Title
Authors

Year

1510	Book AHFS Formulary service 2000 Bethesda - 3546 p		2000
3291	Journal Acta Pol Pharm 2012 ; 69, 1: 95-105.	Physical and chemical properties and stability of sodium cefazolin in buffered eye drops determined with HPLC method. Kodym A, Bilski P, Domanska A, Lukasz Helminiak, Jablonska M, Jachymska A.	2012
795	Journal Am J Health-Syst Pharm 1996 ; 53: 2338-2339.	21-day compatibility of hydromorphone hydrochloride and promethazine hydrochloride in a cassette. Henderson F.	1996
3316	Journal Chem Pharm Bull 2012 ; 60, 1: 86-93.	A 5% Glucose Infusion Fluid Provokes Significant Precipitation of Phenytoin Sodium Injection via Interruption of the Cosolvent Effect of Propylene Glycol. Onuki Y, Ikegami-Kawai M, Ishitsuka K, Hayashi Y, Takayama K.	2012
3958	Journal J Infect Dis 1988 ; 157, 3: 600-601.	A Dilute Solution of Vancomycin and Heparin Retains Antibacterial and Anticoagulant Activities . Henrickson K.J; . Powell K.R; . Schwartz C.L.	1988
2242	Journal Int J Pharm 1998 ; 167, 1-2: 223-228.	A note on the solution chemistry of carboplatin in aqueous solutions. Lederer M, Leipzig-Pagani E.	1998
1232	Journal Br J Pharm Pract 1987 ; 9: 223-226, 236.	A physical compatibility study of furosemide & flucloxacillin injections. Beatson C, Taylor A.	1987
3847	Journal J Pain Palliat Care Pharm 2016 ; 29, 4: 370-373.	A Pilot Chemical and Physical Stability Study of Extemporaneously Compounded Levetiracetam Intravenous Solution. Raphael C.D, Zhao F, Hughes S.E, Juba K.M.	2016
401	Journal Aust J Hosp Pharm 1991 ; 21: 115-118.	A preliminary study of the stability of midazolam in polypropylene syringes. Peterson GM, Khoo BHC, Galloway JG, Paterson J.	1991
2203	Journal J Oncol Pharm Practice 2007 ; 13: 119-126.	A sequential temperature cycling study for the investigation of carboplatin infusion stability to facilitate 'dose-banding'. Kaestner S, Sewell G.	2007
2560	Journal Aust J Hosp Pharm 1994 ; 24: 312-316.	A short-term stability study of an oral solution of dexamethasone. Accordino A, Chambers R, Thomson B.	1994
3279	Journal J Clin Pharm Ther 2012 ; 37, 1: 71-73.	A stability indicating assay for a combination of morphine sulphate with levomepromazine hydrochloride used in palliative care. Al-Tannak N.F, Cable C.G, McArthur D.A, Watson D.G	2012
3817	Poster Gerpac Congress, Giens, France 2015	A stability study of 25 mg/mL phenylephrine hydrochloride and 5 mg/mL tropicamide eye drops. Stordeur F, Chanat C, Brandely M.L, Chast F.	2015
3685	Journal EJHP 2017 ; 24:4 : 235-241	A stability study of amphotericin B, colistin and tobramycin in a hydrophilic suspension commonly used for selective decontamination of the digestive tract by HPLC and in vitro potency measurements. Pfeifer C, Noll S, Gerecke H, Fassauer G, Jira T, Remane Y , Vogel J, Frontini R, Reinhardt R.	2017
3438	Journal J Pharm Biomed Anal 2013 ; 83 : 164-170.	A stability-indicating, ion-pairing, reversed-phase liquid chromatography method for studies of daunorubicin degradation in i.v. infusion fluids. Respaud R, Quenum L, Plichon C, Tournamille J.F, Gyan E, Antier D, Viaud-Massuard M.C.	2013
554	Journal J Parenter Sci Technol 1991 ; 45: 212-217.	A study of the interaction of selected drugs and plastic syringes. Speaker TJ, Turco SJ, Nardone DA, Miripol JE.	1991
525	Journal Int J Pharm 1990 ; 65: 49-56.	A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters. De Vroe C, De Muynck C, Remon JP, Samsom M.	1990
2894	Journal J Dermatolog Treat 2004 ; 15: 295-302.	A topical azythromycin preparation for the treatment of acne vulgaris and rosacea. McHugh RC, Sangha ND, Mc Carty MA et al.	2004
4045	Journal J Pharm Biomed Anal 2016 ;124:365-373	A UHPLC-UV-QTOF study on the stability of carfilzomib, a novel proteasome inhibitor. Sestak V, Roh J, Klepalova L, Kovarikova P.	2016
1332	Journal J Clin Hosp Pharm 1981 ; 6: 209-211.	Absorption of isosorbide dinitrate by PVC infusion bags and administration sets. Lee MG, Fenton-May V.	1981
3595	Manufacturer Hospira 2009	Aciclovir - Summary of Product Characteristics	2009
3933	Manufacturer Teva Laboratoire 2015	Acide zolédronique - (Acide zoledronique Teva Pharma) - Résumé des caractéristiques du produit	2015
576	Journal Drug Intell Clin Pharm 1980 ; 14: 353-357.	Activity of antibiotic admixtures subjected to different freeze-thaw treatments. Holmes CJ, Ausman RK, Walter CW, Kundsin RB.	1980
1624	Journal Am J Health-Syst Pharm 2000 ; 57: 760-762.	Activity of dalteparin sodium in polypropylene syringes. Louie S, Chin A, Gill MA.	2000
811	Journal Am J Health-Syst Pharm 1998 ; 55: 1296-1298.	Activity of enoxaparin sodium in tuberculin syringes for 10 days. Charland SL, Davis DD, Tillman DJ.	1998
466	Journal Am J Hosp Pharm 1991 ; 48: 2172-2175.	Activity of octreotide acetate in a total nutrient admixture. Ritchie DJ, Holstad SG, Westrich TJ, Hirsch JD, O'Dorisio TM.	1991
375	Journal Am J Hosp Pharm 1991 ; 48: 1511-1514.	Activity of urokinase diluted in 0.9% sodium chloride injection or 5% dextrose injection and stored in glass or plastic syringes. Patel JP, Tran LT, Sinai WJ, Carr LJ.	1991
156	Journal Anticancer Drugs 1995 ; 6: 163-164.	Addition of heparin in 5-fluorouracil solution for portal vein infusion has no influence on its stability under clinically relevant conditions. Barberi-Hayob M, Merlin JL, Vigneron M, Conroy T.	1995
4567	Journal Pharmaceutics 2021 ;13, 458.	Addition of Regular Insulin to Ternary Parenteral Nutrition: A Stability Study. Henry H, Lannoy D, Maboudou P, Seguy D, Dine T, Pigny P, Odou P.	2021
64	Journal Am J Hosp Pharm 1992 ; 49: 1672.	Additional data on visual compatibility of foscarnet sodium with morphine sulfate. DiStefano JE, Outman WR.	1992
1242	Journal Pharm Weekbl [Sci] 1988 ; 10: 213-216.	Adsorption of human and porcin insulins to intravenous administration sets. Tol A, Quik RFP, Thyssen JHH.	1988
2119	Journal Eur J Anaesthesiol 2003 ; 20: 124-126.	Adsorption of sufentanil to epidural filters and catheters. Westphal M, Hohage H, Buerckle H, Van Aken H, Ermert T, Brodner G.	2003
167	Journal Int J Pharm 1994 ; 103: 87-92.	Adsorption of vincristine, vinblastine, doxorubicin and mitoxantrone to in-line intravenous filters. Francomb MM, Ford JL, Lee MG.	1994
3508	Manufacturer Sanofi Aventis Group 2013	Aflibercept (Zaltrap®) - Summary of Product characteristics	2013
3635	Manufacturer Novartis Pharmaceuticals UK Ltd 2015	Aldesleukine (Proleukin®) - Summary of Product Characteristics	2015
3417	Poster ADKA Congress, Dresden, Germany 2013	Aliquotierte Levosimendanlösungen - stabil ? Trittler R, Hecklinger J.	2013
3616	Manufacturer Boehringer Ingelheim 2012	Altéplase (Actilyse®) - Résumé des caractéristiques du produit	2012
4471	Manufacturer Kyowa Kirin Pharma 2019	Amétycine 10 mg poudre pour solution injectable - Résumé des caractéristiques du produit - Oct 10, 2019	2019
3598	Manufacturer Clinigen Healthcare Ltd 2016	Amifostine (Ethyol®) - Résumé des caractéristiques du produit	2016
3549	Manufacturer B Braun 2012	Amikacine B Braun - Résumé des caractéristiques du produit.	2012
3524	Manufacturer Sanofi 2013	Amiodarone hydrochloride (Cordarone®) - Summary of Product Characteristics.	2013
3527	Manufacturer Glaxo Smith Kline 2018	Amoxicillin (Amoxil®) – Summary of Product Characteristics	2018
3545	Manufacturer Mylan SAS 2009	Amoxicilline / acide clavulanique - Résumé des caractéristiques du produit	2009
265	Journal Am J Health-Syst Pharm 1995 ; 52: 1463-1464.	Amphotericin B does not mix with fat emulsion. Trissel LA.	1995
1498	Journal Ann Pharmacotherapy 1996 ; 30: 409-412.	Amphotericin B formulated in a lipid emulsion. Cleary JD.	1996
2043	Journal Antimicrob Agents Chemother 1998 ; 42: 762-766.	Amphotericin B in lipid emulsion : stability, compatibility, and in vitro antifungal activity. Walker S, Tailor SAA, Lee M, Louie L, Louie M, Simor AE.	1998
793	Journal J Antimicrob Chemother 1996 ; 37: 1165-1169.	Amphotericin B intralipid formulation: stability and particule size. Ranch?re JY, Latour JF, Fuhrmann C, Lagallarde C, Loreuil F.	1996
984	Journal Ann Pharmacotherapy 1996 ; 30: 298.	Amphotericin B is incompatible with lipid emulsions. Ericsson O, Hallmen AC, Wikstrom I.	1996
3398	Manufacturer Gilead Science (France) 2013	Amphotéricine B (Ambisome®) - Résumé des caractéristiques du produit	2013
3591	Manufacturer Bristol Myers Squibb 2011	Amphotericine B (Fungizone®) - Résumé des caractéristiques du produit	2011
1758	Journal Can J Hosp Pharm 1999 ; 52: 90.	Ampicillin and ciprofloxacin incompatibility. Lewis GM, Donelly RF.	1999
1392	Journal Can J Hosp Pharm 1999 ; 52: 90.	Ampicillin and ciprofloxacin incompatibility. Lewis GM, Donnelly RF.	1999
3528	Manufacturer Essential generics 2012	Ampicillin sodium – Summary of Product Characteristics	2012
3576	Manufacturer Prostrakan 2012	Amsacrine (Amsalyo®) - Résumé des caractéristiques du produit	2012
805	Journal Hosp Pharm 1997 ; 32: 1013-1020.	An automated process for determining the physical compatibility of drugs. Oskroba DM, Leissing NC, Trissel LA.	1997
3760	Journal J Oncol Pharm Practice 1996 ; 2: 107-112.	An evaluation of the stability of granulocyte colony stimulating factor on the short-term storage and delivery from an elastomeric infusion system. Tivnann H, Gaines-Gas R, Thorpe R et al.	1996
4681	Journal Hosp Pharm 2022 ; 57, 1: 69-75.	An Exploratory Study of a New Vancomycin Eye Drops Formulation for Extemporaneous Compounding. Chen P, Mar Z, Giannetti A, Hughes S, Gilbert J, Zhao F.	2022
124	Journal Int Pharm J 1993 ; 7: 14-19.	An in vitro interaction between promethazine hydrochloride and chloroquine phosphate. Abubakar AA, Mustapha A, Wambebe OC.	1993
3725	Journal Dysphagia 2014	An investigation into the stability and sterility of citric acid solutions used for cough reflex testing. Falconer J.R, Wu Z, Lau H, Sue J, Wang L, Pottinger S, Lee E, Alazawi N, Kalllesen M, Gargiulo D.A, Swift S, Svirskis D.	2014
3190	Journal Advance in Haematology 2009 Article ID 704928, 5 page	An NMR Study of the Bortezomib Degradation under Clinical Use Conditions. Bolognese A, Esposito A, Manfra M, Catalano L, Petruzziello F, Martorelli MC, Pagliuca R, Mazzarelli V, Ottiero M, Scalfaro M,	2009
4736	Journal J Pharm Biomed Anal 2023	An Ultra-High-Performance Chromatography method to study the long term stability of gemcitabine in dose banding conditions. Closset M, Colsoul ML, Goderniaux N, Bihin B, Jamart J, Onorati S, Soumoy L, Hecq JD, Odou P, Galanti L.	2023
1895	Journal J Pharm Biomed Anal 2004 ; 35: 57-64.	Analysis by liquid chromatography and infrared spectrometry of di(2-ethylhexyl)phtalate released by multilayer infusion tubing. Bourdeaux D, Sautou-Miranda V, Bagel-Boithias S, Boyer A, Chopineau J.	2004
1917	Journal J Pharm Biomed Anal 1997 ; 15: 537- 543.	Analysis of gentamicin sulfate and a study of its degradation in dextrose solution. Graham AE, Speicher E, Williamson B.	1997
2148	Journal Anal Biochem 2002 ; 309: 117-126.	Analytical validation of a microplate reader-based method for the therapeutic drug monitoring of L-asparaginase in human serum. Lanvers C, Pinheiro JPV, Hempel G, Wuerthwein G, Boos J.	2002
3567	Manufacturer Pfizer 2020	Anidulafungin (Ecalta®) - Summary of Product Characteristics.	2020
3006	Journal J Am Acad Dermatol 1987 ; 16: 984-988.	Anthralin stability in various vehicles. Green PG, Kennedy CT, Forbes DR.	1987
1230	Journal Br J Pharm Pract 1986 ; 8: 218-220.	Anti-emetic / diamorphine mixture compatibility in infusion pumps. Regnard C, Pashley S, Westrope F.	1986
1893	Journal Ann Pharmacotherapy 2004 ; 38: 569-573.	Anti-Xa stability of diluted enoxaparin for use in pediatrics. Dager WE, Gosselin RC, King JF, Christensen CL, Owings JT, Larkin EC.	2004
4445	Journal Chemotherapy 1979 ; 25: 336-345.	Antibiotic compatibility and stability in a parenteral nutrition solution. Reed M.D, Perry E.B, Fennell S.J, Brissie E.O, Ball W.D.	1979
1386	Journal Pharm J 1983 ; 231- 233.	Antibiotic interactions. Gove L.	1983
3952	Journal Hemodial Int 2010 ; 14, 3 : 322-326.	Antibiotic lock: In vitro stability of gentamicin and sodium citrate stored in dialysis catheters at 37°C. Battistella M,. Vercaigne L.M, Cote D,. Lok C.E.	2010
3951	Journal Hemodial Int 2009 ; 13, 3: 322-328.	Antibiotic lock: In vitro stability of vancomycin and four percent sodium citrate stored in dialysis catheters at 37°C Battistella M, Walker S, law S, Lok C.	2009
1103	Journal J Pediatr 1988 ; 112: 813-817.	Antibiotic stability in a pediatric parenteral alimentation solution. Fox AS, Boyer KM, Sweeney HM.	1988
1760	Journal Pharmacotherapy 2000 ; 20: 394-399.	Antibiotic-heparin lock: in vitro antibiotic stability combined with heparin in a central venous catheter. Vercaigne LM, Sitar DS, Penner B, Bernstein K, Wang GQ, Burczynski FJ.	2000
2268	Journal Ann Pharmacotherapy 2008 ; 42, 4: 511-515.	AntiXa stability of diluted dalteparin for pediatric use. Goldenberg NA, Jacobson L, Hthaway H, Tripputi M, Primeaux J, Child J.	2008
3615	Manufacturer Archimeded Pharma 2012	Apomorphine (Apomorphine Archimedes®) - Résumé des caractéristiques du produit	2012
3227	Journal Braz J Pharm Sci 2014 ; 50, 3 : 521-527.	Application of capillary electrophoresis to the simultaneous determination and stability study of four extensively used penicillin derivatives Simon B, Hancu G, Gy?resi A.	2014
4579	Journal Processes 2021 , 9, 453.	Application of the HPLC Method in Parenteral Nutrition Assessment: Stability Studies of Ondansetron Tomczak S, Radwan V, Jelinska A, Stawny M.	2021
3295	Manufacturer LFB Biom?dicaments 2018	Argatroban - Résumé Caractéristiques du Produit	2018
2277	Manufacturer GlaxoSmithKline 2008	Argatroban - Summary of Product Characteristics	2008
4726	Manufacturer Mylan 2023	Arsenic trioxide Mylan - Résumé des caractéristiques du produit	2023
3445	Journal Krankenhauspharmazie 2013 ; 34, 8: 410-411.	Aseptische Herstellung applikationsfertiger Adrenalin-Dauerinjektionen 20 µg/ml. Heeb R.M, Thiesen J, Krämer I.	2013
1160	Journal Int J Pharm 1986 ; 32: 123-131.	Aspects of the degradation kinetics of doxorubicin in aqueous solution. Beijnen JH, van der Houwen OAGJ, Underberg WJM.	1986
4292	Journal Drugs R D 2019 19: 127–140.	Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion. Vimpolsek M, Gottar-Guillier M, Rossy E.	2019
4676	Poster EAHP Congress Vienna 2022	Assessing the stability of Sandoz rituximab biosimilar after exposure to out-of-fridge conditions for 21 days. Borišek R, Šmid I.	2022
4645	Journal JAC Antimicrob Resist 2021	Assessment of ceftolozane/tazobactam stability in elastomeric devices and suitability for continuous infusion via outpatient parenteral antimicrobial therapy. Jamieson C, Drummond F, Hill T, Ozolina L, Gilchrist M, Seaton R.A, Santillo M, Wilkinson A-S, Allwood M.C.	2021
2139	Journal EJHP Science 2006 ; 12,5: 96-99.	Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities. Serrurier C, Chenot ED, Vigneron J, May I, Demor? B.	2006
2815	Journal EJHP 2009 ; 15, 4: 30-32.	Assessment of stability in extemporaneously prepared venlafaxine solutions. Kervale JG, Castagnet S, Chiadmi F, Schlatter J, Benabadji Z, Cisternino S, Fontan JE.	2009
4434	Journal Clin Ther 2019 ; 41, 10: 2162-2170.	Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration. Avery L.M, Chen, I.H, Reyes, S, Nicolau, D.P, Kuti J.L.	2019
4512	Journal EJHP 2020 2020;0:1-5.	Assessment of the stability of citrate- buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS Yellow Cover Document requirements Jamieson C,Ozolina L,Seaton RA, Gilchrist M, Hills T, Drummond F, Wilkinson AS.	2020
4218	Journal EJHP 2020 ; 27, 2: 90-94.	Assessment of the stability of citrate-buffered flucloxacillin for injection when stored in two commercially available ambulatory elastomeric devices: INfusor LV (Baxter) and Accufuser (Woo Young Medical): a study compliant with the NHS Yellow Cover Document (YCD) requirements. Allwood M.C,Stonkute D, Wallace A, Wilkinson A-S, Hills T, Jamieson C,	2020
1873	Journal Clin Ther 2003 ; 25: 1219-1224.	Assessment of the stability of dalteparin sodium in prepared syringes for up to thirty days/ In vitro study. Laposata M, Johnson SM.	2003
1608	Journal Int J Pharm Compound 2001 ; 5: 397-400.	Assessment of the stability of teicoplanin in intravenous infusions. Galanti LM, Hecq JD, Jeuniau P, Vanbeck D, Jamart J.	2001
4532	Manufacturer Roche Products Limited 2021	Atezolizumab (Tecentriq®) - Summary of Product Characteristics	2021
3629	Manufacturer Actavis UK 2014	Atracurium (Atracurium solution for injection/infusion®) - Summary of Product Characteristics	2014
3676	Manufacturer Hospira 2014	Atracurium bésilate (Atracurium Hospira®) - Résumé des caractéristiques du produit	2014
711	Journal Am J Hosp Pharm 1980 ; 37: 492-496.	Avaibility of diazepam from plastic containers. Cloyd JC, Vezeau C, Miller KW.	1980
177	Journal Am J Health-Syst Pharm 1995 ; 52: 2213-2216.	Avaibility of lorazepam after simulated administration from glass and polyvinyl chloride containers. Mancano MA, Boullata JI, Gelone SP, Zitterman RE, Borenstein MR.	1995
1102	Journal Eur J Clin Pharmacol 1981 ; 19: 181-185.	Availability of isosorbide dinitrate, diazepam and chlormethiazole, from i.v. delivery systems. Cossum PA, Roberts MS.	1981
4467	Manufacturer Roche Products Limited 2020	Avastin - Summary of Product Characteristics	2020
4474	Manufacturer Merck 2023	Avelumab (Bavencio®) - Summary of Product Characteristics	2023
3236	Manufacturer Celgene 2011	Azacitidine (Vidaza®) - Résumé des caractéristiques du produit	2011
3547	Manufacturer Sanofi-Aventis France 2011	Aztréonam (Azactam®) - Résumé des caractéristiques du produit	2011
94	Journal Am J Hosp Pharm 1990 ; 47: 1970.	Aztreonam-vancomycin incompatibility. Chandler SW, Folstad J, Trissel LA.	1990
3683	Manufacturer Aguettant 2014	Baclofen - Résumé des caractéristiques du produit	2014
2729	Journal J Pharm Clin 1995 ; 14, 2: 106-111.	Bains de bouche antifongiques: études de stabilité. Vincent I, Schmit B, Houze S, benhaiem N, Jacques L, Taburet AM.	1995
3261	Manufacturer Bristol Myers Squibb 2011	Belatacept (Nulojix®) – Résumé des caractéristiques du produit	2011
3936	Manufacturer GlaxoSmithKline Laboratoire 2016	Bélimumab (Benlysta®) – Résumé des caractéristiques du produits	2016
3721	Manufacturer Spectrum Pharmaceuticals 2014	Belinostat (Beleodaq®) - Summary of Product Characteristics	2014
3158	Manufacturer Astellas Pharma GmbH 2014	Bendamustine (Levact®) - Summary of Product Characteristics	2014
2288	Manufacturer Cephalon 2008	Bendamustine hydrochloride (Treanda®) – Summary of Product Characteristics	2008
3585	Manufacturer Genus Pharmaceuticals 2008	Benzylpenicillin sodium - Summary of Product Characteristics	2008
4582	Journal J Pharm Technol 2021	Beyond-Use Dates Assignment for Pharmaceutical Preparations: Example of Low-Dose Amiodarone Capsules. Brun D, Curti C, Lamy E, Jean C, Bertault-Përez P, Broggi J, Tintori G, Vanelle P.	2021
3978	Journal Am J Health-Syst Pharm 2017 ; 74,9: 202-210	Beyond-use dating of lidocaine alone and in two “magic mouthwash” preparations. Kirk L.M, Brown S.D, Luu Y, Ogle A, Huffman J, O. Lewis P.O.	2017
1269	Journal J Clin Pharm Ther 1988 ; 13: 335-340.	Binding of drugs to end-line filters: a study of four commonly administered drugs in intensive care units. DeMuynck C, De Vroe C, Remon JP, Colardyn F.	1988
857	Journal Am J Hosp Pharm 1983 ; 40: 1323-1328.	Binding of selected drugs to a “treated” inline filter. Kanke M, Eubanks JL, DeLuca PP.	1983
3696	Journal Braz J Pharm Sci 2012 ; 48, 4: 691-698.	Biological and physicochemical stability of ceftazidime and aminophylline on glucose parenteral solution. Santos C.A.D, Oliveira-Nascimento L, Knirsch M.C, Stephano M.A, Pessoa J?nior A, Penna T.C.V.	2012
3539	Manufacturer The Medecines Company 2013	Bivalirudin (Angiox®) - Summary of Product Characteristics.	2013
4154	Manufacturer Accord Health Care 2018	Bleomycin sulfate- Summary of Product Characteristics	2018
3646	Manufacturer Sanofi Aventis France 2013	Bléomycine sulfate (Bléomycine Bellon®) - Résumé des caractéristiques du produit	2013
3774	Manufacturer Amgen 2016	Blinatumomab - (Blincyto®) - Summary of Product Characteristics	2016
1911	Manufacturer Janssen-Cilag Ltd 2016	Bortezomib (Velcade®) - Summary of Product Characteristics	2016
3537	Journal Krankenhauspharmazie 2013 ; 34,11: 500-505.	Bortezomib zur subkutanen Applikation. Lipp HP, Gfrörer W, Riedmüller S.	2013
3495	Manufacturer Takeda 2013	Brentuximab (Adcetris®) - Summary of Product Characteristics	2013
705	Journal Am J Hosp Pharm 1981 ; 38: 183-187.	Bretylium tosylate admixture compatibility. II : Dopamine, lidocaine, procainamide, and nitroglycerin. Lee YC, Malick W, Amann AH, Baaske DM, Shah JJ, Wagenknecht DM, Carter JE.	1981
743	Journal Am J Hosp Pharm 1980 ; 37: 803-808.	Bretylium tosylate intravenous admixture compatibility. I: Stability in common large-volume parenteral solutions. Lee YC, Baaske DM, Amann AH, Carter JE, Mooers MA, Wagenknecht DM, Lai CM.	1980
2878	Journal Can J Hosp Pharm 2009 ; 62, 5: 375-380.	Buffered Lidocaine Hydrochloride Solution With and Without Epinephrine: Stability in Polypropylene Syringes. Pascuet E, Donnelly RF, Garceau D, Vaillancourt R.	2009
3653	Manufacturer Laboratoire Léo 2013	Bumétanide (Burinex®) - Résumé des caractéristiques du produit	2013
3684	Manufacturer Laboratoire Léo 2012	Bumétanide (Burinex®) - Résumé des caractéristiques du produit	2012
181	Journal Med Sci Monit 2015 ; 21:1138-1145.	Butorphanol and Ketamine Combined in Infusion Solutions for Patient-Controlled Analgesia Administration: A Long-Term Stability Study. Fuchao Chen, Hui Xiong, Jinguo Yang, Baoxia Fang, Jun Zhu, Benhong Zhou.	2015
3237	Manufacturer Sanofi Aventis France 2011	Cabazitaxel (Jevtana®) - Résumé des caractéristiques du produit.	2011
3644	Manufacturer Hameln Pharmaceuticals 2010	Calcium gluconate® - Summary of Product Characteristics	2010
4689	Journal Braz J Pharm Sci 2022 ;58: e19175	Captopril oral solution for pediatric use: formulation, stability study and palatability assessment in vivo. Dysarz L.P, Tavares M, Viçosa A.L, Ribeiro M.F, Teixeira R.G.S, Elias S.C, Márcio R. M.	2022
4345	Journal Pharmaceutical Technology in Hospital Pharmacy 2019	Carbidopa Capsules for Insulinoma Diagnostic: Compounding and Stability Study. Curti C, Mathias F, Savelli M, Garrigue P, Lamy E, Guillet B, Vanelle P.	2019
2253	Journal J Synchrotron Rad 2001 ; 8: 716-718.	Carboplatin and oxaliplatin decomposition in chloride medium, monitored by XAS. Curis E, Provost K, Bouvet D, Nicolis I, Crauste-manciet S, Brossard D, B?nazeth S.	2001
2254	Journal New J Chem 2000 ; 24: 1003-1008.	Carboplatin decomposition in aqueous solution with chloride ions monitored by X-ray absorption spectroscopy. Curis E, Provost K, Nicolis I, Bouvet D, B?nazeth S, Crauste-Manciet S, Brion F, Brossard D.	2000
3348	Manufacturer Amgen 2016	Carfilzomib (Kyprolis®) - Résumé des caractéristiques du produit	2016
3314	Manufacturer Bristol Myers Squibb 2011	Carmustine (Bicnu®) – Résumé des caractéristiques du produits	2011
3167	Journal Farm Hosp 2010 ;34:293-7.	Carvedilol stability in paediatric oral liquid formulations. Buontempo F, Bernabeu E, Glisoni RJ, Quiroga E, Bregni C, Chiappetta DA.	2010
4067	Journal Pharmazie 2017 ;72:197-199	Caspofungin infusion solutions (50 mg/mL): chemical stability and antifungal activity against Candida spp. Pinder N, Pelzl L.H; Walther G, Backhaus J, Kurzai O, Hoppe-Ticky T.	2017
1519	Manufacturer Merck Sharp Dohme 2015	Caspofungine (Cancidas®) - Summary of Product Characteristics	2015
2343	Manufacturer Fresenius Biotech 2009	Catumaxomab (Removab®)	2009
3546	Manufacturer Panpharma SA 2007	Cefamandole Flavelab - Résumé des caractéristiques du produit	2007
1479	Journal Krankenhauspharmazie 1995 ; 1: 9-12.	Cefamandolnafat und metronidazol. Chemische stabilität in einer mischung zur intravenösen infusion. Digel S.	1995
3548	Manufacturer Bristol Myers Squibb 2007	Cefepime (Maxipime®) - Summary of Product caracteristics.	2007
2093	Manufacturer Shionogi B.V. 2020	Cefiderocol (Fetcroja®)- Summary of Product Characteristics	2020
3544	Manufacturer Pfizer 2006	Cefoperazone (Cefobid®) - Summary of Product Characteristics	2006
1206	Journal Am J Hosp Pharm 1983 ; 40: 564.	Cefoperazone-aminoglycoside incompatibility. Frear RS.	1983
3677	Manufacturer Sanofi Aventis France 2008	Cefpirome (Cefrom®) - Résumé des caractéristiques du produit	2008
2902	Manufacturer Forrest Pharmaceuticals 2015	Ceftazidime - avibactam (Avycaz®) - Summary of Product Characteristics	2015
3883	Manufacturer Arrow 2016	Ceftazidime - Résumé des caractéristiques du produit	2016
273	Journal Am J Health-Syst Pharm 1996 ; 53: 1302-1305.	Ceftazidime degradation rates for predicting stability in a portable infusion-pump reservoir. Van Doorne V, Bernaards J, DeJonge P.	1996
697	Journal Can J Hosp Pharm 1988 ; 41: 65-71.	Ceftazidime stability in normal saline and dextrose in water. Walker SE, Dratnitsaris G.	1988
3543	Manufacturer Wockhardt 2013	Ceftazidime – Summary of Product Characteristics	2013
4650	Manufacturer Advanz Pharma 2021	Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021.	2021
3803	Manufacturer Laboratoires Merck Sharp & Dohme Chibret 2020	Ceftolozane / tazobactam (Zerbaxa®) - Summary of Product Characteristics	2020
3828	Poster ASHP Midyear 2015	Ceftozolane/tazobactam physical compatibility during simulated Y-site administration. Thabit A.K, Hamada Y, Nicolau D.P.	2015
3523	Manufacturer Roche 2018	Ceftriaxone (Rocephin®) - Summary of Product Characteristics.	2018
2302	Manufacturer Lettre AFFSAPS 30 November 2008 2008 ; 61, 5: 356-357.	Ceftriaxone et incompatibilités physico-chimiques, particulièrement avec les solutions contenant des sels de calcium.	2008
3687	Manufacturer Stravencon 2013	Cefuroxime sodium - Summary of Product Characteristics	2013
275	Journal Am J Health-Syst Pharm 1996 ; 53: 1461-1462.	Cephalosporin-pentamidine isethionate incompatibilities. Lewis JD, El-Gendy A.	1996
674	Journal Can J Hosp Pharm 1992 ; 45: 237-242.	Cephalotin stability in normal saline, five percent dextrose in water, and Dianeal* solutions. Walker SE, Paton TW, Oreopoulos DG.	1992
2220	Manufacturer Merck Serono 2015	Cétuximab (Erbitux®) - Dossier scientifique	2015
2389	Journal Am J Health-Syst Pharm 2003 ; 60: 69-74.	Characterization of an extemporaneous liquid formulation of lisinopril Thompson KC, Zhao Z, Mazakas JM, Beasley CA, Reed RA, Moser CL.	2003
410	Journal Am J Hosp Pharm 1991 ; 48: 1500-1506.	Characterization of cisplatin degradation as affected by pH and light. Zieske PA, Koberda M, Hines JL, Knight CC, Sriram R, Raghavan NV, Rabinow BE.	1991
2723	Journal J Ped Hematol Oncol 2004 ; 26: 179-184.	Chemical and functional analysis of hydroxyurea oral solutions. Heeney MM, Whorton MR, Howard TA.	2004
3898	Journal EJHP 2016 ;23:288-293	Chemical and microbiological stability studies of an aqueous solution of pravastatin sodium salt for drug therapy of the dysphagic patients Bonacucina G, Logrippo S, Cespi M, Ganzetti R, Casettari L, Sestili M, Perinelli D.R, Ricciutelli M, Marziali A, Polidori C, Pa	2016
3622	Journal Int J Pharm Compound 2014 ; 18, 2 : 152-158.	Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride. Weeks Phillip A, Teng Yang, Wu Lei, Sun Mary, Yang Zhen, Chow Diana S-L.	2014
2803	Journal Respiratory Care 2008 ; 683, 12: 1716-1722.	Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium or acetylcysteine sodium. Bonasia PJ, McVicar WK, Williams B, Ong S.	2008
2201	Journal EJHP Science 2007 ; 13, 3: 55-59.	Chemical and physical stability of dexrazoxane, diluted with Ringer's lactate solution, in polyvinyl and polyethylene containers. Kaiser J.D, Vigneron J, Zenier H, May I, Demor? B.	2007
2188	Journal EJHP Science 2007 ; 13, 2: 40-47	Chemical and physical stability of diluted busulfan infusion solutions. Karstens A, Krämer I.	2007
482	Journal J Parenter Sci Technol 1991 ; 45: 108-112.	Chemical and physical stability of etoposide and teniposide in commonly used infusion fluids. Beijnen JH, Beijnen-Bandhoe U, Dubbelman AC, Van Gijn R, Underberg WJM.	1991
436	Journal Am J Hosp Pharm 1991 ; 48: 2635-2637.	Chemical and visual stability of amphotericin B in 5% dextrose injection stored at 4°C for 35 days. Mitrano FP, Outman WR, Baptista RJ, Palombo JD.	1991
903	Journal J Parenter Sci Technol 1993 ; 47: 35-39.	Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration. Inagaki K, Gill MA, Okamoto MP, Takagi J.	1993
4428	Journal J Pediatr Pharmacol Ther 2004 ; 9, 2: 126-132.	Chemical Compatibility of Depacon® with Medications Frequently Administered by Intravenous Y-Site Delivery in Patients with Epilepsy or Head Trauma. Rashed S.M, Sweatman T.W, Thoma L, Hovinga C.A, Phelps S.J.	2004
380	Journal Crit Care Med 1995 ; 23: 1061-1066.	Chemical compatibility of inotropic and vasoactive agents delivered via a multiple line infusion system. Grillo JA, Gonzalez ER, Ramaiya A, Karnes HT, Wells B.	1995
1730	Journal Act Pharm Nord 1991 ; 3: 251.	Chemical compatibility of mitoxantrone and etoposide (VP-16). Björkman S, Roth B.	1991
1461	Journal J Pharm Pharmacol 1994 ; 46: 951-955.	Chemical incompatibility between procainamide hydrochloride and glucose following intravenous admixture. Sianipar A, Parkin JE, Sunderland VB.	1994
585	Journal J Clin Pharm Ther 1988 ; 13: 199-205.	Chemical stabilities of cefaperazone sodium and ceftazidime in 5% dextrose and 0.9% sodium chloride injections. Das Gupta V, Bethea C, Dela Torre M.	1988
961	Journal J Clin Pharm Ther 1990 ; 15: 187-196.	Chemical stabilities of cefuroxime sodium and metronidazole in an admixture for intravenous infusion. Barnes AR.	1990
693	Journal J Clin Pharm Ther 1988 ; 13: 329-334.	Chemical stabilities of famotidine and ranitidine hydrochloride in intravenous admixtures. Das Gupta V, Parasrampuria J, Bethea C.	1988
631	Journal J Parenter Sci Technol 1985 ; 39: 145-148.	Chemical stabilities of hydrocortisone sodium succinate and several antibiotics when mixed with metronidazole injection for intravenous infusion. Das Gupta V, Stewart KR.	1985
2986	Journal J Clin Pharm Ther 1988 ; 13: 165-169.	Chemical stabilities of isoetharine hydrochloride, metaproterenol sulphate and terbutaline sulphate after mixing with normal saline for respiratory therapy. Gupta VD, Parasrampurian J, Gardner SN.	1988
1331	Journal J Clin Hosp Pharm 1986 ; 11 : 449-452.	Chemical stabilities of lignocaine hydrochloride and phenylephrine hydrochloride in aqueous solution. Das Gupta V, Steward KR.	1986
657	Journal J Clin Pharm Ther 1996 ; 21: 173-175.	Chemical stability and adsorption of atracurium besylate injections in disposable plastic syringes. Pramar YV, Loucas VA, Word D.	1996
667	Journal J Clin Pharm Ther 1994 ; 19: 195-198.	Chemical stability and adsorption of succinylcholine chloride injections in disposable plastic syringes. Pramar YV, Moniz D, Hobbs D.	1994
2173	Journal EJHP Science 2006 ; 12, 6: 135-139.	Chemical stability and microbiological potency of intravenous vancomycin hydrochloride syringes for use in the neonatal intensive care. Grioffiths W, Favet J, Ing H, Sadeghipour F, Bonnabry P.	2006
1813	Journal Int J Pharm Compound 2003 ; 7, 4: 310-312.	Chemical stability of cefuroxime sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use. Gupta VD.	2003
2875	Journal Can J Hosp Pharm 2004 ; 57, 5: 283.287.	Chemical Stability of 4-Aminopyridine Capsules. Donnelly RF.	2004
2319	Journal EJHP Science 2009 ; 15, 1: 11-14.	Chemical stability of a solution of bupivacaine hydrochloride 0.125% and sufentanil citrate 0.5 µg/ml for filling syringes using a repeater pump. Janssen K, Wisselo R, Geerlings C, Schouten J.P.	2009
2586	Journal Br Assoc Dermatol 1998 ; 139 (suppl 52): 8-1.	Chemical stability of adepalene and tretinoin when combined with benzoyl peroxyde in presence and in absence of visible light and ultraviolet radiation. Martin B, Meunier C, Montels D.	1998
2252	Journal Neuromodulation 2007 ; 10, 1: 1-5.	Chemical stability of admixture combining ziconotide and bupivacaine during simulated intrathecal administration. Shields D, Montenegro R, Aclan J.	2007
2249	Journal Neuromodulation 2007 ; 10, 1: 12-17.	Chemical stability of admixtures combining ziconotide with baclofen during simulated intrathecal administration. Shields D, Montenegro R, Aclan J.	2007
2280	Journal Int J Pharm Compound 2008 ; 12, 5: 463-466.	Chemical stability of admixtures combining ziconotide with fentanyl or sufentanil during simulated intrathecal administration. Shields DE, Aclan J, Szatkowski A.	2008
2251	Journal Neuromodulation 2005 ; 8, 4: 257-263.	Chemical stability of admixtures combining ziconotide with morphine or hydromorphone during simulated intrathecal administration. Shields D, Montenegro R, Ragusa M.	2005
2298	Journal Int J Pharm Compound 2008 ; 12, 6: 553-557.	Chemical stability of admixtures containing ziconotide 25 mcg/ml and morphine sulfate 10 mg/ml or 20 mg/ml during simulated intrathecal administration. Shields D.E, Aclan J, Szatkowski A.	2008
647	Journal Int J Pharm Compound 1997 ; 1: 347-348.	Chemical stability of amiodarone hydrochloride in intravenous fluids. Pramar YV.	1997
2877	Journal Int J Pharm Compound 2009 ; 13, 5: 445-446.	Chemical Stability of Amitriptyline Hydrochloride in Oral Liquid Dosage Forms. Das Gupta V.	2009
2737	Journal J Pharm Pharmacol 1996 ; 48, 1: 22-26.	Chemical stability of artesunate injection and proposal for its administration by intravenous infusion. Batty KT, Ilett KF, Timothy Davis ME.	1996
3534	Journal Am J Health-Syst Pharm 2013 ; 70:2137-2142	Chemical stability of azacitidine suspensions for injection after cold-chain reconstitution of powder and storage Legeron R, Xuereb F, Djabarouti S, Saux M.C, Breilh D.	2013
3418	Journal Int J Pharm Bio Sci 2013 ; 3, 1: 449-458.	Chemical stability of bortezomib solutions in original manufacturer vial at room temperature and in syringe at 4°C. Berruezo garcia J, Espinosa Bosch M, Sanchez Rojas F, Bosch Ojeda C	2013
3349	Journal Int J Pharm Bio Sci 2012 ; 2, 3: 344-350.	Chemical stability of bortezomib solutions in original manufacturer vials. Bosch-Ojeda C, Sanchez-Rojas M.F, Espinosa-Bosch M.	2012
3180	Journal Int J Pharm Compound 2011 ; 15, 1: 78-80.	Chemical stability of brompheniramine maleate in an oral liquid dosage form. Gupta VD, Gupta VS.	2011
3086	Journal Anaesthesia 2000 ; 55, 9: 853-858.	Chemical stability of bupivacaine, lidocaine and epinephrine in pH-adjusted solutions. Robinson, J, Fernando, R, Sun Wai, W.Y., Reynolds, F.	2000
1814	Journal Int J Pharm Compound 2003 ; 7, 2: 152-154.	Chemical stability of cefazolin sodium after reconstituting in 0.9% sodium chloride injection and storage in polypropylene suyringes for padiatric use. Gupta VD.	2003
4244	Poster 2019	Chemical Stability of Cloxacillin in Sterile Water for Injection (SWFI) Stored in Polypropylene (PP) Syringes (50 and 100 mg/mL) and Glass Vials (250 mg/mL) at 4°C and 25°C. Perks W, Marchensano R, Law S, Iazetta J, Walker SE.	2019
1229	Journal Br J Pharm Pract 1990 ; 12: 53-54, 60.	Chemical stability of cytarabine and vinblastine injections. Weir PJ, Ireland DS.	1990
1372	Journal Int J Pharm Compound 2007 ; 11, 1: 79-81.	Chemical Stability of Desonide in Ear Drops. Gupta,VD.	2007
1701	Journal Int J Pharm Compound 2002 ; 6: 395-397.	Chemical stability of dexamethasone sodium phosphate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes. Gupta VD.	2002
1806	Journal Can J Hosp Pharm 2002 ; 55, 5: 307-312.	Chemical stability of dimenhydrinate in minibags and polypropylene syringes. Donnely RF.	2002
1277	Journal Can J Hosp Pharm 1999 ; 52: 150-155.	Chemical stability of diphenhydramine hydrochloride in minibags and polypropylene syringes. Donnelly RF.	1999
4393	Poster Sunnybrook Health Sciences Centre 2020	Chemical Stability of Epinephrine Diluted in 0.9% Sodium Chloride and Stored in Polypropylene (PP) Syringes at 4°C and 25°C. Hook R, Riss V, Neault A, Ma N, Law S, Walker S.E.	2020
2886	Journal Int J Pharm Compound 2009 ; 13, 3: 250-253.	Chemical Stability of Extemporaneously Compounded Omeprazole Formulations: A methods of compounding. Garg S, Svirskis D, Al-Kabba M, Farhan S, Komeshi M, Lee J, Liu Q, Naidoo S.	2009
4418	Journal J Pediatr Pharmacol Ther 2004 ; 9, 4: 254-258.	Chemical Stability of Extemporaneously Prepared Lorazepam Suspension at Two Temperatures. Ellaria Lee W-M, Lugo R.A, Rusho W.J, MacKay M, Sweeley J.	2004
2031	Journal Int J Pharm Compound 2005 ; 9: 482-483.	Chemical stability of fentanyl in polypropylene syringes and polyvinylchloride bags. Donnelly RF.	2005
1680	Journal Int J Pharm Compound 2002 ; 6: 468-470.	Chemical stability of furosemide in minibags and polypropylene syringes. Donnelly RF.	2002
2367	Journal Int J Pharm Compound 2005 ; 9, 5: 399-401.	Chemical stability of hydralazine hydrochloride after reconstitution in 0.9% sodium chloride injection or 5% dextrose injection for infusion. Gupta V.D.	2005
2835	Journal Int J Pharm Compound 2007 ; 11, 3: 259-261.	Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents Das Gupta V.	2007
2659	Journal Int J Pharm Compound 2010 ; 14, 2: 160-164.	Chemical stability of hydromorphone hydrochloride in patient-controlled analgesia injector. Khondkar D, Chopra P, McArter JP, Rosen JA, Li SK.	2010
2837	Journal Int J Pharm Compound 2005 ; 9, 2: 165-166.	Chemical Stability of Isoniazid in an Oral Liquid Dosage Form Das Gupta V, Sood A.	2005
1750	Journal Int J Pharm Compound 1998 ; 2: 463-465.	Chemical stability of meperidine hydrochloride in polypropylene syringes. Donelly RF, Bushfield TL.	1998
2843	Journal Int J Pharm Compound 2004 ; 8, 6: 489-491.	Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink Donnelly R.	2004
1627	Journal Int J Pharm Compound 2001 ; 5: 148-150.	Chemical stability of methylprednisolone sodium succinate after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes. Das Gupta V.	2001
1957	Journal Int J Pharm Compound 2005 ; 9, 1: 72-74.	Chemical stability of metoclopramide hydrochloride injection diluted with 0.9% sodium chloride injection in polypropylene syringes at room temperature. Gupta VD.	2005
2376	Journal J Sep Sci 2007 ; 30, 12: 1233-1238.	Chemical stability of midazolam injection by high performance liquid chromatography. de Diego M, Godoy G, Mennikent S.	2007
3998	Journal Int J Pharm Compound 2017 ; 21:4 :347-351	Chemical Stability of Morphine, Ropivacaine, and Ziconotide in Combination for Intrathecal Analgesia. Robert J, Sorrieul J, Rossignol E, Beaussart H, Kieffer H, Folliard C, Dupoiron D, Devys C.	2017
154	Journal Pharm Res 1990 ; 7: 452-460.	Chemical stability of pentostatin (NSC-218321), a cytotoxic and immunosuppressant agent. Al-Razzak LA, Benedetti AE, Waugh WN, Stella VJ.	1990
3278	Journal Int J Pharm Compound 2012 ; 16, 1: 80-81.	Chemical Stability of Pentoxifylline in a Topical Cream. Gupta Vishnu D	2012
2849	Journal Int J Pharm Compound 2005 ; 9, 6: 484-486.	Chemical Stability of Perphenazine in Oral Liquid Dosage Forms Das Gupta V.	2005
1631	Journal Int J Pharm Compound 2008 ; 12, 4: 372-374.	Chemical stability of perphenazine in two commercially available vehicles for oral liquid dosage forms Gupta VD.	2008
1891	Journal Int J Pharm Compound 2004 ; 8, 2: 153-155.	Chemical stability of phenylephrine hydrochloride after reconstitution in 0.9% sodium chloride injection for infusion. Gupta VD.	2004
2876	Journal Int J Pharm Compound 2009 ; 13, 5: 438-439.	Chemical Stability of Scopolamine Hydrobromide Nasal Solution. Das Gupta V.	2009
684	Journal Ann Pharmacotherapy 1990 ; 24: 1056-1058.	Chemical stability of suramin in commonly used infusion fluids. Beijnen JH, Van Gijn R, Horenblas S, Underberg WJM.	1990
3835	Journal Current Ther Res 2015 ; 77: 99-104.	Chemical Stability of Telavancin in Elastomeric Pumps. Sand P, Aladeen T, Kirkegaard P, LaChance D, Slover C.	2015
1933	Journal Int J Pharm Compound 2004 ; 8, 5: 404-406.	Chemical stability of terbutaline sulfate injection after diluting with 0.9% sodium chloride injection when stored at room temperature in polyvinyl chloride bags. Gupta VD.	2004
1827	Journal J Parenter Sci Technol 1990 ; 44: 332-335.	Chemical stability of the antitumor mitomycin C in solutions for intravesical instillation. Beijnen JH, Van Gijn R, Underberg WJM.	1990
381	Journal J Parenter Sci Technol 1993 ; 47: 166-171.	Chemical stability of the cardioprotective agent ICRF-187 in infusion fluids. Beijnen JH, Van Gijn R.	1993
527	Journal J Clin Pharm Ther 1987 ; 12: 339-342.	Chemical stability of thiopental sodium injection in disposable plastic syringes. Das Gupta V, Neal Gardner S, Jolowsky CM, Newcomer DR, Stewart KR.	1987
172	Journal J Parenter Sci Technol 1992 ; 46: 111-116.	Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids. Beijnen JH, van Gijn R, Challa EE, Kaijser GP, Underberg WJM.	1992
2248	Journal Neuromodulation 2007 ; 10, 1: 6-11.	Chemical stability of ziconotide-clonidine hydrochloride admixtures with and without morphine sulfate during simulated intrathecal administration. Shields D, Montenegro R.	2007
4412	Journal J Pediatr Pharmacol Ther 2014 ;19,1:25–29.	Chiral Stability of an Extemporaneously Prepared Clopidogrel Bisulfate Oral Suspension. Tynes C.R, Livingston B, Patel H, Arnold J.J.	2014
3326	Journal J Pharm Pract and Res 2012 ; 42, 2: 106-110.	Chiral stability study of oral liquid clopidrogel formulations for infants. Mihaila B, Ellis D, Rozek T, Milne R.	2012
3507	Manufacturer AbbVie 2013	Chirocaine - Summary of Product Characteristics	2013
2199	Manufacturer Mundipharma 2007	Chlorhydrate d'oxycodone (Oxynorm®)– Résumé des caractéristiques du produits	2007
3596	Manufacturer Sanofi 2014	Chlorpromazine (Largactil®) - Summary of Product Characteristics	2014
3520	Manufacturer Sanofi 2011	Cidomycin - Summary of product Chracteristics.	2011
3592	Manufacturer Sandoz 2008	Cimetidine - Résumé des caractéristiques du produit	2008
1201	Journal Am J Hosp Pharm 1981 ; 38: 1919-1922.	Cimetidine hydrochloride compatibility III: Room temperature stability in drug admixtures. Yuhas EM, Lofton FT, Rosenberg HA, Mayron D, Baldinus JG.	1981
1203	Journal Am J Hosp Pharm 1981 ; 38: 1173-1174.	Cimetidine hydrochloride compatibility with preoperative medications. Yuhas EM, Lofton FT, Baldinus JG, Mayron D.	1981
747	Journal Am J Hosp Pharm 1980 ; 37: 390-392.	Cimetidine hydrochloride compatibility. I: Chemical aspects and room temperature stability in intravenous infusion fluids. Rosenberg HA, Dougherty JT, Mayron D, Baldinus JG.	1980
268	Journal Am J Health-Syst Pharm 1996 ; 53: 1850-1851.	Ciprofloxacin and sodium phosphate not compatible during actual Y-site injection. Benjamin BE.	1996
1393	Journal Pharm J 1987 ; 238: 290.	Ciprofloxacin lactate infusion. Lyall D, Blythe J.	1987
3529	Manufacturer Hospira 2013	Ciprofloxacin – Summary of Product Characteristics	2013
1500	Journal Ann Pharmacotherapy 1996 ; 30: 87.	Ciprofloxacin-ampicillin sulbactam incompatibility. Melonakos TK.	1996
3601	Manufacturer Actavis 2012	Cisatracurium Actavis - Résumé des Caractéristiques du Produit	2012
4769	Journal Pharmaceutics 2023 ;15,1404	Cisatracurium Besylate 10 mg/mL Solution Compounded in a Hospital Pharmacy to Prevent Drug Shortages : A Stability Study Involving Four Degradation Products. Roche M, Danel C, Simon N, Kouach M, Bouchfaa M, Berneron C, Odou P, Lannoy D.	2023
3578	Manufacturer Accord Healthcare 2011	Cisplatin - Summary of Product Characteristics	2011
4084	Manufacturer Accord Health Care 2017	Cisplatine - Résumé des caractéristiques du produits	2017
3579	Manufacturer Janssen Cilag 2005	Cladribine Janssen Cilag - Résumé des caractéristiques du produit	2005
3526	Manufacturer Pharmacia 2010	Clindamycin (Dalacin®) - Summary of Product Characteristics	2010
2238	Manufacturer Baxter 2018	Clinomel - Résumé des caractéristiques du produit	2018
2272	Manufacturer Genzyme 2006	Clofarabine (Evoltra®) – Résumé des caractéristiques du produits	2006
4515	Journal Pharmaceutics 2020	Co-Administration of Drugs and Parenteral Nutrition: In Vitro Compatibility Studies of Loop Diuretics for Safer Clinical Practice. Tomczak S, Stawny M, Jelinska A.	2020
4178	Journal EJHP 2017 ; 25, e2	Colistin methanesulfonate infusion solutions are stable over time and suitable for home administration. Post T.E, Kamerling I, van Rossen R, Burggraaf J, Stevens J, Dijkmans A, Heijerman H, Touw D, van Velzen A, Wilms E.	2017
1974	Journal J Pain Symptom Manage 1996 ; 12, 3: 168-171.	Combined administration of opoids with selected drugs to manage pain and other cancer symptoms initial safety screening for compatibility. Chandler SW, Trissel LA, Weinstein SM	1996
1978	Journal Clin Ther 1992 ; 14, 2: 192-195.	Comparative sorption of clomipramine, viloxazine and maprotiline hydrochlorides in polyvinylchloride bags and glass vials. Airaudo C, Bianchi C, Verdier M, Gayte-Sorbier A.	1992
4317	Journal J Pharm Technol 2019 ;35,3:105-109	Comparative Stability of Oral Vitamin K Liquids Stored in Refrigerated Amber Plastic Syringes. Lawson S, Lewis P, Peacock G, Brown S.	2019
4140	Journal Int J Pharm Compound 2018 ;22,4:340-344	Comparative Stability of Vitamin K1 Oral Liquids Prepared in Sterile Water for Injection and Stored in Amber Glass Bottles and Amber Plastic Syringes. Huffman J, Brown S, Lewis P, Lawson S, Ogle A, Peacock G.	2018
2042	Journal Antimicrob Agents Chemother 2002 ; 46: 2327-2332.	Comparative stability studies of antipseudomonal ß-lactams for potential administration through portable elastomeric pumps (home therapy for cystic fibrosis patients) and motor-operated syringes (intensive care units). Viaene E, Chanteux H, Servais H, Mingeot-Leclerq MP, Tulkens PM.	2002
4279	Journal Bio Drugs 2019 ; 33: 193–205.	Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA). Hermosilla J, Sanchez-Martin R, Pérez-Robles R, Salmeron-Garcia A, Casares S, Cabeza J, Cuadros-Rodriguez L, Navas N.	2019
1651	Journal J Clin Pharm Ther 2002 ; 27: 205-209.	Comparison of ceftazidime degradation in glass bottles and plastic bags under various conditions. Ars?ne M, Favetta P, Favier B, Bureau J.	2002
1246	Journal Pharm Weekbl [Sci] 1990 ; 12: 188-189.	Comparison of clonazepam sorption to polyvinyl chloride-coated and polyethylene-coated tubings. Hooymans PM, Janknegt R, Lohman JJHM.	1990
4642	Poster SEFH Congress (Virtual) October 2021 2021	Compatibilidad en Y de atosiban y farmacois habitualmente utilizados en obstetricia. Larossa garcia M, Jimenez-Lozano I, Boix-Montanés A, Mallandrich Miret M, Clemente Bautista M, cabanas Poy M.J., Gorgas Torner	2021
3464	Journal Enferm Clin 2011 21:25-29.	Compatibilidad física de la amiodarona en perfusión continua Monica Maqueda-Palau, Eva Pérez-Juan, Maria Josep Arévalo-Rubert, Sylvia Monica Amoros-Cerda, Bàrbara Ribas-Nicolau.	2011
3466	Journal Enferm Intensiva 2011 ;22:78-82.	Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos B. Ribas Nicolau, E. P?rez Juan, S.M. Amor?s Cerd?, M.J. Ar?valo Rubert, M. Maqueda Palau.	2011
3212	Journal Enferm Intensiva 2011 ;22:78-82.	Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos. Ribas Nicolau, B.; P?rez Juan, E.; Amor?s Cerd?, S.M.; Ar?valo Rubert, M.J.; Maqueda Palau, M.	2011
3134	Journal Enferm Intensiva 2010 ; 21: 96-103.	Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua. Perez Jua En, Maqueda Palau M, Arévalo Rubert Mt, Ribas Nicolau B, Amoros Cerdà SM.	2010
3465	Journal Enferm Intensiva 2010 ;21:96-103.	Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua. E. P?rez Juan, M. Maqueda Palau, M. Ar?valo Rubert, B. Ribas Nicolau, S.M. Amor?s Cerd?.	2010
4332	Poster JFSPH 2019 2019	Compatibilité de Glycophos® avec d’autres médicaments administrés en perfusion aux soins intensifs (SI). Compatibilité de Glycophos® avec d’autres médicaments administrés en perfusion aux soins intensifs (SI)	2019
2109	Journal Pharmactuel 2006 ; 39: 71-75.	Compatibilité de la kétamine injectable lors de l’administration en dérivé avec d’autres médicaments usuels. Pelletier E, Forest JM, Hildgen P.	2006
3766	Journal Pharmactuel 2014 ; 47, 3 : 161-165.	Compatibilité de l’acétylcystéine injectable lors de son administration en Y avec d’autres médicaments usuels Forrest J.M, Hildgen P.	2014
3964	Journal Pharmactuel 2017 ; 50,1 : 27-33.	Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments. Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G.	2017
3176	Poster 16èmes JFSPH, Sion, 18-19 novembre 2010	Compatibilité du Remifentanil avec d'autres médicaments injectables : influence du soluté. Humbert Delaloye V, Berger M, Voirol P, Pannatier A.	2010
2879	Poster GSASA Congress - Lucerne - Switzerland 2008	Compatibilité entre amiodarone, catecholamines et/ou nitroprussiate de sodium, administré en continu par voie veineuse aux soins intensifs adultes. Imesch G., Humbert-Delaloye V., Berger M., Pannatier A.	2008
1909	Journal J Pharm Clin 2000 ; 19: 248-251.	Compatibilité et stabilité du mélange bupivacaïne-sufentanil en poche. Farhang-Asnefi S, Barre J, Callaert S, Boutros A, Causse R, Thebault A.	2000
3767	Journal Pharmactuel 2014 ; 47, 3 : 167-172.	Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels. Legris M.E, Lavoie A, Forrest J.M, Hildgen P.	2014
4742	Journal Pharmactuel 2022 ; 55, 4: 247-255.	Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y. Macoviciuc M, Nguyen C, Forest J-M, Leclair G.	2022
3823	Journal Pharmactuel 2015 ; 48, 3 : 146-152.	Compatibilité physique de médicaments administrés dans l’unité de soins intensifs Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R.	2015
4389	Journal Pharmactuel 2019 ;52,4:206-213	Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine. Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G.	2019
3985	Poster Hopipharm Congress 2017 - Nancy 2017	Compatibilité physique entre médicaments injectables et nutrition parentérale pédiatrique : Evaluation in-vitro. Manai M., Soussi M.A., Lazreg O., Drira C., Ben Tekaya S. et Razgallah Khrouf M.	2017
3216	Journal Pharmactuel 2011 ; 44, 1 : 14-18	Compatibilité physique par évaluation visuelle du salbutamol injectable lors de son administration en Y. Legris ME, Valiquette ME, Lavoie A, Forest JM, Leclair G.	2011
4354	Poster GERPAC Congress 2019 2019	Compatibilité visuelle du Vyxeos lors d'administration en Y avec une sélection de médicaments injectables. Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R.	2019
4654	Poster Communication personnelle 2021	Compatibilité visuelle du Vyxeos® lors d'administration en Y avec une sélection de médicaments injectables. Sicard G, Donnette M, Martin N, Gensollen S, Pourroy B, Fanciullino R.	2021
3177	Poster 16èmes JFSPH, Sion, 18-19 novembre 2010 2010	Compatibilités physico-chimique entre catécholamines, amiodarone, et/ou nitroprussiate de sodium intraveineux. Humbert-Delaloye V, Berger M, Pannatier A.	2010
36	Journal Am J Health-Syst Pharm 1995 ; 52: 2423-2426.	Compatibility and activity of aldesleukin (recombinant interleukin-2) in presence of selected drugs during simulated Y-site administration: Evaluation of three methods. Alex S, Gupta SL, Minor JR, Turcovski-Corrales S, Gallelli JF, Taub D, Piscitelli SC.	1995
311	Journal Am J Health-Syst Pharm 1996 ; 53: 167-169.	Compatibility and activity of enoxaparin sodium in 0.9% sodium chloride injection for 48 hours. Newborn AL, Kessler JM, Joyner KA.	1996
3498	Journal Ann Pharmacotherapy 2008 ; 42, 10: 1416-1424.	Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions. Akapo S, Gupta J, martinez E, Mccrea C, Ye L, Roach M	2008
2787	Journal Am J Health-Syst Pharm 2005 ; 62, 8: 828-833.	Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium. Lee TY, Chen CM, Lee CN, Chaing YC.	2005
310	Journal Am J Hosp Pharm 1991 ; 48: 510-514.	Compatibility and pH variability of four injectable phenytoin sodium products. Markowsky SJ, Kohls PR, Ehresman D, Leppik I.	1991
1932	Journal Int J Pharm Compound 2004 ; 8,5: 398-403.	Compatibility and stability of Aloxi (palonosetron hydrochloride) admixed with dexamethasone sodium phosphate. Trissel LA, Zhang Y.	2004
284	Journal Am J Health-Syst Pharm 1995 ; 52: 2560-2564.	Compatibility and stability of aztreonam and vancomycin hydrochloride. Trissel LA, Xu QA, Martinez JF.	1995
3159	Journal Acta Anaesthesiol Taiwan 2010 ; 48, 3 : 117-121.	Compatibility and stability of binary mixtures of ketorolac tromethamine and tramadol hydrochloride injection concentrate and diluted infusion solution. Lin, T.-F., Lin, F.-S., Chou, W.-H., Yeh, Y.-C., Lin, C.-P., Fan, S.-Z., Sun, W.-Z.	2010
695	Journal Drug Intell Clin Pharm 1988 ; 22: 873-875.	Compatibility and stability of cefazolin sodium, clindamycin phosphate, and gentamicin sulfate in two intravenous solutions. Zbrozek AS, Marble DA, Bosso JA.	1988
3125	Journal Int J Pharm Compound 2010 ; 14, 4: 346-349.	Compatibility and Stability of Cefotaxine, Vancomycin, and Ciprofloxacin in Antibiotic Lock Solutions Containing Heparin. Baker D S, Waldrop Bruce, Arnold John.	2010
1943	Journal Am J Health-Syst Pharm 2004 ; 61: 1924-1927.	Compatibility and stability of ceftazidime sodium and tenoxicam in 5% dextrose injection. Wang DP, Chiou AHJ, Lee DKT.	2004
639	Journal Drug Intell Clin Pharm 1987 ; 21: 806-810.	Compatibility and stability of clindamycin phosphate - aminoglycoside combinations within polypropylene syringes. Zbrozek AS, Marble DA, Bosso JA, Bair JN, Townsend RJ.	1987
566	Journal Am J Hosp Pharm 1983 ; 40: 91-94.	Compatibility and stability of clindamycin phosphate with intravenous fluids. Porter WR, Johnson CA, Cohon MS, Gillespie W.	1983
2022	Journal J Pain Symptom Manage 2005 ; 30: 80-86.	Compatibility and stability of dexamethasone sodium phosphate and ketamine hydrochloride subcutaneous infusions in polypropylene syringes. Watson DG, Lin M, Morton A, Cable CG, McArthur DA.	2005
4431	Journal Medicine 2018 ; 97:50(e13698)	Compatibility and stability of dezocine and tropisetron in 0.9% sodium chloride injection for patient-controlled analgesia administration. Chen P, Chen F, Zhou B-H.	2018
731	Journal Am J Hosp Pharm 1978 ; 35: 669-672.	Compatibility and stability of diazepam injection following dilution with intravenous fluids. Morris ME.	1978
1058	Journal Am J Hosp Pharm 1983 ; 40: 1690-1691.	Compatibility and stability of dobutamine hydrochloride with large-volume parenterals and selected additives. Kirschenbaum HL, Aronoff W, Piltz GW, Perentesis GP, Cutie AJ.	1983
1405	Journal J Clin Pharm Ther 1998 ; 23: 67-72.	Compatibility and stability of fentanyl admixtures in polypropylene syringes. Peterson GM, Miller KA, Galloway JG, Dunne PF.	1998
2205	Journal Arzneimittel Forschung 2006 ; 56, 10: 714-720.	Compatibility and stability of furosemide and dexamethasone combined in infusion solutions. Negro S, Rendon AL, Azuara ML, S?nchez Y, Fern?ndez-Carballido A, Barcia E.	2006
29	Journal J Pharm Sci 1995 ; 84: 267-268.	Compatibility and stability of granisetron, dexamethasone, and methylprednisolone in injectable solutions. Pinguet F, Rouanet P, Martel P, Fabbro M, Salabert D, Astre C.	1995
9	Journal Can J Hosp Pharm 1992 ; 45: 187-192.	Compatibility and stability of hyaluronidase and hydromorphone. Walker SE, Lau DWC.	1992
1194	Journal Am J Hosp Pharm 1983 ; 40: 1007-1009.	Compatibility and stability of labetolol hydrochloride in commonly used intravenous solutions. Yuen PHC, Taddei CR, Wyka BE, Chaudry IA.	1983
1658	Journal J Am Pharm Assoc 2000 ; 40: 520-524.	Compatibility and stability of linezolid injection admixed with aztreonam or piperacillin sodium. Zhang Y, Xu QA, Trissel LA, Willimas KY.	2000
1659	Journal J Am Pharm Assoc 2000 ; 40: 509-514.	Compatibility and stability of linezolid injection admixed with three cephalosporin antibiotics. Xu QA, Trissel LA, Williams KY.	2000
1668	Journal Ann Pharmacotherapy 2000 ; 34: 996-1001.	Compatibility and stability of linezolid injection admixed with three quinolone antibiotics. Zhang Y, Xu QA, Trissel LA, Williams KY.	2000
2353	Journal Int J Pharm Compound 2000 ; 4, 6: 476-479.	Compatibility and stability of linezolid injection admixted with gentamicin sulfate and tobramycin sulfate. Xu Q.A, Trissel L.A, Zhang Y, Williams K.Y.	2000
4034	Journal Afr J Pharm Pharmacol 2012 ;27,6:2055-2060	Compatibility and stability of lornoxicam with morphine, tramadol or fentanyl in infusion solutions. Chen F-C, Fang B-X, Li P, Zheng F, Shi X-Y.	2012
1866	Journal Int J Pharm 1998 ; 174: 157-177.	Compatibility and stability of morphine in binary admixtures with haloperidol, midazolam, dexamethasone or methylprednisolone. Vermeire A, Remon JP.	1998
3434	Journal Can J Hosp Pharm 2013 ; 66, 3 : 167-170.	Compatibility and Stability of Morphine Sulphate and Naloxone Hydrochloride in 0.9% Sodium Chloride for Injection. Kistner C, Ensom M.H.H, Decarie D, Lauder G, Carr R.R.	2013
4310	Journal Kaohsiung J Med Sci 2017 ; 63, 1: E9-E16.	Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs. Mizuta N, Nakagawa T, Yamamoto K, Nishioka T, Kume M, Makimoto H, Yano I, Minami H, Hiral M.	2017
6	Journal Am J Hosp Pharm 1994 ; 51: 2138-2142.	Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22 and 32°C. Trissel LA, Xu QA, Martinez JF, Fox JL.	1994
25	Journal Am J Hosp Pharm 1993 ; 50: 1410-1414.	Compatibility and stability of ondansetron hydrochloride, dexamethasone, and lorazepam in injectable solutions. McGuire TR, Narducci WA, Fox JL.	1993
872	Journal Ann Pharmacotherapy 1997 ; 31: 1465-1470.	Compatibility and stability of paclitaxel combined with cisplatin and with carboplatin in infusion solutions. Zhang YP, Xu QA, Trissel LA, Gilbert DL, Martinez F.	1997
1286	Journal Ann Pharmacotherapy 1998 ; 32: 1013-1016.	Compatibility and stability of paclitaxel combined with doxorubicin hydrochloride in infusion solutions. Trissel LA, Xu QA, Gilbert DL.	1998
2312	Journal Int J Pharm Compound 2009 ; 13, 1: 78-80.	Compatibility and stability of palonosetron hydrochloride and propofol during simulated Y-site administration. Trissel L.A, Trusley C, Kupiec T.C, Ben M.	2009
2227	Journal Int J Pharm Compound 2008 ; 12, 2: 156-160.	Compatibility and stability of palonosetron hydrochloride with four neuromuscular blocking agents during simulated Y-site administration. Trusley C, Ben M, Kupiec TC, Trissel LA.	2008
2228	Journal Int J Pharm Compound 2008 ; 12,2: 170-173.	Compatibility and stability of palonosetron hydrochloride with gentamicin, metronidazole, or vancomycin during simulated Y-site administration. Kupiec T, Ben M, Trusley C, Trissel LA.	2008
2281	Journal Int J Pharm Compound 2008 ; 12, 5: 460-462.	Compatibility and stability of palonosetron hydrochloride with lactated Ringer's, Hetastarch in lactated electrolyte, an mannitol injections during simulated Y-site administration. Ben M, Kupiec T, Trusley C, Trisel LA.	2008
3075	Journal EJHP Science 2009 ; 15, 4: 78-82.	Compatibility and stability of parenteral analgesic admixtures for multimodal analgesia Balayssac D, Badaroux L, Rodier C, Sautou-Miranda V, Bazin JE, Chopineau J.	2009
3366	Journal J Pharm Sci 2012 ; DOI 10.1002 / jps.23403	Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration. Kwong Glover Z.W, Gennaro L, Yadav S, Demeule B, Wong P.Y, Sreedhara A.	2012
925	Journal Can J Hosp Pharm 1998 ; 51: 55-57.	Compatibility and stability of propafenone hydrochloride with five critical-care medications. Dupuis LL, Trope A, Giesbrecht E, Wong B.	1998
934	Journal Int J Pharm Compound 1998 ; 2: 318-321.	Compatibility and stability of ranitidine hydrochloride with six cephalosporins during simulated Y-site administration. Inagaki K, Kambara M, Mizuno M, Okuda J, Gill MA, Nishida M.	1998
3927	Journal Int J Pharm Compound 2017 ; 21, 1 : 66-75.	Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate. Wu G,Yeung S,Chen F.	2017
3928	Journal Int J Pharm Compound 2017 ; 21, 1: 76-82.	Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride. Wu G, Yeung S, Chen F.	2017
3327	Journal Am J Health-Syst Pharm 2012 ; 69:1405-1409	Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions. LaPlante K.L, Woodmansee S, Mermel L.A.	2012
4693	Journal Drug Design Dev Ther 2022 ;16:1433-1440.	Compatibility and Stability of Ten Commonly Used Clinical Drugs in Pediatric Electrolyte Supplements Injection. Shen H, Fu Y, Chen Y, Xia W, Jia Z, Yu Q, Zhang L, Han L.	2022
3132	Journal J Palliat Med 2010 ; 13, 3: 273-277.	Compatibility and stability of ternary admixtures of tramadol, haloperidol, and hyoscine. Negro S, Martin A, Azuara L, Sanchez Y, Barcia E.	2010
2211	Journal J Clin Pharm Ther 2007 ; 32: 441-444.	Compatibility and stability of tramadol and dexamethasone in solution and its use in terminally ill patients. Negro S, Salama A, S?nchez Y, AzuaraM.L, Barcia B.	2007
1671	Journal Int J Pharm 1996 ; 139: 243-247.	Compatibility and stability of vancomycin hydrochloride with PVC infusion material in various conditions using stability-indicating high-performance liquid chromatographic assay. Khalfi F, Dine T, Gressier B, Luyckx M, Brunet C, Ballester L, Goudaliez F, Cazin M, Cazin JC.	1996
4061	Journal Int J Pharm Compound 2018 ; 22,1 :86-94	Compatibility and stability of VARUBI (Rolapitant) injectable emulsion admixed with intravenous granisetron hydrochloride. Wu George, Powers Dan, Yeung S, Chen F, Neelon K.	2018
4062	Journal Int J Pharm Compound 2018 ;22,1:76-85	Compatibility and stability of VARUBI (Rolapitant) injectable emulsion admixed with intravenous palonosetron hydrochloride injection and dexamethasone sodium phosphate injection. Wu George, Powers Dan, Yeung S, Chen F, Neelon K.	2018
1033	Journal Am J Health-Syst Pharm 1999 ; 56: 985-989.	Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide in 0.9% sodium chloride injection. Wolfe JL, Thoma LA, Du C, Goldspiel BR, Gallelli JF, Grimes GJ, Potti GK.	1999
1606	Journal Am J Health-Syst Pharm 2001 ; 58: 594-598.	Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate in 0.9% sodium chloride injection. Yuan P, Grimes GJ, Shankman SE, Daniels CE, Goldspiel BR, Potti GK.	2001
1325	Journal JPEN 1982 ; 6: 163-165.	Compatibility of 5-fluorouracil and total nutrition solutions. Hardin TC, Clibon U, Page CP, Cruz AB.	1982
4435	Journal Anaesthesiol Intensive Ther 2020 ; 52, 1: 23-27.	Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection. Hanifah S, Nugroho B.H, Chabib L.	2020
307	Journal Am J Hosp Pharm 1994 ; 51: 1792-1799.	Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration. Trissel LA, Martinez JF.	1994
3	Journal Am J Health-Syst Pharm 1995 ; 52: 2208-2212.	Compatibility of amifostine with selected drugs during simulated Y-site administration. Trissel LA, Martinez JF.	1995
390	Journal Am J Hosp Pharm 1986 ; 43: 1482-1485.	Compatibility of aminophylline and methylprednisolone sodium succinate intravenous admixtures. Johnson CE, Cohen IA, Craft DA, Lizer MH.	1986
364	Journal Am J Hosp Pharm 1989 ; 46: 97-100.	Compatibility of aminophylline and verapamil in intravenous admixtures. Johnson CE, Lloyd CW, Mesaros JL, Rubley GJ.	1989
1259	Journal Am J Hosp Pharm 1981 ; 38: 900-901.	Compatibility of aminophylline with hydrocortisone sodium succinate or dexamethasone sodium phosphate in 5% dextrose injection. Jhunjhunwala VP, Bhalla HL.	1981
1172	Journal Am J Hosp Pharm 1981 ; 38: 377-378.	Compatibility of amphotericin B with certain large-volume parenterals. Jurgens RW, DeLuca PP, Papadimitriou D.	1981
2900	Journal EJHP 2009 ; 15, 5: 32-38.	Compatibility of an injectable high strength oxycodone formulation with typical diluents, syringes, tubings,infusion bags and drugs for potential co-administration. Hines S, Pleasance S.	2009
2125	Journal Hospital Pharmacist 2003 ; 10: 354-361.	Compatibility of an injectable oxycodone formulation with typical diluents, syringes, tubings, infusion bags and drugs for potential co-administration. Gardiner PR.	2003
1982	Journal Am J Health-Syst Pharm 2005 ; 62: 834-837.	Compatibility of anidulafungin with other drugs during simulated Y-site administration. Trissel LA, Ogundele AB.	2005
1055	Journal Can J Hosp Pharm 1983 ; 36: 43-52.	Compatibility of antibiotics and other drugs in total parenteral nutrition solutions. Faragos S.	1983
431	Journal Am J Hosp Pharm 1975 ; 33: 1010-1013.	Compatibility of antineoplastic, antibiotic and corticosteroid drugs in intravenous admixtures. McRae MP, King JC.	1975
3019	Journal Curr Med Res Opin 2007 ; 23: 2477-2483.	Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs. Bonasia P, Cook C, Cheng Y et al.	2007
3764	Journal Am J Health-Syst Pharm 2014 2014; 71: 1831-1832.	Compatibility of argatroban injection with select antiarrhythmic drugs Jakimczuk P.J, Churchwell M.D, Howard M.S, Mauro V.F, Alexander K.S, Boddu S.H.S.	2014
2004	Journal Am J Health-Syst Pharm 2005 ; 62: 1381-1384.	Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administration. Patel K, Hursting MJ.	2005
1963	Journal Am J Health-Syst Pharm 2004 ; 61: 2415-2418.	Compatibility of argatroban with selected cardiovascular agents. Honisko ME, Fink JM, Militello MA, Mauro VF, Alexander KS.	2004
1260	Journal Am J Hosp Pharm 1981 ; 38: 871-875.	Compatibility of azathioprime sodium with intravenous fluids. Johnson CA, Porter WA.	1981
4456	Journal Scientific reports 2020 10:1788	Compatibility of aztreonam in four commercial peritoneal dialysis fluids. Tobudic S, Prager I, Kussmann M, Obermüller M, Ursli M, Zeitlinger M, Wiesholzer M, Burgmann H, Poeppl W, Reznicek G.	2020
99	Journal Am J Health-Syst Pharm 1995 ; 52: 1086-1090.	Compatibility of aztreonam with selected drugs during simulated Y-site administration. Trissel LA, Martinez JF.	1995
4177	Journal Int J Pharm Compound 2018 ;22,6:516-526	Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4. Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A.	2018
2774	Journal Ann Pharmacotherapy 2004 ; 38: 967-972.	Compatibility of Budesonide Inhalation Suspension with Four Nebulizing Solutions. McKenzie J.E, Mario Cruz-Rivera M.	2004
529	Journal Pharm Weekbl [Sci] 1991 ; 13: 254-256.	Compatibility of bupivacaine and iohexol in two mixtures for paediatric regional anaesthesia. Van Asten P, Glerum JH, Spaanderman ER, Van Niekerk J, Van Dijk A.	1991
220	Journal Am J Health-Syst Pharm 1997 ; 54: 61-64.	Compatibility of bupivacaine hydrochloride and morphine sulfate. Johnson CE, Christen C, Perez MM, Ma M.	1997
221	Journal Am J Hosp Pharm 1992 ; 49: 2149.	Compatibility of bupivacaine hydrochloride with hydromorphone hydrochloride or morphine sulfate. Neels JT.	1992
3378	Journal Am J Health-Syst Pharm 2013 ; 70:515-519.	Compatibility of butorphanol and droperidol in 0.9% sodium chloride injection Chen F-C, Fang B-X, Li P, Yang J-G, Zhou B-H.	2013
3805	Journal Am J Health-Syst Pharm 2015 ; 72:1374-1378.	Compatibility of butorphanol with granisetron in 0.9% sodium chloride injection packaged in glass bottles or polyolefin bags. Chen F.C, Xiong H, Liu H.M, Fang B.X, Li P.	2015
3910	Journal EJHP 2016 ; 23: 352-358.	Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions. Polonini H.C, Silva S .L, de Almeida T.R, Brand?o M.A, Ferreira A.O.	2016
4732	Journal Am J Health-Syst Pharm 2023 80, 3;164–170	Compatibility of calcium chloride with milrinone, epinephrine, vasopressin, and heparin via in vitro testing and simulated Y-site administration. Kenneally A, Agbana P, Gardner B, Bae Y, Mitchell T, Beckman E.	2023
2247	Journal Int J Pharm Compound 2008 ; 12, 3: 276-278.	Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration. Chan P, Heatherly K, Kupiec T.C, Trissel L.A.	2008
3542	Journal Am J Health-Syst Pharm 2015 ; 72:390-395	Compatibility of cefepime and vancomycin during simulated Y-site administration of prolonged infusion Berti A.D, Hutson P.R, Schulz L.T, Webb A.P, Rose W.E.	2015
93	Journal Am J Health-Syst Pharm 1996 ; 53: 2185-2188.	Compatibility of cefmetazole sodium with commonly used drugs during Y-site delivery. Hutchings SR, Rusho WJ, Tyler LS.	1996
79	Journal Am J Hosp Pharm 1991 ; 48: 111-113.	Compatibility of cefoperazone sodium and cimetidine hydrochloride in 5% dextrose injection. Lee DKT, Wang DP, Lee A.	1991
87	Journal Am J Hosp Pharm 1991 ; 48: 108-110.	Compatibility of cefoperazone sodium and furosemide in 5% dextrose injection. Lee DKT, Lee A, Wang DP.	1991
1670	Journal Pharmazie 1998 ; 53: 112-116.	Compatibility of cefpirome and cephalotin with PVC bags during simulated infusion and storage. Khalfi F, Dine T, Gressier B, Luyckx M, Brunet C, Ballester L, Goudaliez F, Kablan J, Cazin M, Cazin JC.	1998
3249	Journal Am J Health-Syst Pharm 2011 ; 68: 2163-2169.	Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB.	2011
900	Journal Ann Pharmacotherapy 1992 ; 26: 1221-1226.	Compatibility of ceftazidime and aminophylline admixtures for different methods of intravenous infusion. Pleasants RA, Vaughan LM, Williams DM, Fox JL.	1992
3984	Journal Hosp Pharm 2017 ,52;3 : 221-228	Compatibility of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Piperacillin-Tazobactam with Vancomycin in Dextrose 5% in Water. Meyer K, Santarossa M, Danziger L.H, Wenzler E.	2017
2269	Journal Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.	Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H.	2008
3846	Journal Pharmazie 2016 71: 185?191.	Compatibility of cholecalciferol, haloperidol, imipramine hydrochloride, levodopa/carbidopa, lorazepam, minocycline hydrochloride, tacrolimus monohydrate, terbinafine, tramadol hydrochloride and valsartan in SyrSpend® SF PH4 oral suspensions. Polonini HC, Silva SL, Cunha CN, Brand?o MAF, Ferreira AO.	2016
434	Journal Am J Hosp Pharm 1991 ; 48: 2166-2171.	Compatibility of ciprofloxacin injection with selected drugs and solutions. Goodwin SD, Nix DE, Heyd A, Wilton JH.	1991
14	Journal Am J Health-Syst Pharm 1997 ; 54: 1193-1195.	Compatibility of ciprofloxacin lactate with sodium bicarbonate during simulated Y-site administration. Gilbert DL, Trissel LA, Martinez JF.	1997
4460	Journal Scientific reports 2019 9:6512	Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions. Kussmann M, Ferth A, Obermüller M, Pichler P, Zeitlinger M, Wiesholzer , Burgmann H, Poeppl W, Reznicek G.	2019
299	Journal Am J Health-Syst Pharm 1997 ; 54: 1735-1741.	Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration. Trissel LA, Martinez JF, Gilbert DL.	1997
413	Journal Am J Hosp Pharm 1990 ; 47: 1373-1377.	Compatibility of cisplatin and fluorouracil in 0.9% sodium chloride injection. Stewart CF, Fleming RA.	1990
565	Journal Drug Intell Clin Pharm 1986 ; 20: 960-963.	Compatibility of clindamycin phosphate with amikacin sulfate at room temperature and with gentamicin sulfate and tobramycin sulfate under frozen conditions. Marble DA, Bosso JA, Townsend RJ.	1986
644	Journal Drug Intell Clin Pharm 1988 ; 22: 54-57.	Compatibility of clindamycin phosphate with aztreonam in polypropylene syringes and with cefoperazone sodium, cefonicid sodium, and cefuroxime sodium in partial-fill glass bottles. Marble DA, Bosso JA, Townsend RJ.	1988
421	Journal Am J Hosp Pharm 1985 ; 42: 839-843.	Compatibility of clindamycin phosphate with cefotaxim sodium or netilmicin sulfate in small-volume admixtures. Foley PT, Bosso JA, Bair JN, Townsend RJ.	1985
3012	Journal Hosp Pharm 2015 ; 50, 3: 214-220.	Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration Sullivan T, Forrest J.M, Leclair G.	2015
549	Journal Int J Pharm Compound 1997 ; 1: 121-122.	Compatibility of common respiratory therapy drug combinations. Owsley HD, Rusho WJ.	1997
132	Journal Am J Health-Syst Pharm 1997 ; 54: 181-184.	Compatibility of commonly used bone marrow transplant drugs during Y-site delivery. Najari Z, Rusho WJ.	1997
3715	Journal Am J Health-Syst Pharm 2014 ; 71:1534-1535	Compatibility of conivaptan injection with select cardiovascular medications. Mauro V.F, Howard M.S, Boddu S.H.S, Churchwell M.D.	2014
227	Journal Am J Hosp Pharm 1994 ; 51: 2292.	Compatibility of cyclizine lactate and haloperidol lactate. Fawcett JP, Woods DJ, Munasiri B, Becket G.	1994
3981	Journal EJHP 2017 ;24:162?166	Compatibility of dexamethasone sodium phosphate with 5-HT3 receptor antagonists in infusion solutions: a comprehensive study He G, Zeng F, Lei K, Xia S, Deng L, Zhang C, Liu D.	2017
389	Journal Am J Hosp Pharm 1991 ; 48: 2161-2166.	Compatibility of dexamethasone sodium phosphate with hydromorphone hydrochloride or diphenhydramine hydrochloride. Walker SE, DeAngelis C, Iazzetta J, Eppel JG.	1991
712	Journal Am J Hosp Pharm 1980 ; 37: 496-500.	Compatibility of diazepam with intravenous fluid containers and administration sets. Parker WA, MacCara ME.	1980
2087	Journal Pharmactuel 2004 ; 37: 17-20.	Compatibility of dimenhydrinate injectable by Y administration. Ferreira E, Forest JM, Hildgen P.	2004
250	Journal Am J Health-Syst Pharm 1997 ; 54: 566-569.	Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials. Mazzo DJ, Nguyen-Huu JJ, Pagniez S, Denis P.	1997
1754	Journal Int J Pharm Compound 1999 ; 3: 241-244.	Compatibility of docetaxel with selected drugs during simulated Y-site administration. Trissel LA, Gilbert DL, Wolkin AC.	1999
2262	Journal Am J Health-Syst Pharm 2008 ; 65: 1261-1265.	Compatibility of doripenem with other drugs during simulated Y-site administratioN Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.	2008
251	Journal Am J Health-Syst Pharm 1997 ; 54: 2708-2713.	Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration. Trissel LA, Gilbert DL, Martinez JF.	1997
1897	Journal EJHP 2001 ; 7, 3: 108-115.	Compatibility of doxorubicin, daunorubicin and epirubicin with low-density polyethylene and polyvinyl chloride, and stability in various conditions of storage. Sautou-Miranda V, Brigas F, Thibault M, Chopineau J.	2001
789	Journal Am J Hosp Pharm 1990 ; 47: 604-606.	Compatibility of drugs separated by a fluid barrier in a retrograde intravenous infusion system. Garner SS, Wiest DB.	1990
963	Journal J Clin Pharm Ther 1990 ; 15: 371-376.	Compatibility of enalaprilat with dobutamine, dopamine, heparin, nitroglycerin, potassium chloride and nitroprusside. Schaaf LJ, Tremel LC, Wulf BG, Vernon KK.	1990
3708	Poster ECOP 2 Krakow 2014	Compatibility of epirubicin-loaded DC Beads with different contrast media. Sarakbi I, Thiesen J, Krämer I.	2014
3918	Journal J Oncol Pharm Practice 2016 ; 22: 749-756.	Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media. Sarakbi I, Krämer I.	2016
8	Journal Am J Hosp Pharm 1988 ; 45: 368-371.	Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration. Karnatz NN, Wong J, Kesler H, Baaske DM, Speicher ER.	1988
4598	Journal Int J Pharm Compound 2021 ;78,4:336-349	Compatibility of Estradiol, Estriol; Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base. Polonini H, Dijkers E, Ferreira A, Zander C, Taylor S.	2021
319	Journal Am J Health-Syst Pharm 1995 ; 52: 997-999.	Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia. Hadzija BW, Lubarsky DA.	1995
1410	Journal J Am Pharm Assoc 1999 ; 39: 141-145.	Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection. Trissel LA, Martinez JF, Simmons M.	1999
1722	Journal EJHP 2002 ; 2: 33-40.	Compatibility of etoposide solution with polyvinyl chloride and low density polyethylene containers and its stability in different storage conditions. Gras C, Sautou-Miranda V, Bagel-Boithias S, Brigas F, Chopineau J.	2002
1803	Journal Am J Health-Syst Pharm 2003 ; 60: 80-85.	Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration. Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB.	2003
1993	Journal Am J Health-Syst Pharm 2005 ; 62: 1190-1192.	Compatibility of fentanyl citrate, ketamine hydrochloride, and droperidol in 0.9% sodium chloride injection stored in polyvinyl chloride bags. Lee DKT, Wang DP, Harsono R, Wong CY.	2005
104	Journal Am J Health-Syst Pharm 1997 ; 54: 185-189.	Compatibility of filgrastim with selected antimicrobial drugs during simulated Y-site administration. Hall PD, Yui D, Lyons S, Bosso JA.	1997
244	Journal Am J Hosp Pharm 1994 ; 51: 1907-1913.	Compatibility of filgrastim with selected drugs during simulated Y-site administration. Trissel LA, Martinez JF.	1994
4458	Journal Eur J Clin Microbiol Infec Dis 2017 36:2237–2242.	Compatibility of fosfomycin with different commercial peritoneal dialysis solutions. Kussmann M, Baumann A, Hauer S, Pichler P, Zeitlinger M, Wiesholzer M, Burgmann H, Poeppl W, Reznicek G.	2017
367	Journal Am J Hosp Pharm 1985 ; 42: 116-119.	Compatibility of furosemide with aminoglycoside admixtures. Thompson DF, Allen LV, Desai SR, Rao PS.	1985
1423	Journal J Am Pharm Assoc 1999 ; 39: 514-518.	Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. Trissel LA, Martinez JF, Gilbert DL.	1999
4534	Journal Int J Pharm Compound 2021 ;25,5:422-426	Compatibility of Gestrinone, Nimesulide, and Piroxican in Pentravan for Transdermal and Transmucosal Application. Polonini H, De Oliveira Ferreira A, Dijkers.	2021
49	Journal Am J Health-Syst Pharm 1995 ; 52: 208.	Compatibility of granisetron hydrochloride with selected alkaline drugs. Trissel LA, Martinez JF.	1995
182	Journal Am J Health-Syst Pharm 1997 ; 54: 56-60.	Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration. Trissel LA, Gilbert DL, Martinez JF.	1997
1676	Journal Int J Pharm 1997 ; 154: 95-102.	Compatibility of granisetron towards glass and plastics and its stability under various storage conditions. Hourcade F, Sautou-Miranda V, Normand B, Laugier M, Picq F, Chopineau J.	1997
982	Journal Ann Pharmacotherapy 1995 ; 29: 1168.	Compatibility of haloperidol and diphenhydramine in a hypodermic syringes. Ukhun IA.	1995
1970	Journal Support Care Cancer 2003 ; 11, 2: 107-113.	Compatibility of haloperidol and hyoscine-N-butyl bromide in mixtures for subcutaneous infusion to cancer patients in palliative care. Barcia E, Reyes R, Azuara M.L, S?nchez Y, Negro S.	2003
617	Journal Am J Hosp Pharm 1982 ; 39: 843-844.	Compatibility of haloperidol lactate and heparin sodium. Solomon DA, Nasinnyk KK.	1982
229	Journal Am J Hosp Pharm 1994 ; 51: 2962-2963.	Compatibility of haloperidol lactate with benztropine mesylate. Jackson CW, Cunningham K.	1994
341	Journal Am J Hosp Pharm 1985 ; 42: 1352-1355.	Compatibility of heparin sodium and morphine sulfate. Baker DE, Yost GS, Craig VL, Campbell RK.	1985
767	Journal Ann Pharmacotherapy 1997 ; 31: 789-790.	Compatibility of hydromorphone and prochlorperazine, and irritation due to subcutaneous prochlorperazine infusion. Trinkle R.	1997
216	Journal Am J Hosp Pharm 1994 ; 51: 2963.	Compatibility of hydromorphone hydrochloride with haloperidol lactate and ketorolac tromethamine. Huang E, Anderson RP.	1994
4558	Journal Milit Med 2016 ; 181, 10:1305.	Compatibility of Hydroxyethyl Starch and Tranexamic Acid for Battlefield Co-Administration. Studer, N.M, Yassin, A.H, Keen, D.E.	2016
1910	Manufacturer Baxter 2002	Compatibility of imiglucerase (personal communication)	2002
21	Journal Am J Hosp Pharm 1986 ; 43: 2803-2809.	Compatibility of imipenem-cilastatin sodium with commonly used intravenous solutions. Bigley FP, Forsyth RJ, Henley MW.	1986
2090	Journal Pharmactuel 2004 ; 37: 193-196.	Compatibility of injectable pantoprazole in Y-site administration. Pere H, Chasse V, Forest JM, Hildgen P.	2004
4521	Journal Pharmaceutical Technology in Hospital Pharmacy 2020	Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit. Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B.	2020
2164	Journal Perit Dial Int 2006 ; 26, 4: 498-502.	Compatibility of insulin over 24 hours in standard and bicarbonate-based peritoneal dialysis solutions contained in bags made of different materials. Voges M, Divinop-Filho JC, Faict D, Somers F, Vermeulen P.	2006
4398	Journal J Pharm Pract and Res 2020	Compatibility of intravenous busulfan with BBraun giving sets, ﬂudarabine and Posiﬂush. Smith E. K., Shergold J.A., McWhinney B.C.	2020
4440	Journal Ann Nutr Metab 2018 ; 73: 227-233.	Compatibility of Intravenous Fat Emulsion with Antibiotics for Secondary Piggyback Infusion. Omotani S, Aoe M, Esaki S, Nagai K, Hatsuda Y, Mukai J, Teramachi H, Myotoku M.	2018
3459	Journal Cancer Chemother Pharmacol 2013 ; 72: 509-513.	Compatibility of intravenous fosaprepitant with intravenous 5-HT3 antagonists and corticosteroids. Sun S, Schaller J, Placek J, Duersch B.	2013
4464	Journal PlosOne 2018 13(1): e0190577.	Compatibility of intravenous ibuprofen with lipids and parenteral nutrition, for use as a continuous infusion. Garcia J, Garg A, Song Y, Fotios A, Andersen C, Garg S.	2018
3948	Journal JPEN 2012 ;30. 416?424.	Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation. Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P .	2012
312	Journal Am J Health-Syst Pharm 1997 ; 54: 570-571.	Compatibility of iron dextran with neonatal parenteral nutrient solutions. Mayhew SL, Quick MW.	1997
313	Journal Am J Hosp Pharm 1992 ; 49: 2233-2235.	Compatibility of iron dextran with total nutrient admixtures. Tu YH, Knox NL, Biringer JM, Eichman ML, Schweinsberg PD, Howard JR.	1992
3829	Poster ASHP Midyear 2015	Compatibility of isavunazonium sulfate during simulated Y-site administration. So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.	2015
1864	Journal Pain 1998 ; 75: 389-390.	Compatibility of ketamine and morphin injections. Lau MH, Hackman C, Morgan DJ.	1998
1934	Journal Am J Health-Syst Pharm 2004 ; 61: 1438-1445.	Compatibility of ketamine hydrochloride and fentanyl citrate in polypropylene syringes. Ambados F, Brealey J.	2004
321	Journal Am J Health-Syst Pharm 1997 ; 54: 205.	Compatibility of ketamine hydrochloride and meperidine hydrochloride. Ambados F.	1997
469	Journal Am J Hosp Pharm 1990 ; 47: 1097-1100.	Compatibility of ketorolac tromethamine injection with common infusion fluids and administration sets. Floy BJ, Royko CJ, Fleitman JS.	1990
4603	Journal Hosp Pharm 2021 ; 56, 4: 228-234.	Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration. Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G.	2021
1072	Journal Am J Health-Syst Pharm 1999 ; 56: 1458-1459.	Compatibility of levofloxacin with 34 medications during simulated Y-site administration. Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA.	1999
4176	Journal Am J Health-Syst Pharm 2018 ;75:1467-1477	Compatibility of linezolid with commercial peritoneal dialysis solutions Poeppl W, Rainer-Harbach E, Kussmann M, Pichler P, Zeitlinger M, Wiesholzer M, Burgmann H, Reznicek G.	2018
2466	Journal Am J Hosp Pharm 1981 ; 38: 1750-1753.	Compatibility of lithium citrate syrup with 10 neuroleptic solutions Theesen KA, Wilson JE, Newton DW, Ueda CT.	1981
218	Journal Am J Hosp Pharm 1993 ; 50: 2311.	Compatibility of magnesium sulfate and morphine sulfate in 0.9% sodium chloride injection. Vogt C, Ruggaber S.	1993
1047	Journal Am J Hosp Pharm 1984 ; 41: 323-324.	Compatibility of magnesium sulfate solutions with various antibiotics during simulated Y-site injection. Souney PF, Colucci RD, Mariani G, Campbell D.	1984
298	Journal Am J Health-Syst Pharm 1995 ; 52: 320-321.	Compatibility of mannitol and sodium bicarbonate in injectable fluids. Matuschka PR, Smith WR, Vissing RS.	1995
1415	Journal JPEN 1999 ; 23: 67-74.	Compatibility of medications with 3-in-1 parenteral nutrition admixtures. Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M.	1999
4507	Journal Am J Health-Syst Pharm 2020 ;77,23:1980-1985	Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing. Ross E, Salinas A, Petty K, Her C, Carpenter J.	2020
4376	Journal Int J Pharm Compound 2020 ;24,1:83-85	Compatibility of Melphalan in Iodinated Contrast Media. Shi Z, Abruzzo T, Wanasathop A, Li S K.	2020
266	Journal Am J Health-Syst Pharm 1996 ; 53: 2853-2855.	Compatibility of meropenem with commonly used injectable drugs. Patel PR.	1996
3922	Journal Perit Dial Int 2016 doi:10.3747/pdi.2016.0001	Compatibility of meropenem with different commercial dialysis solutions. Wiesholzer, Winter A, Kussmann M, Zeitlinger M, Pichler P, Burgmann H, Reznicek G,Poepp l W.	2016
2108	Journal Int J Pharm Compound 2006 ; 10: 230-232.	Compatibility of micafungin injection with other drugs during simulated Y-site co-administration. Trusley C, Kupiec TC, Trissel LA.	2006
186	Journal Am J Health-Syst Pharm 1995 ; 52: 2020-2022.	Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration. Swart EL, Mooren RAG, Van Loenen AC.	1995
1842	Journal Arzneimittel Forschung 1995 ; 45: 93-98.	Compatibility of morphin, baclofen, floxuridine and fluorouracil in an implantable infusion pump. Sadjack A, Wintersteiger R.	1995
980	Journal Aust J Hosp Pharm 1995 ; 25: 352.	Compatibility of morphine and ketamine for subcutaneous infusion. Ambados F.	1995
1492	Journal Can J Hosp Pharm 1995 ; 48: 155-160.	Compatibility of morphine and midazolam or haloperidol in parenteral admixtures. LeBelle MJ, Savard C, Gagnon A.	1995
1020	Journal Am J Hosp Pharm 1987 ; 44: 67.	Compatibility of morphine sulfate injection and prochlorperazine injection. Zuber DEL.	1987
519	Journal Aust J Hosp Pharm 1991 ; 21: 316.	Compatibility of morphine tartrate admixtures in polypropylene syringes. Poggi GL.	1991
616	Journal Am J Hosp Pharm 1982 ; 39: 841-843.	Compatibility of nalbuphine hydrochloride with other preoperative medications. Jump WG, Plaza VM, Poremba A.	1982
405	Journal Am J Hosp Pharm 1985 ; 42: 1108-1109.	Compatibility of narcotic analgesic solutions with various antibiotics during simulated Y-site injection. Nieves-Cordero AL, Luciw HM, Souney PF.	1985
2550	Journal Aust J Hosp Pharm 1993 ; 23: 35-37.	Compatibility of nebulizer solutions Roberts GW, Rossi S.O.P.	1993
316	Journal Am J Health-Syst Pharm 1996 ; 53: 2611-2613.	Compatibility of neonatal parenteral nutrient solutions with selected intravenous drugs. Veltri M, Lee CKK.	1996
1200	Journal Am J Hosp Pharm 1981 ; 38: 1737-1742.	Compatibility of netilmycin sulfate injection with commonly used intravenous injections and additives. Chaudry IA, Bruey KP, Hurlburt LE, Oden EM.	1981
1960	Journal J Pharm Biomed Anal 2005 ; 37: 259-264.	Compatibility of nitroglycerin, diazepam and chlorpromazine with a new multilayer material for infusion containers. Kambia NK, Dine T, Dupin-Spriet T, Gressier B, Luycks M, Goudaliez F, Brunet C.	2005
3865	Journal Int J Pharm Compound 2016 ; 20, 3 : 236-238.	Compatibility of Norepinephrine Bitartrate with Levofloxacin and Moxifloxacin During Simulated Y-site Administration. Vicky M, Samit S, Jaymin P, Michael C T.	2016
2012	Journal Am J Health-Syst Pharm 2005 ; 62: 2001-2005.	Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers. Bougouin C, Thelcide C, Crespin-Maillard F, Maillard C, Kinowski JM, Favier M.	2005
16	Journal Am J Health-Syst Pharm 1995 ; 52: 1554-1556.	Compatibility of ondansetron hydrochloride and piperacillin sodium-tazobactam sodium during simulated Y-site administration. Chung KC, Moon YSK, Chin A, Ulrich WU, Gill MA.	1995
332	Journal Ann Pharmacotherapy 1995 ; 29: 1106-1109.	Compatibility of ondansetron hydrochloride with meperidine hydrochloride for combined administration. Xu QA, Trissel LA, Fox JL.	1995
1725	Journal Can J Hosp Pharm 2001 ; 54: 112-113.	Compatibility of oxytocin, zidovudine, and penicillin G. Oliver C, Law S.	2001
1865	Journal Int J Pharm 1999 ; 178: 77-82.	Compatibility of paclitaxel in 5% glucose solution with ECOFLAC® low-density polyethylene containers - Stability under different storage conditions. Sautou-Miranda V, Brigas F, Vanheerswinghels S, Chopineau J.	1999
158	Journal Am J Hosp Pharm 1994 ; 51: 2804-2810.	Compatibility of paclitaxel injection vehicle with intravenous administration and extension sets. Trissel LA, Xu QA, Kwan J, Martinez JF.	1994
2016	Journal Am J Health-Syst Pharm 2005 ; 62: 1998-2000.	Compatibility of palonosetron with cyclophosphamide and with ifosfamide during Y-site administration. Xu QA, Trissel LA.	2005
3210	Journal Int J Pharm Compound 2011 ; 15, 3: 259-261.	Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations. Jasti Bhaskara R, Saraf Poonam.	2011
301	Journal Am J Health-Syst Pharm 1997 ; 54: 1295-1300.	Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration. Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM.	1997
4538	Journal Archives of Disease in Childhood 2020 ; 105: 395-397.	Compatibility of pentoxifylline and parenteral medications. Campbell A, Petrovski M, Senarathna G, Mukadam ,Strunk T, Batty K.	2020
81	Journal Am J Hosp Pharm 1994 ; 51: 672-678.	Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection. Trissel LA, Martinez JF.	1994
1501	Journal Int J Pharm 1999 ; 185: 113-121.	Compatibility of plastics with cytotoxic drug solutions - comparison of polyethylene with other container materials. Beitz C, Bertsch T, Hannak D, Schrammel W, Einberger C, Wehling M.	1999
391	Journal Am J Hosp Pharm 1987 ; 44: 1620-1624.	Compatibility of premixed theophylline and methylprednisolone sodium succinate intravenous admixtures. Johnson CE, Cohen IA, Michelini TJ, McMahon RE.	1987
372	Journal Am J Hosp Pharm 1988 ; 45: 609-612.	Compatibility of premixed theophylline and verapamil intravenous admixtures. Johnson CE, Lloyd CW, Aviles AI, Rybarz KL.	1988
1860	Journal Int J Pharm 1996 ; 130: 251-255.	Compatibility of propofol diluted in 5% glucose with glass and plastics (polypropylene, molyvinylchloride) containers. Sautou-Miranda V, Levadoux E, Groueix MT, Chopineau J.	1996
300	Journal Am J Health-Syst Pharm 1997 ; 54: 1287-1292.	Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration. Trissel LA, Gilbert DL, Martinez JF.	1997
1863	Journal Journal of clinical anesthesia 1996 ; 8: 329-336.	Compatibility of propofol, fentanyl,and vecuronium mixtures designed for potential use in anesthesia and patient transport. Isert PR, Lee D, Naidoo D, Carasso ML, Kennedy RA.	1996
1198	Journal Am J Hosp Pharm 1982 ; 39: 1685-1687.	Compatibility of propranolol hydrochloride injection with intravenous infusion fluids in plastic containers. Cummings DS, Park MK, Howard B.	1982
3913	Journal EJHP 2018 ;25,3:150-156.	Compatibility of proton pump inhibitors in a preservative-free suspending vehicle. Polonini H.C, Silva S.L, Loures S, Almy R, Balland A, Brandao M.A.F, Ferreira A.O.	2018
59	Journal Am J Health-Syst Pharm 1997 ; 54: 2192-2196.	Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration. Trissel LA, Gilbert DL, Martinez JF, Kim MC.	1997
1665	Journal J Clin Pharm Ther 2002 ; 21: 39-45.	Compatibility of ropivacaine with morphine, sufentanil, fentanyl, or clonidine. Öster Svedberg K, McKenzie J, Larrivee-Elkins C.	2002
295	Journal Am J Health-Syst Pharm 1996 ; 53: 1048-1051.	Compatibility of selected critical care drugs during Y-site administration. Yamashita SK, Walker SE, Choudhury T, Iazzetta J.	1996
1035	Journal J Parenter Sci Technol 1983 ; 37: 129-132.	Compatibility of several antibiotics or hydrocortisone when added to metronidazole solution for intravenous infusion. Bisaillon S, Sarrazin R.	1983
207	Journal Am J Health-Syst Pharm 1995 ; 52: 2024-2025.	Compatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injection. Ku YM, Min DI, Kumar V, Noormohamed SE.	1995
3827	Poster ASHP Midyear 2015	Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions. Ghazi I.M, Hamada Y, Nicolau D.P.	2015
1165	Journal Int J Pharm 1980 ; 4: 263-265.	Compatibility of the cephalosporin, cefamandole nafate with injections. Bowtle WJ, Heasman MJ, Prince AP, Easthope DA.	1980
249	Journal Am J Health-Syst Pharm 1996 ; 53: 1041-1045.	Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration. Trissel LA, Martinez JF.	1996
1420	Journal J Clin Pharm Ther 1999 ; 24: 125-132.	Compatibility of tirofiban HCl with dopamine HCl, famotidine, sodium heparin, lidocaine HCl and potassium chloride during simulated Y-site administration. Bergquist PA, Hunke WA, Reed RA, Manas D, Forsyth RJ, Kenney RR, Cook J, Holahan M.	1999
1338	Journal Am J Hosp Pharm 1985 ; 42: 777-778.	Compatibility of total nutrient admixtures and secondary cardiovascular medications. Baptista RJ, Dumas GJ, Bistrian BR, Condella F, Blackburn GL.	1985
2002	Journal Am J Health-Syst Pharm 2005 ; 62: 1299-1302.	Compatibility of tramadol hydrochloride injection with selected drugs and solutions. Abanmy NO, Zaghloul IY, Radwan MA.	2005
4407	Journal Am J Health-Syst Pharm 2020 ;77,8:649–657.	Compatibility of treprostinil sodium and dopamine hydrochloride during simulated Y-site administration. Bustin A, Ramsey Z, Hanna B, Kaushal G.	2020
924	Journal J Pharm Pharmacol 1998 ; 50: 407-411.	Compatibility of tropisetron with glass and plastics. Stability under different storage conditions. Brigas F, Sautou-Miranda V, Normand B, Geneve S, Chopineau J.	1998
3813	Journal Hosp Pharm 2015 ; 50, 8: 710-713.	Compatibility of Vancomycin and Oxacillin During Simulated Y-Site Delivery. Teibel H.M, Knoderer C.A, Nichols K.R.	2015
1748	Journal Int J Pharm Compound 1997 ; 1: 354-355.	Compatibility of vancomycin hydrochloride and famotidine in 5% dextrose injection. Wang DP, Wang MT, Wong CY, Lee DKT.	1997
1228	Journal Am J Hosp Pharm 1981 ; 38: 380-381.	Compatibility of various admixtures at Y-injection sites of intravenous administration sets. Part2. Allen LV, Stiles ML.	1981
730	Journal Am J Hosp Pharm 1977 ; 34: 939-943.	Compatibility of various admixtures with secondary additives at Y-injection site of intravenous administration sets. Allen LV, Saul Levinson R, Phisutsinthop D.	1977
1067	Journal EJHP 1999 ; 5: 106-110.	Compatibility of various drugs used in intensive care medicine in polyethylene, PVC and glass infusion containers. Zeidler C, Dettmering D, Schrammel W, Spieteller M.	1999
1057	Journal Am J Hosp Pharm 1983 ; 40: 1205-1207.	Compatibility of verapamil hydrochloride injection with commonly used additives. Cutie MR.	1983
706	Journal Am J Hosp Pharm 1981 ; 38: 231.	Compatibility of verapamil hydrochloride with other additives. Cutie MR.	1981
371	Journal Am J Hosp Pharm 1988 ; 45: 142-145.	Compatibility of verapamil hydrochloride with penicillin admixtures during simulated Y-site injection. Thompson DF, Stiles ML, Allen LV, Tu YH.	1988
552	Journal Int J Pharm Compound 1997 ; 1: 356-358.	Compatibility of warfarin sodium with selected drugs and large-volume parenteral solutions. Martinez JF, Trissel LA, Gilbert DL.	1997
4319	Journal Hosp Pharm 2020 ; 55, 5: 332-337.	Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.	2020
54	Journal J Pharm Clin 1995 ; 14: 26-30.	Compatibility PVC-psychotropic drugs during an infusion. Bureau A, Lahet JJ, D?Athis P, Vailleau JL, Cosmidis V, Martin L.	1995
1713	Journal Int J Pharm Compound 2002 ; 6: 311-315.	Compatibility screening of bivalirudin during simulated Y-site administration with other drugs. Trissel LA, Saenz CA.	2002
1721	Journal Int J Pharm Compound 2001 ; 5: 69-72.	Compatibility screening of Hextend during simulated Y-site administration with other drugs. Trissel LA, Williams KY, Baker MB.	2001
1925	Journal J Am Pharm Assoc 2000 ; 40: 515-519.	Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. Trissel LA , Williams KY, Gilbert DL.	2000
1662	Journal J Oncol Pharm Practice 2002 ; 8: 33-37.	Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs. Trissel LA, Saenz CA, Ingram DS, Ogundele AB.	2002
1712	Journal Int J Pharm Compound 2002 ; 6: 230-233.	Compatibility screening of Precedex during simulated Y-site administration with other drugs. Trissel LA, Saenz CA.	2002
4404	Poster JFSPH 2019 2019	Compatibility studies of seven commonly used drugs for parenteral administration in palliative care. Müller U, Haller F, Wiedemeier P, Steuer C.	2019
162	Journal Int J Pharm 1994 ; 105: 83-87.	Compatibility study of methotrexate with PVC bags after repackaging into two types of infusion admixtures. Benaji B, Dine T, Goudaliez F, Luyckx M, Brunet C, Mallevais ML, Gressier B, Cazin M, Cazin JC.	1994
1888	Journal Ziekenhuisfarmacie 1986 ; 2: 45-48.	Compatibility study of midazolam. Janknegt R, Van den Berg TJ, De Jong M, Oldenhof HGJ, Steenhoek A.	1986
1468	Journal Int J Pharm 1994 ; 107: 111-119.	Compatibility with medical plastics and stability of continuously and simultaneously infused isosorbide dinitrate and heparin. Sautou V, Chopineau J, Gremeau I, Chevrier R, Bruneaux F.	1994
4027	Journal Hosp Pharm 2017 ;52,10:685-690	Compatibility, Stability, and Efficacy of Vancomycin Combined With Gentamicin or Ethanol in Sodium Citrate as a Catheter Lock Solution. Wei Y, WonJoon Yang J, Boddu S, Jung R, Churchwell M.	2017
4023	Journal Hosp Pharm 2017 ; 52,7 : 478-482.	Compounded Apixaban Suspensions for Enteral Feeding Tubes. Carabello M, Donmez S, Nathan K, Zhao F.	2017
3983	Journal EJHP 2016 ; 24: 157-161.	Compounding and stability evaluation of atorvastatin extemporaneous oral suspension using tablets or pure powder. Zaid A.N, Assali M, Zalmout S, Basheer A.	2016
2988	Journal J Clin Pharm Ther 2007 ; 32: 489-496.	Compounding of vitamin A, D3, E, and K3 supplements for cystic fibrosis patients: formulation and stability study. Huyghebaert N, de Beer J, Vervaet C et al.	2007
1278	Journal Can J Hosp Pharm 1998 ; 51: 13-19.	Concentration and solution dependent stability of cloxacillin intravenous solutions. Walker SE, Dufour A, Iazetta J.	1998
1674	Journal Hosp Pharm 1998 ; 33: 1515-1522.	Concentration dependency of vancomycin hydrochloride compatibility with beta-lactam antibiotics during simulated Y-site administration. Trissel LA, Gilbert DL, Martinez JF.	1998
2490	Journal Am J Hosp Pharm 1989 ; 46: 304-307.	Concentration uniformity of extemporaneously prepared ranitidine suspension Karnes HT, Harris SR, Garnett WR, March C.	1989
1637	Journal Can J Hosp Pharm 2000 ; 53: 24-31.	Concentration-dependant compatibility and stability of dexamethasone and midazolam. Wong AH, Law S, Walker SE, Bowles SK.	2000
1070	Journal Am J Health-Syst Pharm 1999 ; 56: 1891.	Concentration-dependent incompatibility of vinorelbine tartrate and heparin sodium. Balthasar JP.	1999
269	Journal Am J Health-Syst Pharm 1996 ; 53: 84-85.	Concentration-dependent precipitation of sodium bicarbonate with ciprofloxacin lactate. Trissel LA.	1996
3262	Journal J Oncol Pharm Practice 2011 ; 17, 4: 395-399.	Conditions causing gemcitabine crystallization. Manners S, Galettis P, de Souza P.	2011
3718	Manufacturer Bayer Healthcare Corporation 2012	Conivaptan (Vaprisol®) - Summary of Product Characteristics	2012
2446	Journal Am J Health-Syst Pharm 1998 ; 55: 1299-1301.	Content uniformity and stability of nifedipine in extemporaneously compounded oral powders Helin MM, Kontra KM, Naaranlahti TJ, Wallenius KJ.	1998
4470	Journal Critical care 2005 ; 9(Suppl 1) P37	Continuous versus intermittent infusion of temocillin in intensive care unit patient. Claeysoone K, Basma V, Hens R, Van Bambeke F, de Jongh R, Tulkens P.	2005
2231	Journal J Antimicrob Chemother 2008 ; 61, 2: 382-388.	Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.	2008
501	Journal Am J Hosp Pharm 1985 ; 42: 129-130.	Crystal formation after reconstituting cefazolin sodium with 0.9% sodium chloride injection. Senholzi CS, Kerns MP.	1985
1371	Journal Am J Hosp Pharm 1985 ; 42: 2436.	Crystal formation after reconstituting cefazolin sodium with 0.9% sodium chloride injection. Bornstein M, Templeton RJ.	1985
1302	Journal Drug Intell Clin Pharm 1988 ; 22: 173-174.	Cyclosporine binding to components in medication administration sets. Parr MD, Barton SD, Haver VM, Porter WH.	1988
3580	Manufacturer Accord Healthcare France 2016	Cytarabine Accord - Résumé des caractéristiques du produit	2016
850	Journal Drug Intell Clin Pharm 1982 ; 16: 765-767.	Cytosine arabinose stability in intravenous admixtures with sodium bicarbonate and in plastic syringes. Munson J, Kubiak EJ, Cohon MS.	1982
3605	Manufacturer Lipomed 2010	Dacarbazine (Dacarbazine Lipomed®) - Résumé des caractéristiques du produit	2010
3267	Manufacturer Lipomed 2011	Dacarbazine Lipomed - Summary of Product Characteristics Lipomed Laboratories	2011
3266	Manufacturer Lipomed 2011	Dacarbazine solutions: In Use stability of dacarbazine lipomed® Lipomed Laboratories	2011
4153	Manufacturer Orphan Europe (UF) Limited 2014	Dactinomycin (Cosmegen Lyovac®) - Summary of Product Characteristics	2014
3752	Manufacturer Durata Therapeutics Holding 2014	Dalbavancin (Dalvance®) - Summary of Product Characteristics	2014
1509	Manufacturer Norgine 2014	Dantrolene sodium (Dantrium®) - Summary of Product Characteristics	2014
3218	Journal Perit Dial Int 2011 ; 31: 492?495.	Daptomycin Compatibility in Peritoneal Dialysis Solutions Peyro Saint Paul L, Albessard F, Gaillard C, Debruyn D, Ryckelynck J Ph, Antoine Coquerel, Lobbedez T	2011
2271	Manufacturer Novartis 2006	Daptomycine (Cubicin®) Résumé des caractéristiques du produits	2006
4190	Manufacturer Janssen 2018	Daratumumab (Darzalex®) - Summary of Product Characteristics.	2018
3604	Manufacturer Sanofi Aventis France 2012	Daunorubicine (Cérubidine®) - Résumé des caractéristiques du produit	2012
3577	Manufacturer Galen Limited	Daunorubicine (Daunoxome®) - Résumé des caractéristiques du produit
4355	Manufacturer Jazz Pharmaceuticals UK 2019	Daunorubicine/cytarabine liposomale (Vyxeos®) - Summary of Product Characteristics	2019
2217	Journal Ziekenhuisfarmacie 1997 ; 13, 1: 21-23.	De stabiliteit van clonazepaminjectievloeistof. Guchelaar H.J, Hartog M.E.	1997
2240	Manufacturer Janssen Pharmaceuticals 2019	Décitabine (Dacogen®) - Summary of Product caracteristics	2019
1882	Journal Ziekenhuisfarmacie 1993 ; 9: 97-101.	Decrease of sufentanil citrate concentration during formulation and application of an epidural infusion solution. Bosch EH, Van Doorne H, Brouwers JRBJ, Marskamp A, Meevis RF.	1993
3671	Manufacturer Teva UK Ltd 2016	Deferoxamine - Résumé des caractéristiques du produit	2016
3701	Manufacturer Gentium SPa 2014	Defibrotide (Defitelio®) - Summary of Product Characteristics	2014
2291	Journal Drug Dev Ind Pharm 2000 ; 26, 11: 1221-1226.	Degradation kinetics of neostigmine in solution. Yeh MK.	2000
3390	Journal Int J Pharm 1993 ; 99: 73-78.	Degradation kinetics of the antitumor drug nimustin (ACNU) in aqueous solution. Van der Houwen, O.AG.J, Beijnen J.H, Bult A, Bekers O, Goossen R.M.J, Underberg W.J.M.	1993
1157	Journal Int J Pharm 1988 ; 43: 131-138.	Degradation kinetics of vinblastine sulphate in aqueous solutions. Vendrig DEMM, Smeets BPGM, Beijnen JH, van der Houwen OAGJ, Holthuis JJM.	1988
2570	Journal Am J Hosp Pharm 1994 ; 51: 1205-1207.	Degradation of captopril in solutions compounded from tablets and standard powder. Chan DS, Sato AK, Claybaugh JR.	1994
3093	Journal J Pharm Sci 2010 ; 99, 3 : 1288-1298.	Degradation of paclitaxel and related compounds in aqueous solutions III: Degradation under acidic pH conditions and overall kinetics Tian J, Stella VJ.	2010
2243	Journal Int J Pharm 1997 ; 146: 263-269.	Degradation pathway of carboplatin in aqueous solution. Pujol M, Girona V, Prat J, Munoz M, De Bolos J.	1997
4636	Journal J Oncol Pharm Practice 2022 ;	Design and stability of pediatric oral formulation of imatinib Hinterlang M, Gendron A, Fleury F, Rieutord A, Vrana A , Schlatter J, Annereau M.	2022
2884	Journal Int J Pharm 2015 ; 487 : 270-273.	Design and stability study of a paediatric oral solution of methotrexate 2 mg/ml Vrignaud S, Briot T, Launay A, Kempf M, Lagarce F.	2015
3886	Journal Eur J Pharm Sci 2016 ; 92 : 220-223.	Design and stability study of an oral solution of amlodipine besylate for pediatric patients. van der Vossen A.C, van der Velde I, Smeets O.S.N.M,. Postma D.J, Vermes A,. Koch B.C.P, Vulto A.G,.Hanff L.M.	2016
3361	Journal Int J Pharm 2012 ; 423: 360-364.	Design of a pediatric oral formulation with a low proportion of hydrochlorothiazide. Santovena A, Hernandez-Paiz Z, Farina J.B.	2012
2717	Journal J Liquid Chrom 1995 ; 18: 3117-3128.	Determination of ceftazidime and pyridine by HPLC: application to a viscous eye drop formulation. Barnes AR.	1995
1757	Journal J Clin Pharm Ther 1998 ; 23: 311-314.	Determination of compatibility and stability of drugs used in palliative care. Schrijvers D, Tai-Apin C, De Smet MC, Cornil P, Vermorken JB, Bruyneel P.	1998
835	Journal Int J Pharm 1979 ; 4: 21-26.	Determination of the stability of mitomycin C by high performance liquid chromatography. Edwards D, Selkirk AB, Taylor RB.	1979
2239	Journal Chinese J New Drugs 2005 ; 14, 2: 189-191.	Determination of the stability of oxaliplatin for injection by dual wavelength spectrophotometry. Wang C, Zhang X, Liu HY.	2005
3296	Journal J Chromatographic Sci 2009 ; 47: 1-7.	Determination of Tramadol, Metamizole, Ropivacaine, and Bupivacaine in Analgesic Mixture Samples by HPLC with DAD Detection. Salmeron-Garcia A, Navas N, Martin A, Roman E, Cabeza J, Capitan-Vallvey L.F	2009
3971	Journal Int J Pharm Compound 2017 ; 21, 2 : 164-170.	Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs. Gorman G, Sokom S, Coward L, Arnold J J.	2017
4750	Journal Pharmaceutics 2023 ,15, 755.	Development and Stability of a New Formulation of Pentobarbital Suppositories for Paediatric Procedural Sedation. Lebrat M, Bouattour Y, Gaudet C, Yessaad M, Jouannet M, Wasiak M, Dhifallah I, Beyssac E, Garrait G, Chennell P, Sautou V.	2023
3875	Journal EJHP 2016 ; 23: 4: 213-218.	Development and stability study of glibenclamide oral liquid paediatric formulations for the treatment of permanent neonatal diabetes mellitus. Estevez P, Boscolo O, Quiroga E, Penuto R.F, Buontempo F, Tripodi V, Lucangioli S.	2016
2317	Journal EJHP Science 2009 ; 15, 1: 3-5.	Development and stability testing of a concentrated injectable clonidine solution for intrathecal analgesia. Hollenwaeger M, Borquin Challandes I, Fallab L.C, Schaad N, Zelger G.	2009
4498	Journal Pharmaceutical Technology in Hospital Pharmacy 2020	Development and validation of a new HPLC method for the analysis of a novel oral suspension formulation of 50 mg/mL ursodesoxycholic acid for newborns. Hausherr A, Roessle C, Pinet E, Vasseur V, Abarou T, Benakouche S, Bourdon O, Storme T.	2020
4628	Journal Pharmaceuticals 2021 ; 14, 943.	Development and Validation of a New Storage Procedure to Extend the In-Use Stability of Azacitidine in Pharmaceutical Formulations. Iudicello A, Genovese F, Strusi V, Dominici M, Ruozi B.	2021
3319	Journal Int J Pharm 2012 ; 433, 1-2 : 119-120.	Development and validation of a paediatric oral formulation of clonidine hydrochloride de Goede A.L, Boedhram R.R, Eckhardt M, Hanff L.M, Koch B.C.P, Vermaat C.H, Vermes A.	2012
2165	Journal J Liquid Chrom Rel Technol 2006 ; 29, 16: 2353-2365.	Development and validation of an HPLC method for oxytocin in Ringer’s lactate and its application in stability analysis. Kumar V, Madabushi R, Derendorf H, Boothby LA, Breland BD, Hatton RC, Doering PL.	2006
3399	Poster EAHP Congress Paris 2013	Development of a hydrochlorothiazide 0.5 mg/mL oral solution for children. Li Y.Y, Postma D.J, Wagenaar H.W.G.	2013
4653	Journal EJHP 2021 ; 28: 331-335.	Development of a sterile morphine hydrogel for the local treatment of painful skin ulcers. Jansen MMPM, van Waas VPH, Verzijl JM, Burger D.	2021
3297	Journal Chromatographia 2008 ; 68, 9-10: 767-772.	Development of an LC–DAD Method for Analysis of Dexketoprofen, Tramadol, and Haloperidol. Study of the Stability of Mixtures Used for Patient-Controlled Analgesia. Salmeron-Garcia A, Lopez-Lopez E, Roma E, Cabeza J, Navas N, Capitan-Vallvey L.F.	2008
2904	Journal Ann Pharm Fr 2005 ; 63: 162-166.	Development of an oxybutynin chloride solution: from formulation to quality control. Fratta A, Bordenave J, Boissinot C, Le Grand J, Esquirol C, Radideau E, Benoit G.	2005
650	Journal Int J Pharm Compound 1997 ; 1: 274-277.	Development of clonidine hydrochloride injections for epidural and intrathecal administration. Trissel LA, Hassenbusch SJ.	1997
3285	Journal Yakugaku Zasshi 2009 129, 6: 767-771.	Development of New Mixing Method of Busulfex® Injecton for the Purpose of Improvement of Medical Safety Method; The Prefilled Syringe Method. Senoo M, Tajika K, Shimizu H, Hamada M, Dobashi Y, Dan K, Katayama S.	2009
3569	Journal EJHP 2014 ;21:34-38	Development of ready-to-use cefuroxime syringes for use in ophthalmology. Fleury-Souverain S, Sadeghipour F, Bonnabry P.	2014
2287	Journal EJHP Science 2008 ; 14, 1: 14-18.	Development of ready-to-use ketamine hydrochloride syringes for safe use in post-operative pain. Stucki MC, Leury-Souverain S, Sautter AM, Sadeghipour F, Bonnabry P.	2008
4229	Journal Int J Pharm Compound 2017 ;24,6:519-527	Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure. Ma N, Perks W, Law S, John I, Walker S.	2017
2759	Journal Pediatr Neurol 1999 ; 20: 195-197.	Development of two stable oral suspensions of gabapentin. Nahata MC.	1999
2721	Journal J Pad Ophtalmol Strabismus 2000 ; 37, 6: 333-337.	Development of Two Stable Oral Suspensions of Levodopa-Carbidopa for Children With Amblyopia Nahata MC, Morosco RS, Leguire LE.	2000
2949	Journal Pharmazie 2007 ; 62: 519-521.	Development validation and stability study of pediatric atenolol syrup. Foppa T, Murakami FS, Silva MAS.	2007
3700	Journal Braz J Pharm Sci 2010 ; 46, 1 : 109-114.	Development, stability and in vitro permeation studies of gels containing mometasone furoate for the treatment of dermatitis of the scalp. Salgado A.C.G.B; Silva A.M.N.N; Machado M.C.J.C; Duarte MA.S.C; Ribeiro, Helena M.O.M.	2010
4712	Poster GERPAC Congrès - octobre 2022 2022	Développement de formulations buvables de vinorelbine à usage pédiatrique. Macqueron L, Régnier L, Robinet P, Leroy AM, Lester MA, Boivin PN, Le Corre P.	2022
3668	Manufacturer Hospira 2015	Dexamethasone - Summary of Product Characteristics	2015
3851	Journal Can J Hosp Pharm 2016 ; 69, 1: 49-51.	Dexamethasone 1 mg/mL Suspension Prepared from Crushed Tablets: Stability in Glass and Plastic Bottles and Plastic Syringes. Ensom M.H.H, D?carie D.	2016
28	Journal PDA J Pharm Sci Technol 1996 ; 50: 261-267.	Dexamethasone phosphate stability and contamination of solutions stored in syringes. Lau DWC, Law S, Walker SE, Iazzetta J.	1996
3581	Manufacturer Clinigen Healthcare 2013	Dexrazoxane (Cardioxane®) - Résumé des caractéristiques du produit	2013
2224	Journal Bolletino SIFO 2007 ; 53: 178-180.	Dexrazoxane: Stabilià in soluzione. Romanazzi C, Sferra S, Campi A, Rabino B, Barbieri M, Castellani S, Sabbatini L, Scanavacca P.	2007
1388	Journal Pharm J 1982 ; 228: 238-239.	Diamorphine hydrochloride compatibility with saline. Page J, Hudson S.	1982
1385	Journal Pharm J 1985 ; 235: 171.	Diamorphine injection BP incompatibility. Kirk B, Hain WR.	1985
506	Journal J Pharm Pharmacol 1989 ; 41: 275-277.	Diamorphine stability in aqueous solution for subcutaneous infusion. Omar OA, Hoskin PJ, Johnston A, Hanks W, Turner P.	1989
3885	Journal Int J Pharm 2016 ; 506 : 414-419.	Diazepam sorption to PVC- and non-PVC-based tubes in administration sets with quantitative determination using a high-performance liquid chromatographic method. Su-Eon Jin, Siwon You, Seungho Jeon, Sung-Joo Hwang.	2016
3613	Manufacturer Primius Lab 2013	Dihydralazine (Nepressol®) - Résumé des caractéristiques du produit	2013
1809	Journal EJHP 2003 ; 3: 34-42.	Diluted solution of sodium ioxitalamate in paediatrics: A stability and cost effectiveness study. Arrault XL, Rieutord A, Hassan M, Brion F.	2003
2292	Journal EJHP 2016 ;23:22-27	Diluting ferric carboxymaltose in sodium chloride infusion solution (0.9% w/v) in polypropylene bottles and bags: effects on chemical stability Philipp E, Braitsch M, Bichsel T, Mühlebach S.	2016
2074	Journal Ann Intern Med 1998 ; 128: 1049.	Dissolving phenytoin precipitate in central venous access device. Tse T, Abdullah R.	1998
4487	Journal Pharmaceutics 2020 ; 12, 786.	Do Ophthalmic Solutions of Amphotericin B Solubilised in 2-Hydroxypropyl- -Cyclodextrins Possess an Extended Physicochemical Stability? Chennell P, Yessaad M, Abd El Kader F, Jouannet M, Wasiak M, Bouattour Y, Sautou V.	2020
3606	Manufacturer Wokhardt 2013	Dobutamine - Summary of Product Characteristics	2013
1352	Journal Am J Hosp Pharm 1984 ; 41: 2588-2589.	Dobutamine-heparin mixture inadvisable. Hasegawa GR, Eder JF.	1984
3130	Manufacturer Sanofi Avantis France 2009	Docétaxel (Taxotere®) – Résumé des caractéristiques du produits	2009
3911	Journal EJHP 2017 ; 24: 230-234.	Does an interaction exist between ketamine hydrochloride and Becton Dickinson syringes? Closset M, Hecq J D, Gonzalez E, Bihin B, Jamart J, L Galanti L.	2017
3638	Manufacturer Hospira 2010	Dopamin (Dopamine 40 mg/mL sterile concentrate®) - Summary of Product Characteristics	2010
1397	Journal Pharm J 1990 ; 244: 218.	Dopamine dilutions. Garner ST, Murdoch JM.	1990
2332	Manufacturer Janssen-Cilag 2009	Doripenem (Doribax®) - Laboratoire informations	2009
3612	Manufacturer Amdipharm Mercury Company 2012	Doxapram (Dopram) - Summary of Product Characteristics	2012
3645	Manufacturer Accord Healthcare 2014	Doxorubicin - Summary of Product Characteristics	2014
3142	Manufacturer SP Europe 2010	Doxorubicin hydrochloride liposome (Caelyx®) - Summary of Product Characteristics	2010
3143	Manufacturer Teva Laboratoire 2015	Doxorubicin hydrochloride liposome (Myocet®) - Summary of Product Characteristics	2015
3144	Manufacturer Ortho Biotech 2010	Doxorubicin liposome (Doxil®) - Product Information	2010
681	Journal Can J Hosp Pharm 1991 ; 44: 71-78.	Doxorubicin stability in syringes and glass vials and evaluation of chemical contamination. Walker S, Lau D, DeAngelis C, Iazetta J, Coons C.	1991
3402	Journal J Oncol Pharm Practice 2013 ; 19, 1: 65-74.	Doxorubicin-loaded drug-eluting beads (DC Bead®) for use in transarterial chemoembolization: A stability assessment. Hecq, J.-D., Lewis, A.L., Vanbeckbergen, D., Athanosopoulos, A., Galanti, L., Jamart, J., Czuczman, P., Chung, T.	2013
4009	Manufacturer Panpharma 2017	Droperidol - Résumé des Caractéristiques du Produit	2017
1187	Journal Am J Hosp Pharm 1983 ; 40: 94-97.	Droperidol stability in intravenous admixtures. Ray JB, Newton DW, Nye MT, Leet WA.	1983
2146	Journal Am J Health-Syst Pharm 2006 ; 63: 2379-2382.	Drug compatibility with new polyolefin infusion solution containers. Trissel LA, Xu QA, Baker M.	2006
763	Journal Cancer Treat Rep 1985 ; 69: 1325-1326.	Drug precipitation within IV tubing : A potential hazard of chemotherapy administration. Cohen MH, Jonhson-Early A, Hood MA, McKenzie M, Citron ML, Jaffe N, Krasnow SH.	1985
817	Journal Am J Health-Syst Pharm 1998 ; 55: 683-685.	Drug stability and pyridine generation in ceftazidime injection stored in an elastomeric infusion device. Stendal TL, Klem W, Tonnesen HH, Kjonniksen I.	1998
1928	Journal J Pain Symptom Manage 2004 ; 28, 3: 268-272.	Drug stability testing to support clinical feasibility investigations for intrathecal baclofen-clonidine admixture. Alvarez JC, De Mazancourt Ph, Chartier-Kastler E, Denys P.	2004
1088	Journal JAMA 1984 ; 252: 2392.	Drug trapping in intravenous infusion side arms. Johnston A, McKenzie MA, Krasnow SH, Hood MA, Cohen MH.	1984
4608	Manufacturer Astra Zeneca 2021	Durvalumab (Imfinzi - Summery of Product Characteristics, updated August 2021)	2021
2348	Manufacturer Alexion Europe SAS 2007	Eculizumab (Soliris®) – Summary of Product Characteristics	2007
348	Journal Am J Hosp Pharm 1985 ; 42: 335-339.	Effect of a polyethylene-lined administration set on the avaibility of diazepam injection. Hancock BG, Black CD.	1985
170	Journal Am J Hosp Pharm 1975 ; 62: 44-45.	Effect of briefly heating cyclophosphamide solutions. Brooke D, Scott JA, Bequette RJ.	1975
2396	Journal Am J Health-Syst Pharm 2008 ; 65: 441-447.	Effect of buffer and antioxidant on stability of a mercaptopurine suspension Aliabadi HM, Romanick M, Desai S, Lavasanifar A.	2008
351	Journal Am J Hosp Pharm 1986 ; 43: 2795-2799.	Effect of flow rate and type of IV container on adsorption of diazepam to IV administration systems. Yliruusi JK, Uotila JA, Kristoffersson ER.	1986
2361	Journal J Clin Pharm Ther 2009 ; 34, 4 : 423-428.	Effect of freeze-thawing on the long-term stability of calcium levofolinate in 5% dextrose stored on polyolefin infusion bags. Lebitasy M, Hecq J.D, Athanassopoulos A, Vanbeckbergen D, Jamart J, Galanti L.	2009
575	Journal Am J Hosp Pharm 1982 ; 39: 104-108.	Effect of freezing and microwave thawing on the stability of six antibiotic admixtures in plastic bags. Holmes CJ, Ausman RK, Kundsin RB, Walter CW.	1982
2020	Journal Can J Hosp Pharm 2005 ; 58: 65-70.	Effect of freezing on stability of a fortified 5 mg/ml ticarcillin ophtalmic solution. Blondeel S, Pelloquin A, Pointereau-Bellanger A, Thuillier A, Fernandez C.	2005
2110	Journal EJHP Science 2006 ; 12, 3: 52-56.	Effect of freezing, long term storage and microwave thawing on the stability of ceftriaxone sodium in 5% dextrose infusion polyolefin bags at 2-8°C. Hecq JD, Evrard JM, Vanbeckbergen DF, Jamart J, Galanti LM.	2006
2015	Journal Ann Pharmacotherapy 2005 39: 1654-1658.	Effect of freezing, long term storage, and microwave thawing on the stability of ketorolac tromathamine. Hecq JD, Boitquin LP, Vanbeckbergen DF, Jamart J, Galanti LM.	2005
3076	Journal Ann Pharm Fr 2009 ; 67: 427-432.	Effect of freezing, long-term storage and microwave thawing on the stability of a mixture of diclofenac and sodium bicarbonate in glucose 5% polyolefin bags. François JH, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.	2009
1958	Journal EJHP Science 2005 ; 11: 23-25.	Effect of freezing, long-term storage and microwave thawing on the stability of cefuroxime sodium in 5% dextrose infusion polyvinyl chloride bags. Hecq JD, Schlesser V, Vanbeckbergen D, Jamart J, Galanti L.	2005
2320	Journal EJHP Science 2009 ; 15, 1: 15-19.	Effect of freezing, long-term storage and microwave thawing on the stability of sodium folinate. Cadrobbi J, Hecq J.D, Vanbeckbergen D, Jamart J, Galanti L.	2009
1892	Journal Int J Pharm Compound 2004 ; 8, 2: 156-159.	Effect of freezing, long-term storage and microwave thawing on the stability of tramadol in 5% dextrose infusion in polyvinyl chloride bags. Lebrun J, Hecq JD, Vanbeckbergen D, Jalart J, Galanti LM.	2004
2034	Journal EJHP Science 2005 ; 11, 5: 111-113.	Effect of freezing, long-term storage and microwave thawing on the stability of vancomycin hydrochloride in 5% dextrose infusions. Rodenbach MP, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.	2005
1648	Journal Int J Pharm Compound 2002 ; 6: 391-394.	Effect of freezing, long-term storage, and microwave thawing on the stability of cefepime in 5% dextrose infusion polyvinyl chloride bags. Schlesser V, Hecq J-D, Vanbeckbergen D, Jamart J, Galanti LM.	2002
1258	Journal Am J Hosp Pharm 1981 ; 38: 537-540.	Effect of gentamicin on heparin activity. Tyler LS, Rehder TL, Davis RB.	1981
510	Journal Pharm World Sci 1993 ; 15: 269-275.	Effect of glucose 5% solution and bupivacaine hydrochloride on absorption of sufentanil citrate in a portable pump reservoir during storage and simulated infusion by an epidural catheter. Roos PJ, Glerum JH, Schroeders MJH.	1993
3439	Journal Perit Dial Int 2013 ; 33:458-461	Effect of Glucose Concentration on the Stability of Daptomycin in Peritoneal Solutions. Parra M.A, Campanero M.A, S?daba B, Irigoyen A, Garc?a-L?pez L,Fernandez-Reyes M.J, Ramon Azanza J.	2013
729	Journal Am J Hosp Pharm 1977 ; 34: 1071-1074.	Effect of inline filtration on the potency of drugs administered intravenously. Rusmin S, Welton S, DeLuca P, DeLuca PP.	1977
703	Journal Am J Hosp Pharm 1980 ; 37: 935-941.	Effect of inline filtration on the potency of low-dose drugs. Butler LD, Munson JM, DeLuca PP.	1980
4439	Journal Nutrients 2019 ; 11: 559.	Effect of Lipid Emulsion on Stability of Ampicillin in Total Parenteral Nutrition. Stawny M, Gostynska A, Dettlaff K, Jelinska A, Główka E, Ogrodowczyk M.	2019
509	Journal Pharm World Sci 1993 ; 15: 139-144.	Effect of pH absorption of sufentanil citrate in a portable pump reservoir during storage and administration under simulated epidural conditions. Roos PJ, Glerum JH, Meilink JW, Zwang L.	1993
464	Journal Am J Hosp Pharm 1986 ; 43: 2209-2213.	Effect of pretreatment with 0.9% sodium chloride or insulin solutions on the delivery of insuline from an infusion system. Furberg H, Kruse Jensen A, Salbu B.	1986
160	Journal Am J Hosp Pharm 1994 ; 51: 2701-2704.	Effect of sodium chloride concentration and temperature on melphalan stability during storage and use. Pinguet F, Martel P, Rouanet P, Fabbro M, Astre C.	1994
2953	Journal J Pharm Sci 1982 ; 71: 585-587.	Effect of some formulation adjuncts o the stability of benzoyl peroxide. Gupta VD.	1982
587	Journal Am J Hosp Pharm 1983 ; 40: 1024-1025.	Effect of storage temperature and time stability of cefmenoxime, ceftriaxone, and cefotetan in 5% dextrose injection. Smith BR.	1983
347	Journal Am J Hosp Pharm 1991 ; 48: 2627-2630.	Effect of syringe filter and IV administration set on delivery of propofol emulsion. Bailey LC, Tang KT, Rogozinski BA.	1991
3284	Journal Yakugaku Zasshi 2008 ; 128, 8: 1221-1226.	Effect of the Admixture of Tetracycline and Nadifloxacin Ointments on Their Stability and Their Antibacterial Activity. Kawamoto T, Tayama Y, Sawa A, monde T, Sashima S, Yoshioka M, Miyake K, Morita S, Kihira K.	2008
2008	Journal Ann Pharmacotherapy 2005 ; 39: 1244-1248.	Effect of the freezing conditions and microwave thawing power on the stability of cefuroxime in dextrose 5% infusion polyolefin bags at 4°C. Hecq JD, Boitquin LP, Vanbeckbergen DF, Jamart J, Galanti LM.	2005
352	Journal Am J Hosp Pharm 1986 ; 43: 2789-2794.	Effect of tubing length on adsorption of diazepam to polyvinyl chloride administration sets. Yliruusi JK, Uotilo JA, Kristoffersson ER.	1986
2115	Journal J Pain Symptom Manage 2006 ; 31, 6: 563-567.	Effect of tubing on loss of clonazepam administered by continuous subcutaneous infusion. Schneider JJ, Good Ph, Ravenscroft PJ,.	2006
194	Journal Am J Hosp Pharm 1990 ; 47: 1559-1562.	Effect of vehicle ionic strength on sorption of nitroglycerin to a polyvinyl chloride administration set. Loucas SP, Maager P, Mehl B, Loucas ER.	1990
1349	Journal Aust J Hosp Pharm 1987 ; 17: 31-34.	Effects of freezing, long term storage and microwave thawing on the stability of three antibiotics reconstituted in minibags. Sanburg AL, LyndonRC, Sunderland B.	1987
1946	Journal Can J Hosp Pharm 2004 ; 57, 5: 276-282.	Effects of freezing, long-term storage, and microwave thawing on the stability of piperacillin plus tazobactam in 5% dextrose for infusion. Hecq JD, Berlage V, Vanbeckbergen D, Jamart J, Galanti L.	2004
2432	Journal Am J Health-Syst Pharm 1997 ; 54: 2483-2487.	Effects of ingredients on stability of captopril in extemporaneously prepared oral liquids Lye MY, Yow KL, Lim LY, Chan SY, Chan E, Ho PC.	1997
1353	Journal Am J Hosp Pharm 1984 ; 41: 1835-1837.	Effects of presaturation on nitroglycerin delivery by polyvinyl chloride infusion sets. Nix DE, Tharpe WN, Francisco GE.	1984
592	Journal J Pharm Clin 1989 ; 8: 101-106.	Effects of storage temperature and pH on the stability of cefotaxime in PVC bags. Barthes D, Fauconneau B, Martin JP, Courtois P.	1989
1736	Journal J Clin Pharm Ther 1999 ; 24: 145-150.	Effects of sucrose, citric buffer and glucose oxidase on the stability of captopril in liquid formulations. Liu J, Chan Y, Ho PC.	1999
146	Journal Clin Ther 1992 ; 14: 821-824.	Effects of temperature, solution composition, and type of container on the stability and absorption of carmustine. Hadji-Minaglou-Gonzalvez MF, Gayte-Sorbier A, Airauto CB, Verdier M.	1992
4314	Journal J Am Pharm Assoc 2017 ; 56, 4: 457-461.	Effects of Time and Storage Conditions on the Chemical and Microbiologic Stability of Diluted Buprenorphine for Injection. DenHerder J.M, Reed R.L, Sargent J.L, Bobe G, Stevens J.F, Helen E Diggs H.E.	2017
4331	Journal Pharmaceutical Technology in Hospital Pharmacy 2019	Emulsion Stability of Different Intravenous Propofol Formulations in Simulated Co-Administration with Remifentanil Hydrochloride. Nilsson N, Nezvalova-Henriksen K, Tho I.	2019
4717	Manufacturer 2022 Daiichi Sankyo Europe Gmb	Enhertu®- Résumé des caractéristiques du produit	2022
3862	Journal Hosp Pharm 2016 ; 51, 3: 246-251.	Enzymatic Stability of Alteplase Solution for Injection: Effect of Various Methods of Thawing Frozen Solutions. Cutshall B.T, Gorman G.S, Freeman M.K ,. Kyle J.A.	2016
2307	Journal Palliative Med 1995 ; 9, 4: 315-318.	Epidural diamorphine and bupivacaine stability study. Kreeger L, Cowin P, Noble-Gresty J, Naysmith A.	1995
3642	Manufacturer International Medication System (UK) 2013	Epinephrine - Résumé des Caractéristiques du Produit	2013
659	Journal Can J Hosp Pharm 1996 ; 49: 62-65.	Epinephrine stability in plastic syringes and glass vials. Donnely RF, Yen M.	1996
683	Journal Can J Hosp Pharm 1990 ; 43: 265-272.	Epirubicin stability in syringes and glass vials and evaluation of chemical contamination. Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C.	1990
3632	Manufacturer Hospira 2017	Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics	2017
798	Journal Ann Pharmacotherapy 1996 ; 30: 1501-1502.	Epoetin alfa loss with NaCl 0.9% dilution. Widness JA, Schmidt R.	1996
3934	Manufacturer GlaxoSmithKline Laboratoire 2016	Eptifibatide (Integrilin®) - Résumé des caractéristiques du produit	2016
3250	Manufacturer Eisai Ltd 2011	Eribulin (Halaven®) - Summary of Product Characteristics.	2011
1912	Manufacturer Merck Sharp Dohme 2016	Ertapenem (Invanz®) - Summary of Product Characteristics	2016
4480	Manufacturer Jazz Pharmaceuticals UK. 2020	Erwinase, Lyophilisate for solution for injection.	2020
3674	Manufacturer PanPharma 2016	Erythromycin lactobionate - Summary of Product Characteristics	2016
4700	Manufacturer AS Kalceks 2022	Esketamine 25 mg/mL solution for injection/infusion. - Summary of Product Characteristics	2022
3607	Manufacturer AOP Orphan Pharmaceuticals AG 2013	Esmolol hydrochloride for injection - Summary of Product Characteristics	2013
2284	Manufacturer Astra Zenaca 2007	Esomeprazole sodium (Nexium IV®) – Summary of Product Characteristics	2007
4612	Journal OFIL 2014 24;2:86-90	Estabilidad de la solución de gentamicina y heparina para sellado de catéter. Villaba-Moreno AM, Gil-Navarro MV, Cotrina-Luque J, Pérez-Moreno MA, Chamorro-de Vega E.	2014
3489	Journal Farm Hosp 1998 ; 22, 5: 249-251.	Estabilidad de las soluciones orales de clohidrato de metadona al 0,1% y 0,5% en suero fisiologico. Soy D, Roca M, Deulofeu R, Montes E, Codina C, Ribas J.	1998
2202	Journal Investig Clin Farm 2005 ; 2, 4: 195-203.	Estabilidad de parecoxib en dilucion con ostros farmacos y administrado en perfusion continua IV para el control del dolor postoperatorio. Acin Lazaro MP, bono Arino C, martinez Bazan R, manzanares Marin I, Faci Bouthelier A, Velamazan Blocona MJ, Facorro Gaspar E,	2005
2105	Journal Farm Hosp 1999 ; 23: 357-360.	Estabilidad de una mezcla de etomidato y pentotal para administracion intravenosa en bolo. Valverde molina F, Hernandez Hernandez G, Munoz Castillo M, Novales Duran J, Gallego Fernandez C.	1999
3198	Journal Farm Hosp 2008 ; 32, 6 : 344-348.	Estabilidad en suero fisiológico del busulfán intravenoso en un envase de poliolefinas. Nebot Martinez J, Alos Alminana M, Diez Sales O.	2008
2100	Journal Farm Hosp 1995 ; 19: 38-40.	Estabilidad fisica y quimica del sulfato magnesico combinado con heparina sodica en solucion salina al 0,9 por 100. Gervas S, Gosalbez F.	1995
2103	Journal Farm Hosp 1999 ; 23: 103-108.	Estabilidad y compatibilidad del metamizol en jeringa y en mezclas intravenosas. Noguera Rodriguez A, Sancho Chust V, Medina Hernandez C, Medina Hernandez MJ, Jimenez Torrez NV.	1999
2841	Journal Atencion Pharmaceutica 2009 ; 11, 3: 161-166.	Estudio de estabilidad de la mezcla ondansetron-dexametasona en cloruro sodico 0,9%. Gonzalves Navaro M, Carril Aviles M, Borras Almenar C, Romero Crespo I, Jimenez Torres NV.	2009
3706	Journal Farm Hosp 2014 ;38, 3:154-161	Estudio de estabilidad de oxaliplatino y doxorrubicina para su administración intraperitoneal con hipertermia. Escudero-Ortiz V, Duart-Duart M.J, P?rez-Ruixo C, P?rez-Ruixo J.J, Valenzuela B.	2014
3384	Journal Farm Hosp 2013 ;37,1:10-14	Estudio de estabilidad de tiaprida en disolución para administración en perfusión intravenosa continua. Otero F.M	2013
2104	Journal Farm Hosp 2000 ; 24: 145-150	Estudio de la estabilidad de mezclas ciclofosfamida/mesna e ifosfamida/mesna en soluciones intravenosas de gran volumen. Iriarte Izura MA, Gozalo garcia MJ, Marcotegui Ros F, Nagore Indurain C, Urdaniz Baztan AO.	2000
3655	Manufacturer Bristol Myers Squibb 2016	Etoposide phosphate (Etopophos®) - Résumé des caractéristiques du produit	2016
2181	Journal Bull Cancer 1995 ; 82: 189-195.	Etude de compatibilité physicochimique 5- fluoro-uracile (nouvelle préparation française) - acide folinique. Milano G, Renée N.	1995
3791	Poster Apifh Congress, Paris November 2014 2014	Étude de la compatibilité physico-chimique du phloroglucinol injectable durant les mélanges au sein des tubulures en Y. Sadou Yaye H, Burtet E, Hamel C, Aljhni R, Gard C, Tilleul P.	2014
3240	Poster Congrès SFPO 2011	Etude de la stabilité d'une solution de bortézomib à 1 mg/mL conditionnée en seringue de polypropylène. Perissutti M, Vigneron J, Zenier H, May I, Demoré B.	2011
504	Journal Sci Tech Pharm 1987 ; 3: 33-40.	Etude de la stabilité dans des solutions diluées destinées à la perfusion de deux antimitotiques dérivés de la podophyllotoxine : l’étoposide (VP 16), le téniposide (VM 26). Hamon M, Plas-Remoissenet D, Kubab-Alajati S.	1987
1455	Journal J Pharm Clin 1995 ; 14: 178-179.	Etude de la stabilité de deux benzamides antiémétiques en poches PVC de chlorure de sodium 0.9% et de glucose 5% sur une période de 5 mois. Demoré B, Raffy F, Commun N, Vigneron J, Hoffman MA, Hoffman M.	1995
4007	Poster Hopipharm Congress 2017-Nancy 2017	Etude de la stabilité de la vancomycine à 40 mg/ml au cours d'une perfusion de 24 heures. Masse M, Genay S, Carta N, Delannoy-Rousseli?re C, Moreau F, Barthelemy C, Faure K, Decaudin B, Odou P.	2017
3761	Book Master en pharmacie - University of Geneva 2014	Etude de la stabilité de solutions de prostaglandine E1 à 48 et 72 heures en vue d'une administration parentérale en continu à des patients de néonatalogie. Chavan E.	2014
3447	Poster SFPO Congress, Mandelieu, France 2013	Etude de la stabilité d’une solution de bortézomib à 2,5 mg/mL par chromatographie liquide à haute performance couplée à un détecteur à barrettes de diodes et à un détecteur évaporatif à diffusion de lumière. Giovanelli M, Vigneron J, May I, Nicolas A.	2013
4714	Poster GERPAC Congrès - octobre 2022 2022	Etude de stabilité d'un biosimilaire du Bevacizumab dans les flacons et après dilution dans du NaCl 0.9% en poche de polyoléfine. Vieillard V, Paul M	2022
3848	Thesis Thèse de doctorat en pharmacie 2014	Etude de stabilité d'un collyre à l'amphotéricine B 0,5%. Dermu Marine.	2014
4041	Poster SNPHPU Congress 12th 2017	Etude de stabilité d'un collyre de ceftazidime à 50mg/ml conditionné en flacon de polyéthylène basse densité. Jobard M, Brandely-Piat M-L, El Deeb G, Labat L, Cros C, Chast F, Batista R.	2017
4424	Poster 11ème Recontres Convergences Santé Hôpital 2016	Etude de stabilité d'une suspension buvable de cloxacilline à usage pédiatrique. Barbazan C, Le Daré, Lester M-A, Boivin P-N.	2016
4578	Thesis 2011	Etude de stabilité de médicaments anticancéreux injectables : apports analytiques et pharmaceutiques Respaud R.	2011
3120	Poster Congrès HOPIPHARM 2010	Etude de stabilité de solutions intravitréennes de vancomycine à 10 mg/ml. Maillot-Pyszczek V, Bourdeaux D, Sautou V, Chopineau J.	2010
1520	Manufacturer B Braun 2001	Etude de stabilité des médicaments en Ecoflac®	2001
2760	Journal Pharm Hosp et Clin 2007 ; 42, 171 : 171-176.	Etude de stabilité d’un collyre à ,6 mg/ml de ticarciline. Galvez O,Mullot JU, Mullot H, Simon L, Grippi R, Payen C, Bonneau D, Huart B, Gentes P.	2007
4066	Poster APHIF 2017 - Congress 2017 2017	Etude de stabilité physico-chimique et microbiologique des collyres de ciclosporine à 0.5 ; 5 et 20 mg/mL conditionnés en flacons de polyéthylène basse densité. Mordohay A, Chanat C, Bezia C, Fresneau J, Jobard M, Brandely-Piat M.L, Batista R.	2017
1289	Journal Pharmakon 1998 ; 116: 145-148.	Etude de stabilité visuelle du chlorhydrate de chlorpromazine, du chlorure de potassium, de la furosémide et de l’héparine sodique en perfusion continue. Hecq JD, Evrard JM, Gillet P, Grosdent N.	1998
3383	Journal Farm Hosp 2013 ;37,1:4-9	Evaluación de la estabilidad de un jarabe de hidrato de cloral al 7% en envases mono y multidosis bajo condiciones ambiente y de refrigeración. Bustos-Fierro C, Olivera M. E, Manzo P.G, Jimenez-Kairuz A.K.	2013
4643	Journal EJHP 2021	Evaluation of 30-day stability of morphine hydrochloride and clonidine at high and low concentrations in polypropylene syringes. Catry E, Colsoul M-L, Closset M, Nyssen C, Hubert J, Soumoy L, Bihin B, Jamart J, Hecq J-D, Galanti L.	2021
1645	Journal EJHP 2010 ; 16: 42-47.	Evaluation of a diltiazem hydrochloride gel for the treatment of anal fissure. Pinto JF, Salgado AC, Alves ML, Alves S, Neves C, Falcao F.	2010
2991	Journal Drug Dev Ind Pharm 1997 ; 23: 285-291.	Evaluation of oil/water-type cyclosporine gel ointment with commercially available oral solution. Tamura T, Takayama K, Satoh H et al.	1997
4627	Journal Adv Ther 2019 36:442–450	Evaluation of Physicochemical and Biological Stability of 36-Months-Aged SB5 (Adalimumab Biosimilar) for 4 Weeks at Room Temperature. Park D, Yun J, Hwang S-J, Park SJ.	2019
4637	Journal Braz J Pharm Sci 2021 ;57: e18896.	Evaluation of physicochemical and microbiological stability of liquid preparation from tizanidine hydrochloride tablets - a Hospital concern. Gobetti C, da Silva Bitencourt, A, Vinícius Ayres M, Peixoto de Freitas A.L, Loureiro Mendez A.S, Garcia C.V.	2021
739	Journal Am J Hosp Pharm 1978 ; 35: 402-406.	Evaluation of some pharmaceutical aspects of intrathecal methotrexate sodium, cytarabine and hydrocortisone sodium succinate. Cradock JC, Kleinmann LM, Rahman A.	1978
3861	Journal J Pharm Pract and Res 2016 ; 46: 28-33.	Evaluation of stability of melatonin in extemporaneously compounded oral suspensions. Friciu M , Savji T , Zaraa S, Leclair G.	2016
4525	Journal Adv Ther 2020 ; 37: 4308–4324.	Evaluation of the Physico-Chemical and Biological Stability of SB8 (Aybintio), a Proposed Biosimilar to Bevacizumab, Under Ambient and In-Use Conditions. Park D, Kim J, Yun J, Park S.J.	2020
4003	Journal EJHP 2017 ; 25, 3: 157-164.	Evaluation of the physicochemical and biological stability of reconstituted and diluted SB2 (infliximab). Kim J, Chung J, Park S, Jung S, Kang D.	2017
3825	Journal J Pharm Pract and Res 2015 ; 496: 421-431.	Evaluation of the physicochemical and functional stability of diluted REMSIMA(R) upon extended storage—A study compliant with NHS (UK) guidance. Young B.L, Ali Khan M, Chapman T.J, Parry R,. Connolly M.A, Watts A.G.	2015
2730	Journal J Pharm Pract and Res 2015 ; 45: 152-158.	Evaluation of the physicochemical compatibility of cyclosporin infusion and parenteral nutrition when intravenously administered via the same central line lumen. Coutsouvelis J, Yao-Da Dong, Witney K, Li W, Corallo C.	2015
4252	Journal Int J Pharm Compound 2019 ;23,2:163-166	Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit. Lardinois B, Dimitriou A, Delcave C, Jamart J, Bihin B, Soumoy L, Hecq JD, Galanti LM.	2019
4157	Journal Pediatric Anesthesia 2018	Evaluation of the stability and stratification of propofol and ketamine mixtures for pediatric anesthesia. Izgi M, Basara B, Muderrisoglu A, Yilbas A.A, Uluer M.S, Celebioglu B.	2018
3345	Journal Int J Pharm Compound 2012 ; 16, 5: 428-430.	Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date. Peacock G.F, Sauvageot J.	2012
3667	Journal Int J Pharm Compound 2014 ; 18, 3: 253-255.	Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Peacock Gina F,Sauvageot Jurgita	2014
4117	Journal Drug Design Dev Ther 2017 ;11:2087-2097	Evaluation of the stability of linezolid in aqueous solution and commonly used intravnous fluids. Taylor R, Sunderland B, Luna G, Czarniak P.	2017
3843	Journal Int J Pharm Compound 2016 ; 20, 1: 81-85	Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date. Peacock G.F, Sauvageot J, Hill A, Killian A.	2016
2828	Journal J Clin Pharm Ther 2008 ; 33, 3: 263-271.	Evaluation of the stability of morphine sulphate in combination with Instillagel®. Abdelmageed R, Labyad N, Watson DG, Pournamdari M, Cable CG, Stanley E.	2008
4373	Journal EJHP 2020 ; 27(e1):e87-e92.	Evaluation of the stability of vancomycin solutions at concentrations used in clinical services. Masse M, Genay S, Martin Mena A, Carta N, Lannoy D, Barthélémy C, Décaudin B, Odou P.	2020
4426	Journal Medicine 2019 98:21(e15747)	Evaluation of Y-site compatibility of home total parenteral nutrition and intravenous loop diuretics. Watrobska-Swietlikowska D, Pietka M, Stanislaw Klek S.	2019
3408	Journal Pharmactuel 2013 ; 46, 1 : 16-21.	Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels. Tollec S, Touzin K, Pelletier E, Forest J.M.	2013
829	Journal Int J Pharm 1988 ; 42: 41-46.	Examination of sorption and photodegradation of amsacrine during storage in intravenous burette administration sets. Cartwright-Shamoon JM, McElnay JC, D'Arcy PF.	1988
3759	Journal Yakugaku Zasshi 2014 ; 134, 2: 293-298.	Examination of the cause of changing solution color by mixing aminophylline and dopamine, the compatibility of which was indicated by the supplier. Igarashi K, Kawahara M.	2014
3169	Journal Pain Clinic 1999 ; 11: 213-216.	Experimentation about precipitation of pharmacological association: morphine and ketorolac. Raffaeli W, Pari G, Visani L et al.	1999
2932	Journal J Pharm Pract and Res 2005 ; 35: 181-182.	Extemporaneous isoniazid mixture: stability implications. Haywood A, Mangan M, Grant G et al.	2005
4729	Journal Pharmaceutics 2023 ; 15, 208.	Extemporaneous Preparation of 20 mg/mL Ganciclovir in Artificial Tears in Comparison with SterileWater for Ophthalmic Administration: Formulation and Stability Study. Leanpolchareanchai J, Tangteerakoon P, Supapsophon P, Sukavatcharin S, Simaroj P, Suksiriworapong J.	2023
2926	Journal Am J Health-Syst Pharm 2006 ; 63: 254-257.	Extemporaneous sildefanil citrate oral suspensions for the treatment of pulmonary hypertension in children. Nahata MC, Morosco RS, Brady MT.	2006
3682	Journal EJHP 2016 ;23:33-37	Extemporaneous sotalol hydrochloride oral solutions for use in paediatric cardiology: formulation and stability study. Klovrzova S, Zahalka L, Kriz T, Zahalkova O, Matysova L, Sklubalova Z, Horak P.	2016
4436	Journal Anaesthesiol Intensive Ther 2018 ; 50, 3: 221-225.	Extended compatibility of fentanyl and ketamine in dextrose 5%. Hanifah S, Kennedy R.A; Ball P.A.	2018
4755	Journal J Oncol Pharm Practice 2023	Extended physicochemical stability of cetuximab in opened vials and infusion bags when stored at 4°C and 25°C. Vieillard V, Le Guyader G, Jallades A, Astier A.	2023
110	Journal Int J Pharm 1989 ; 54: 181-189.	Extended stability of 5-fluorouracil and methotrexate solutions in PVC containers. Vincke BJ, Verstraeten AE, El Eini DID, Mc Carthy TM.	1989
4191	Journal GaBI Journal 2018	Extended stability of a biosimilar of trastuzumab (CT-P6) after reconstitution in vials, dilution in polyolefin bags and storage at varioustemperatures. Vieillard V, Astier A, Paul M.	2018
1995	Journal Am J Health-Syst Pharm 2005 ; 62: 1073-1074.	Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injection. Chin A, Liu S, Ting-Chan J, Gill MA.	2005
4026	Journal Hosp Pharm 2017 ; 52, 8 : 570-573	Extended Stability of Epinephrine Hydrochloride Injection in Polyvinyl Chloride Bags Stored in Amber Ultraviolet Light-Blocking Bags. Van Matre E.T, Ho K.C., Lyda C, Fullmer B.A, Oldlan A.R, Kiser T.H.	2017
88	Journal J Acquired Immune Defic Syndr 1992 ; 5: 354-358.	Extended stability of ganciclovir for outpatient parenteral therapy for cytomegalovirus retinitis. Mole L, Oliva C, O?Hanley P.	1992
3350	Journal Am J Health-Syst Pharm 2012 ; 69:1999-2001	Extended stability of intravenous acetaminophen in syringes and opened vials. Kwiatkowski J.L, Johnson C.E, Wagner D.S.	2012
4737	Journal Hosp Pharm 2023 ; 58, 2/ 183-187.	Extended Stability of Isoproterenol Hydrochloride Injection in Polyvinyl Chloride Bags Stored in Amber Ultraviolet Light Blocking Bags. Van Matre E.T, Rice P.J, Wempe M.F, Lyda C, Kiser T.H.	2023
3301	Journal Hosp Pharm 2012 ; 47, 4: 289-292.	Extended Stability of Magnesium Sulfate Infusions Prepared in Polyolefin Bags. Sayre B.E, Prettyman T, Kaushal G.	2012
3866	Journal Int J Pharm Compound 2016 ; 30, 3 : 247-249.	Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children. Nahata M C.	2016
2097	Journal Int J Pharm Compound 2006 ; 10: 156-158.	Extended stability of oxytocin in common infusion solutions. Trissel LA, Zhang Y, Douglass K, Kastango E.	2006
2337	Journal Can J Hosp Pharm 2009 ; 62, 2: 135-141.	Extended Stability of Pantoprazole for Injection in 0.9% Sodium Chloride or 5% Dextrose at 4°C and 23°C Walker S.E, Iazzetta J, Law S.	2009
4271	Journal Adv Ther 2019	Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties Yun J, Kim J, Chung J, Hwang S-J, Park S-J.	2019
3329	Journal Hosp Pharm 2012 ; 47, 7: 538-543.	Extended Stability of Sodium Bicarbonate Infusions Prepared in Polyolefin Bags. Sayre B.E, Prettyman T, Kaushal G.	2012
3945	Journal Can J Hosp Pharm 2017 ; 70,1 : 7-12.	Extended Stability of Sodium Phosphate Solutions in Polyvinyl Chloride Bags. Perks W, Iazzetta J, Chan P.C, Brouzas A, Law S,Walker S.E.	2017
4016	Journal Ann Pharm Fr 2017 ; 75, 6: 420-435.	Extended stability of the rituximab biosimilar CT-P10 in its opened vials and after dilution and storage in polyolefin bag. Vieillard V, Paul M, Ibrahim T, Astier A.	2017
4649	Journal GaBI Journal 2021 ; 10, 4	Extended stability of the trastuzumab biosimilar ABP 980 (KANJINTI™) in polyolefin bags and elastomeric devices. Davies L, Milligan K, Corris M, Clarke I, Dwyer P, Lee S-E, Teraoka J, Crouse-Zeineddini J, Hippenmeyer J.	2021
2642	Journal Int J Pharm 1982 ; 11, 4: 329-336.	Factors affecting captopril stability in aqueous solution Timmins P, Jackson IM, Yu-chang John Wang.	1982
1182	Journal Am J Hosp Pharm 1981 ; 38: 1449-1454.	Factors affecting diazepam infusion: solubility, administration-set composition, and flow rate. Mason NA, Cline S, Hyneck ML, Berardi RR, Ho NFH, Flynn GL.	1981
122	Journal Int J Pharm Pract 1993 ; 2: 39-43.	Factors affecting the physical and chemical stability of morphine sulphate solutions stored in syringes. Grassby PF, Hutchings L.	1993
522	Journal Can J Hosp Pharm 1989 ; 42: 97-103.	Famotidine stability in total parenteral nutrient solutions. Walker SE, Iazetta J, Lau DWC, Madorin PL.	1989
3463	Journal Nursing 2011 ; 29 :62-6	Fármacos en perfusión continua en la unidad de cuidados intensivos: estudio de compatibilidad. Eva Perez Juan, Maria Jos? Arévalo Rubert , Silvia Monica Amoros Cerda , Palau M.M, Nicolau B.R.	2011
3758	Journal J Pharm Pract and Res 2014 ; 44, 89?94	Feasibility and stability of metaraminol in pre-filled syringes. To T.P, Ching M.S, Booth J.C, Zeglinski P, McGrath A, Elli A.G,Garrett K.	2014
3819	Journal J Pharm Biomed Anal 2015 ; 118: 105-112.	Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend® SF PH4 oral suspensions. Ferreiraa A.O, Poloninia H.C, Silva S.L, Patricio F.B, Brand?oa M.A.F, Raposoa N.R.B.	2015
3503	Manufacturer Hameln Pharmaceuticals 2012	Fentanyl - Summary of product Characteristics	2012
3618	Manufacturer Amgen 2014	Filgrastim (Neupogen®) - Summary of Product Characteristics	2014
1413	Journal Int J Pharm Compound 1999 ; 3: 67-68.	Five-day stability of vinorelbine in 5% dextrose injection and in 0.9% sodium chloride injection at room temperature. Lieu CL, Chin A, Gill MA.	1999
3522	Manufacturer Actavis 2013	Flucloxacillin - Summary of Product Characteristics.	2013
3565	Manufacturer Aguettant 2008	Flumazenil Aguettant - Résumé des caractéristiques du produit.	2008
3474	Manufacturer Accord Healthcare Limited 2009	Fluorouracil - Summary of Product Characteristics	2009
1998	Journal Am J Health-Syst Pharm 1998 55: 1315-1316.	Fluorouracil precipitate. Allwood MC.	1998
3992	Journal Int J Pharm 2016 ; 509 : 279:284.	Formulation and charaterization of 0,1% rapamycin cream for the treatment of Tuberous Sclerosis Complex-related angiofibromas. Bougueon G, Lagarce F, Martin L, Pailhoriès H, Bastiat G, Vrignaud S.	2016
3800	Journal Iranian J Pharm Res 2003 : 157-160.	Formulation and Clinical Evaluation of Povidone-Iodine Ophthalmic Drop. Rahim Bahri Najafi, Soleyman Mohammadi Samania, Nahid Pishvab, Fateme Moheimania.	2003
2786	Journal Am J Health-Syst Pharm 2005 ; 62, 5: 485-491.	Formulation and efficacy of triamcinolone acetonide mouthwash for treating oral lichen planus. Ungphaiboon S, Nittayananta W, Vuddhakul V, Maneenuan D, Kietthubthew S, Wongpoowarak W, Phadoongsombat N.	2005
3321	Journal Int J Pharm Compound 2012 ; 16, 4: 342-346.	Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets. Zaid Abdel Naser, Malkieh Numan, Kharoaf Maher, Ghoush Abeer Abu, Al-Ramahi Rowa.	2012
3785	Journal J Pain Palliat Care Pharm 2014 ;,28, 4: 367?370.	Formulation and Stability of an Extemporaneously Compounded Oral Solution of Chlorpromazine HCl Prohotsky D.L, . Juba K.M, Zhao F.	2014
4547	Journal EJHP 2021	Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia. Lin Y-S, Lin S-C, Hsieh Y-T,Liu L-Y,Lin C-H, Shen L-J, Huang C-F.	2021
2682	Journal Int J Pharm Pract 1991 ; 1: 19-22.	Formulation and stability of cefuroxime eye-drops. Oldham GB.	1991
2476	Journal Am J Hosp Pharm 1986 ; 43: 1489-1491.	Formulation and stability of diazepam suspension compounded from tablets Strom JG, Jr, Kalu AU.	1986
2542	Journal Ann Pharmacotherapy 1997 ;31:1291-1295.	Formulation and stability of naltrexone oral liquid for rapid withdrawal from methadone. Fawcett JP, Morgan NC, Woods DJ.	1997
3669	Journal Ann Pharm Fr 2015 ; 73, 1: 31-36.	Formulation and stability study of a pediatric 2% phenylephrine hydrochloride eye drop solution Dreno C, Gicquel T, Harry .M, Tribut O, Aubin F, Brandhonneur N, Dollo G.	2015
4170	Journal Int J Pharm Compound 2018 22,5:433-439	Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding. Zhao F, Dave V.S, Mar M, Perri J.	2018
4523	Journal Pharm Dev Technol 2021	Formulation and stability study of hydroxychloroquine sulfate oral suspensions. El Mershati S, Thouvenin A , Secretan P-H, De Lonlay P, Tuchmann-Durand C, Cisternino S, Schlatter J.	2021
4360	Journal Hosp Pharm 2019	Formulation and Stability Study of Omeprazole Oral Liquid Suspension for Pediatric Patients. Oriana Boscolo, Francesco Perra, Leandro Salvo, Fabiàn Buontempo, and Silvia Lucangioli.	2019
4008	Poster Hopipharm Congress 2017-Nancy 2017	Formulation et étude de stabilité de crèmes au sirolimus dosées à 0,1, à 0,25 ou à 0,5% m/m. Vrignaud S, Bougueon G, Briot T, Truffaut C, Martin L, Pailhori?s H, Bastiat G, Clerc M-A, Lagarce F.	2017
4104	Journal Pharmaceutical Technology in Hospital Pharmacy 2018	Formulation of a 3-months Stability Oral Viscous Budesonide Gel and Development of an Indicating Stability HPLC Method. Bonnet M, Dermu M, Roessle C, Bellaiche M, Abarou T, Vasseur V, Benakouche S, Storme T.	2018
3017	Journal Eur Hosp Pharm 1996 ; 2: 176-180.	Formulation of a stable calcium gluconate gel for topical treatment of hydrofluoric acid burns. Rotheli-Simmen B, Martinelli E, Muhlebach S.	1996
2720	Journal J Ocular Pharm Ther 2007 ; 23, 3: 292-303.	Formulation of sirolimus eye drops corneal permeation studies. Buech G, Bertelmann E, Pleyer U, Siebenbrodt I, Borchert HH.	2007
4517	Journal EJHP 2020	Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa. Cordero-Ramos J, Merino-Bohórquez V, Delgado-Valverde , Barros-Tornay R, Cameán-Fenández M, Calleja-Hernández M.A.	2020
4079	Journal J Pharm Anal 2017 ; 7, 4: 237-243.	Formulation, stability testing, and analytical characterization of melatonin-based preparation for clinical trial. Filali S, Bergamelli C, Tall M.L, Salmon D, Laleye D, Dhelens C, Diouf E, Pivot C, Pirot F.	2017
2295	Manufacturer Merck Sharp Dohme 2013	Fosaprepitant (Emend®) - Summary of Product Characteristics	2013
3662	Manufacturer Clinigen 2014	Foscavir (Foscarnet®) - Summary of Product Characteristics	2014
3663	Manufacturer Panpharma 2011	Fosfomycine (Fosfomycine Panpharma®) - Résumé des caractéristiques du produit	2011
1419	Journal Int J Pharm Compound 1999 ; 3: 235-238.	Fosphenytoin Y-site stability studies with lorazepam and midazolam hydrochloride. Riggs RM, English BA, Webster AA, McGuire JM, Riordan JM.	1999
2124	Journal EJHP Science 2006 ; 12, 4: 72-75.	Freeze thaw treatment of ketorolac tromethamine in 5% dextrose infusion polyolein bags: effect of drug concentration and microwave power on the long-term stability at 4°C. Hecq JD, Boitquin L, Lebrun C, Vanbeckbergen D, Evrard JM, Jamart J, Galanti L.	2006
1329	Journal Br J Parent Ther 1986 ; march/april: 42-44.	Freeze-thaw stability of antibiotics used in an IV additive service. Brown AF, Harvey DA, Hoddinott DJ, Britton.	1986
3639	Manufacturer Wockhardt 2013	Furosemide - Summary of Product Characteristics	2013
1855	Journal J Pharm Biomed Anal 2000 ; 23: 803-817.	Furosemide assay in pharmaceuticals by Micellar liquid chromatography: study of the stability of the drug. Carla-Broch S, Esteve-Romero J, Garcia-Alvarez-Coque MC.	2000
4060	Journal EJHP 2018 ;25,3:144-149	Furosemide ethanol-free oral solutions for paediatric use : formulation, HPLC method and stability study. Zahalka L, Klovrzova S, Matysova L, Sklubalova Z, Solich P.	2018
3661	Manufacturer Laboratoire L?o 2012	Fusidate de sodium (Fucidine®) - Résumé des caractéristiques du produit	2012
3496	Manufacturer Actavis 2009	Gemcitabin Actavis solution - Stability Study	2009
1913	Manufacturer Pfizer Europe 2020	Gemtuzumab ozogamicin (Mylotarg® - Summary of Product Characteristics)	2020
3643	Manufacturer Sanofi 2015	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics	2015
1395	Journal Thromb Haemost 1980 ; 43: 67.	Glass adsorption of highly purified urokinase. Toki N, Sumi H.	1980
3599	Manufacturer Amco Amdipharm Mercry 2013	Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics	2013
1643	Journal Hosp Pharm 1994 ; 29: 76.	Haldol-benztropine incompatibility. Raleigh F, Gibler B.	1994
985	Journal Ann Pharmacotherapy 1996 ; 30: 549.	Haloperidol and diphenhydramine compatibility. Raleigh FR, Gibler BS.	1996
1022	Journal Drug Intell Clin Pharm 1986 ; 20: 886.	Heparin and aminoglycosides instability. Hutchinson SMW.	1986
3540	Manufacturer Wockhardt 2010	Heparin sodium - Summary of Product Characteristics.	2010
3113	Book Compendium Suisse des m?dicaments 2010	Herceptin	2010
3796	Journal Br Ophtalmol 1995 ; 79: 753-755.	High dose intravitreal ganciclovir for CMV retinitis: a shelf life and cost comparison study. Morlet N, Young S, Naidoo D et al.	1995
1151	Journal J Chromatogr 1981 ; 212: 339-346.	High-performance liquid chromatographic determination of sodium nitroprusside. Baaske DM, Smith MD, Karnatz N, Carter JE.	1981
3757	Journal Antimicrob Agents Chemother 2014 ; 58 : 2849-2855.	How To Minimize Toxic Exposure to Pyridine during Continuous Infusion of Ceftazidime in Patients with Cystic Fibrosis? Bourget P, Amin A, Dupont C, Abely M, Desmazes-Dufeu N, Dubus J.C, Jouani B.-L., Merlette C, Nov?-Josserand R, Pages J, Panzo R	2014
2166	Journal J Liquid Chrom Rel Technol 2003 ; 26, 17: 2909-2929.	HPLC-DAD methods for studying the stability of solutions containing hydromorphone, ketorolac, haloperidol, midazolam, famotidine, metoclopramide, dimenhydrinate and scopolamine. Nassr S, Dubuc MC, Lavoie P, Brazier JL.	2003
2011	Journal Krankenhauspharmazie 2005 ; 26, 6: 206-210.	HPLC-stabilitätuntersuchungen zu rekonstituierten Bortezomib-Lösungen. Friess D, Nguyen HC, Lipp HP.	2005
1733	Journal Pharmazie 1999 ; 54: 542-544.	HPTLC-based stability assay for determination of amiodarone in intravenous admixtures. Kopelent-Frank H, Schimper A.	1999
3617	Manufacturer Wockhardt 2011	Hyaluronidase (Hyalase®) - Summary of Product Characteristics	2011
3184	Manufacturer CP Pharmaceuticals 2005	Hyaluronidase (Hyalase®) - Summary of Product characteristics.	2005
2275	Journal Int J Pharm 1998 ; 173: 221-232.	Hydrolysis kinetics and stability predictions for a mixture of R and S temocillin isomers. Craig Dyar S, Notari RE.	1998
2215	Journal Chem Pharm Bull 1984 ; 32, 3: 1113-1119.	Hydrolysis of succinylcholine chloride in pH range 3.0 to 4.5. Boehm J.J, Poust R.I.	1984
2364	Poster PharmSciFair 2009	Hydromorphone and dipyrone in PCA devices: Is still a therapy with hydromorphone? M?ller S, Trittler R, Schubert R, Strehl E.	2009
120	Journal Can J Hosp Pharm 1988 ; 41: 177-182.	Hydromorphone and morphine stability in portable infusion pump cassettes and minibags. Walker SE, Coons C, Matte D, DeAngelis C, Iazzetta J, Kolos C, Birkhans B.	1988
3932	Manufacturer Serb Laboratoire 2015	Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit	2015
3600	Manufacturer UCB Pharma SA 2009	Hydroxyzine (Atarax®) - Résumé des caractéristiques du produit	2009
1380	Journal Am J Hosp Pharm 1984 ; 41: 74.	Identification of labetolol precipitate. Alam AS.	1984
1915	Manufacturer Genzyme 2010	Imiglucerase (Cerezyme®) -Summary of product Characteristics	2010
3530	Manufacturer Hospira 2013	Imipenem/Cilastatin – Summary of Product Characteristics	2013
1871	Journal Int J Pharm 2002 ; 234: 205-212.	Impact of deep freezing on the stability of 25 mg/ml vancomycin ophtalmic solutions. Sautou-Miranda V, Libert F, Grand-Boyer A, Gellis C, Chopineau J.	2002
2649	Journal Int J Pharm 2002 ; 234, 1-2: 205-212.	Impact of deep freezing on the stability of 25 mg/ml vancomycin ophtalmic solutions. Sautou-Miranda V, Libert F, Grand-Boyer A, Gellis C, Chopineau J.	2002
2733	Journal J Pharm Clin 1999 ; 18: 179-182.	Impact of deep-freezing on pefloxacin eye drops stability. Gellis C, Sautou-Miranda V, Arvouet A.	1999
4605	Journal Ann Allergy 2012 ; 2:28.	Impact of physical incompatibility on drug mass flow rates: example of furosemide-midazolam incompatibility. Foinard A, Décaudin B, Barthélémy C, Debaene B, Odou P.	2012
4757	Journal Hosp Pharm 2023 ; 58, 3: 304-308.	In Vitro Assessment of Compounded Lurasidone Suspensions for Enteral Feeding Tubes. Wojcinski J, Nathan K, Zhaohttps F.	2023
966	Journal JPEN 1991 ; 15: 536-539.	In vitro assessment of vancomycin HCl compatibility after coinfusion with a specialized amino acid formulation. Martins AM, McDougal A, Hamilton D, Igwemezie L, McErlane K.	1991
4352	Journal J Clin Pharm Ther 2019 ; 44: 875-882.	In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag. Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y.	2019
979	Journal Int Pharm J 1995 ; 9: 57.	In vitro compatibility of granisetron with selected alkaline drugs. D'Arcy PF.	1995
3294	Journal EJHP 2012 ; 19: 57-64.	In vitro compatibility of remifentanil hydrochloride and sufentanil citrate with selected drugs Humbert-Delaloye V, Berger M, Voirol P, Pannatier A.	2012
3381	Journal EJHP 2013 ; 20:110-116.	In vitro compatibility of various cardioactive drugs during simulated Y-site administration. Humbert-Delaloye V, Berger-Gryllaki M, Voirol P, Gattlen L, Pannatier A.	2013
4048	Journal Hosp Pharm 2017 ;52,11:752-760	In vitro evaluation of eslicarbazepine delivery via enteral feeding tubes. Reindel K, Zhao F, Hughes S, Dave V.	2017
209	Journal Am J Hosp Pharm 1990 ; 47: 1574-1579.	In vitro evaluation of the stability of raniditine hydrochloride in total parenteral nutrient mixtures. Williams MF, Hak LJ, Dukes G.	1990
643	Journal Cancer Treat Rep 1987 ; 71: 1189-1192.	In vitro stability and compatibility of daunorubicin, cytarabine, and etoposide. Seargeant LE, Kobrinsky NL, Sus CJ, Nazeravich DR.	1987
3205	Journal AAPS Pharm Sci 2011 ; 15, 2 : 264-272.	in vitro stability and compatibility of tenecteplase in central venous access devices. Lentz, Y.K. , Joyce, M., Lam, X.	2011
3953	Journal Hemodial Int 2011 ; 15, 2 : 364-272.	In vitro stability and compatibility of tenecteplase in central venous access devices. Lentz Y.K, Joyce M, Lam X.	2011
4484	Journal Drugs R D 2022 ;22, 95–104	In Vitro Stability and Recovery Studies of Pimavanserin in Water and in Different Vehicles Orally Administered. Bokser A D, Holmes Adegbenle Y, Stoisavljevic V, Norton J C.	2022
2793	Journal Hosp Pharm 2015 ; 50, 4 : 296-303.	In Vitro Stability Evaluation of Different Pharmaceutical Products Containing Meropenem. Tomasello C, Leggieri A, Cavalli R, Di Perri G, D?Avolio A.	2015
2468	Journal J Pharm Sci 2023 ; 112: 963-973.	In vitro Stability of Biosimilar Insulin Aspart SAR341402 in the Medtronic MiniMed Insulin Pumps. Mohnicke M, Blecher A, Beichert K, Bidlingmaier B, Todt E-J, Dette C, Rotthaeuser B, Mukherjee B.	2023
3149	Journal Diabetes Tech and Ther 2006 ; 8, 3: 358-368.	In Vitro Stability of Insulin Lispro in Continuous Subcutaneous Insulin Infusion. DeFelippis MR, Bell MA, Heyob JA, Storms SM.	2006
1037	Journal J Pharm Sci 1984 ; 73: 838-839.	In vitro stability of sodium nitroprusside solutions for intravenous administration. Mahony C, Brown JE, Stargel WW, Verghese CP, Bjornsson TD.	1984
1322	Journal JPEN 1983 ; 7: 156-158.	In vitro study of inline filtration of medications commonly administered to pediatric cancer patients. Ennis CE, Merritt RJ, Neff DN.	1983
4194	Journal Bio Drugs 2018 32;619-625	In-Use Physichochemical and Biological Stability of the Trastuzumab Biosimilar CT-P6 Upon Preparation for Intravenous Infusion. Kim S.J, Lee J.W, Kang H.Y, Kim S.Y, Shin Y.K, Kim K.W, Oh J.S, Lim K.J, Kim J.Y.	2018
3812	Journal Int J Pharm Compound 2015 ; 19, 5 : 432-436.	In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers. Bhattacharya S, Parekh S, Dedhiya M.	2015
4518	Journal EJHP 2020	In-use stability of diluted thiamazole (methimazole) infusion solutions in prefilled 0.9% sodium chloride infusion bags for continuous infusion. Mohr A, Krämer I.	2020
2975	Poster ESCP 2014 2014	In-Use stability of herceptin for subcutaneous injection with different administration materials. Nalenz H, Schoenhammer K, Dietel E, Heynen S.R, Grauschopf U, Mahler H.C.	2014
264	Journal Pharm Hosp Fr 1997 ; 121: 124.	Incompatibilité physico-chimique entre l’oméprazole et la vancomycine. Leboucher G, Charpiat B.	1997
1625	Journal Int J Pharm Compound 2001 ; 5: 314-321.	Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration. Trissel LA, Saenz C, Williams YW, Ingram D.	2001
4429	Journal Medicine 2016 ; 95:25(e3824)	Incompatibilities of lornoxicam with 4 antiemetic medications in polyolefin bags during simulated intravenous administration. Fang B-X, Li P, Shi X-Y, Chen F.C, Wang L.H.	2016
2630	Journal Hosp Pharm 1981 ; 16: 486-487.	Incompatibilities with orally administered liquid neuroleptic medication combinations. Raleigh F.	1981
921	Journal Hosp Pharm 1998 ; 33: 284-292.	Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration. Trissel LA, Gilbert DL, Martinez JF.	1998
241	Journal Am J Health-Syst Pharm 1996 ; 53: 2639.	Incompatibility between ceftriaxone sodium and labetolol hydrochloride. Leader WG, Jones JM.	1996
1084	Journal Lancet 1988 ; 1(8587): 700.	Incompatibility between fat emulsion and calcium plus heparin in parenteral nutrition of premature babies. Raupp P, von Kriek R, Schmidt E, Pfahl HG, G?nther O.	1988
3873	Journal Am J Health-Syst Pharm 2016 ; 73:755.	Incompatibility between irinotecan and fluorouracil injections Tan X, Hu J.	2016
205	Journal Am J Health-Syst Pharm 1996 ; 53: 184.	Incompatibility of amiodarone hydrochloride and evacuated glass bottles. Strozyk WR, Williamson R, Thompson D.	1996
200	Journal Am J Health-Syst Pharm 1995 ; 52: 2340.	Incompatibility of amiodarone hydrochloride and sodium bicarbonate injections. Korth-Bradley JM, Ludwig S, Callaghan C.	1995
3868	Journal J Oncol Pharm Practice 2016 ; 22: 571-572	Incompatibility of busulfan with 1 ml Luer-Lock syringes. Loboda C, Lider P, Vigneron J.	2016
106	Journal Am J Hosp Pharm 1990 ; 47: 519.	Incompatibility of cefoperazone and promethazine. Scott SM.	1990
260	Journal Am J Hosp Pharm 1993 ; 50: 2054, 2057.	Incompatibility of cefotaxime sodium and vancomycin sulfate during Y-site administration. Szof C, Walker PC.	1993
103	Journal Am J Health-Syst Pharm 1995 ; 52: 1347.	Incompatibility of cefotetan disodium and promethazine hydrochloride. Erickson SH, Ulici D.	1995
1739	Journal Am J Health-Syst Pharm 1990 ; 47: 519.	Incompatibility of cefperazone and promethazine. Scott SM.	1990
1399	Journal Pharm J 1987 ; 238: 577.	Incompatibility of ceftazidime and vancomycin. Cairns CJ, Robertson J.	1987
1744	Journal Am J Health-Syst Pharm 1999 ; 56: 384.	Incompatibility of ceftriaxone sodium with lactated Ringer’s injection. Burkiewicz JS.	1999
95	Journal Am J Hosp Pharm 1991 ; 48: 77.	Incompatibility of ceftriaxone with vancomycin. Pritts D, Hancock D.	1991
3475	Journal Am J Health-Syst Pharm 2013 ;70:1966-1970.	Incompatibility of ciprofloxacin and meropenem injections. Chen L.Y, Chen J, Waters V, Boodhan S.	2013
1085	Journal Radiology 1989 ; 173: 91-92.	Incompatibility of contrast agents with intravascular medications. Irving HD, Burbridge BE.	1989
3486	Journal Cardiovasc Intervent Radiol 2013 ; 36: 237-238.	Incompatibility of contrast medium and trisodium citrate. Delcour C, Brunnix G.	2013
1607	Journal Hosp Pharm 2000 ; 35: 1192-1196.	Incompatibility of erythromycin lactobionate and sulfamethoxazole/trimethoprim with linezolid injection. Trissel LA, Zhang Y, Xu QA.	2000
3664	Journal Am J Health-Syst Pharm 2014 ; 71:901-902.	Incompatibility of esmolol hydrochloride and furosemide in a central venous access port Zhao B, Sun W.	2014
155	Journal Am J Health-Syst Pharm 1995 ; 52: 710-715.	Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium. Trissel LA, Martinez JF, Xu QA.	1995
1326	Journal Am J Roentgenol 1986 ; 146: 1300-1301.	Incompatibility of Hexabrix and papaverine. Pilla TJ, Beshany SE, Shields JB.	1986
2349	Journal Am J Health-Syst Pharm 2009 ; 66: 1253-1254.	Incompatibility of imipenem–cilastatin and amoxicillin Pourroy B, Milano Bausset E, Boulamery A, Gauthier Villano L, Braguer B.	2009
1745	Journal Am J Health-Syst Pharm 1992 ; 49: 836-838.	Incompatibility of injectable indomethacin with gentamicin sulfate or tobramycin sulfate. Thompson DF, Heflin NR.	1992
494	Journal Am J Hosp Pharm 1992 ; 49: 836,838.	Incompatibility of injectable indomethacin with gentamicin sulfate or tobramycin sulfate. Thompson DF, Heflin NR.	1992
1137	Journal Am J Hosp Pharm 1990 ; 47: 1745-1746.	Incompatibility of iron dextran and a total nutrient admixture. Vaughan LM, Small C, Plunkett V.	1990
228	Journal Am J Hosp Pharm 1994 ; 51: 2964.	Incompatibility of ketorolac tromethamine with haloperidol lactate and triethylperazine maleate. Mendenhall A, Hoyt DB.	1994
476	Journal Am J Hosp Pharm 1992 ; 49: 2960-2962.	Incompatibility of ketorolac tromethamine with selected postoperative drugs. Knapp AJ, Mauro VF, Alexander KS.	1992
89	Journal Am J Hosp Pharm 1993 ; 50: 2521-2522.	Incompatibility of labetalol hydrochloride and furosemide. Zeisler J, Alagna C.	1993
1079	Journal Am J Hosp Pharm 1985 ; 42: 2651.	Incompatibility of morphine sulfate and prochlorperazine edisylate in syringes. Stevenson JG, Patriarca C.	1985
3380	Journal Ann Pharmacotherapy 2013 ;47:426-427.	Incompatibility of Piritramide with Cephalosporins. Eckle V-S, Heim E, Hahn M, Grasshoff C.	2013
1646	Journal Anaesthesia 2001 ; 56: 920.	Incompatibility of prochlorperazine and ketoprofen. Kannan S.	2001
1672	Journal Anesthesiology 1998 ; 89: 1609.	Incompatibility of propofol emulsion with anesthesic drugs. Lamontagne C, Brouillette D, Hardy JF.	1998
3101	Journal Perit Dial Int 2002 ; 22: 93-94.	Incompatibility of Vancomycin and Ceftazidime for Intraperitoneal Use. Wazny LD, Blake PG.	2002
3930	Manufacturer Serb laboratoire 2013	Indocyanine (Infracyanine®) - Résumé des caractéristiques du produit	2013
754	Manufacturer Merck Sharp & Dohme 2019	Infliximab (Remicade®) – Summary of Product Characteristics	2019
3137	Journal Retina 2010 ; 30, 1: 81-84.	Infliximab stability after reconstitution, dilution, and storage under refrigeration. Beer PM, Wong SJ, Schartman JP, Kulas KE, Hartman CL, Giganti M, Falk NS.	2010
4452	Poster Congrès Hopipharm 2019	Influence d'un ajout de L-carnitine dans les mélanges de nutrition parentérale destinés aux patients à domicile. Sémély D, Bello W, Daupin J, Lebland C, Carrez L, Berger M, Sadeghipour F.	2019
3869	Journal J Pharm Pharmacol 2016 ; 68: 433-438.	Influence of 5% dextrose volume on amphotericin B deoxycholate preparation Sun P, Chen J, Zhang Z, Gao X, Chen P, Li X.	2016
951	Journal PDA J Pharm Sci Technol 1998 ; 52: 129-133.	Influence of DL methionine and sodium metasulphite on the photostability of vitamin K1. Ho PC, Wong VK.	1998
1147	Journal J Pharm Pharmacol 1991 ; 43: 601-604.	Influence of intravenous administration set composition on the sorption of isosorbide dinitrate. De Muynck C, Colardyn F, Remon JP.	1991
39	Journal J Pharm Clin 1997 ; 16: 45-48.	Influence of intravenous admixtures on the stability of the new solution of 5-fluorouracil. Farhang-Asnafi S, Callaert S, Barre J, Tillement JP, Thebault A.	1997
2134	Journal J Pharm Sci 1998 ; 87, 12: 1572-1576.	Influence of pH, temperature and buffers on cefepime degradation kinetics and stability predictions in aqueous solutions. Fubara JO, Notari RE.	1998
2005	Journal Am J Health-Syst Pharm 2005 ; 62: 1347-1348.	Influence of temperature and drug concentration on nafcillin precipitation. Chan V.	2005
2463	Journal Am J Hosp Pharm 1979 ; 50: 486-488.	Instability of aqueous captopril solutions Anaizi NH, Swenson C.	1979
1167	Journal Antimicrob Agents Chemother 1987 ; 31: 610-611.	Instability of vancomycin in infusaid drug pump model 100. Grennberg RN, Saeed AM, Kennedy DJ, McMillian R.	1987
1091	Journal Anesthesiology 1974 ; 40: 400-404.	Insulin adsorption by glass infusion bottles, polyvinylchloride infusion containers, and intravenous tubing. Petty C, Cunningham NL.	1974
1175	Journal Am J Hosp Pharm 1981 ; 38: 995-997.	Insulin adsorption to polyolefin infusion bottles and polyvinyl chloride administration sets. Hirsch JI, Wood JH, Thomas RB.	1981
1245	Journal JPEN 1989 ; 13: 539-543.	Insulin adsorption to three-liter ethylen vinyl acetate bags during 24-hour infusion. Doglietto GB, Bellantone R, Bossola M, Perri V, Ratto C, Pacelli F, Sofo L, Migliore A, Manna R, Crucitti F.	1989
3935	Manufacturer Sanofi Laboratoire 2016	Insuline glulisine (Insulines Sanofi Apidra®) - Résumé des caractéristiques du produit	2016
1359	Journal Am J Hosp Pharm 1985 ; 42: 2420-2421.	Interaction between vancomycin and ticarcillin. Perest M, Allison J.	1985
433	Journal Am J Hosp Pharm 1986 ; 43: 2221-2224.	Interaction of aztreonam with nafcillin in intravenous admixtures. Riley CM, Lipford LC.	1986
377	Journal Am J Hosp Pharm 1988 ; 45: 1350-1352.	Interaction of heparin sodium and dopamine hydrochloride in admixtures studied by microcalorimetry. Pereira-Rosario R, Utamura T, Perrin JH.	1988
1120	Journal Am J Hosp Pharm 1974 ; 31: 72-78.	Interactions between drugs and plastic intravenous fluid bags. Part I: Sorption studies on 17 drugs. Moorhatch P, Chiou WL.	1974
1173	Journal Am J Hosp Pharm 1981 ; 38: 1308-1314.	Interactions between drugs and polyvinyl chloride infusion bags. Kowaluk EA, Roberts MS, Blackburn HD, Polack AE.	1981
499	Journal Hosp Pharm 1991 ; 26: 634-635.	Intramuscular antibiotic preparation and administration using a 1% lidocaine diluent: policies for the pediatric patient. Rockwell K, Burch K.	1991
4548	Journal Clin Ther 2020 ; 42, 8: 1580-1586.	Intravenous Compatibility of Ceftazidime/Avibactam and Aztreonam Using Simulated and Actual Y-site Administration. O'Donnell J.N, Xu A, Lodise T.P.	2020
1109	Journal Crit Care Med 1990 ; 18: 858-861.	Intravenous infusions of nitroprusside, dobutamine, and nitroglycerin are compatible. Horrow JC, Digregorio J, Barbieri EJ, Rupp E.	1990
4666	Journal J Anal Sci Tech 2020 ; 11: 32.	Intravenous patient-controlled analgesia: in vitro stability profiles of mixtures containing fentanyl, hydromorphone, oxycodone, nefopam, ondansetron, and ramosetron. Lee C.H, Kim A.R, Lee M.K, Oh J.S, Lee D.K, Choi S.S.	2020
4724	Journal Int J Pharm Compound 2022 ;26,6:522-526	Intravenous Physical Compatibility of Heparin Sodium and Furosemide. Maktabi B, Howard MS, Baki G, Churchwell MD	2022
732	Journal Am J Hosp Pharm 1975 ; 32: 575-578.	Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 1: Stability with common intravenous fluids. Gardella LA, Zaroslinski JF, Possley LH.	1975
738	Journal Am J Hosp Pharm 1978 ; 35: 581-584.	Intropin (dopamine hydrochloride) intravenous admixture compatibility. Part 3: Stability with miscellaneous additives. Gardella LA, Kesler H, Amann A, Carter JE.	1978
2324	Journal Int J Pharm 2009 ; 369, 1-2 : 30-37	Investigation into the sorption of nitroglycerin and diazepam into PVC tubes and alternative tube materials during application Treleano A, Wolz G, Brandsch R, Welle F.	2009
3666	Journal Int J Pharm Compound 2014 ; 18, 3: 248-252.	Investigation of Physical and Chemical Stability of an Ointment with Herbals Zdoryk Oleksandr A,Khokhlova Kateryna O,Georgiyants Victoriya A,Vyshnevska Liliia I.	2014
4644	Journal Adv Ther 2021 ; 38 : 5609–5622	Investigation of the Physicochemical and Biological Stability of the Adalimumab Biosimilar CT-P17. Kyeong Shin Y, Yong Han W, Jung Kim S, Woo Kim K, Won Ro J, Bin Lee J, Seok Oh J, Astier A.	2021
1961	Journal Int J Pharm 2005 ; 293: 303-310.	Investigation of the release behavior of DEHP from infusion sets by paclitaxel-loaded polymeric micelles. Kim SC, Yoon HJ, Lee JW, Yu J, Park ES, Chi SC.	2005
4012	Journal EJHP 2018 ; 25, e2	Investigations into the physical and chemical stability of concentrated co-trimoxazole intravenous infusions. Khaleel I, Tabish R Zaidi S, Shastri M, Suji Eapen M, Chiau Ming L, Wanandy T, P Patel R.	2018
4570	Journal Pharmaceuticals 2019	Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients. Greenhill K, Hornsby E, Gorman G.	2019
2655	Journal Int J Pharm 2008 ; 353, 1-2: 1-7.	Invitro release and stability of an artesunate rectal gel suitable for pediatric use. Gaudin K, Barbaud A, Boyer C, Langlois MH, Lagueny AML, Dubost JP, Millet P, Fawaz F.	2008
4377	Journal Radiology 1992 ; 184: 385-387.	Ionic lodinated Contrast Medium and Amobarbital Sodium Mixtures: Potential for Precipitation. Monsein L.H, Miller T.J, Kuwahara S.K, Sostre S, Debrun G.M.	1992
3352	Manufacturer Bristol Myers Squibb 2011	Ipilimumab (Yervoy®) - Summary of Product Characteristics	2011
3129	Manufacturer Pfizer 2008	Irinotécan (Campto®) – Résumé des caractéristiques du produits	2008
1391	Journal Can J Hosp Pharm 1998 ; 51: 271-272.	Is heparin always compatible with TPN and fat emulsion admixtures? Vanstone GL.	1998
4617	Manufacturer Sanofi Genzyme 2021	Isatuximab - SARCLISA 20mg/mL concentrate for solution for infusion - Summary of Product Characteristics - updated 16 August 2021	2021
2864	Manufacturer Astellas Pharma 2015	Isavuconazonium (Cresemba®) - Summary of Product Characteristics	2015
3660	Manufacturer Hospira 2016	Isoprenaline (Isuprel®) - Résumé des caractéristiques du produit	2016
3341	Journal Krankenhauspharmazie 2001 ; 7: 331-333.	Ist teurer immer auch besser? Analytiklabor der Apotheke unterstütz Einkauf sentcheidungen bei Carboplatin-Präparaten. Trittler R, Jung B, Strehl E.	2001
1270	Journal J Pharm Belg 1980 ; 35: 389-393.	IV infusion of glyceryl trinitrate. Study of the sorption on various plastic containers. Mathot F, Bonnard J, Han P, Bosly J.	1980
3084	Manufacturer Bristol Myers Squibb 2009	Ixabepilone (Ixempra®) – Summary of Product Characteristics	2009
3488	Journal Farm Hosp 1995 ; 19, 1: 41-44.	Jarabe de midazolam: Estudio de estabilidad de una solucion oral para uso hospitaliaro. Caldes R, Ciges S.M, Borras E, Calvelo R, Lisart F.	1995
3501	Manufacturer Pfizer 2011	Ketamine hydrochloride (Ketalar®) - Summary of Product Characteristics	2011
3593	Manufacturer Beacon Pharmaceuticals 2011	Ketorolac trometamol (Ketorolac®) - Summary of Product Characteristics	2011
1703	Journal Krankenhauspharmazie 1995 ; 16: 101-103.	Kompatibilität von enalaprilat i.v. mit ausgewählten arzneimitteln. Schuster F, Bernard R.	1995
1481	Journal Krankenhauspharmazie 1994 ; 9: 337-340.	Kompatibilität von ofloxacin mit ampicillin. Messerschmidt W.	1994
3686	Manufacturer Eusapharma 2013	L asparaginase (Kidrolase®) - Résumé des caractéristiques du produit	2013
3609	Manufacturer Aspen Pharma 2013	Labetalol (Trandate®) - Summary of Product Characteristics	2013
1014	Journal Clin Pharmacol Ther 1988 ; 43: 183.	Lack of photodegradation but significant adsorption of nifedipine in administration systems. Larsen JS, Uden DL, Zaske DE.	1988
1819	Journal J Clin Pharm Ther 2002 ; 27: 139-142.	Leaching of diethyl hexyl phtalate from polyvinyl chloride bags into intravenous etoposide solution. Demoré B, Vigneron J, Perrin A, Hoffman MA, Hoffman M.	2002
1984	Journal Am J Health-Syst Pharm 2005 ; 62: 182-188.	Leaching of diethylhexyl phtalate from multilayer tubing into etoposide infusion solutions. Bagel-Boithias S, Sautou-Miranda V, Bourdeaux D, Tramier V, Boyer A, Chopineau J.	2005
455	Journal Am J Hosp Pharm 1986 ; 43: 2800-2802.	Leaching of diethylhexyl phtalate from polyvinyl chloride bags into intravenous cyclosporine solution. Venkataramanan R, Burckart GJ, Ptachcinski RJ, Blaha R, Logue LW, Bahnson A, Giam CS, Brady JE.	1986
140	Journal Am J Hosp Pharm 1993 ; 50: 1405-1409.	Leaching of diethylhexyl phthalate from polyvinyl chloride containers by selected drugs and formulation components. Pearson SD, Trissel LA.	1993
165	Journal Int J Pharm 1994 ; 105: 89-93.	Leaching of diethylhexyl phthlate from PVC bags into intravenous teniposide solution. Faouzi MA, Dine T, Luyckx M, Gressier B, Goudaliez F, Mallevais ML, Brunet C, Cazin M, Cazin JC.	1994
4665	Manufacturer Sanofi Aventis 2021	LEMTRADA 12 mg concentrate for solution for infusion - Summary of Product Characteristics. Updated 24-Sep-2021	2021
3920	Manufacturer Fresenius Kabi 2018	Levofloxacine - Résumé Caractéristique du Produit	2018
3369	Manufacturer MEDAC France 2011	Levofolinate de sodium Medac - Résumé des caractéristiques du produits	2011
4571	Manufacturer Orion Pharma 2010	Levosimendan (Simdax 2.5 mg/ml) - Summary of Product Characteristics	2010
1126	Journal Am J Hosp Pharm 1983 ; 40: 97-101.	Lidocaine stability in cardioplegic solution stored in glass bottles and polyvinyl chloride bags. Lackner TE, Baldus D, Butler CD, Amyx C, Kessler G.	1983
3286	Journal Yakugaku Zasshi 2010 ; 130, 10: 1369-1374.	Light-induced Deterioration Test of Carboplatin under Clinical Settings. Okamoto Y, Tazumi K, Sanada Y, Tsugane M, Uejima E.	2010
3560	Manufacturer Pharmacia 2013	Linezolid (Zyvox®) - Summary of Product Characteristics	2013
2163	Journal Perit Dial Int 2002 ; 22: 419-422.	Linezolid stability in peritoneal dialysis solutions. Manley HJ, McClaran ML, Bedenbaugh A, Peloquin CA.	2002
2654	Journal Int J Pharm 2007 ; 344, 1-2: 150-153.	Liposomal amphotericin B eye drops to treat fungal keratitis: physico-chemical and formulation stability. Morand K, Bartoletti AC, Bochot A, Barratt G, Brandely ML, Chast F.	2007
4479	Journal J Oncol Pharm Practice 2020 ;27,6:1328-1332	Long term stability of an admixture of alizapride and ondansetron in 0.9% sodium chloride solution polyolefin bags stored at 5 +/- 3°C. Closset M, Goderniaux N, Colsoul M-L, Soumoy L, Bihin B, Jamart J, Odou P, Hecq J-D, galanti L.	2020
1291	Journal Int J Pharm Pract 1995 ; 3: 253-255.	Long term stability of heparin in dextrose-saline intravenous fluids. Wright A, Hecker J.	1995
35	Journal Am J Health-Syst Pharm 1995 ; 52: 2128-2130.	Long term stability of interferon alfa-2b diluted to 2 million units/mL. Schepart BS, Burns BA, Evans S, Poleon G.	1995
1962	Journal Pharmakon 2004 ; 36, 1: 8-14.	Long term stability of sufentanyl citrate with levobupivacaine hydrochloride in 0.9% sodium chloride infusion P.V.C bags at 4°C. Hecq JD, Boitquin L, Evrard JM, Vanbeckbergen D, Jamart J, Galanti L.	2004
3115	Journal Ann Pharm Fr 2010 ; 68: 157-162.	Long term stability of the hydrochloride of tramadol and alizapride in dextrose 5% polyolefin bags at 5 +/- 3°C. Athanasopoulos A, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.	2010
2174	Journal EJHP Science 2006 ; 12, 6: 129-134.	Long-term physical and chemical stability of a generic paclitaxel infusion under simulated storage and clinical-use conditions. Kattige A.	2006
4568	Journal Journal of Chemotherapy 2021	Long-term physico-chemical stability of 5-fluorouracile at standardised rounded doses (SRD) in MyFuser® portable infusion pump. Closset M,Onorati S, Colsoul M.L,Goderniaux N,Bihin B, Jamart J, Soumoy L, Hecq J.D, Odou P, Galanti L.	2021
3386	Journal Int J Pharm 2013 ; 448: 101-104.	Long-term physico-chemical stability of diluted trastuzumab. Paul M, Vieillard V, Da Silva Lemos R, Escalup L, Astier A.	2013
4735	Journal J Oncol Pharm Practice 2023	Long-term physicochemical stability of 5-fluorouracil at selected standardised rounded doses in polyolefin bags. Closset M, Onorati S, Colsoul M-L, Goderniaux N, Bihin B, Jamart J, Soumoy L, Hecq J-D, Odou P, Galanti L.	2023
4573	Journal Am J Health-Syst Pharm 2021 ;78, 9:806–812,	Long-term physicochemical stability of acyclovir 5 mg/mL solution stored in polypropylene bags as a simulated hospital stock preparation. Legeron R, Bougueon G, Berroneau A, De-Germay S, Bernadou JM, Djabarouti S, Crauste-Manciet S, Xuereb F.	2021
4374	Journal Int J Pharm Compound 2020 ;24,1:64-68	Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit. Lardinois B, Dimitriou A, Delcave C, Soumoy L, Jamart J, Bihin B, Hecq J-H, Galanti L.M.	2020
4342	Journal Int J Pharm Compound 2019 ;23,5:434-437	Long-term Physicochemical Stability of Concentrated Solutions of Salbutamol (Albuterol) in Polypropylene Syringes for Use in the Intensive Care Unit and in Obstetrics. Lardinois B, Baltzis A, Delcave C, Soumoy L, Jamart J, Bihin B, Hecq JD, Galanti L.	2019
4148	Journal Pharmaceutical Technology in Hospital Pharmacy 2018	Long-Term Stability Comparison between an Original and a Generic Version of Piperacillin/Tazobactam in Dextrose 5% Infusion Polyolefin Bags at 5+/-3°C after Microwave Freeze-Thaw Treatment. Huvelle S, Godet M, Galanti L, Closset M, Bihin B, Jamart J, Hecq J.D.	2018
4199	Journal EJHP 2018	Long-term stability of 0.1% rapamycin hydrophilic gel in the treatment of facial angiofibromas. Le Guyader G, Vieillard V, Andrieux K, Rollo M, Thirion O, Wolkenstein P, Paul M.	2018
4584	Journal EJHP 2021	Long-term stability of 10 mg/mL dobutamine injectable solutions in 5% dextrose and normal saline solution stored in polypropylene syringes and cyclic-oleofin- copolymer vials. Gilliot S, Henry H, Carta N, Genay S, Barthélémy C, Décaudin B, Odou P.	2021
2323	Journal Can J Hosp Pharm 2009 ; 62, 1	Long-Term Stability of 5-Fluorouracil in 0.9% Sodium Chloride after Freezing, Microwave Thawing, and Refrigeration Galanti L, Lebitasy M.P, Hecq J.D, Cadrobbi J, Vanbeckbergen D, Jamart J.	2009
1475	Journal J Pharm Biomed Anal 1996 ; 14: 395-399.	Long-term stability of 5-fluorouracil stored in PVC bags and in ambulatory pump reservoirs. Martel P, Petit I, Pinguet F, Poujol S, Astre C, Fabbro M.	1996
2771	Journal Skin Pharm Appl Skin Physiol 1999 ; 12: 266-270.	Long-term stability of 8-methoxypsoralen in ointments for topical PUVA therapy (Cream PUVA). Martens-Lobenhoffer J, Rinke M, Losche D.	1999
2789	Journal Bone Marrow Transplantation 2006 ; 37, 8: 781-784.	Long-term stability of a patient-convenient 1mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels. Elefante A, Muindi J, West K, Dunford L, Abel S, Paplham P, Brown K, Hahn T, Padmanabhan S, Battiwalla M, McCarthy PL.	2006
3001	Journal Ann Pharm Fr 2015 ; 73: 108-113.	Long-term stability of aciclovir in 0.9% NaCl infusion polyolefin bags at 2-8°C after freeze-thaw treatment: A generic product versus the brand name. Dewulf J, Galanti L, Godet M, Gillet P, Jamart J, Hecq JD.	2015
3312	Journal Ann Pharm Fr 2012 ; 70, 3: 139-154.	Long-term stability of bevacizumab repackaged in 1 mL polypropylene syringes for intravitreal administration. Paul M, Vieillard V, Roumi E, Cauvin A, Despiau M.C, Laurent M, Astier A.	2012
656	Journal J Clin Pharm Ther 1996 ; 21: 185-189.	Long-term stability of cefuroxime and cefazolin sodium in intravenous infusions. Galanti LM, Hecq JD, Vanbeckbergen D, Jamart J.	1996
2808	Journal Int J Pharm Compound 2015 ; 19, 3: 268-270.	Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles. Dewulf J, Hecq J.D, Huvelle S, Godet M, Gillet P, Jamart J, Galanti L.M.	2015
3925	Journal Ann Pharm Fr 2016 ; 75, 1 : 30-39.	Long-term stability of dexamethasone and alizapride or ondansetron in sodium chloride 0.9% polyolefin bag at 5±3 C. Simar J, Godet M, Hecq J.-D, Closset M, Gillet P, Langhendries C, Bihin B, Jamart J, Galanti L.	2016
3323	Journal Int J Pharm 2012 ; 436, 1-2: 282-290.	Long-term stability of diluted solutions of the monoclonal antibody rituximab. Paul M, Vieillard V, Jaccoulet E, Astier A.	2012
2827	Journal Am J Health-Syst Pharm 2009 ; 66: 1722-1725.	Long-term stability of extemporaneously prepared captopril oral liquids in glass bottles Brustugun J, Lao YE, Fagern?s C, Br?nden J, Kristensen S.	2009
394	Journal Am J Hosp Pharm 1989 ; 46: 2333-2335.	Long-term stability of famotidine 20 mg/L in a total parenteral nutrient solution. DiStefano JE, Mitrano FP, Baptista RJ, Der MM, Silvestri Ap, Palombo JD, Bistrian BR.	1989
4021	Journal J Oncol Pharm Practice 2017 ;25,2: 303-308	Long-term stability of ganciclovir in polypropylene containers at room temperature. Guichard N, Bonnabry P, Rudaz S, Fleury S.	2017
3874	Journal Ann Pharm Fr 2016 ; 74: 283-287.	Long-term stability of ketamine hydrochloride 50 mg/ml injection in 3 ml syringes Huvelle S, Godet M, Hecq J.D, Gillet P, Bihin B, Jamart J, Galanti L.	2016
4248	Journal Hosp Pharm 2019 ; 55, 3: 199-193.	Long-Term Stability of Lorazepam in Sodium Chloride 0.9% Stored at Different Temperatures in Different Containers. Colsoul M.L, Breuer A, Goderniaux N, Hecq J.D, Soumoy L, Bihin B, Jamart J, Galanti L.	2019
1885	Journal Pharm World Sci 1999 ; 21: 144-146.	Long-term stability of morphine and bupivacaine mixture for spinal use. Essink-Tjebbes CM, Burger DM, Beelen, Wuis EW, Heckster YA.	1999
3572	Journal Int J Pharm Compound 2014 ; 18, 1 : 78-82.	Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C. Hecq J-D, Godet M, Gillet P, Jamart J, Galanti L.	2014
4201	Journal Am J Health-Syst Pharm 2020 ; 77, 9: 681-689.	Long-term stability of ready-to-use 1-mg/mL midazolam solution. Gilliot S, Masse M, Feutry F, Barthélémy C, Décaudin B, Genay S, Odou P.	2020
2204	Journal J Oncol Pharm Practice 2007 ; 13: 99-103.	Long-term stability of sodium folinate in dextrose 5% polyolefin bags at 4°C. Cadrobbi J, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.	2007
1908	Journal J Pain Symptom Manage 2004 ; 28, 1: 4-6.	Long-term stability of sufentanil citrate with levobupivacaine hydrochloride in 0.9% sodium chloride infusion PVC bags at 4°C. Boitquin L, Hecq JD, Evrard JM, Vanbeckbergen D, Jamart J, Galanti L.	2004
3255	Journal Ann Pharm Fr 2011 ; 69, 6 : 296-301.	Long-term stability of temocillin in dextrose 5% and in sodium chloride 0.9% polyolefin bags at 5±3°C after freeze-thaw treatment Rolin C, Hecq J.D, Tulkens P, Vanbeckbergen D, Jamart J, LGalanti L.	2011
3154	Journal J Antimicrob Chemother 2010 ; 65, 9: 2045-2046.	Long-term stability of temocillin in elastomeric pumps for outpatient antibiotic therapy in cystic fibrosis patients. Carryn S, Couwenbergh N, Tulkens PM	2010
365	Journal Med Sci Monit 2015 ; 21:2528-2534.	Long-Term Stability of Tramadol and Ketamine Solutions for Patient-Controlled Analgesia Delivery. Junfeng Gu, Wengang Qin, Fuchao Chen, Zhongyuan Xia.	2015
3082	Journal J Oncol Pharm Practice 2009 ; 15: 195-200.	Long-term stability of tramadol chlorhydrate and metoclopramide hydrochloride in dextrose 5% polyolefin bag at 4°C. Athanasopoulos A, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.	2009
2814	Journal Ann Pharm Fr 2009 ; 67: 272-277.	Long-term stability of tramadol hydrochloride and droperidol mixture in 5% dextrose infusion polyolefin bags at 5 +/- 3°C. Lebitasy M, Hecq JD, Vanbeckbergen D, Jamart J, Galanti L.	2009
1899	Journal Int J Pharm Compound 2004 ; 8, 3: 231-235.	Long-term stability of Trimix : a three drug injection used to treat rectile dysfunction. Trissel LA, Zhang Y.	2004
931	Journal J Clin Pharm Ther 1997 ; 22: 353-356.	Long-term stability of vancomycin hydrochloride in intravenous infusions. Galanti LM, Hecq JD, Vanbeckbergen D, Jamart J.	1997
2111	Journal EJHP Science 2006 ; 12, 3: 57-59.	Long-term stability of voriconazole 4 mg/ml in dextrose 5% polyvinyl chloride bags at 4°C. Cadrobbi J, Hecq JD, Lebrun C, Vanbeckbergen D, Jamart J, Galanti L.	2006
3856	Journal Int J Pharm Compound 2016 ; 20, 2:164-166.	Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures Nahata M.C.	2016
3313	Journal J Oncol Pharm Practice 2012 ; 18, 2: 218-221.	Long-term stability study of clofarabine injection concentrate and diluted clofarabine infusion solutions. Kaiser J, Krämer I.	2012
2495	Journal Am J Hosp Pharm 1986 ; 43: 380-383.	Long-term stability study of histamine in sterile bronchoprovocation solutions Marwaha RK, Johnson BF.	1986
532	Journal Ann Pharmacotherapy 1996 ; 30: 343-346.	Lorazepam stability in parenteral solutions for continuous intravenous administration. Hoey LL, Vance-Bryan K, Clarens DM, Wright DH, Konstantinides FN, Guay DRP.	1996
1980	Journal Act Pharm Nord 1991 ; 3, 3: 131-136.	Loss of nitroglycerin during passage through two different infusion sets. Hansen HC, Spillum A.	1991
1108	Journal Crit Care Med 1983 ; 11: 50-52.	Loss of nitroglycerin to cardiopulmonay bypass apparatus. Dasta JF, Jacobi J, Wu LS, Sokoloski T, Beckley P, Reilley TE, Howie MB.	1983
239	Journal Am J Health-Syst Pharm 1996 ; 53: 655-658.	Loss of quinidine gluconate injection in a polyvinyl chloride infusion system. Darbar D, Dell'Orto S, Wilkinson GR, Roden DM.	1996
4739	Journal PlosOne 2023 18(2): e0282164.	Low-dose erythromycin in pediatrics: Formulation and stability of 20 mg hard gelatin capsules. Thevin P, Curti C, Benech A, Jean C, Lamy E, Castera Ducros C, Primas N, Bertault-Perez P, Vanelle P.	2023
4740	Manufacturer Roche Products Limited 2021	MabThera 500 mg concentrate for solution for infusion. Summary of Product Characteristics Updated 07-Oct-2021	2021
1522	Manufacturer Maco Pharma 2001	Macoflex N®	2001
3838	Manufacturer Martindale Pharmaceuticals Ltd 2007	Magnesium Sulphate - Summary of Product Characteristics	2007
4457	Journal J Obstet Gynaecol Can 2016 ;38,10:936e944.	Magnocaine: Physical Compatibility and Chemical Stability of Magnesium Sulphate and Lidocaine Hydrochloride in Prefilled Syringes. Houlihan, S, Decarie, D, Benes, C, Cleve, R, Vidler M, Magee L.A, Ensom M.H.H, vonDadelszen P.	2016
4344	Journal EJHP 2018	Management of diabetic foot ulcers: a 25% lidocaine topical cream formulation design, physicochemical and microbiological assessments. Yay? HS, Faucheron A, Dupont L, El Kouari F, Fekkar A, Bellanger A, Tilleul P.	2018
3307	Journal Hosp Pharm 2012 ; 47, 1: 27-30.	Managing the intravenous calcium shortage: Evaluation of calcium chloride stability in 0.9% sodium chloride and dextrose 5% water polyvinyl chloride bags. Kiser T.H, Barber G.R, Robinson A.	2012
1861	Journal Int J Pharm 1996 ; 127: 255-259.	Medical plastics: compatibility of alfentanil and propofol alone or mixed. Stability of the alfentanil-propofol mixture. Levadoux E, Sautou V, Bazin JE, Schoeffler P, Chopineau J.	1996
4490	Journal Sci Pharm 2020 ; 88, 25	Medication Safety in Intravenous Therapy: A Compatibility Study and Analysis of Reaction Products of Dihydralazine and Metamizole. Koller A.K, Fischer O, Krebs S.	2020
3584	Manufacturer Aspen Pharma 2013	Melphalan (Alkéran®) - Résumé des caractéristiques du produit	2013
3602	Manufacturer Baxter SAS 2013	Mesna (Uromitexan®)- Summary of Product Characteristics	2013
3637	Manufacturer Hameln Pharmaceuticals 2014	Methotrexate (Methotrexate solution for injection®) - Summary of Product Characteristics	2014
978	Journal Can J Hosp Pharm 1994 ; 47: 147.	Methotrexate and cytarabine for intrathecal administration. Dick DM, Woloschuk DMM.	1994
1021	Journal J Clin Hosp Pharm 1986 ; 11: 343-348.	Methotrexate in solutions - A stability test for the hospital pharmacy. Dyvik O, Grislingaas AL, Tonnesen HH, Karlsen J.	1986
3594	Manufacturer Zentiva 2013	Metronidazole (Flagyl®) - Summary of Product Characteristics	2013
3573	Manufacturer Astellas 2013	Micafungin (Mycamine®) – Summary of Product Characteristics	2013
823	Journal Am J Health-Syst Pharm 1998 ; 55: 1584-1587.	Microbial inhibitory properties and stability of topotecan hydrochloride injection. Patel K, Craig SB, McBride MG, Palepu NR.	1998
3859	Journal RRJHCP 2016 ; 1, 3: 31-37.	Microbiological and Physico-Chemical Stability of Ketamine Solution for Patient-Controlled Analgesia Systems. Foy G, Poinsignon V, Mercier L, Laurent S, Paci A.	2016
2118	Journal J Pain Symptom Manage 2006 ; 32, 1: 90-97.	Microbiological and physicochemical stability of fentanyl and sufentanil solutions for patient-controlled delivery-systems. Chapalain-Pargade S, Laville I, Paci A, Chachaty E, Mercier L, Bourget Ph.	2006
3126	Journal J Pain Symptom Manage 2010 ; 40, 1: 87-94.	Microbiological and Physicochemical Stability of Oxycodone Hydrochloride Solutions for Patient-Controlled Delivery Systems. Amri A, Achour AB, Chachaty E, Mercier L, Bourget P, Paci A.	2010
4366	Journal Braz J Pharm Sci 2019 ;55:e17351	Midazolam and haloperidol for palliative sedation: physicochemical stability and compatibility of parenteral admixtures. Estan-Cerezo G, Rodriguez-Lucena F.J, Matoses Chirivella C, Jiminez-Pulido I, Garcia-Monsalve A, Navarro-Ruiz A.	2019
2007	Journal J Pharm Biomed Anal 2005 ; 38: 709-713.	Migration of diethylhexyl phtalate from PVC into intravenous cyclosporine solutions. Gotardo MA, Monteiro M.	2005
1699	Journal Krankenhauspharmazie 2000 ; 21: 107-109.	Mischbarkeit von serotonin-antagonisten mit dexamethason und heparin. Plaas S, Heck C, Kubrich M.	2000
3315	Poster Communication orale Hopipharm 2012	Mise en évidence d'une incompatibilité physico-chimique entre la phénytoïne sodique et le paracétamol injectable en flacon. Louvrier M, Dhennain S, Hocahrt S, Zawadski E, Bouffart S, Moquay E.	2012
3128	Manufacturer Prostrakan 2013	Mitomycine (Amétycine®) - Résumé Caractéristiques du Produit	2013
3575	Manufacturer Prostrakan 2013	Mitomycine (Ametycine®) - Résumé des caractéristiques du produit	2013
3640	Manufacturer Hospira 2013	Mitoxantrone - Summary of Product Characteristics	2013
465	Journal Am J Hosp Pharm 1990 ; 47: 297-298.	More information on the visual compatibility of hetastarch with injectable critical-care drugs. Wohlford JG, Wright JC, Wilson MR.	1990
322	Journal Am J Health-Syst Pharm 1996 ; 53: 2639.	More on compatibility of mannitol and sodium bicarbonate in injectable fluids. Matuschka PR, Hill LJ.	1996
2362	Poster ADKA Congress 2009 2009	Morphin-Haloperidol mischungen in PCA Pumpen : Kompatibel? Trittler R, M?ller S, Esteban M.	2009
2363	Poster ADKA Congress 2006	Morphin-Metamizol mischungen zur kontinuierlichen parenteralen applikation : Sind sie immer inkompatibel? M?ller S, Trittler R, Schubert R, von Hornstein W.F, Strehl E.	2006
3531	Manufacturer Wockhardt 2014	Morphine sulphate 10 mg/mL injection BP – Summary of Product Characteristics	2014
2055	Journal Int J Pharm 2006 ; 307: 278-284.	Morphine, haloperidol and hyoscine N-butyl bromide combined in sc infusion solutions : compatibility and stability evaluation in terminal oncology patients. Negro S, Reyes R, Azuara ML, Sanchez Y, Barcia E.	2006
626	Journal Am J Hosp Pharm 1982 ; 39: 1495-1498.	Moxalactam disodium compatibility with intramuscular and intravenous diluents. Bornstein M, Lo AY, Thomas PN, Wilham WL.	1982
3162	Manufacturer Bayer HealthCare 2010	Moxifloxacine (Izilox®) - Résumé des caractéristiques du produits	2010
3109	Manufacturer Bayer Schering Pharma 2010	Moxifloxacine (Izilox®) -Notice information	2010
1366	Journal Am J Hosp Pharm 1981 ; 38: 462,464.	Nafcillin sodium incompatibility with acidic solutions. Jeglum EL, Winter E, Kotos M.	1981
3672	Manufacturer Mylan SAS 2016	Nalbuphine Mylan - Résumé des caractéristiques du produit	2016
3264	Poster AAPS Congress - Washington, October 2011 2011	Nalbuphine stability at 1 mg/mL concentration. Hammer C, Perello L, Dory A, Lev?que D, Ubeaud-S?quier G.	2011
2678	Journal Int J Pharm Compound 2000 ; 4: 69-71.	Naratriptan hydrochloride in extemporaneously compounded oral suspensions. Zhang YP, Trissel LA, Fox JL.	2000
4068	Manufacturer 2018 Biogen Idec Ltd	Natalizumab (Tysabri®) - Summary of Product Characteristics	2018
3938	Manufacturer Lilly S.A 2016	Necitumumab (Portrazza®) – Résumé des caractéristiques du produits	2016
2311	Journal J Clin Pharm Ther 2009 ; 34: 25-31.	Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion. Kambia N.K, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C.	2009
2265	Journal J Pharm Sci 1990 ; 79, 1: 48-52.	Nefopam hydrochloride degradation kinetics in solution. Tu YH, Wang DP, Allen LV.	1990
958	Journal Ann Pharmacotherapy 1990 ; 24: 440-442.	Netilmicin sulfate stability in combinaison with metronidazole or ranitidine hydrochloride in NaCl 0.9% infusion. Vervloet E, Lammers J, Tan LSL, Van Mourik CH, Rots M.	1990
4561	Journal Pharmaceutical Technology in Hospital Pharmacy 2021 ; 6(1): 20200013.	New liquid oral formulations of hydroxychloroquine: a physicochemical stability study. Lebreton V, Bourcier B, Cosson K, Lagarce F, Spiesser-Robelet L, Vrignaud S.	2021
3306	Journal EJOP 2012 ; 6, 1: 1-2.	New stability studies for fludarabine according to the European Pharmacopoeia 7.0 Trittler R.	2012
3941	Manufacturer Concordia International 2017	Nicardipine - Summary of Product Characteristics	2017
3614	Manufacturer American Regent Inc 2013	Nicardipine Injection - Summary of Product Characteristics	2013
3206	Journal Int J Pharm Compound 2011 ; 15, 2: 166-169.	Nifedpine in Compounded Oral and Topical Preparations. McCluskey Susan V, Brunn Gregory J.	2011
708	Journal Am J Hosp Pharm 1980 ; 37: 201-205.	Nitroglycerin compatibility with intravenous fluid filters containers, and administration sets. Baaske DM, Amann AH, Wagenknecht DM, Mooers M, Carter JE, Hoyt HJ, Stoll RG.	1980
1113	Journal Am J Hosp Pharm 1989 ; 46: 2031-2035.	Nitroglycerin delivery through a polyethylene-lined intravenous administration set. Tracy TS, Bowman L, Black CD.	1989
4652	Manufacturer Bristol Myers Squibb Pharmaceuticals 2022	Nivolumab (Opdivo®) - Summary of Product Characteristics	2022
642	Journal Hosp Pharm 1988 ; 23: 44,49, 59.	Norepinephrine stability in saline solutions. Baumgartner TG, Knudsen AK, Dunn AJ, Kilroy RA.	1988
3455	Journal J Drug Deliv Sci Tecnol 2012 ; 22, 4: 347-352.	Novel formulation and clinical evaluation of nalidixic acid ointment in impetigo. Tous S.S, El Sayed A.M, Abd El Mohsen M.G, Yoissef E.M.K, Agban M.N, Boushra M.F.	2012
4720	Manufacturer Paratek Pharmaceuticals 2021	Nuzyra (amadacycline - Full prescribing infomation. Paratek Pharmaceuticals updated May 2021.	2021
3768	Manufacturer Roche Products Limited 2014	Obinutuzumab (Gazyvaro®) - Summary of Product Characteristics	2014
4086	Manufacturer Novartis Pharma 2017	Octréotide - (Sandostatine®)- Résumé des caractéristiques du produit	2017
3138	Manufacturer GlaxoSmithKline 2009	Ofatumumab (Arzerra®) - Summary of Product Characteristics	2009
3562	Manufacturer Sanofi 2014	Ofloxacin (Tarivid®) - Summary of Product Characteristics	2014
889	Journal Pharm Weekbl [Sci] 1991 ; 13: 207-209.	Ofloxacin intravenous. Compatibility with other antibacterial agents. Janknegt R, Stratermans T, Cilissen J, Lohman JJHM, Hooymans PM.	1991
3776	Manufacturer Teva Pharmaceuticals 2014	Omecetaxine (Synribo®) - Summary of Product Characteristics	2014
3658	Manufacturer Sandoz 2014	Omeprazole - Summary of Product Characteristics.	2014
3574	Manufacturer Accord Healthcare France SAS 2013	Ondansetron - Résumé des caractéristiques du produit	2013
1396	Journal J Clin Oncol 1993 ; 11: 197.	Ondansetron compatible with sodium acetate. Hauser AR, Trissel LA, Martinez JF.	1993
3924	Journal Ann Pharm Fr 2016 ; 75, 1 : 17-29.	One-month stability study of a biosimilar of infliximab (Remsima®) after dilution and storage at 4 C and 25 C. Vieillard V, Astier A, Sauzay C, Paul M.	2016
3949	Poster JFSPH Congress, Bern, Switzerland. 2016	Optimisation du processus de préparation des solutions de melphalan destinées à l’administration intra-vitréenne dans le traitement du rétinoblastome et étude de leur stabilité Brönnimann C, Berger-Gryllaki M, Podilsky G, Sadeghipour F.	2016
3787	Manufacturer The Medicines Company 2016	Oritavancin diphosphate (Orbactiv®) - Summary of Product Characteristics	2016
4211	Journal PlosOne 2019	Overcoming stability challenges during continuous intravenous administration of high-dose amoxicillin using portable elastomeric pumps. Binson G, Grignon C, Le Moal G, Lazaro P, Lelong J, Roblot F, Venisse N, Dupuis A.	2019
3589	Manufacturer PanPharma 2013	Oxacilline PanPharma – Résumé des caractéristiques du produits	2013
3413	Journal Pharm Res 2004 ; 21, 5: 891-894.	Oxaliplatin degradation in the presence of chloride: Identification and cytotoxicity of the monochloro monooxalato complex. Jerremalm E, Hedeland M, Wallin I, Bondesson U, Ehrsson H.	2004
3634	Manufacturer Accord Healthcare 2011	Oxaliplatine (Oxaliplatine Accord®) - Résumé des caractéristiques du produit	2011
2366	Poster ADKA Congress 2009	Oxycodon-Metamizol in PCA pumpen : Kompatibel? M?ller S, Trittler R, Schubert R.	2009
1903	Journal Am J Obstet Gynecol 2002 ; 186: 496-498.	Oxytocin preparation stability in several common obstetric intravenous solutions. Gard JW, Alexander JM, Bawdon RE, Albrecht JT.	2002
1956	Manufacturer Hospira UK Limited 2015	Paclitaxel - Summary of Product Characteristics	2015
3157	Manufacturer Celgene Europe Limited 2015	Paclitaxel albumin (Abraxane®) - Summary of Product Characteristics	2015
669	Journal Ann Pharmacotherapy 1994 ; 28: 35-36.	Paclitaxel stability and compatibility in polyolefin containers. Chin A, Ramakrishnan RR, Yoshimura NN, Jeong EWS, Nii LJ, DiMeglio LS.	1994
4101	Journal Pharmaceutical Technology in Hospital Pharmacy 2018	Paediatric formulation: budesonide 0.1 mg/mL viscous oral solution for eosinophilic esophagitis using cyclodextrins. Ey C, Hosselet C, Villon B, Mar?on F.	2018
1955	Journal Ann Pharmacotherapy 2005 ; 39: 280-283.	Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration. Trissel LA, Zhang Y.	2005
2214	Journal Int J Pharm Compound 2007 ; 11, 6: 520-524.	Palonosetron hydrochloride compatibility and stability with three beta-lactam antibiotics during simulated Y-site administration. Ben M, Trusley C,Kupiec T.C, Trissel L.A.	2007
3619	Manufacturer Wockhardt 2016	Pamidronate (Pamidronate Actavis®) - Summary of Product Characteristics	2016
755	Manufacturer MSD France 2016	Pancuronium (Pavulon®) - Résumé des caractéristiques du produit	2016
3769	Manufacturer B Braun laboratoire 2014	Paracatamol (Paracetamol B Braun®) - Résumé des caractéristiques du produit	2014
3504	Manufacturer Pfizer 2012	Parecoxib (Dynastat®) - Summary of Product Characteristics	2012
4173	Manufacturer Baxalta Innovations GmbH 2018	Pegaspargase (Oncaspar®) - Résumé des Caractéristiques du Produit	2018
3771	Manufacturer Merck Sharp Dohme 2017	Pembrolizumab (Keytruda®) - Summary of Product Characteristics	2017
1914	Manufacturer Eli Lilly 2016	Pemetrexed (Alimta®) - Summary of Product Characteristics	2016
4589	Manufacturer Mylan 2021	Pemetrexed Mylan - Résumé des caractéristiques du produit	2021
4629	Manufacturer 2021 Sandoz	Pemetrexed Sandoz - Summary of Product Characteristics (SmPc)	2021
3559	Manufacturer Sanofi Aventis France 2013	Pentamidine diiséthionate (Pentacarinat®) - Résumé des caractéristiques du produit	2013
1235	Journal Br J Pharm Pract 1988 ; 10: 22-23.	Pentamidine infusion stability. Leigh PH, Buddle GC.	1988
4024	Poster SFPO Congress 2017 - Nantes 2017	Pénurie mondiale d'Etopophos et conséquences pratiques : Intérêt des études de stabilité dans le choix d'un générique. Sadou Yaye H, Rieber Z, HassaniI L, Hoffmann-Martinot C, Babiard M, Aouti H, Bellanger A, Tilleul P.	2017
4686	Manufacturer Roche Products Ltd. 2022	Pertuzumab (Perjeta®) - Summary of Product Characteristics.	2022
3525	Manufacturer AMCO Amdipharm Mercury 2012	Pethidine hydrochloride - Summary of product Characteristics	2012
3871	Poster Synprefh Congress Clermont Ferrand, France 2016	Peut-on administrer le céfotaxime en Y avec d'autres médicaments injectables ? Soussi M.A, Soualah-alila R, jenene F, Lazreg O, Razgallah Khrouf M.	2016
2175	Journal J Pharm Clin 2006 ; 25, 3: 147-152.	Peut-on conditionner les solutions de docétaxel dans des poches en PVC ? Dalle M, Sautou-Miranda V, Balayssac D, Bourlon S, Bagel S, Chopineau J.	2006
1317	Journal Pharm J 1987 ; 238: 476-478.	Pharmaceutical aspects of home infusion therapy for cancer patients. Adams PS, Haines-Hutt RF, Bradford E, Palmer A, Rowland CG.	1987
4747	Journal Pharmaceutics 2023 ,15, 957.	Pharmaceutical Oral Formulation of Methionine as a Pediatric Treatment in Inherited Metabolic Disease. Querin B, Schweitzer-Chaput A, Cisternino S, Auvity S, Fauqueur A-S, Negbane A, Hadchouel A, Schlatter J, Cotteret C.	2023
4283	Journal Eur J Pharm Sci 2019	Pharmaceutical preformulation studies and paediatric oral formulations of sodium dichloroacetate. Lopalco A, Curci A, Lopedota A, Cutrignelli A, Laquintana V, Franco M, Denora N.	2019
1274	Journal TAP Pharmazeutische Zeitung 1997 ; 31: 30-33.	Pharmazeutische aspekte von topotecan-infusionen. Krämer I, Thiesen J.	1997
1482	Journal Krankenhauspharmazie 1992 ; 3: 98-100.	Pharmazeutische kompatibilität der kombination cefotiam und ampicillin. Messerschmidt W.	1992
1692	Journal Krankenhauspharmazie 1998 ; 19: 226-228.	Pharmazeutische kompatibilität von piperacillin mit metronidazol. Messerschmidt W.	1998
1949	Journal Clinical Cancer Research 2001 ; 7: 1569-1576.	Phase I trial of 96 hour continuous infusion of dexrazoxane in patients with advanced malignancies. Tetef ML, Synold TW, Chow W, Leong L, Margolin K, Morgan R, Rashko J, Shibata S, Somlo G, Yen Y, Groshen S, Johnson K, Lenz HJ, Gandara D, Doroshow JH.	2001
3620	Manufacturer Beacon Pharmaceuticals 2012	Phenylephrine - Summary of Product Characteristics	2012
3770	Manufacturer Eclat Pharmaceuticals 2014	Phenylephrine hydrochloride (Vazculep®) - Summary of Product Characteristics	2014
1169	Journal Am J Hosp Pharm 1981 ; 38: 358-362.	Phenytoin sodium solubility in three intravenous solutions. Pfeifle CE, Adler DS, Gannaway WL.	1981
3621	Manufacturer Renaudin 2008	Phosphate dipotassique - Résumé des caractéristiques du produit	2008
1887	Journal Int J Pharm 1995 ; 123: 229-235.	Photochemical decomposition of midazolam. IV . Study of pH dependant stability by high-performance liquid chromatography. Andersin R, Tammilehto S.	1995
1265	Journal J Clin Pharm Ther 1990 ; 15: 291-300.	Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography. Wood MJ, Irwin WJ, Scott DK.	1990
2816	Journal J Pharm Biomed Anal 1999 ; 25: 269-275.	Photodegradation of folic acid in aqueous solution Aktar J, Khan A, Ahmad I.	1999
796	Journal PDA J Pharm Sci Technol 1996 ; 50: 158-162.	Photodegradation of furosemide solutions. Asker AF, Ferdous AJ.	1996
1918	Journal J Pharm Sci 1997 ; 86, 12: 1410-1416.	Photodegradation of irinotecan (CPT-11) in aqueous solutions : identification of fluorescent products and influence of solution composition. Dodds HM, Craik DJ, Rivory LP.	1997
1383	Journal J Pharm Pharmacol 1978 ; 30: 47P.	Photodegradation of solutions of the antitumour drug DTIC. Stevens MFG, Peatey L.	1978
948	Journal J Pharm Sci 1994 ; 83: 463-467.	Photodegradation of some quinolones used as antimicrobial therapeutics. Tiefenbacher EM, Haen E, Przybilla B, Kurz H.	1994
1920	Journal Drug Stability 1996 ; 1: 118-122.	Photodegradation reactions of CPT-11, a derivative of campothecion, part i: chemical structure of main degradation products in aqueous solution. Akimoto K, Kaway A, Ohya K et al.	1996
1921	Journal Drug Stability 1996 ; 1; 141-146.	Photodegradation reactions of CPT-11, a derivative of campothecion, part ii: photodegradation behaviour of CPT-11 in aqueous solution. Akimoto K, Kawai A, Ohya K.	1996
1696	Journal J Pharm Biomed Anal 1999 ; 21: 851-857.	Photodegradation studies on Atenolol by liquid chromatography. Andrisano V, Gotti R, Leoni A, Cavrini V.	1999
1284	Journal Photochem Photobiol 1981 ; 34: 131-134.	Photoinactivation of anthracyclines. Williams BA, Tritton TR.	1981
847	Journal J Pharm Pharmacol 1980 ; 32: 860-862.	Photolytic degradation of adriamycin. Tavoloni N, Guarino AM, Berck PD.	1980
145	Journal J Pharm Clin 1992 ; 11: 285-295.	Photosensibility of 5-fluorouracile and methotrexate in translucent or opaque perfusers. Lorillon P, Corbel JC, Mordelet MF, Basle B, Guesnier LR.	1992
1851	Journal J Pharm Biomed Anal 2001 ; 25, 3-4: 589-597.	Photostability and phototoxicity studies on diltiazem. Andrisano V, Hrelia P, Gotti R, Leoni A, Cavrini V.	2001
2089	Journal Pharmazie 2004 ; 59: 457-463.	Photostability of epinephrine - the influence of bisulfite and degradation products. Brustugun J, Kristensen S, Tonnesen HH.	2004
1965	Journal PDA J Pharm Sci Technol 2004 ; 58, 6: 296-308.	Photostability of sympatomimetic agents in commonly used infusion media in the absence and presence of bisulfite. Brustugun J, Kristensen S, Tonnesen HH.	2004
3571	Journal Hosp Pharm 2014 ; 49, 1: 42-47.	Physical and Chemical Compatibility of Injectable Acetaminophen During Simulated Y-Site Administration. Anderson C, Boehme S, Ouellette J, Stidham C, MacKay M.	2014
289	Journal Ann Pharmacotherapy 1993 ; 27: 704-707.	Physical and chemical compatibility of intravenous ciprofloxacin with other drugs. Jim LK.	1993
4369	Journal J Pharm Biomed Anal 2020 ;178:112896	Physical and chemical stability of a generic etoposide formulation as an alternative to etoposide phosphate Sadou Yayé H, Hassani L, Secrétan PH, Babiard M, Aouati H, Bellanger A, Tilleul P, Yagoubi N, Do B, Rietveld I.	2020
4001	Journal Int J Pharm Compound 2017 ; 21:4 :322-329	Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox). Ip K,Carvalho M,Shan A,Banov D.	2017
4059	Journal EJHP 2017 ; 25, e2	Physical and chemical stability of ceftaroline in an elastomeric infusion device. Madfai F, Zaidi S, Ming L, Wanandy T, Patel R.	2017
3183	Journal EJOP 2010 ; 4, 3: 11-13.	Physical and chemical stability of cisplatin infusions in PVC containers. Sewell G	2010
4455	Journal J Oncol Pharm Practice 2020 online first	Physical and chemical stability of cytarabine in polypropylene syringes. Ben Ayed W, Drira C, Ali Soussi M, Ouesleti H, Hamdene B, Khrouf M, Safta F, Fradi I.	2020
1937	Journal Ann Pharmacotherapy 2004 ; 38: 1612-1616.	Physical and chemical stability of daptomycin with nine medications. Lai JJ, Brodeur SK.	2004
4602	Journal Hosp Pharm 2021 ; 56, 4: 215-220.	Physical and Chemical Stability of Dexamethasone Sodium Phosphate in Intravenous Admixtures Used to Prevent Chemotherapy-Induced Nausea and Vomiting. Buga I, Uzoma J.I, Reindel K, Rashid K, Diep T, McCartan P, Zhao F.	2021
3195	Journal EJHP 2011 ; 17, 2: 39-43.	Physical and chemical stability of docetaxel infusions. MacLeod S, Sewell G.	2011
2270	Journal Ann Pharmacotherapy 2008 ; 42, 9: 1247-1251.	Physical and chemical stability of esomeprazole sodium solutions. Kupiec TC, Aloumanis V, Ben M, Trissel LA, Chan P, Patterson J.	2008
4174	Journal Int J Pharm Compound 2018 ;22,6:504-511	Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase). Ip K, Shan A, Yan W, Banov D.	2018
1411	Journal J Am Pharm Assoc 1999 ; 39: 146-150.	Physical and chemical stability of etoposide phosphate solutions. Zhang Y, Trissel LA.	1999
1422	Journal J Am Pharm Assoc 1999 ; 39: 509-513.	Physical and chemical stability of gemcitabine hydrochloride solutions. Xu QA, Zhang Y, Trissel LA.	1999
3610	Journal J Oncol Pharm Practice 2014 ; 20, 1: 51-57.	Physical and chemical stability of high-dose ifosfamide and mesna for prolonged 14-day continuous infusion. Zhang, Y., Kawedia, J.D., Myers, A.L., McIntyre, C.M., Anderson, P.M., Kramer, M.A., Culotta, K.	2014
1706	Journal Int J Pharm Compound 2002 ; 6: 74-76.	Physical and chemical stability of hydromorphone hydrochloride 1.5 and 80 mg/ml packaged in plastic syringes. Trissel LA, Xu QA.	2002
1707	Journal Int J Pharm Compound 2002 ; 6: 70-73.	Physical and chemical stability of low and high concentrations of morphine sulfate with bupivacaine hydrochloride packaged in plastic syringes. Trissel LA, Xu QA, Pham L.	2002
1708	Journal Int J Pharm Compound 2002 ; 6: 66-69.	Physical and chemical stability of low and high concentrations of morphine sulfate with clonidine hydrochloride packaged in plastic syringes. Xu QA, Trissel LA, Pham L.	2002
31	Journal Hosp Pharm 1996 ; 31: 965-970.	Physical and chemical stability of methotrexate sodium, cytarabine, and hydrocortisone sodium succinate in Elliott’s B solution. Zhang Y, Xu QA, Trissel LA, Gilbert DL.	1996
1661	Journal J Oncol Pharm Practice 2002 ; 8: 27-32.	Physical and chemical stability of methotrexate, cytarabine, and hydrocortisone in Elliott’s B Solution for intrathecal use. Trissel LA, King KM, Zhang Y, Wood AM.	2002
1709	Journal Int J Pharm Compound 2002 ; 6: 62-65.	Physical and chemical stability of morphine sulfate 5 mg/ml and 50 mg/ml packaged in plastic syringes. Trissel LA, Xu QA.	2002
2172	Journal J Oncol Pharm Practice 2006 ; 12, 4: 211-222.	Physical and chemical stability of paclitaxel infusions in different container types. Donyai P, Sewell GJ.	2006
1936	Journal Ann Pharmacotherapy 2004 ; 38: 1608-1611.	Physical and chemical stability of palonosetron HCl in 4 infusion solusions. Trissel LA, Xu QA.	2004
1950	Journal J Oncol Pharm Practice 2004 ; 10: 191-195.	Physical and chemical stability of palonosetron HCl with cisplatin, carboplatin and oxaliplatin during simulated Y-site administration. Trissel LA, Yanping Z.	2004
2107	Journal Int J Pharm Compound 2006 ; 10: 234-236.	Physical and chemical stability of palonosetron hydrochloride with dacarbazine and with methylprednisolone sodium succinate during simulated Y-site administration. Trissel LA, Zhang Y, Xu QA.	2006
2279	Journal Am J Health-Syst Pharm 2008 ; 65, 18: 1735-1759.	Physical and chemical stability of palonosetron hydrochloride with five common parenteral drugs during simulated Y-site administration. Kupiec T, Trusley C, Ben M, Trissel LA.	2008
2196	Journal Am J Health-Syst Pharm 2007 ; 64, 11: 1209-1213.	Physical and chemical stability of palonosetron hydrochloride with five opiate agonists during Y-site administration. Trissel LA, Trusley C, Ben M, Kupiec TC.	2007
2009	Journal Int J Pharm Compound 2005 ; 2005, 9, 4: 320-322.	Physical and chemical stability of palonosetron hydrochloride with fluorouracil and with gemcitabine hydrochloride during simulated Y-site administration. Trissel LA, Zhang Y.	2005
2286	Journal Int J Pharm Compound 2008 ; 12, 4: 368-371.	Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated Y-site administration. Ben M, Trusley C, Kupiec TC, Trissel LA.	2008
1975	Journal Int J Pharm Compound 2005 ; 9, 3: 235-237.	Physical and chemical stability of palonosetron hydrochloride with lorazepam and midazolam hydrochloride during simulated Y-site administration. Trissel LA, Xu QA.	2005
1976	Journal Int J Pharm Compound 2005 ; 9, 3: 238-241.	Physical and chemical stability of palonosetron hydrochloride with topotecan hydrochloride and irinotecan hydrochloride during simulated Y-site administration. Trissel LA, Xu QA.	2005
2179	Journal Int J Pharm Compound 2007 ; 11, 1: 82-85.	Physical and chemical stability of palonosetron with metoclopramide and promethazine during simulated Y-site administration. Trusley C, Ben M, Kupiec TC, Trissel LA.	2007
2114	Journal Ann Pharmacotherapy 2006 ; 40, 6: 1082-1085.	Physical and chemical stability of pemetrexed in infusion solutions. Zhang Y, Trissel LA.	2006
2036	Journal Ann Pharmacotherapy 2005 ; 39, 12: 2026-2028.	Physical and chemical stability of pemetrexed solutions in plastic syringes. Zhang Y, Trissel LA.	2005
4691	Journal Int J Pharm Compound 2022 ;26,3:248-254	Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine. Catry E, Colsoul ML, Closset Me, Hubert J, Soumoy L, Bihin B, Thiry E, Jamart J, Hecq JD, Galanti L.	2022
3691	Journal J Oncol Pharm Practice 2016 ; 22: 21-25	Physical and chemical stability of proflavine contrast agent solutions for early detection of oral cancer Kawedia L.D, Zhang Y-P, Myers A.L, Richards-Kortum R.R, Kramer M.A, Gillenwater A.M, Culotta K.S.	2016
3611	Journal J Oncol Pharm Practice 2014 ; 20, 1: 58-64.	Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions. Zhang, Y.-P, Myers, A.L., Trinh, V.A, Kawedia, J.D, Kramer, M.A, Benjamin, R.S, Tran, H.T.	2014
3163	Journal EJHP 2010 ; 16, 5: 26-28.	Physical and chemical stability of Taxotere 1-vial 20mg/mL infusion solution following refrigerated storage. Acott SR, Hart M.	2010
1898	Journal Int J Pharm Compound 2004 ; 8, 3: 228-230.	Physical and chemical stability of treprostinil sodium injection packaged in plastic syringe pump reservoirs. Xu QA, Trissel LA, Pham L.	2004
3881	Journal Int J Pharm Compound 2016 ; 20, 4 : 343-346	Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump. Tomasello C, Leggieri A, Rabbia F, Veglio F, Baietto L,Fulcheri C, De Nicol? A, De Perri G, D'Avolio A.	2016
3849	Journal Curr Pharm Biotech 2013 ; 14, 2: 220-225.	Physical and structural stability of the monoclonal antibody, trastuzumab (Herceptin®), intravenous solutions. Pabari R.M, Ryan B, Ahmad W, Ramtoola Z.	2013
4559	Journal Drug Design Dev Ther 2020 ;14, 4179-4187.	Physical Compatibility and Chemical Stability of Fentanyl and Naloxone Hydrochloride in 0.9% Sodium Chloride Injection Solution for Patient-Controlled Analgesia Administration. Chen P, Chen F, Lei J, Zhou B.	2020
2297	Journal Int J Pharm Compound 2008 ; 11, 6: 550-552	Physical compatibility and chemical stability of a concentrated solution of atropine sulfate (2 mg/ml) for use as an antidote in nerve agent casualties. Donnelly R.F, Corman C.	2008
561	Journal Current Ther Res 1976 ; 20: 359-368.	Physical compatibility and chemical stability of amikacin sulfate in large-volume parenteral solutions. Part II. Nunning BC, Granatek AP.	1976
682	Journal Ann Pharmacotherapy 1991 ; 25: 123-126.	Physical compatibility and chemical stability of amphotericin B in combination with magnesium sulfate in 5% dextrose injection. Raymond GG, Davis RL.	1991
865	Journal Int J Pharm Compound 1998 ; 2: 79-81.	Physical compatibility and chemical stability of atracurium besylate and midazolam hydrochloride during intravenous coinfusion. Bhatt-Mehta V, Hirata S.	1998
1931	Journal Can J Hosp Pharm 2004 ; 4: 230-235.	Physical compatibility and chemical stability of bupivacaine and hydromorphone in polypropylene syringes. Donnely RF.	2004
4131	Journal Hosp Pharm 2019 ;54,1:32-36.	Physical Compatibility and Chemical Stability of Injectable and Oral Ranitidine. Fleming K, Donnelly R.	2019
2322	Journal Can J Hosp Pharm 2009 ; 62, 1	Physical Compatibility and Chemical Stability of Ketamine–Morphine Mixtures in Polypropylene Syringes. Donnelly R.F.	2009
2192	Journal Am J Health-Syst Pharm 2007 ; 64, 13: 1410-1414.	Physical compatibility and chemical stability of mycophenolate mofetil during simulated Y-site administration with commonly coadministered drugs. Cochran BG, Sowinski KM, Fausel C, Overholser BR.	2007
1971	Journal Support Care Cancer 2001	Physical compatibility and in vivo evaluation of drug mixtures forsubcutaneous infusion to cancer patients in palliative care. Azuara ML, Sanchez Y, Reyes R, Barcia E.	2001
4245	Poster 2019	Physical Compatibility and Stability of Ascorbic acid Injection in Polyvinyl Chloride Minibags at 4ºC and Room Temperature (25ºC). Iazetta J, Law S, Adhikari NKJ, Lamontagne F, Kanji S, Walker SE.	2019
3186	Journal Am J Health-Syst Pharm 2011 ; 68:377-378.	Physical compatibility of 4% sodium citrate with 23.4% sodium chloride, fluconazole, and micafungin. Bryan Dotson B, Churchwell MD.	2011
3122	Journal Am J Health-Syst Pharm 2010 ; 67: 1195-1198.	Physical compatibility of 4% sodium citrate with selected antimicrobial agents. Dotson B, Lynn S, Savakis K, Churchwell MD.	2010
3201	Journal J Pediatr Pharmacol Ther 2006 ; 11:233?6.	Physical compatibility of alprostadil with commonly used IV solutions and medications in the neonatal intensive care unit. Dice JE.	2006
4491	Journal Eur J Pedia 2020	Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pilar P, De Miguel M, Campino A.	2020
4651	Journal Eur J Pedia 2021 ;180,1169–1176.	Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pascual P, De Miguel M, Campino A.	2021
1822	Journal Am J Health-Syst Pharm 2003 ; 60: 1650-1652.	Physical compatibility of antithymocyte globulin (rabbit) with heparin sodium and hydrocortisone sodium succinate. Trissel LA, Seanz C.	2003
3470	Journal Support Care Cancer 2012 ; 20: 2501-2509.	Physical compatibility of binary and tertiary mixtures of morphine and methadone with other drugs for parenteral administration in palliative care. Destro M, Ottolini L, Vicentini L, Boschetti S.	2012
3268	Journal Am J Health-Syst Pharm 2012 ;69: 98.	Physical compatibility of calcium gluconate and magnesium sulfate injections. Beauregard N, Bertrand N, Dufour A, Blaizel O, Leclair G	2012
4528	Journal Int J Pharm Compound 2021 ;25,1:52-61	Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N.	2021
3429	Journal Am J Health-Syst Pharm 2015 ; 72:483-486	Physical compatibility of cisatracurium with selected drugs during simulated Y-site administration Foushee J.A, Fox L.M, Gormley L.R, Lineberger M.S.	2015
4055	Journal Am J Health-Syst Pharm 2018 , 75, 1:36-44	Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration. Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.	2018
3131	Journal Can J Hosp Pharm 2010 ; 63, 2: 154-155.	Physical compatibility of high-concentration bupivacaine with hydromorphone, morphine and fentanyl. Donnely RF, Wong K, Spencer J.	2010
4419	Journal J Pediatr Pharmacol Ther 2008 ; 13, 3: 155-161.	Physical Compatibility of Ibuprofen Lysine Injection with Selected Drugs During Simulated Y-site Injection. Holt R.J, Siegert S.W.K, Krishna A.	2008
4254	Journal Pharmaceutical Technology in Hospital Pharmacy 2019 ;4,1:29-40	Physical Compatibility of Intravenous Drugs Commonly Used in Intensive Care Units: An Observational Study and Physical Compatibility Laboratory Tests on Anti-Infective Drugs D'Huart E, Vigneron J, Demoré B.	2019
4108	Journal Am J Health-Syst Pharm 2018 ;75;8:510-512	Physical compatibility of levetiracetam injection with heparin, dobutamine, and dopamine. Cruz K, Chrchwell M, Mauro V, Boddu.	2018
4411	Journal Int J Pharm Compound 2020 ;24,3:238-241.	Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions. Wilder A.G, Foushee J.A, Fox L.M, Navalle J, Wright A.M, Greer M.A.	2020
169	Journal Am J Hosp Pharm 1993 ; 50: 2359-2363.	Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Trissel LA, Martinez JF.	1993
2346	Journal Am J Health-Syst Pharm 2009 ; 66: 986-987.	Physical compatibility of metoprolol tartrate injection with selected cardiovascular agents Newland A.M, Mauro V.F, Alexander K.S.	2009
4057	Journal Hosp Pharm 2018 ; 53, 2: 125-127.	Physical Compatibility of Micafungin With Sodium Bicarbonate Hydratation Fluids Commonly Used With High-Dose Methotrexate Chemotherapy. Joiner L, Ynes C, Arnold J, Miller R, Gorman G.	2018
4506	Journal Am J Health-Syst Pharm 2020 ;77,23:1938-1940.	Physical compatibility of milrinone 1 mg/mL with select cardiovascular medications during simulated Y-site administration. Griffith S, Stapleton E, Padilla S, Mruk A, Thomas C.	2020
4144	Journal EJHP 2018 ;75,14:1010-1012	Physical compatibility of milrinone with levofloxacin and ceftriaxone injection. Ross A, Boddu S, Mauro V, Churchwell M.	2018
4545	Journal Journal of Nippon Medical school 2021	Physical compatibility of nafamostat with analgesics, sedatives, and muscle relaxants for coronavirus disease treatment. Kondo M, Nagano M, Yoshida M, Yoshida N, Tagui N, Yoshida M, Sugaya K, Takase H.	2021
4655	Journal Am J Health-Syst Pharm 2022 ;79,1:27-33	Physical compatibility of Normosol-R with critical care medications used in patients with COVID-19 during simulated Y-site administration. Holyk A, Lindner A, Lindner S, Shippert B	2022
1902	Journal Can J Hosp Pharm 2004 ; 57, 2: 90-96.	Physical compatibility of pantoprazole with selected medications during simulated Y-site administration. Walker SE, Wyllie A, Law S.	2004
1953	Journal Am J Health-Syst Pharm 2004 ; 61: 2289-2293.	Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Trissel LA, Saenz CA, Ogundele AB, Ingram DS.	2004
4543	Journal Archives of Disease in Childhood 2018 ;104:292–295.	Physical compatibility of pentoxifylline and intravenous medications. Senarathna G, Strunk T, Petrovski M, Batty K.	2018
4145	Journal Am J Health-Syst Pharm 2018 ;75,14:1048-1056	Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration. Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P.	2018
4080	Journal Anaesthesia 2017 ;124,3:776-781	Physical Compatibility of Propofol-Sufentanil Mixtures. Zbytovska J, Gallusova J, Vidlarova L, Prochazkova K, Simek J, Stepanek F.	2017
3558	Journal Can J Hosp Pharm 2013 ; 66, 5: 332.	Physical Compatibility of Ranitidine and Metoclopramide in 50-mL Minibags of Normal Saline. Rowe H, Riley J, Newby B.	2013
58	Journal Can J Hosp Pharm 1985 ; 38: 160-161.	Physical compatibility of ranitidine HCl with preoperative injectable medications. Parker WA.	1985
4723	Journal Am J Health-Syst Pharm 2022 https://doi.org/10.1093/a	Physical compatibility of remimazolam with opioid analgesics, sedatives, and muscle relaxants during simulated Y-site administration. Kondo M, Yoshida N, Yoshida M, Tanaka C, Tagami T, Horik K, Sugaya K, Takase H	2022
3416	Journal Am J Health-Syst Pharm 2013 ; 70: 932-937	Physical compatibility of sodium citrate with alcohol and cefepime. Csaba M, Boddu,S.H.S , Churchwell M.D.	2013
3254	Journal Am J Health-Syst Pharm 2011 ; 68: 2265-2270.	Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L.	2011
4524	Poster ESCP Symposium, Geneva, Switzerland 2009	Physical compatibility of the propofol emulsion with 33 drugs used in anaesthesiology. Stucki C, Sautter A-M, Bonnabry P.	2009
3967	Journal J Pharm Pharmacol 2017 ;69,7:448-462	Physical compatibility of total parenteral nutrition and drugs in Y-site administration to children from neonates to adolescents. Staven V, Herra I, Wang S, Grönlie I,Tho I.	2017
3942	Journal Am J Health-Syst Pharm 2017 ; 74, 5: 280-281.	Physical compatibility of valproate sodium injection with dobutamine and dopamine. Frank M.I, Boddu S.H.S, . Mauro V.F,. Churchwell M.D.	2017
3421	Journal Am J Health-Syst Pharm 2013 ;70:1163-1166.	Physical compatibility of vancomycin and piperacillin sodium–tazobactam at concentrations typically used during prolonged infusions. Leung E, Venkatesan N, Ly S.C, Scheetz M.H.	2013
3379	Journal Am J Health-Syst Pharm 2013 ;70:520-524.	Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration. Fox L.M, Wilder A.G, Foushee J.A.	2013
1801	Journal Am J Health-Syst Pharm 2003 ; 60: 1271-1272.	Physical compatibility of vasopressin with medications commonly used in cardiac arrest. Feddema S, Rusho WJ, Tyler LS, Barker B.	2003
1647	Journal Anaesthesia 2001 ; 56: 294.	Physical incompatibility between atracurium and intravenous diclofenac. Ackland G.	2001
3557	Journal Can J Hosp Pharm 2013 ; 66, 5: 310-312	Physical Incompatibility between Parenteral Cloxacillin and Vancomycin. Chan A, Tawfik G, Cheng W.	2013
2117	Journal Ann Pharmacotherapy 2006 ; 40, 7: 1289-1292.	Physical instability of frozen pemetrexed solutions in PVC bags. Zhang Y, Trissel LA.	2006
4370	Journal EJHP 2018 2018;0:1-7	Physical stability of an all-in one parenteral nutrition admixture for preterm infants upon mixing with micronutrients and drugs Staven V, Wang S, Gronlie I, Tho I.	2018
4368	Journal J Pharm Health Care Sci 2019 ; 5: 25.	Physical, chemical, and microbiological stability study of diluted atropine eye drops. Saito J, Imaizumi H, Yamatani A.	2019
1660	Journal Pharm World Sci 1999 ; 21: 137-141.	Physico-chemical stability of docetaxel premix solution and docetaxel infusion solutions in PVC bags and polyolefine containers. Thiesen J, Krämer I.	1999
3707	Journal J Oncol Pharm Practice 2014 ; 20: 183-189	Physico-chemical stability of eribulin mesylate containing concentrate and ready-to-administer solutions. Spindeldreier K, Thiesen J, Lipp H.P, Krämer I.	2014
1723	Journal Pharmazie 1998 ; 53: 386-391.	Physico-chemical stability of infusion solutions for epidural administration containing fentanyl and bupivacaine or lidocaine. Sattler A, Jage J, Krämer I.	1998
2825	Journal Int J Pharm Compound 2015 ; 19, 3: 261-267.	Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials. Mueller C, Dietel E, Heynen S, Nalenz H, Goldbach P, Mahler H, Schmidt J, Grauschopf U, Schoenhammer K.	2015
3225	Journal EJHP Science 2011 ; 17, 1: 7-12.	Physico-chemical stability of nelarabine infusion solutions in EVA infusion bags. Kaiser J, Krämer I.	2011
4126	Journal Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,3:135-142	Physico-Chemical Stability of Sodium Thiosulfate Infusion Solutions in Polyolefin Bags at Room Temperature over a Period of 24 Hours. D'Huart E, Vigneron J, Ranchon F, Vantard N, Rioufol C, Demor2 B	2018
3041	Journal Acta Pol Pharm 2006 ; 63: 293-299.	Physicochemical and microbiological properties of eye drops containing cefuroxime. Kodym A, Zawiswa T, Taberska J , Kukula H.	2006
3755	Journal Int J Pharm Compound 2014 ; 18, 5: 427-431.	Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition. Bourget P, Amin A, Vidal F, Pieyre M, Dosso E.O, Beauvais R, Loeuillet R.	2014
4052	Journal Pharmaceutical Technology in Hospital Pharmacy 2017	Physicochemical and microbiological stability of a new paediatric oral solution of clonidine. Verhlac C, Bourdon F, Titecat M, Frealle E, Dhorne C, Berneron C, Odou P.	2017
4695	Journal Int J Pharm Compound 2022 ;24,6:342-351	Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt. Pramar Y, Mandal T, Bostanian L, Kader C, Morris T Graves R.	2022
3789	Journal Int J Pharm Compound 2015 ; 19, 1: 73-77.	Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions. Amin A, Bourget P, Vidal F, Cartier F, Beauvais R, Do Nascimento Afonso V.	2015
4575	Journal Int J Pharm Compound 2021 ;25,2:169-175	Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt. Pramar Y, Mandal T, Bostanian L, Le G, Morris T, Richard A.	2021
4530	Journal Int J Pharm Compound 2021 ;25,5:431-439	Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt. Pramar Y, Mandal T, Bostanian L, Kader C, Morris T, Graves R.	2021
4741	Journal Int J Pharm Compound 2023 ;27,2:160-168	Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt. Pramar Y, Mandal T, Bostanian L, Kader C, Morris T, Graves R	2023
4272	Journal Pharm Dev Technol 2019	Physicochemical and microbiological stability of two news oral liquid formulations of clonidine hydrochloride for pediatric patients. Merino-Bohorquez, Delgado-Valverde M, Garcia-Palomo M, Dàvila- Pousa MC, Canete C, Villaronga M, Rodriguez-Marrodan B, Lopez-Ro	2019
2530	Journal Int J Pharm Compound 2022 ;26,4:330-335	Physicochemical and Microbiological Stability of Vancomycin 10-mg/mL Intravitreal Syringes. Bartoll A, Bellés Medall M, Peñarrocha J, Escrig L, Clemente R, Azuara J.	2022
761	Journal EJHP 2015 ;22:89-93	Physicochemical and microbiological stability studies of a melatonin oral suspension in a commercially available vehicle for paediatric use. Zerbit J, Bordenave J, Benoit G.	2015
4011	Journal EJHP 2016 2016;0:1-11	Physicochemical compatibility and emulsion stability of propofol with commonly used analgesics and sedatives in an intensive care unit. Gersonde F, Eisend S, Haake N, Kunze T.	2016
4461	Journal Molecules 2019 24, 1242.	Physicochemical Compatibility and Stability of Linezolid with Parenteral Nutrition. Tomczak S, Stawny M, Dettlaff K, Kieliszek, M, Słominska D, Jelinska A.	2019
1847	Journal J Pharm Biomed Anal 2003 ; 32, 6: 1235-1241.	Physicochemical compatibility between ketoprofen kysine salt injections (Artrosilene®) and pharmaceutical products frequently used for combined therapy by intravenous administration. Anacardo R, Perilli O, Bartolini S, Gentile MM, Mazzeo P, Carlucci G.	2003
1859	Journal Il Farmaco 2002 ; 57: 925-930.	Physicochemical compatibility between thiocolchicoside injections (Miotens®) and pharmaceutical products frequently used for combined therapy. Anacardio R, Perilli O, Pagnanelli F, Bartolini S, gentile MM, Mazzeo P, Carlucci G.	2002
4371	Journal Journal of Parenteral and Enteral Nutrition 2018	Physicochemical Compatibility of Amiodarone with Parenteral Nutrition. Mediavilla MM, Molina A, Navarro L, Grau L, Pujol MD, Cardenete J, Cardona D, Riera P.	2018
3705	Journal EJHP 2014 ;21:161-166	Physicochemical compatibility of commonly used analgesics and sedatives in the intensive care medicine. Knudsen L, Eisend S, Haake N, Kunze T.	2014
4357	Journal Nutrition in clinical Practice 2020 ; 35: 967-972.	Physicochemical Compatibility of Dexmedetomidine With Parenteral Nutrition. Campos-Baeta, Saavedra-Mitjans M, Garin N, Cardenete J, Cardona D, Riera P.	2020
2790	Journal Int J COPD 2007 ; 1, 4: 599-607.	Physicochemical compatibility of fluconasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions. Kamin W, Schwabe A, Krämer I.	2007
1506	Journal EJHP 2015 ;22:107-112.	Physicochemical compatibility of high concentration drugs usually Y-site administered in intensive care units. Lopez-Cabezas C, Guerrero L, Molas G, Anglada H, Soy D.	2015
150	Journal J Pharm Clin 1993 ; 12: 31-35.	Physicochemical compatibility of methotrexate with co-administered drugs during cancer chemotherapy regimens. Aujoulat P, Coze C, Braguer D, Raybaud C.	1993
3334	Journal EJHP 2013 ;20:36-41	Physicochemical compatibility of nebuliser solution admixtures containing colistimethate and hypertonic saline or colistimethate, fluticasone-17-propionate, ipratropium bromide and salbutamol sulfate. Krämer I, Walz-Jung H, Stanko C, Kamin W.	2013
3440	Journal Pharmazie 2013 ; 68: 744-748.	Physicochemical compatibility of nebulizable drug admixtures containing colistimethate and tobramycin. Wollstadt A, Krämer I, Kamin W.	2013
2770	Journal Pharmazie 2007 ; 62, 10: 760-766.	Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol. Krämer I, Schwabe A, Lichtinghagen R, Kamin W.	2007
126	Journal Am J Health-Syst Pharm 1996 ; 53: 2606-2610.	Physicochemical compatibility of propofol with thiopental sodium. Prankerd RJ, Jones RD.	1996
2053	Journal Anesth Analg 2003 ; 97: 1646-1651.	Physicochemical compatibility of propofol-lidocaine mixture. Masaki Y, Tanaka M, Nishikawa T.	2003
3919	Journal Eur J Pharm Sci 2017 ; 96: 449-455.	Physicochemical stability and compatibility testing of levetiracetam in all-in-one parenteral nutrition admixtures in daily practice. Aeberhard C, Steuer C, Saxer C, Huber A, Stanga Z, Mühlebach S.	2017
4633	Journal Pharmaceutics 2021 ; 13, 1447.	Physicochemical Stability and Compatibility Testing of Voriconazole in All-in-One Parenteral Nutrition Admixtures. Reber E, Neyer P, Schönenberger K.A, Saxer C, Bernasconi L, Stanga Z, Huber A, Hammerer-Lercher A, Mühlebach S.	2021
4696	Journal Pharmaceutical Technology in Hospital Pharmacy 2022 2022; 7(1): 20220005	Physicochemical stability of 20 mg/mL amiodarone hydrochloride oral suspension in SyrSpend® SF PH4 (liquid) Adoum A, Le P., Faisant S, Legendre P, Lester MA, Boivin PN.	2022
4077	Journal Pharmaceutical Technology in Hospital Pharmacy 2018	Physicochemical Stability of 5 mg/mL Pediatric Prednisone Oral Suspensions in Syrspend® SF PH4. Bonnaure Anne-Claire, Bellay R, Rault P, Lester M.A, Boivin P.N.	2018
3124	Journal EJHP Science 2010 ; 16, 1: 17-22.	Physicochemical stability of a 1mg/ml dexamethasone acetate oral suspension. Tiphine T, Armand A, Navas D, Dailly E, Menanteau M, Thomare P.	2010
4096	Journal Pharm Dev Technol 2014	Physicochemical stability of a new topical timolol 0.5% gel formulation for the treatment of infant hemangioma. Merino-Bohorquez V, Casas M, Caracuel F, Camean M, Fernandez-Anguita M.J, Ramirez*Soto G, Lucero M.J.	2014
4673	Journal Pharmaceutics 2022 ;14,1:118	Physicochemical Stability of a Novel Tacrolimus Ophtalmic Formulation for the Treatment of Ophtalmic Inflammatory Diseases. Barrieu M, Chennell P, Yessaad M, Bouattour Y, Wasiak M, Jouannet M, Le Basle Y, Sautou V.	2022
4350	Journal EJHP 2019 ;0:1-5	Physicochemical stability of an admixture of lidocaine and ketamine in polypropylene syringe used in opioid-free anaesthesia. Beiler B, Barraud D, Vigneron J, Demor? B.	2019
4030	Journal Int J Pharm Compound 2017 ; 21, 5 : 430-435	Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt. Graves R, Phan K, Bostanian L, Mandal T, Pramar Y.	2017
4697	Journal Pharmaceutical Technology in Hospital Pharmacy 2022 2022; 7(1): 20220003	Physicochemical stability of azacitidine suspensions at 25 mg/mL in polypropylene syringes stored under different conditions of storage. Trambloy Q, Vigneron J, Clarot I, Blaise F, D’Huart E, Demoré B.	2022
4362	Journal EJHP 2018 Eur J Hosp Pharm 2018;0:1	Physicochemical stability of binary admixtures of paracetamol and dexketoprofen-trometamol for patient-controlled analgesia use. Lopez Navarro AA, Martinez Gomez MA, Gras Colomer E, Campillos P, Climente Marti M.	2018
3804	Journal EJHP 2014 ;22:150-155.	Physicochemical stability of cabazitaxel and docetaxel solutions. Lazzarini R, Salvadori S, Trapella C, Guerrini R, Marzola E, Pasini G, Dalpiaz A.	2014
4761	Journal Pharmaceutical Technology in Hospital Pharmacy 2023 ; 8(1): 20220009	Physicochemical stability of Cabazitaxel Zentiva® solution in vials after opening and diluted- solutions in three infusion bags. D'Huart E, Sacrez M, Vigneron J, Demoré B.	2023
4097	Journal Pharm Dev Technol 2013	Physicochemical stability of captopril and enalapril extemporaneous formulations for pediatric patients. Casas M, Alvarez J, Lucero M.	2013
4047	Journal J Oncol Pharm Practice 2017 ;25,2: 339-350	Physicochemical stability of carfilzomib (Kyprolis®) containing solutions in glass vials, ready-to-administer plastic syringes and infusion bags over a 28-day storage period. Kim S.H, Krämer I.	2017
4762	Journal EJHP 2021 Knoll L, et al. Eur J Hos	Physicochemical stability of carmustine-containing medicinal products after reconstitution and after dilution to ready-to-administer infusion solutions stored refrigerated or at room temperature Knoll L, Kraemer I, Thiesen J.	2021
4268	Journal Pharmaceutical Technology in Hospital Pharmacy 2019	Physicochemical Stability of Cefotaxime Sodium in Polypropylene Syringes at High Concentrations for Intensive Care Units. D'Huart E, Vigneron J, Blaise F, Charmillon A, Demoré B.	2019
4478	Journal Int J Pharm Compound 2020 ;24,5:413-419	Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt. Pramar Y, Mandal T, Bostanian L, Le G, Morris T, Graves R.	2020
4520	Journal Pharmaceutical Technology in Hospital Pharmacy 2020	Physicochemical stability of compounded midazolam capsules over a one-year storage period. Boivin P-N, Legendre P, Bonnaure A-C, M-A.	2020
4251	Journal Int J Pharm Compound 2019 ;23,2:157-162	Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base, SuspendIt. Pramar YV, Mandal TK, Bostanian LA, Nguyen ATQ, Morris TC, Graves RA.	2019
4677	Poster EAHP Congress Vienna 2022	Physicochemical stability of diluted "Thiotepa Riemser" infusion solutions in prefilled 5% glucose infusion bags. Linxweiler H, Thiesen J, Krämer I.	2022
3258	Journal Int J Pharm Compound 2011 ; 15, 6 : 515-520.	Physicochemical Stability of Diluted Trastuzumab Infusion Solutions in Polypropylene Infusion Bags. Kaiser J, Krämer I.	2011
3343	Poster ECOP Congress, Budapest, Hungary 2012	Physicochemical stability of diluted trastuzumab solutions stored 6 months at 4°C. Vieillard V, da Silva R, Astier A, Paul M.	2012
4767	Journal Pharmaceutical Technology in Hospital Pharmacy 2023 ;8,1	Physicochemical stability of durvalumab (Imfinzi® ) concentrate for solution in original vials after first opening. Almasi K, Thiesen J, Krämer I.	2023
4125	Journal EJHP 2020 ; 27, 1: 43-48.	Physicochemical stability of etoposide diluted at range concentrations between 0.38 and 1.75 mg/mL in polyolefin bags. D'Huart E, Vigneron J, Lider P, Demoré B.	2020
4353	Journal J Clin Pharm Ther 2019	Physicochemical stability of extemporaneously prepared clonidine solutions for use in neonatal abstinence syndrome. Lu D, Harmanjeet H, Wanandy T, Paine M, . PetersonG.M, Patel R.	2019
4107	Journal Pharmaceutical Technology in Hospital Pharmacy 2018	Physicochemical Stability of Extemporaneously Prepared Oral Suspension of Fluconazole 50 mg/mL in SuspendIt. Ip K, Shan A, Carvalho M, Baker S, Banov D.	2018
4748	Journal Pharmaceutics 2023 ,15, 309.	Physicochemical Stability of Generic Thiotepa Concentrate and Ready-to-Administer Infusion Solutions for Conditioning Treatment. Linxweiler H, Thiesen J, Krämer I.	2023
4635	Journal Pharmaceutical Technology in Hospital Pharmacy 2021 ; 6(1): 20210005.	Physicochemical stability of human insulin 1 I.U./mL infusion solution in 50 mL polypropylene syringes. Mohr A, Erdnüß F, Krämer I.	2021
2241	Journal J Oncol Pharm Practice 2000 ; 6, 3: 115-121.	Physicochemical stability of irinotecan injection concentrate and diluted infusion solutions in PVC bags. Thiesen J, Krämer I.	2000
4600	Journal EJOP 2021 ; 4: 3.	Physicochemical stability of lurbinectedin reconstituted at 500 µg/mL and diluted at 15, 30, and 70 µg/mL in 0.9% sodium chloride and 5% dextrose. Loeuille G, Vigneron J, D’Huart E, Demoré B.	2021
3896	Journal Pharmaceutical Technology in Hospital Pharmacy 2016 ;1,2:73-81	Physicochemical Stability of Mozobil® (Plerixafor) Solution for Injection in Glass Vials and Plastic Syringes over a Three-Month Storage Period Kim S.H, Thiesen J, Krämer I.	2016
4267	Journal EJHP 2019	Physicochemical stability of nefopam and nefopam/droperidol solutions in polypropylene syringes for intensive care units. D'Huart E, Vigneron J, Clarot I, Demoré B.	2019
4250	Journal Ann Pharm Fr 2019 ;77,3:212-221.	Physicochemical stability of norepinephrine bitartrate in polypropylene syringes at high concentrations for intensive care units. D'Huart E, Vigneron J, Clarot I, Demoré B.	2019
2883	Journal Am J Health-Syst Pharm 2009 ; 66, 21: 1929-1933.	Physicochemical stability of oxaliplatin in 5% dextrose injection stored in polyvinyl chloride, polyethylene, and polypropylene infusion bags. Eiden C, Philibert L, Bekhtari K, Poujol S, Malosse F, Fr?d?ric Pinguet F.	2009
4143	Journal EJHP 2016 ; 25, 4	Physicochemical stability of oxycodone-ketamine solutions in polypropylene syringe and polyvinyl chloride bag for patient-controlled analgesia use. Daouphars M, Hervou?t C.H, Bohn P, Martin D, Rouvet J, Basuyau F, Varin R.	2016
4334	Journal J Oncol Pharm Practice 2020 ; 26, 3: 641-646.	Physicochemical stability of pembrolizumab admixture solution in normal saline intravenous infusion bag. Sundaramurthi P, Sean Chadwick S, Narasimhan C.	2020
4702	Journal EJOP 2022 ; 5: 2.	Physicochemical stability of pemetrexed diarginine at 25 mg/mL in partially-used vials and at 3 and 12 mg/mL diluted in dextrose 5% or in sodium chloride 0.9% in polyolefin bags. Nisse Y-E, Sobalak N, Vigneron J, Demoré B.	2022
4754	Journal J Oncol Pharm Practice 2023 ;29,3:	Physicochemical stability of PF-05280014 (trastuzumab-qyyp; TrazimeraTM), a trastuzumab biosimilar, under extended in-use conditions. Weiser S, Burns C, Zartler E	2023
4756	Journal J Oncol Pharm Practice 2022 ;29, 5: 1032-1043	Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev®), a bevacizumab biosimilar, under extended in-use conditions. Weiser S, Burns C, Zartler E.	2022
3397	Poster EAHP Congress Paris 2013	Physicochemical stability of ready-to-administer epinephrine injection solutions 20 µg/mL, 50 mL. Heeb R.M, Krämer I.	2013
4043	Journal Pharmaceutical Technology in Hospital Pharmacy 2017 ;2,4: 145-157.	Physicochemical Stability of Reconstituted Decitabine (Dacogen®) Solutions and Ready-to-Administer Infusion Bags when Stored Refrigerated or Frozen. Kim S, Heeb R, Krämer I.	2017
4711	Poster GERPAC Congrès - octobre 2022 2022	Physicochemical stability of subcutaneous daratumumab (DARZALEX® 1800 mg injection solution) in plastic syringes over a period of 28 days stored refrigerated or at room temperature. Knoll L, Thiesen J, Klassen M, Reinders L, Türk J, Krämer I.	2022
4115	Journal Drug Design Dev Ther 2016 ;10:3873-3878	Physicochemical stability of ternary admixtures of butorphanol, ketamine, and droperidol in polyolefin bags for patient-controlled analgesia use. Fang B, Wang L, Gu J, Chen F, Shi X.	2016
4516	Journal GaBI Journal 2020 ; 9, 4	Physicochemical stability of the bevacizumab biosimilar, ABP 215, after preparation and storage in intravenous bags. Seckute J, Castellanos I, Bane S.	2020
4763	Journal Pharmaceutical Technology in Hospital Pharmacy 2023 ;8,1	Physicochemical stability of urea-containing Mitomycin C preparations in glass vials (1.0 mg/mL) and plastic syringes (2.0, 0.4, 0.2 mg/mL) Almasi J, Erdnuss F, Thiesen J, Krämer I.	2023
4348	Journal Can J Hosp Pharm 2019 ;72(5):360-8	Physicochemical Stability of Vancomycin at High Concentrations in Polypropylene Syringes. D'Huart E, Vigneron J, Charmillon A, Clarot I, Demoré B.	2019
4035	Journal EJHP 2017 ;0:1-5	Physicochemical stability of voriconazole in elastomeric devices. Harmanjeet H, Zaidi S.T.R, Ming L.C, Wanandy T, Patel R.P.	2017
4745	Journal Pharmaceutical Technology in Hospital Pharmacy 2023	Physicochemical stability study of a biosimilar of Bevacizumab in vials and after dilution in 0.9% NaCl in polyolefin intravenous bags. Vieillard V, Paul M	2023
3448	Journal Ann Pharm Fr 2013 ; 71, 5: 358-363.	Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction. Vieillard V, Eychenne N, Astier A, Yiou R, Deffaux C, Paul M.	2013
4493	Journal J Oncol Pharm Practice 2020	Physicochemical stability study of MYL-1401O, a biosimilar of trastuzumab, following a transient temperature excursion. Le Guyader G, Vieillard V, Paul M.	2020
4692	Journal The Scientific World Journal 2022	Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease. Hinterlang M, Sebti M, Cotteret C, Vidal F, Neven B, Cisternino S, Schlatter J.	2022
3895	Journal Ann Pharmacotherapy 2016 ; 50: 790-792.	Physicochemical Stability Study of Polymyxin B in Various Infusion Solutions for Administration to Critically Ill Patients Lim Tze-Peng, Kim-Hor Hee D, Lee W, Qi-Min Teo J, Cai Y,Yu-Hng Chia S, Yee-Kiat Leaw J, Jing-Yi Lee S, Soon-U Lee L, Kwa A.L.	2016
4669	Journal Neuromodulation 2021 : 1-16.	Physicochemical Stability Study of the Morphine-Ropivacaine-Ziconotide Association in Implantable Pumps for Intrathecal Administration. Robert J, Sorrieul J, Dupoiron D, Jubier-Hamon S, Bienfait F, Visbecq A, Devys C.	2021
3472	Journal Krankenhauspharmazie 2007 ; 28, 5: 170-178.	Physikalisch-chemische kompatilibität von Mischinhalationslösungen und suspensionen zur simultanen feuchtinhalationstherapie bei Mukoviszidose Patienten. Krämer I, Schwabe A, Kamin W.	2007
3538	Journal Krankenhauspharmazie 2013 ; 11: 524-525.	Physikalisch-chemische Stabilität einer Metoprolol-Injektionslösung 1 mg/ml, 50 ml. Gilcher Th, Heeb R M, Krämer I.	2013
3986	Journal Krankenhauspharmazie 2017 ;38:377-82.	Physikalisch-chemische Stabilität von Carfilzomib (Kyprolis®) im Originalbehältnis nach Erstanbruch und in applikationsfertigen Zubereitungen. Kim S, Krämer I.	2017
3110	Poster Poster ADKA Congress May 2010 2010	Physikalisch-chemische Stabilität von Clofarabin-Zubereitungen. Kaiser J, Krämer I.	2010
4004	Journal Krankenhauspharmazie 2017 ;38,7:334?340.	Physikalisch-chemische Stabilität von Oxaliplatin-beta-Infusionslösungskonzentrat und Infusionslösungen in 5 % Glucose in Polyolefin-Infusionsbeuteln. Krämer I, Sarakbi I, Thiesen J, Mainz.	2017
4018	Journal Krankenhauspharmazie 2017 ;38:423-429	Physikalisch-chemische Stabilität von rekonstituierten Trabectedin-haltigen Lösungen. Lipp H-P, Gfrörer W	2017
999	Journal JPEN 1985 ; 9: 220-224.	Piggyback compatibility of antibiotics with pediatric parenteral nutrition solution. Watson D.	1985
3586	Manufacturer Actavis France 2010	Piperacilline tazobactam Actavis® - Résumé des caractéristiques du produit	2010
3590	Manufacturer Dakota Pharm 2011	Piperacilline - Résumé des caractéristiques du produit	2011
3320	Manufacturer CTI Life Sciences Limited 2012	Pixantrone (Pixuvri®) - Summary of Product Characteristics	2012
1223	Journal Am J Hosp Pharm 1980 ; 37: 618.	Plastic IV container for nitroglycerin. Amann AH, Baaske DM, Wagenknecht DM.	1980
2078	Journal J Ped Surg 2000 ; 35: 1775-1781.	Polyvinylchloride infusion lines expose infants to large amounts of toxic plasticizers. Loff S, Kabs F, Witt K, Sartoris J, Mandl B, Niessen KH, Waag KL.	2000
4380	Manufacturer Merck Sharp & Dohme Limited 2019	Posaconazole (Noxafil®) - Summary of Product Characteristics	2019
3839	Journal Current Ther Res 2015 ; 77: 105-110.	Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions. Gu Z, Parra C, Wong A, Nguyen A, Cheung R, Catalano T.	2015
1941	Journal Am J Health-Syst Pharm 2004 ; 61: 1586-1589.	Potency and stability of frozen urokinase solutions in syringes. Dedrick SC, Ramirez-Rico J.	2004
892	Journal Am J Hosp Pharm 1992 ; 49: 1156-1164.	Practical guidelines for preparing and administering amphotericin B. Kintzel PE, Smith GH.	1992
4716	Journal J Pediatr Pharmacol Ther 2022 ;27,7:625-631	Pre-formulation and Stability Study of 20 mcg Clonidine Hydrochloride Pediatric Capsules. Wasilewski M, Curti C, Panuccio C, Bouguergour C, Primas N, Lamy E, Castera-Ducros C, Jean C, Pirre Bertault-Peres P, Vanelle P	2022
1959	Journal Hosp Pharm 2005 ; 40, 2: 154-155.	Precipitate formation after subconjonctival administration of ceftazidime and vancomycin. Mac Lellan C, Papadopoulos A.	2005
2073	Journal Can J Anesth 1998 ; 45: 347-351.	Precipitate formed by thiopentone and vecuronium causes pulmonary embolism. Taniguchi T, Yamamoto K, Kobayashi T.	1998
3377	Journal Anaesthesia 1983 ; 38: 601-602.	Precipitation betwen meptazinol and thiopentone. Huddy NC, Durcan JJ.	1983
3372	Journal Rev Bras Anestesiol 2013 ; 63, 1: 163-166.	Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine. Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S.	2013
3374	Journal Anaesthesia 2001 ; 56: 494-495.	Precipitation in Manchester: ketorolac/cyclizine Smith R.P.R, Jones M.	2001
270	Journal Am J Health-Syst Pharm 1997 ; 54: 1449.	Precipitation of amphotericin B from IV fat emulsion. Heide PE.	1997
138	Journal Am J Health-Syst Pharm 1997 ; 54: 1845-1848.	Precipitation of fluorouracil in elastomeric infusers with a polyisoprene reservoir and in polypropylene syringes with an elastomeric joint. Corbrion V, Crauste-Manciet S, Allain P, Brossard D.	1997
233	Journal Am J Health-Syst Pharm 1996 ; 53: 1850.	Precipitation of lorazepam during infusion by volumetric pump. Grillo JA, Barie PS.	1996
780	Journal Ann Pharmacotherapy 1996 ; 30: 1037-1038.	Precipitation of lorazepam infusion. Boullata J, Gelone SP, Mancano MA, Borenstein MR, Zitterman R.	1996
969	Journal N Engl J Med 1991 ; 325: 1315-1316.	Precipitation of ondansetron in alkaline solutions. Jarosinski PF, Hirschfeld S.	1991
1741	Journal Am J Hosp Pharm 1993 ; 50: 2518-2521.	Precipitation of paclitaxel during infusion by pump. Pfeifer RW, Hale KN, Cronquist SE, Daniels M.	1993
173	Journal J Infus Chemother 1994 ; 4: 140-142.	Precipitation of paclitaxel from continuous infusion fluids. Williams DA, Naik A.	1994
2071	Journal Anesth Analg 2002 ; 95: 785.	Precipitation of protamine by cefazolin. Ng HP, Koh KF.	2002
3373	Journal J R Soc Med Sh Rep 2011 ; 2: 58.	Precipitation of thiopental with muscle relaxants: a potential hazard. Khan S, Stannard N, Greijn J.	2011
1099	Journal Ann Intern Med 1984 ; 101: 880.	Precipitation of verapamil in an intravenous line. Tucker R, Gentile JF.	1984
1351	Journal Am J Hosp Pharm 1984 ; 41: 2588.	Precipitation of verapamil with nafcillin. Tucker R, Gentle JF.	1984
1100	Journal Ann Intern Med 1982 ; 97: 619.	Precipitation of verapamil. Bar-Or D, Kulig K, Marx JA, Rosen P.	1982
2557	Journal Aust J Hosp Pharm 1991 ; 21: 239-241.	Prednisolone stability in a hydroalcoholic prednisolone mixture. Sullivan JA.	1991
1424	Journal Am J Emerg Med 1999 ; 17: 333-337.	Prehospital stability of diazepam and lorazepam. Gottwald MD, Akerd LC, Liu PK, Orsulak PJ, Corry M, Bacchetti P, Fields SM, Loxenstein DH, Alldredge BK.	1999
2051	Journal Br J Anaesth 2003 ; 90: 179-182.	Premixed solutions of diamorphine in ropivacaine for epidural anaesthesia: a study on long-term stability. Sanchez del Aguila MJ, Jones MF, Vohra A.	2003
4050	Journal Pharmaceutical Technology in Hospital Pharmacy 2017 ;2,4:193-201	Preparation and physico-chemical stability of dexamethasone oral suspension. Binson G, Venisse N, Bacle A, Beuzit K, Dupuis A.	2017
4492	Journal Int J Antimicrob Agents 2020	Preparation and physicochemical stability of 50 mg/ml hydroxychloroquine oral suspension in Syrspend pH4 dry. Binson G, Venisse N , Sauvaget A , Bacle A , Lazaro P , Dupuis A.	2020
4256	Journal Pharmaceutics 2019 ;11,190:	Preparation and Physicochemical Stability of Liquid Oral Dosage Forms Free of Potentially Harmful Excipient Designed for Pediatric Patients. Binson G, Beuzit K, Migeot V, Marco L, Troussier B, Venisse N, Dupuis A.	2019
3624	Journal Int J Pharm Compound 2014 ; 18, 2 : 169-174.	Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets. Zaid Abdel Naser, Assali M, Qaddomi A, Ghanem M, Zaaror Yara Abu.	2014
2998	Journal J Pharm Technol 1989 ; 5: 202-205.	Preparation and stability of an oral suspension of dipyridamole. Ameer B, Callahan RJ, Dragotakes SC et al.	1989
2692	Journal J Am Pharm Assoc 2007 ; 47, 6; 747-755.	Preparation and stability of extemporaneous oral liquid formulations of oseltamivir using commercially available capsules. Winiarski AP, Infeld MH, Tscherne R, Bachinsky M, Rucki R, Nagano-Mate K.	2007
2810	Journal Antimicrob Agents Chemother 2009 ; 53, 2: 798-799.	Preparation and stability of voriconazole eye drop solution. Dupuis A, Tournier N, Le Moal G, Venisse N.	2009
2567	Journal Pakistan J Biol Sci 2000 ; 3, 10: 1755-1757.	Preparation and stability study of diclofenac sodium suppositories. Ahmed M, Jalil R, Islam MA, Shaheen SM.	2000
4719	Journal SAGE Open Medicine 2022 ; 10: 20503121221135568.	Prepared omadacycline for injection: Nine-day stability and sterility in an elastomeric pump. Bower J, Wright K, Burdette J.	2022
4751	Journal Pharmaceutics 2023 https://doi.org/10.3390/	Product Validation and Stability Testing of Pharmacy Compounded Cholic Acid Capsules for Dutch Patients with Rare Bile Acid Synthesis Defects. Polak Y, Jacobs B.A.W, Bouwhuis N, Hollak C.E.M, Kroon M.A.G.M, Kemper E.M.	2023
4583	Journal Int J Pharm Compound 2021 ;25,3:246-257	Prolonged In-use Stability of Diluted Atezolizumab in Commercial Intravenous Bags Hui A, Yin J, Liu W, Zheng K.	2021
4163	Journal Int J Pharm Compound 2018 22;5:417-423	Prolonged In-Use Stability of Reconstituted Herceptin in Commercial Intravenous Bags. Nalenz H, K?pf E, Dietel E.	2018
3956	Journal ASAIO Journal 2005 ; 51,6:761-763.	Prolonged Stability of Stored Vancomycin, Gentamicin, and Heparin for Use in the Antibiotic-Lock Technique. Bastani B; Amin K; Herr A.	2005
3659	Manufacturer AstraZeneca 2016	Propofol (Diprivan®) - Résumé des caractéristiques du produit	2016
3502	Manufacturer Astra Zeneca 2012	Propofol (Diprivan®) - Summary of Products Characteristics	2012
919	Journal Anesth Analg 1998 ; 86: 422-426.	Propofol and thiopental in a 1:1 volume mixture is chemically stable. Lazar ER, Jolly DT, Tam YK, Hrazdil J, Tawfik SR, Clanachan AS.	1998
660	Journal Ann Pharmacotherapy 1996 ; 30: 228-232.	Propofol compatibility with other intravenous drug products - Two new methods of evaluating IV emulsion compatibility. Michaels MR, Stauffer GL, Haas DP.	1996
3091	Journal Wien Med Wochenschr 2005 ; 155, 13-14: 337-343.	Prüfung von Stabilität und Kompatibilität von Flucloxacillin (Floxapen®) und Ceftazidim (Fortum®) in zwei Infusionslösungen:Relevanz für die klinische Praxis. Thalhammer F, Maier-Salamon A, Jäger W.	2005
4044	Journal Pharm Sci Communications 2017 ;9:5:28-35	Quality assessment and stability study of compounded furosemide syrup. Alfred-Ugbendo D, Zdoryk O.A, Georgiyants V.A.	2017
4192	Journal Pediatric Anesthesia 2018	Quality control and stability of ketamine, remifentanil and sufentanil syringes in a pediatric operating theater. Bourdon F, Simon N, Lannoy D, Berneron C, D?caudin B, Reumaux L, Duhamel A, Richart P, Odou P.	2018
2000	Journal J Pharm Biomed Anal 2005 ; 38: 180-185.	Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products. Bouligand J, Storme T, Laville I, Mercier L, Oberlin O, Vassal J, Bourget Ph, Paci A.	2005
653	Journal Int J Pharm Compound 1997 ; 1: 125-127.	Quantification of metoprolol tartrate and propranolol hydrochloride in pharmaceutical dosage forms : stability of metoprolol in aqueous mixture. Das Gupta V.	1997
1357	Journal Ann Pharmacotherapy 1989 ; 23: 91-92.	Quinolones and penicillins incompatibility. Janknegt R, Schrouff GGM, Hooymans PM, Hermens WJHH, Lohman JJHM.	1989
1513	Manufacturer Monarch Pharmaceuticals Ireland 2006	Quinupristine / dalfopristine (Synercid®) - Résumé des caractéristiques du produit	2006
1518	Manufacturer Hospira UK Ltd 2013	Raltitrexed (Tomudex®) - Summary of Product Characteristics	2013
3773	Manufacturer Eli Lilly 2014	Ramicirumab (Cyramza®) - Summary of Product Characteristics	2014
1166	Journal Int J Pharm 1980 ; 6: 63-76.	Rapid adsorptive loss of nitroglycerin from aqueous solution to plastic. Sokoloski TD, Wu CC, Burkman AM.	1980
514	Journal Ann Pharmacotherapy 1997 ; 31: 297-302.	Rapid loss of fentanyl citrate admixed with fluorouracil in polyvinyl chloride containers. Xu QA, Trissel LA, Martinez JF.	1997
4255	Journal J Pharm Anal 2013 ;3,6:408-414	Rapid, simple and stability-indicating determination of polyhexamethylene biguanide in liquid and gel-like dosage forms by liquid chromatography with diode-array detection. Kusters M, Beyer S, Kutschera S, Schlesingera H, Gerhartzb M.	2013
1517	Manufacturer Sanofi-Aventis 2015	Rasburicase (Fasturtec®) - Summary of Product Characteristics	2015
4	Journal Act Pharm Biol Clin 1995 ; 8: 525-528.	Reconstitution centralisée du ganciclovir : méthode de contrôle et étude de stabilité. Zazempa V, Morgenszejn J, Paul M, Astier A.	1995
353	Journal Am J Hosp Pharm 1987 ; 44: 2519-2524.	Reductive destruction of dacarbazine, procarbazine hydrochloride, isoniazid, and iproniazid. Lunn G, Sansone EB.	1987
2341	Poster Poster ESCP Stockholm May 2005	Release of di(2-ethylhexyl)phtalate from polyvinylchloride bags during docetaxel infusions Bourlon S, Sautou-Miranda V, Dalle M.
1271	Journal J Pharm Belg 1982 ; 37: 153-156.	Reliable continuous IV perfusion system for diazepam. Mathot F, Bonnard J, Paris P, Bosly J.	1982
3519	Manufacturer Glaxo Smith Kline 2011	Remifentanil hydrochloride(Ultiva®) - Summary of Product Characteristics	2011
2212	Manufacturer Actavis UK Ltd 2015	Reteplase (Rapilysin®) - Summary of Product Characteristics	2015
3541	Manufacturer Sanofi 2011	Rifampicin (Rifadin®) – Summary of Product Characteristics	2011
3968	Manufacturer Fresenius Kabi 2015	Ringer lactate - Résumé des Caractéristiques du Produit	2015
3564	Manufacturer B Braun 2012	Rocuronium B Braun - Résumé des caractéristiques du produit.	2012
3432	Manufacturer Celgene Corporation 2020	Romidepsin (Istodax®) - Summary of Product Characteristics	2020
2360	Journal Int J Pharm Compound 2008 ; 12, 1: 83-85.	Room temperature stability of injectable succinylcholine dichloride. Roy J.J, Boismenu D, Mamer O.A, Nguyen B.T, Forest J.M, Hildgen P.	2008
1516	Manufacturer Mercury Pharmaceuticals Limited 2012	Ropivacaine (Naropeine®) - Summary of Product Characteristics	2012
4438	Journal Pharmaceutics 2020 ; 12: 292	Safe Practice of Y-Site Drug Administration: The Case of Colistin and Parenteral Nutrition Stawny M, Gostyńska A, Nadolna M, Jelińska A.	2020
4103	Journal Pharmaceutical Technology in Hospital Pharmacy 2018	Safe use of Dexamethasone in pediatrics: design and evaluation of a novel stable oral suspension. Santovena--Estevez A, Dorta-Vera D, Gonzelez-Garcia I, Suarez-Gonzalez J, Teigell-Perez N, Farina J.	2018
1496	Journal Hosp Pharm 1996 ; 31: 1425-1428.	Screening cladribine for Y-site physical compatibility with selected drugs. Trissel LA, Martinez JF, Gilbert DL.	1996
3781	Journal EJHP 2015 ;22:1 56-58	Screening for physicochemical incompatibilities of intravenous drugs in intensive care units: the case of monobasic potassium phosphate and furosemide. Humbert-Delaloye V, Berger-Gryllaki M, Voirol P, Testa B, Pannatier A	2015
905	Journal Hosp Pharm 1994 ; 29: 1010-1017.	Screening teniposide for Y-site physical incompatibilities. Trissel LA, Martinez JF.	1994
2014	Journal J Clin Pharm Ther 2005 ; 30: 455-458.	Seventy-two-hour stability of Taxol® in 5% dextrose or 0.9% sodium chloride in Viaflo®, Freeflex®, Ecoflac® and Macoflex N® non PVC bags. Pourroy B, Botta C, Solas C, Lacarelle B, Braguer D.	2005
2683	Journal Int J Pharm Pract 1993 ; 23: 163-167.	Shelf life of cefuroxime eye-drops when dispensed in artificial tear preparations. Hebron B, Scott H.	1993
1050	Journal Am J Hosp Pharm 1984 ; 41: 300-302.	Shelf life of unrefrigerated succinylcholine chloride injection. Boehm JJ, Dutton DM, Poust RI.	1984
2001	Journal J Pharm Biomed Anal 2005 ; 38: 332-336.	Shelf lives of aseptically prepared medicines - stability of hydrocortisone sodium succinate in PVC and non-PVC bags and in polypropylene syringes. Rigge DC, Jones MF.	2005
1929	Journal J Pharm Biomed Anal 2004 ; 35: 1251-1256.	Shelf lives of aseptically prepared medicines - stability of netilmicin injection in polypropylene syringes. Rigge DC, Jones MF.	2004
2026	Journal J Pharm Biomed Anal 2005 ; 39: 339-343.	Shelf lives of aseptically prepared medicines - stability of piperacillin/tazobactam in PVC and non-PVC bags. Rigge D, Jones MF.	2005
119	Journal J Clin Pharm Ther 1994 ; 19: 361-369.	Shelf-lives and factors affecting the stability of morphine sulphate and meperidine (pethidine) hydrochloride in plastic syringes for use in patient-controlled analgesic devices. Strong ML, Schaaf LJ, Pankaskie MC, Robinson DH.	1994
4137	Journal Newsletter Stabilis 2018 41;2-6	Short Report : Extended Stability Studies on Bortezomib Injection and Infusions of Cisplatin and Pemetrexed (all Accord Healthcare). Patel T, Sewell G.	2018
3456	Journal Curr Med Res Opin 2011 ; 27, 12: 2241-2243.	Short-term stability of a new generic sodium ferric gluconate in complex with sucrose. Baribeault D.	2011
3772	Manufacturer Janssen Biotech 2017	Siltuximab (Sylvant®) - Summary of Product Characteristics	2017
4675	Journal Pharmaceuticals 2021 ;14, 1242.	Simple Approach to Enhance Green Tea Epigallocatechin Gallate Stability in Aqueous Solutions and Bioavailability: Experimental and Theoretical Characterizations. Secretan P-H, Thirion O, Sadou Yayé H, Damy T, Astier A, Paul M, Do B.	2021
2475	Journal Hosp Pharm 2015 ; 50: 376-379.	Simulated Y-Site Compatibility of Vancomycin and Piperacillin-Tazobactam Wade J, Cooper M, Ragan R.	2015
2340	Journal Can J Hosp Pharm 2005 ; 58, 4: 212-222.	Simulation of Y-Site Compatibility of Irinotecan and Leucovorin at Room Temperature in 5% Dextrose in Water in 3 Different Containers Walker S.E, Law S, Puodziunas A.	2005
2027	Journal Can J Hosp Pharm 2005 ; 58: 212-222.	Simulation of Y-site compatibility of irinotecan and leucovorin at room temperature in 5% dextrose in water in 3 different containers. Walker SE, Shirley L, Puodziunas A.	2005
4522	Journal J Pharm Biomed Anal 2020	Six months stability investigation of sufentanil and ropivacaine/levobupivacaine admixtures in plastic container by LC-UV. Lin Q, Van Schepdael A, Adams E.	2020
3745	Journal Am J Hosp Pharm 1979 ; 36: 881.	Sodium chloride residue provides potential for drug incompatibiities. Kuenhle C, Moore	1979
2028	Journal EJHP Science 2005 ; 11, 4: 88-90.	Sodium nitroprusside stability at 1 µg/ml in aqueous solutions. Kaisserlian CE, Razzouq N, Astier A, Paul M.	2005
1316	Journal Pharm J 1987 ; 239: 599-601.	Sodium nitroprusside stability in light-protective administration sets. Davidson SW, Lyall D.	1987
3969	Journal Neuromodulation 2017	Solubility and stability of Baclofen 3 mg/mL intrathecal formulation and its compatibility with implantable programmable intrathecal infusion systems. Yue B, Brendel R, Lukitsch A, Prentice T, Doty B.	2017
707	Journal Am J Hosp Pharm 1980 ; 37: 95-98.	Solubility and stability of phenytoin sodium when mixed with intravenous solutions. Carmichael RR, Mahoney CD, Jeffrey LP.	1980
4282	Journal Drugs R D 2017	Solubilization and Stability of Mitomycin C Solutions Prepared for Intravesical Administration. Myers A-L, Zhang Y-P, Kawedia J-D, Zhou X,. Sobocinski S-M, Metcalfe M-J, Kramer M-A, Dinney C.P.N, Kamat A-M.	2017
4701	Journal Pharm Dev Technol 2018 ; 23, 10: 1024-1029.	Solution stability of Captisol-stabilized melphalan (Evomela) versus Propylene glycol-based melphalan hydrochloride injection. Singh R, Chen J, Miller T, Bergren M, Mallik R.	2018
2868	Journal Int J Pharm Compound 2000 ; 4, 2: 146-149.	Some Studies of the Stability of Compounded Cefazolin Ophthalmic Solution. Kommanaboyina B, Lindauer RF, Rhodes CT, Grady LT.	2000
379	Journal Am J Hosp Pharm 1985 ; 42: 2679-2683.	Sorption of amiodarone to polyvinyl chloride infusion bags and administration sets. Weir SJ, Szucs Myers VA, Bengtson KD, Ueda CT.	1985
190	Journal Am J Hosp Pharm 1986 ; 43: 1945-1950.	Sorption of four drugs to polyvinyl chloride and polybutadiene intravenous administration sets. Lee MG.	1986
1161	Journal Int J Pharm 1987 ; 39: 183-188.	Sorption of parenteral nitrates during administration with a syringe pump and extension set. Allwood MC.	1987
350	Journal Am J Hosp Pharm 1990 ; 47: 369-373.	Sorption of various drugs in polyvinyl chloride, glass, and polyethylene-lined infusion containers. Martens HJ, De Goede PN, Van Loenen AC.	1990
896	Journal J Clin Pharm Ther 1992 ; 17: 223-227.	Sorption studies of dipotassium clorazepate salt (Tranxene®) and midazolam hydrochloride (Hypnovel®) in polyvinyl chloride and glass infusion containers. Bianchi C, Airaudo CB, Gayte-Sorbier A.	1992
621	Journal Am J Hosp Pharm 1982 ; 39: 1018-1021.	Sorptive loss of diazepam and nitroglycerin from solutions to three types of containers. Yliruusi JK, Sothmann AG, Laine RH, Rajasilta RA, Kristoffersson ER.	1982
1472	Journal Int J Pharm 1994 ; 110: 197-201.	Sorptive loss of diazepam, nitroglycerin and warfarin sodium to polypropylene-lined infusion bags (Softbags). Salomies HEM, Heinonen RM, Toppila MAI.	1994
2168	Journal Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534.	Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution. Ozdemir FA, Anilanmert B, Pekin M.	2005
3563	Manufacturer Sanofi Aventis France 2013	Spiramycine adipate (Rovamycine®) - Résumé des caractéristiques du produit	2013
1700	Journal Krankenhauspharmazie 1996 ; 17: 398-399.	Stabilität hochkonzentrierter dobutaminlösungen. Ritter C.	1996
1691	Journal Krankenhauspharmazie 1999 ; 20: 121-125	Stabilität und kompatibilität von zytostatika-zubereitungen mit infusionlösungsbehältern aus polyethylen. Beitz C, Einberger C, Wehling M.	1999
3235	Poster ADKA Congress 2011 2011	Stabilität von Argatroban-Dauerinjektionslösungen in applikationsfertigen Konzentrationen. Klemmer A, Krämer I.	2011
2289	Journal Pharmazie 1994 ; 49, 10: 775-777.	Stabilität von bendamustinhydrochloride in infusion lösungen. Maas B, Huber C, Krämer I.	1994
1698	Journal Krankenhauspharmazie 1997 ; 18: 474-478.	Stabilität von dopaminhydrochlorid (Dopamine Solvay°) in mischungen mit infusionlösungen. Körner A, Bonnacker I.	1997
1687	Journal Krankenhauspharmazie 2000 ; 21: 435-438.	Stabilität von gemcitabin. Müller H-J, Frank C.	2000
3346	Journal Krankenhauspharmazie 2012 ; 33: 427-431.	Stabilität, Qualität und Analytik individueller Noradrenalin-Zubereitungen. H?llein L, Bennack E, Holzgrabe U.	2012
4323	Poster ADKA Kongress 2019	Stabilitätsprüfung von applikationsfertigen Adrenalin- und Noradrenalinverdünningen. Wethmar U, Hochbrügge H, Strobel HG.	2019
1688	Journal Krankenhauspharmazie 1999 ; 20: 55-58.	Stabilitätsstudie zu alizaprid im PVC-infusionbeutel. M?ller H-J, Frank C.	1999
1689	Journal Krankenhauspharmazie 1997 ; 18: 468-473.	Stabilitätsstudie zu apomorphin-hydrochlorid im PVC-infusionbeutel. Müller H-J, Berg J.	1997
1694	Journal Krankenhauspharmazie 1998 ; 19: 553-557.	Stabilitätsstudie zu fosfomycin-dinatrium (Fosfocin° p.i. 5.0) in applikationsfertigen perfusorspritzen. Stahlmann SA, Frey OR, Kovar K-A.	1998
1685	Journal Krankenhauspharmazie 1998 ; 19: 229-234.	Stabilitätsstudie zu metamizol-natrium im PVC-infusionbeutel. Müller H-J, Berg J.	1998
1684	Journal Krankenhauspharmazie 1998 ; 19: 469-472.	Stabilitätsstudie zu pentoxifyllin im PVC-infusionbeutel. Müller H-J, Frank C.	1998
1690	Journal Krankenhauspharmazie 1997 ; 18: 75-79.	Stabilitätsstudie zu tramadolhydrochlorid im PVC-infusionbeutel. Müller H-J, Berg J.	1997
1697	Journal Krankenhauspharmazie 2000 ; 21: 615-617.	Stabilitätsuntersuchung von Dipidolor°-zubereitungen. Witt C, Wolkewitz B, Lorenz C.	2000
3244	Poster SFPO Congress Mandelieu, France 2011	Stabilité chimique et microbiologique d'une suspension de mercaptopurine à 5 mg/mL. Sutra C, Guillemot C, Monnier S, Puiset F, Canonge JM.	2011
2881	Poster SFPO Congress 2009	Stabilité d'un anticorps monoclonal d'intérêt thérapeutique après reconstitution: le rituximab. Jaccoulet E, Guirao S, Morand K, Astier A, Paul M.	2009
3317	Poster APHIF Congress 2009	Stabilité de l'infliximab en solutions diluées. Guirao S, Paul M, Jaccoulet E, Morand K, Astier A.	2009
4128	Poster GRITA Symposium Perfusion 2017, Lille, France. 2017	Stabilité de la vancomycine à des doses méningées dans les seringues au cours d'une perfusion de 24 heures. Masse M, Genay S, Carta N, Moreau F, Delannoy-Rousselière C, Barthélémy C, Décaudin B, Faure K, Odou P.	2017
3119	Poster Congrès HOPIPHARM 2010	Stabilité de la vincristine sans conservateurs. Henriet Th, El Kateb N, Jourdan N, Faure P, Bellenger P.	2010
2882	Poster SFPO Congress 2009	Stabilité de solutions diluées de bévacizumab en fonction de la température. Morand K, Paul M, Lahlou A, Blanchet B, Astier A.	2009
604	Manufacturer Baxter 1998	Stabilité des médicaments dans l'Intermate® SV50, 100, 200	1998
3816	Poster SFPO Congress, Nantes, France 2015	Stabilité des poches d'azacitidine pour injection intraveineuse (1- 4 et 2,4 mg/mL) conservées à 4°C. Balouzet C, Chanat C, Jobard M, Brandely-Piat ML, Chast F.	2015
3723	Journal Archives de Pédiatrie 1998 ; 5, 10: 1170-1171.	Stabilité des préparations extemporanées de doxapram (Doprams®) à usage néonatal. Barb? F, Legagneur H, Boisseau D, Badonnel Y, Boutroy M.J.	1998
2130	Journal Bull Cancer 1999 ; 86, 11: 946-954.	Stabilité du mélange 5-fluoro-uracil-acide fonique : influence des concentrations, du contenant et de la forme de l’acide folinique. Lokiec F, Amirault P, Bonnans H, Gauzan MF, Sauvage N, Santoni J.	1999
3516	Poster SFPO Congress, Mandelieu, France. 2013	Stabilité du melphalan à 2 mg/ml dans le chlorure de sodium 0,9% dans des conditions pratiques d'utilisation. Vigneron J, Zenier H, May I, Nicolas A.	2013
2261	Journal Can J Hosp Pharm 2008 ; 61, 3: 191-195.	Stabilité et compatibilité de l'association ondansétron-méthylprednisolone en solution. Fernandez C, Pelloquin A, Berthoume M, Bellanger A, Farinotti R.	2008
4119	Poster Hôpitaux Universitaire de Genève 2004	Stabilité et compatibilité de solutions injectables d'amiodarone (Cordarone®) Marcoz N, Ing H, Sautter AM, Saadi JF, Roulin JF, Bonnabry P.	2004
1868	Journal Nutr Clin Metab 2003 ; 17: 8-14.	Stabilité galénique de mélanges commercialisés de nutrition parentérale en présence de médicaments: médicaments dans le mélange. Husson E, Crauste-Manciet S, Hadj-Salah E, ,Segier JC, Broissard D.	2003
2344	Manufacturer Ebewe Pharma 2009	Stabilité physico-chimique de la gamme oncologie Ebewe Pharma France après dilution.	2009
3246	Poster SFPO Congress Mandelieu, France 2011	Stabilité physico-chimique de la suspension d'azacitidine (25 mg/mL) conservée à 4°C. Vieillard V, Appudurai O, Voytenko S, Astier A, Paul M.	2011
4025	Poster SFPO Congress 2017 - Nantes 2017	Stabilité physico-chimique de solutions de Nivolumab à 1 mois. Vieillard V, Bardo P, Akrout W, Le Guyader G, Astier A, Paul M.	2017
4358	Journal Ann Fr Anesth Réanim 2014 ; 33, 5: 304-309.	Stabilité physico-chimique des solutions injectables de bésilate de cisatracurium dans les conditions cliniques d'utilisation Pignard J, Bourdeaux D, Kauffmann S, Constantin J.M, Sautou V.	2014
3265	Poster SFPO Congress, France 2011	Stabilité physico-chimique du bévacizumab à 25 mg/mL conservée à 4°C en seringue polypropylène. Vieillard V, Cauvin A, Roumi E, Despiau MC, Laurent M, Voytenko S, Astier A, Paul M.	2011
3446	Poster SFPO Congress, Mandelieu, France 2013	Stabilité physicochimique de solutions diluées d'ipilimumab : résultats préliminaires à 1 mois. Bardo P, Vieillard V, Astier A, Paul M.	2013
3344	Poster ECOP Congress, Budapest, Hungary 2012	Stabilité physicochimique du bevacizumab 5 mg/mL dilué dans le chlorure de benzalkonium 0.1 mg/mL. Moine M, Vieillard V, Astier A, Paul M.	2012
196	Journal J Clin Pharm Ther 1991 ; 16: 203-207.	Stabilities of dobutamine, dopamine, nitroglycerin and sodium nitroprusside in disposable plastic syringes. Pramar Y, Das Gupta V, Neal Gardner S, Yau B.	1991
1239	Journal Pharm Weekbl [Sci] 1986 ; 8: 286-288.	Stability after freezing and thawing of solutions of mitomycin C in plastic minibags for intravesical use. Stolk LML, Fruijtier A, Umans.	1986
240	Journal Am J Health-Syst Pharm 1995 ; 52: 1904-1909.	Stability and activity of alteplase with injectable drugs commonly used in cardiac therapy. Lam XM, Ward CA, de C du M?e CPR.	1995
1318	Journal Pharm J 1987 ; 238: 116-118.	Stability and administration of intravenous Augmentin. Ashwin J, Lynn B, Taskis CB.	1987
2046	Journal Antimicrob Agents Chemother 2003 ; 47: 1991-1994.	Stability and antibacterial activity of cefepime during continuous infusion. Sprauten PF, Beringer PM, Louie ST, Synold TW, Gill MA.	2003
4264	Journal Acta Ophtalmol 2008	Stability and antibacterial potency of ceftazidime and vancomycin eyedrops reconstituted in BSS against Pseudomonas aeruginosa and Staphylococcus aureus. Karampatakis V, Papanikolaou T, Giannousis M, Goulas A, Mandraveli K, Kilmpasani M, Alexiou-Daniel S, Mirtsou-Fidani V.	2008
454	Journal Am J Hosp Pharm 1986 ; 43: 94-97.	Stability and availability of cyclosporine in 5% dextrose injection or 0.9% sodium chloride injection. Ptachcinski RJ, Logue LW, Burckart GJ, Venkataramanan R.	1986
453	Journal Am J Hosp Pharm 1986 ; 43: 692-694.	Stability and availability of cyclosporine stored in plastic syringes. Ptachcinski RJ, Walker S, Burckart GJ, Venkataramanan R.	1986
1469	Journal Int J Pharm 1996 ; 128: 283-286.	Stability and compatibility of 2.5 mg/ml methotrexate solution in plastic syringes over 7 days. Jacolot A, Arnaud P, Lecompte D, Alamercery S, Caroff E, Naveau C, Guillot T, Bousselet M, Brion F.	1996
1817	Journal J Oncol Pharm Practice 2003 ; 9: 109-112.	Stability and compatibility of 5-fluorouracil infusions in the Braun Easypump®. Roberts S, Sewell GJ.	2003
2184	Journal J Pain Symptom Manage 2006 ; 32, 4: 297-299.	Stability and compatibility of a meperidine-clonidine mixture in portable pump reservoirs for the management of cancer pain syndromes. Vranken JH, van Kan HJM, ven der Vegt MH.	2006
152	Journal Pharm Acta Helv 1995 ; 70: 141-148.	Stability and compatibility of a mixture of the anti-cancer drugs etoposide, cytarabine and daunorubicine for infusion. Chevrier R, Sautou V, Pinon V, Demecop F, Chopineau J.	1995
285	Journal Clin Ther 1996 ; 18: 246-255.	Stability and compatibility of admixtures of intravenous ciprofloxacin and selected drugs. Elmore RL, Contois ME, Kelly J, Noe A, Poirier A.	1996
2086	Journal J Pharm Pract and Res 2003 ; 33: 279-281.	Stability and compatibility of alfentanil hydrochloride and morphine sulfate in poypropylene syringes. Sharley NA, Burgess NG.	2003
2648	Journal Int J Pharm 1999 ; 190, 1: 103-107.	Stability and compatibility of an aerosol mixture including N-acetylcysteine, netilmicin and betamethasone Rieutord A, Arnaud P, Dauphin JF, Brion F.	1999
1178	Journal Am J Hosp Pharm 1981 ; 38: 1914-1918.	Stability and compatibility of antitumor agents in glass and plastic containers. Benvenuto JA, Anderson RW, Kerkof K, Smith RG, Loo TL.	1981
1467	Journal Int J Pharm 1995 ; 118: 181-189.	Stability and compatibility of baclofen and morphine admixtures for use in an implantable infusion pump. Sitaram BR, Tsui M, Rawicki HB, Lam S, Courage P, Sitaram M, Chapman CB.	1995
1966	Journal Support Care Cancer 2005 ; 13, 4: 239-245.	Stability and compatibility of binary mixtures of morphine hydrochloride with hyoscine-n-butyl bromide. Barcia E, Reyes R, Azuara L, Sànchez Y, Negro S.	2005
4746	Poster 2023	Stability and Compatibility of Bupivacaine and Hydromorphone in PVC and non-DEHP bags for 30 days at 4°C and 25°C. Shead K, Derrick H, Lyons D, Law S, Ma N.H.	2023
1759	Journal Antimicrob Agents Chemother 2001 ; 45: 2643-2647.	Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients. Servais H, Tulkens PM.	2001
539	Journal Drug Intell Clin Pharm 1988 ; 22: 592-593.	Stability and compatibility of cimetidine hydrochloride and aminophylline in dextrose 5% in water injection. Baptista RJ, Mitrano FP.	1988
164	Journal J Clin Pharm Ther 1994 ; 19: 95-100.	Stability and compatibility of cisplatin and carboplatin with PVC infusion bags. Benaji B, Dine T, Luyckx M, Brunet C, Goudaliez F, Mallevais ML, Cazin M, Gressier B, Cazin JC.	1994
226	Journal Can J Hosp Pharm 1991 ; 44: 289-295.	Stability and compatibility of combinations of hydromorphone and a second drug. Walker SE, DeAngelis C, Iazzetta J.	1991
1497	Journal Can J Hosp Pharm 1993 ; 46: 61-65.	Stability and compatibility of combinations of hydromorphone and dimenhydrinate lorazepam or prochlorperazine. Walker SE, Iazetta J, DeAngelis C, Lau DWC.	1993
4185	Journal Hosp Pharm 2019 ; 54, 5: 330-334.	Stability and Compatibility of Diphenhydramine Hydrochloride in Intravenous Admixtures : A New Look at an Old Drug. Sabins D, Diep T, McCartan P, Patel S, Zhao F	2019
3172	Journal J Clin Pharm Ther 2011 ; 36, 1: 99-102.	Stability and compatibility of doxofylline with phentolamine mesilate in 0·9% sodium chloride or 5% dextrose injection for intravenous infusion. Xu F, Xu G, LSu L, Feng E.	2011
2305	Journal Anaesthesia 2008 63, 9: 972-978.	Stability and compatibility of drug mixtures in an implantable infusion system. Bianchi F, Ginggen A, Tardy Y.	2008
161	Journal Am J Hosp Pharm 1994 ; 51: 2706-2709.	Stability and compatibility of etoposide in 0.9% sodium chloride injection in three containers. Barthes DM, Rochard EB, Pouliquen IJ, Rabouan SM, Courtois PY.	1994
1613	Journal Can J Hosp Pharm 2000 ; 53: 338-345.	Stability and compatibility of etoposide in normal saline. Lepage R, Walker SE, Godin J.	2000
262	Journal Am J Hosp Pharm 1993 ; 50: 703-706.	Stability and compatibility of fluconazole and aminophylline in intravenous admixtures. Johnson CE, Jacobson PA, Pillen HA, Woycik CL.	1993
411	Journal Am J Hosp Pharm 1991 ; 48: 2158-2160.	Stability and compatibility of fluorouracil and mannitol during simulated Y-site administration. Woloschuk DMM, Wermeling JR, Pruemer JM.	1991
513	Journal Ann Pharmacotherapy 1996 ; 30: 756-761.	Stability and compatibility of fluorouracil with morphine sulfate and hydromorphone hydrochloride. Xu QA, Trissel LA, Martinez JF.	1996
148	Journal Pharm Weekbl [Sci] 1992 ; 14: 365-369.	Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags. Dine T, Cazin JC, Gressier B, Luycks M, Brunet C, Cazin M, Goudaliez F, Mallevais ML, Toraub I.	1992
70	Journal Am J Hosp Pharm 1991 ; 48: 2641-2643.	Stability and compatibility of ganciclovir sodium in 5% dextrose injection over 35 days. Silvestri AP, Mitrano FP, Baptista RJ, Williams DA.	1991
1633	Journal Can J Hosp Pharm 2002 ; 55: 27-38.	Stability and compatibility of granisetron alone and in combination with dexamethasone in 0.9% sodium chloride and 5% dextrose in water solutions. Walker SE, Law S.	2002
57	Journal Am J Health-Syst Pharm 1996 ; 53: 294-304.	Stability and compatibility of granisetron hydrochloride in IV solutions and oral liquids and during simulated Y-site injection with selected drugs. Mayron D, Gennaro AR.	1996
1867	Journal J Pain Symptom Manage 2001 ; 22, 6: 1042-1047.	Stability and compatibility of hydromorphone hydrochloride in an implantable infusion system. Hildebrand KR, Elsberry DE, Anderson VC.	2001
1678	Journal Int J Pharm 1997 ; 153: 13-24.	Stability and compatibility of intrathecal admixtures containing baclofen and high concentrations of morphine. Sitaram BR, Tsui M, Rawicki HB, Lam S, Sitaram M.	1997
1988	Journal Am J Health-Syst Pharm 2005 ; 62: 88-92.	Stability and compatibility of levofloxacin and metronidazole during simulated and actual Y-site administration. Sprandel KA, Styrszula DE, Deyo K, Sibley C, Rodvold KA.	2005
619	Journal Am J Hosp Pharm 1982 ; 39: 1013-1015.	Stability and compatibility of lidocaine hydrochloride with selected large-volume parenterals and drugs additives. Kirschenbaum HL, Aronoff W, Perentesis GP, Plitz GW, Cutie AJ.	1982
1620	Journal Am J Health-Syst Pharm 2001 ; 58: 1753-1756.	Stability and compatibility of methylprednisolone acetate and ropivacaine hydrochloride in polypropylene syringes for epidural administration. Saverio Robustelli della Cuna F, Mella M, Magistrali G, Ricci M, Losurdo A, Goglio AM.	2001
211	Journal Am J Hosp Pharm 1991 ; 48: 1237-1241.	Stability and compatibility of methylprednisolone sodium succinate and cimetidine hydrochloride in 5% dextrose injection. Strom JG, Miller SW.	1991
263	Journal Am J Hosp Pharm 1993 ; 50: 698-702.	Stability and compatibility of minocycline hydrochloride and rifampicin in intravenous solutions at various temperatures. Pearson SD, Trissel LA.	1993
1276	Journal Can J Hosp Pharm 1998 ; 51: 110-116.	Stability and compatibility of morphine with bupivacaine. Shiffman E, Walker SE, Yoon T, Yeung M.	1998
2083	Journal J Pharm Pract and Res 2002 ; 32: 65-68.	Stability and compatibility of morphine, midazolam and bupivacaine combinaisons for iontravenous infusion. La Forgia SP, Sharley NA, Burgess NG, Doecke CJ.	2002
1869	Journal J Pain Symptom Manage 2003 ; 25, 5: 464-471.	Stability and compatibility of morphine-clonidine admixtures in an implantable infusion system. Hildebrand KR, Elsberry DD, Hassenbusch SJ.	2003
4036	Journal EJHP 2017 ;25,4: 200-203.	Stability and compatibility of ondansetron with haloperidol in parenteral admixtures. Estan-Cerezo G, Matoses-Chirivella C, Soriano-Iriga L, Murcia-Lopez A.C, Rodrguez-Lucena F.J, Navarro-Ruiz A.	2017
2122	Journal EJHP Science 2006 ; 12, 4: 81-84.	Stability and compatibility of paracetamol injection admixed with ketoprofen. Kambia NK, Luyckx M, Dine T, Dupin-Sriet T, Gressier B, Brunet C.	2006
1069	Journal Am J Health-Syst Pharm 1999 ; 56: 1835-1838.	Stability and compatibility of promethazine hydrochloride and dihydroergotamine mesylate in combination. Peek BT, Webster KD, Da Camara CC.	1999
3140	Journal Int J Pharm Compound 2010 ; 14, 5 : 436-439.	Stability and Compatibility of Reconstituted Caspofungin in Select Elastomeric Infusion Device. Tsiouris M, Ulmer M, Yurcho J F, Hooper K L, Gui M.	2010
1906	Journal Am J Health-Syst Pharm 2004 ; 61: 38-45.	Stability and compatibility of reconstituted ertapenem with commonly used iv infusion and coinfusion solutions. McQuade MS, Van Nostrand V, Shariter J, Kanike JD, Forsyth RJ.	2004
66	Journal Can J Hosp Pharm 1996 ; 49: 140-145.	Stability and compatibility of reconstituted hydromorphone with potassium chloride or heparin. Avelar MA, Walker SE.	1996
345	Journal Can J Hosp Pharm 1996 ; 49: 290-298.	Stability and compatibility of reconstituted sterile hydromorphone with midazolam. Walker SE, Meinders A, Tailor H.	1996
1421	Journal J Am Pharm Assoc 1999 ; 39: 505-509.	Stability and compatibility of tacrolimus and fluconazole in 0.9% sodium chloride. Johnson CE, Truong NM.	1999
4444	Journal Clinical Nutrition 1999 ; 19, 3: 159-165.	Stability and compatibility of Teicoplanin in parenteral nutrition solutions used in pediatrics. Tounian P, Jehl F, Pauliat S, Morgant G, Ghirardi L, Selva M.A, Fontaine J.L, Aymard P, Girardet J.P.	1999
2140	Journal EJHP Science 2006 ; 12, 5: 91-95.	Stability and compatibility of the ready-to-use solution of paracetamol admixted with phloroglucinol for intravenous infusion. Kambia NK, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C.	2006
2890	Journal Acta Pharm 2000 ; 50: 219-228.	Stability and compatibility of thiamine hydrochloride in liquid dosage forms et various temperatures. El-Khawas M, Boraie NA.	2000
1603	Journal Am J Health-Syst Pharm 2001 ; 58: 1218-1223.	Stability and compatibility of tirofiban hydrochloride during simulated Y-site administration with other drugs. Bergquist PA, Manas D, Hunke WA, Reed RA.	2001
1075	Journal J Pharm Biomed Anal 1997 ; 16: 199-205.	Stability and compatibility of topotecan hydrochloride for injection with common infusion solutions and containers. Craig SB, Bhatt UH, Patel K.	1997
1026	Journal Am J Health-Syst Pharm 1999 ; 56: 875-881.	Stability and compatibility of topotecan hydrochloride with selected drugs. Mayron D, Gennaro AR.	1999
3385	Journal J Antimicrob Chemother 2013 ; 68: 1179-1182.	Stability and compatibility of vancomycin for administration by continuous infusion. Raverdi V, Ampe E, Hecq JD, Tulkens PM.	2013
1656	Journal Pharmazie 1994 ; 49: 425-427.	Stability and compatibility studies of cefaloridine, cefuroxime and ceftazidime with PVC infusion bags. Faouzi A, Dine T, Luyckx M, Gressier B, Brunet C, Goudaliez F, Mallevais ML, Cazin M, Cazin JC.	1994
40	Journal Pharm Sci Communications 1994 ; 4: 97-101.	Stability and compatibility studies of four cytostatic agents (fluorouracil, dacarbazine, cyclophosphamide and ifosfamide) with PVC infusion bags. Dine T, Lebegue S, Benaji B, Gressier B, Segard V, Goudaliez F, Luyckx M, Brunet C, Mallevais ML, Kablan J, Cazin M, Cazin JC.	1994
144	Journal Int J Pharm 1991 ; 77: 279-285.	Stability and compatibility studies of vinblastine, vincristine, vindesine and vinorelbine with PVC infusion bags. Dine T, Luyckx M, Cazin JC, Goudaliez F, Mallevais ML.	1991
1667	Journal Int J Pharm 1996 ; 138: 125-128.	Stability and compatibility study of a carboplatin solution in syringes for continuous ambulatory infusion. Vali?re C, Arnaud P, Caroff E, Dauphin JF, Cl?ment G, Brion F.	1996
166	Journal Int J Pharm 1994 ; 101: 257-262.	Stability and compatibility study of carboplatin with three portable infusion pump reservoirs. Rochard E, Barthes D, Courtois P.	1994
2141	Journal J Antimicrob Chemother 2003 ; 51: 651-658.	Stability and compatibility study of cefepime in comparaison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units. Barinian N, Chanteux H, Viaene E, Servais H, Tulkens PM.	2003
423	Journal Am J Hosp Pharm 1985 ; 42: 332-335.	Stability and cost analysis of clindamycin-gentamicin admixtures given every eight hours. Mansur JM, Abramowitz PW, Lerner SA, Smith RB, Townsend RJ.	1985
2120	Journal J Pharm Biomed Anal 2006 ; 41: 1363-1366.	Stability and degradation kinetics of meropenem in powder for injection and reconstituted sample. Mendez A.S.L, Dalomo J, Steppe M; Schapoval E.E.S.	2006
4289	Journal Photochemical & Photobiological Sciences 2018	Stability and degradation of indocyanine green in plasma, aqueous solution and whole blood. Mindt S, Karampinis I, John M, Neumaier M, Nowak K.	2018
4298	Journal Biomed Chromatogr 2019 ; 33, 4:e4471	Stability and degradation products of imipenem applying High-Resolution Mass Spectrometry: an analytical study focused on solutions for infusion. Fabio de Souza Barbosa F, Capra Pezzi L, Tsao M, Franco de Oliveira T, Dias Macedo S.M, Schapoval E.E.S, Mendez A.S.L.	2019
4670	Journal Molecules 2022 ; 27(3): 1070.	Stability and Formulation of Erlotinib in Skin Creams. Nguyen D, Secrétan P-H, Cotteret , Jacques-Gustave E, Greco C, Bodemer C, Schlatter J, Cisternino S.	2022
2057	Journal J Antimicrob Chemother 2003 ; 51: 849-855.	Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. Droste JC, Jeraj HA, MacDonald A, Farrington K.	2003
3754	Journal Int J Pharm Compound 2014 ;18, 5: 418-426.	Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation. Robert M.C, Spurr-Michaud S, Frenette M, Young D, Gipson Ilene K, Dohlman Claes H.	2014
1379	Journal Aust J Hosp Pharm 1986 ; 16: 55-56.	Stability and light sensitivity of sodium nitroprusside infusions. Saunders A.	1986
2076	Journal Ann Emerg Med 2003 ; 42: 9-13.	Stability and microbiology of inhalant N-acetylcysteine used as an intravenous solution for the treatment of acetaminophen poisoning. Dribben WH, Porto SM, Jeffords BK.	2003
3844	Journal Ann Pharmacotherapy 2016 ; 50: 243-244.	Stability and Osmolality of Extemporaneously Prepared Clonidine Oral Liquid for Neonates. Sauberan J.B, Phuong P, Ilog N.D, Rossi S.S.	2016
1904	Journal Am J Health-Syst Pharm 2003 ; 60: 916-922.	Stability and preservative effectiveness of treprostinil sodium after dilution in common intravenous diluents. Phares KR, Weiser WE, Miller SP, Myers MA, Wade M.	2003
305	Journal Am J Hosp Pharm 1992 ; 49: 1463-1466.	Stability and sorption of calcitriol in plastic tuberculin syringes. Pecosky DA, Parasrampuria J, Li LC, Stelmach A.	1992
475	Journal Am J Hosp Pharm 1992 ; 49: 119-122.	Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers. Taormina D, Abdallah HY, Venkataramanan R, Logue L, Burckart GJ, Ptachcinski RJ, Todo S, Fung JJ, Starzl TE.	1992
468	Journal Am J Hosp Pharm 1991 ; 48: 2631-2634.	Stability and sterility of biosynthetic human insulin stored in plastic insulin syringes for 28 days. Tarr BD, Campbell RK, Workman TM.	1991
1346	Journal Am J Hosp Pharm 1981 ; 38: 881-883.	Stability and sterility of cimetidine admixtures frozen in minibags. Walker SE, Paton TW, Fabian TM, Liu CC, Coates PE.	1981
1986	Journal Am J Health-Syst Pharm 2005 ; 62: 896-899.	Stability and sterility of dolasetron mesylate in syringes stored at room temperature. Steiner ME, Lensmeyer G, Vermeulen LC.	2005
4413	Journal J Pediatr Pharmacol Ther 2016 ; 21, 4: 322-326.	Stability and Sterility of Enoxaparin 8 mg/mL Subcutaneous Injectable Solution. Moffett B.S, Dinh K, Placencia J, Pelkey G, Rocky Hui S-K, Teruya J.	2016
1679	Journal Int J Pharm 2001 ; 212: 93-99.	Stability and sterility of meglumine gadoterate injection repackaged in plastic syringes. Micard S, Rieutord A, Prognon P, Hassan M, Brion F.	2001
2402	Journal Am J Health-Syst Pharm 2006 ; 63: 2240-2247.	Stability and viscosity of a flavored omeprazole oral suspension for pediatric use Burnett JE, Balkin ER.	2006
1193	Journal Am J Hosp Pharm 1983 ; 40: 1010-1012.	Stability and visual compatibility of bretylium tosylate with selected large-volume parenterals and additives. Perentesis GP, Plitz GW, Kirschenbaum HL, Navalakha P, Aronoff W, Cutie AJ.	1983
3810	Journal Int J Pharm Compound 2015 ; 19, 5 : 420-427.	Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF. Geiger C M, Sorenson B, Whaley P.	2015
4449	Journal J Pharm Pract and Res 2020	Stability assessment of levoﬂoxacin in three different suspension vehicles. Tardif V.,Lepage O.,Friciu M., St-Jean I., Forest J.M.	2020
4215	Journal Int J Pharm Compound 2019 ;23,1:82-87	Stability Assessment of Topical Amitriptyline HCl Extemporaneously Compounded with Lipoderm Base and PLO Gel Mediflo 30. Shakshuki A, Agu R.U.	2019
4560	Journal J Pediatr Pharmacol Ther 2021 ; 26, 3: 265-270.	Stability Determination of an Extemporaneously Compounded Ambrisentan Suspension by High Performance Liquid Chromatography Analysis. Cramer J, Bevry M, Handler S, Tillman K, Abourashed E.A.	2021
4499	Journal J Pharm Pract and Res 2020	Stability evaluation of an extemporaneously compounded carbimazole oral suspension. Song Y, Lwin E, Ellis D, Turner S, Williams D, Garg S.	2020
4648	Journal PlosOne 2021 16(11): e0260279.	Stability evaluation of compounded clonidine hydrochloride oral liquids based on a solidphase extraction HPLC-UV method. Coache D, Friciu M, Roullin G, Boule M, Forest J-M, Leclair G.	2021
4694	Journal PlosOne 2022	Stability evaluation of compounded hydroxyurea 100 mg/mL oral liquids using a novel analytical method involving chemical derivatization. Coache D, Friciu M, Bernine Marcellin R, Bonnemain L, Viau A, Gaëlle Roullin V, Forest J.M, Leclair G.	2022
4544	Journal Int J Pharm Compound 2021 ;25,3:236-240	Stability Evaluation of Minoxidil in FOAMIL Foam Base with Bracketing Study Design. Lupatini , Sidhu R, Patel H, Bichar K.	2021
4664	Journal Biomed Chromatogr 2022 ;e5340.	Stability evaluation of morphine, hydromorphone, metamizole and esketamine containing analgesic mixtures applied for patient-controlled analgesia in hospice and palliative care. Harder M, Fiegl-Lechner A, Oberacher H, Horvath U.E.I, Schlager A, Jeske M, Kerndler S, Schüllner F, Bonn G.F, Rainer M.	2022
4183	Poster Professional Practice Conference - the Canadian So 2018	Stability if 4 and 10 mcg/mL Remifentanil Solutions Stored in Syringes at Room Temperature (23°C). Hook R, Riss V, Scharrer E, Law S, Walker S.E.	2018
4403	Journal J Pharm Biomed Anal 2020 ; 179: 112973.	Stability in clinical use and stress testing of meropenem antibiotic by direct infusion ESI-Q-TOF: Quantitative method and identification of degradation products. De Souza Barbosa F, Capra Pezzi L, Tsao M, Manoela Dias Macedo S, Franco de Oliveira T, Schapoval EES, Mendez ASL.	2020
3188	Journal J Clin Pharm Ther 2011 ; 36, 2: 161-165.	Stability indicating HPLC assay for the determination of piritramide and droperidol in PCA solutions. Selbach S, Diederich WE, Fett, Fründ SD, Koch T, Eberhart LHJ.	2011
3798	Journal Analytical Letter 1994 . 27: 1159-1164.	Stability indicating HPLC assay of zidovudine in extemporaneously syrup. Radwan M.A.	1994
2865	Journal Int J Pharm 2001 ; 223: 49-54.	Stability indicating HPLC method for the estimation of oxycodone and lidocaine in rectal gel Gebauer MG, McClure AF, Vlahakis TL.	2001
4230	Poster Prof Practice Conference - Canadian Society of PH 2017	Stability of 0.2 and 10 mg/mL Hydromorphone Solutions In CADD reservoirs, PVC and Ethylene/Propylene Co-Polymer (PAB) Bags at Room Temperature (23°C°). Perls W, Law S, Iazetta J, Walker S.	2017
2494	Journal Am J Hosp Pharm 1986 , 43: 2225-2228.	Stability of 1% rifampin suspensions prepared in five syrups Krukenberg CC, Mischler PG, Massad EN, Moore LA, Chandler AD.	1986
4216	Poster Sunnybrook 2019	Stability of 1.0, 0.2 and 0.025 mg/mL Milrinone Solutions Stored in Syringes at 4ºC and at Room Temperature (25ºC). Hook R, Riss V, Scharrer E, Robillard J, Law S, Walker SE.	2019
4228	Poster Prof Practice Conference - Canadian Society of PH 2017	Stability of 10 and 50 microg/mL Fentanyl Solutions in CADD Reservoirs, PVC containers and Ethylene/Propylene Co-Polymer (PAB) Bags at Refrigerated (4°C) and Room Temperature (23°C). Law S, Perks W, Iazetta J, Walker S.	2017
1972	Journal Drug Dev Ind Pharm 2016 ; 42, 1: 166-174.	Stability of 10 mg/mL cefuroxime solution for intracameral injection in commonly used polypropylene syringes and new ready-to-use cyclic olefin copolymer sterile vials using the LC–UV stability-indicating method. Feutry, F., Simon, N., Genay, S., Lannoy, D., Barthelemy, C., Decaudin, B., Labalette, P., Odou, P.	2016
4574	Journal Am J Hosp Pharm 2021 ;78,9:825–831	Stability of 10-mg/mL and 50-mg/mL ketamine oral solutions. Ancedy D, Sebti M, Postaire M, Vidal F, Cisternino S.	2021
4070	Journal Hosp Pharm 2018 ;53, 2: 73-74.	Stability of 2 mg/mL Adenosine Solution in Polyvinyl Chloride and Polyolefin Infusion Bags. DeAngelis M, Ferrara A, Gregory K, Zammit K, Zhao F.	2018
4246	Poster 2019	Stability of 2.5mg/mL Indocyanine Green (ICG) Solutions Stored in Syringes at 25ºC, 4ºC, -20ºC and -67ºC. Perks W, Law S, Marchesano R, Walker SE.	2019
4223	Poster Prof Practice Conference - Canadian Society of PH 2019	Stability of 20,40 and 50 microg/mL Fentanyl Solutions Stored in Syringes at Room Temperature (23°C). Riss V, Hook R, Neault A, Scharrer E, Law s, Walker S.E.	2019
3818	Journal Pharmaceutical Technology in Hospital Pharmacy 2017 ;2, 1:11-16.	Stability of 25 mg/mL 5-azacitidine suspension kept in fridge after freezing. Balouzet C, Chanat C, Jobard M, Brandely-Piat M-L, Chast F.	2017
4231	Poster Professional Practice Conference - Canadian Societ 2018	Stability of 4 and 10 mcg/mL Remifentanil Solutions Stored in Syringes at Room Temperature (23°C) Roxanne Hook, Vera Riss, Erica Scharrer, Shirley Law and Scott E. Walker	2018
1675	Journal Int J Pharm Compound 2002 ; 6, 2: 155-157.	Stability of 4-Aminopyridine and 3,4-Diaminopyridine oral capsules Trissel LA, Zhang Y, Xu QA.	2002
4087	Journal Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,1:31-37	Stability of 5 mg/mL Nitrendipine Oral Suspension in SyrSpend® SF PH4. Bellay R, Bonnaure A.C, Rault P, Pertuisel S, Lester M.A, Boivin P.N.	2018
4596	Journal Am J Health-Syst Pharm 2021 ;78,15:444–1447	Stability of 5% vancomycin ophthalmic solution prepared using balanced salt solution after freezing for 90 days. Roura-Turet J, Rodriguez-Reyes M, Guerrero-Molina L, Soy-Muner D, López-Cabezas C.	2021
2496	Journal Am J Hosp Pharm 1986 ; 43: 118-120.	Stability of 5-aminosalicylic acid suspension Montgomery HA, Smith FM, Scott BE, White SJ, Gerald KB.	1986
840	Journal Can J Hosp Pharm 1986 ; 39: 60-66.	Stability of 5-fluorouracil and flucytosine in parenteral solutions. Biondi L, Nairn JG.	1986
2331	Journal Hospital Pharmacy Europe 2009 ; 42 : 30-31.	Stability of 5-fluorouracil and sodium folinate admixture. Cadrobbi J, Hecq J.D, Vanbeckbergen D, Jamart J, Galanti L.	2009
4759	Poster Sunnybrook Healt Science Centre 2023	Stability of 5-fluorouracil at 4°C, 25°C, and 33°C stored in NiproSureFuser+ Ambulatory Balloon Infusers. Ma NH, Charbonneau LF, Law S, Walker S.	2023
1812	Journal Int J Pharm Compound 2000 ; 4, 4: 320-323.	Stability of 5-fluorouracil in an extemporaneously compounded ophtalmic solution. Fuhrman LC, Godwin DA, Davis RA.	2000
842	Journal J Pharm Clin 1990 ; 9: 155-158.	Stability of 5-fluorouracil to heat and light. Pinguet F, Favre G, Canal P, Pujol A, Soula G.	1990
3975	Poster EAHP congress - Cannes 2017	Stability of 50 and 100 µg/0,1mL intraocular solutions of voriconazole at 2-8°C. Roche M, Simon N, Bourdon F, Dhorne C, Berneron C, Lannoy D, Odou P.	2017
2221	Journal Am J Health-Syst Pharm 2007 ; 64, 23: 2480-2482.	Stability of 70% alcohol solutions in polypropylene syringes for use in ethanol-lock therapy. Cober M.P, Johnson C.E.	2007
4284	Journal Journal of Chemotherapy 2018 ; 30, 6-8: 371-374.	Stability of 90 mg/mL cefuroxime sodium solution for administration by continuous infusion. Vercheval C, Streel S, Servais A-C, Fillet M, Van Hees T.	2018
4197	Journal Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,4:219-226	Stability of a 50 mg/mL Ceftazidime Eye-Drops Formulation. Gautier E, Saillard J, Deshayes C, Vrignaud S, Lagarce F, Briot T.	2018
1601	Journal Hosp Pharm 2001 ; 36: 950-954.	Stability of a baclofen and clonidine hydrochloride admixture for intrathecal administration. Godwin DA, Kim NH, Zuniga R.	2001
442	Journal Am J Hosp Pharm 1989 ; 46: 732-737.	Stability of a concentrated trimethoprim-sulfamethoxazole admixtures. Jarosinski PF, Kennedy PE, Gallelli JF.	1989
2395	Journal Am J Health-Syst Pharm 2008 ; 65: 558-561.	Stability of a flavored formulation of acetylcysteine for oral administration Siden R, Johnson CE.	2008
2191	Journal J Oncol Pharm Practice 2007 ; 13: 33-37	Stability of a heparin-free 50% ethanol lock solution for central venous catheters. Pomplum M, Johnson JJ, Johnston S, Kolesar JM.	2007
4661	Journal J Pharm Biomed Anal 2022	Stability of a high-concentrated aqueous solution of idarubicin stored in a polypropylene syringe for transarterial chemoembolization Bourcier B, Lagarce R, Lebreton V.	2022
3473	Journal Int J Pharm 2015 ; 495, 2: 956-962.	Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization. Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B.	2015
4053	Journal Am J Health-Syst Pharm 2017 ;74,24:2060-2064	Stability of a pyrimethamine suspension compounded from bulk powder. Lewis P, Cluck D, Huffman J, Ogle A, Brown S.	2017
2591	Journal Can J Hosp Pharm 1988 ; 41: 121-123.	Stability of a sotalol hydrochloride oral liquid formulation. Dupuis LL, James G, Bacola G.	1988
2138	Journal Eur J Anaesthesiol 2002 ; 19: 295-297.	Stability of a sufentanil-ropivacaine mixture in a glass and a PVC reservoir. Brodner G, Ermert T, Van Aken H et al.	2002
460	Journal Am J Hosp Pharm 1987 ; 44: 358-360.	Stability of acetazolamide sodium in 5% dextrose and 0.9% sodium chloride injection. Parasrampuria J, Das Gupta V, Stewart KR.	1987
2434	Journal Am J Health-Syst Pharm 1996 ; 53: 1944-1949.	Stability of acetazolamide, allopurinol, azathioprine, clonazepam, and flucytosine in extemporaneously compounded oral liquids Allen LV, Jr, Erickson MA,	1996
3999	Journal Int J Pharm Compound 2017 ; 21:4 :339-346	Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4. De Oliveira Ferreira, Polonini H, Loures da Silva S, Buzinari Aglio N.C, Abreu J, Fernandes Brand?o M.A.	2017
2426	Journal Am J Health-Syst Pharm 1997 ; 54: 549-553.	Stability of acetylcysteine in an extemporaneously compounded ophthalmic solution Anaizi NH, Swenson CF, Dentinger PJ.	1997
2400	Journal Am J Health-Syst Pharm 2007 ; 64: 762-766.	Stability of acetylcysteine solution repackaged in oral syringes and associated cost savings Kiser TH, Oldland AR, Fish DN.	2007
822	Journal Am J Health-Syst Pharm 1998 ; 55: 574-577.	Stability of acyclovir sodium 1, 7, and 10 mg/ml in 5% dextrose injection and in 0.9% sodium chloride injection. Zhang Y, Trissel LA, Martinez JF, Gilbert DL.	1998
1717	Journal Int J Pharm Compound 2001 ; 5: 75-77.	Stability of acyclovir sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use. Ling J, Das Gupta V.	2001
68	Journal J Clin Pharm Ther 1989 ; 14: 451-456.	Stability of acyclovir sodium in dextrose and sodium chloride injections. Das Gupta V, Pramar Y, Bethea C.	1989
2216	Journal J Pharm Biomed Anal 1998 ; 17: 415-418.	Stability of adenosin infusion. Proot P, Schepdael A.V, Raymakers A.A, Hoogmartens J.	1998
820	Journal Am J Health-Syst Pharm 1998 ; 55: 1161-1164.	Stability of adenosine 6 microg/ml in 0.9% sodium chloride solution. Naud C, Marti B, Fernandez C, Astier A, Paul M.	1998
1948	Journal J Pain Symptom Manage 2004 ; 28, 6: 603-611.	Stability of admixtures containing morphine sulfate, bupivacaine hydrochloride, and clonidine hydrochloride in an implantable infusion system. Classen AM, Wimbish GH, Kupiec TC.	2004
930	Journal J Clin Pharm Ther 1997 ; 22: 339-345.	Stability of admixtures of pethidine and metoclopramide in aqueous solution, 5% dextrose and 0.9% sodium chloride. Hor MMS, Chan SY, Yow KL, Lim LY, Chan E.	1997
824	Journal Am J Health-Syst Pharm 1998 ; 55: 1602-1605.	Stability of albumin-free interferon alfa-2b for 42 days. Appenheimer MM, Schepart BS, Poleon GP, Evans SS.	1998
2960	Journal Respiratory Care 1991 ; 36: 1387-1390.	Stability of albuterol and tobramycin when mixed for aerosol administration. Gooch MD.	1991
2670	Journal Int J Pharm Compound 1998 ; 2: 394-396.	Stability of albuterol in continuous nebulization. Hunter DA, Yoo SD, Fox JL.	1998
2255	Manufacturer Ebewe Pharma 2007	Stability of Alexan "Ebewe" infusion solutions.	2007
3902	Journal Int J Pharm Compound 2016 ; 20, 5 : 426-434.	Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions. Polonini Hudson C, Loures Sharlene,de Araujo Edson Peter, Brand?o Marcos Ant?nio F, Ferreira Anderson O.	2016
3994	Journal Int J Pharm Compound 2017 ; 3: 255-263	Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions. De Oliveira Ferreira A, Polonini H C, Loures da Silva S, Cerqueira de Melo V Augusto, de Andrade L, Fernandes Brand?o Marcos A.	2017
2422	Journal Am J Health-Syst Pharm 1998 ; 55: 1915-1920.	Stability of alprazolam, chloroquine phosphate, cisapride, enalapril maleate, and hydralazine hydrochloride in extemporaneously compounded oral liquids Allen LV, Jr, Erickson MA,	1998
3961	Journal Int J Pharm Compound 2017 ; 21, 2: 150-153.	Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers. McCluskey S.V,Kirkham K,Munson J.M.	2017
1816	Journal Int J Pharm Compound 2003 ; 7, 3: 230-232.	Stability of amikacin sulfate in autodose infusion system bags. Zhang Y, Trissel LA.	2003
550	Journal Int J Pharm Compound 1997 ; 1: 132-134.	Stability of aminocaproic acid injection admixtures in 5% dextrose injection and 0.9% sodium chloride injection. Zhang YP, Trissel LA.	1997
478	Journal Am J Hosp Pharm 1992 ; 49: 2962-2963.	Stability of aminophylline in bacteriostatic water for injection stored in plastic syringes at two temperatures. Nahata MC, Morosco RS, Hipple TF.	1992
1188	Journal Am J Hosp Pharm 1983 ; 40: 428-432.	Stability of aminophylline injection in three parenteral nutrient solutions. Niemiec PW, Venderveen TW, Hohenwarter MW, Gadsden RH.	1983
242	Journal Am J Hosp Pharm 1986 ; 43: 917-921.	Stability of amiodarone hydrochloride in admixtures with other injectable drugs. Campbell S, Nolan PE, Bliss M, Wood R, Mayersohn M.	1986
2541	Journal Ann Pharmacotherapy 1997 ;31:851-852.	Stability of amiodarone in an oral suspension stored under refrigeration and at room temperature. Nahata MC.	1997
3792	Journal J Ped Pharm Pract 1999 ; 4: 186-189.	Stability of amiodarone in extemporaneous oral suspension prepared from commercially available vehicles. Nahata M.C, Morosco R.S, Hipple T.F.	1999
2689	Journal J Am Pharm Assoc 1999 ; 39: 375-377.	Stability of amlodipine mesylate in two liquid dosage form. Nahata MC, Morosco RS, Hipple TF.	1999
2951	Journal J Clin Pharm Ther 1994 ; 19: 313-315.	Stability of amoxicillin and potassium clavulanate in co-amoxiclav oral suspension. Mehta AC, Hart-Davies S, Payne J, Lacey RW..	1994
2508	Journal Am J Hosp Pharm 1988 ; 45: 1092-1099.	Stability of amoxicillin trihydrate-potassium clavulanate in original containers and unit dose oral syringes Tu YH, Stiles ML, Allen LV, Jr, Olsen KM, Barton CI, Greenwood RB.	1988
12	Journal Am J Health-Syst Pharm 1997 ; 54: 683-686.	Stability of amphotericin B 0.05 and 0.5 mg/ml in 20% fat emulsion. Owens LC, Fleming RA, Restino MS, Cruz JM, Hurd DD.	1997
2820	Journal J Pharm Biomed Anal 2006 ; 42: 362-366.	Stability of amphotericin B and nystatin in antifungal mouthrinses containing sodium hydrogen carbonate Groeschke J, Solassol I, Bressolle F, Pinguet F.	2006
1407	Journal Hosp Pharm 1998 ; 33: 1203-1207.	Stability of amphotericin B cholesteryl sulfate complex after reconstitution and admixture. Xu QA, Trissel LA, Gilbert DL.	1998
497	Journal Am J Hosp Pharm 1991 ; 48: 1681.	Stability of amphotericin B in 5% dextrose injection at 25°C. Kintzel PE, Kennedy PE.	1991
439	Journal Am J Hosp Pharm 1991 ; 48: 283-285.	Stability of amphotericin B in 5% dextrose injection at concentrations used for administration through a central venous line. Kintzel PE, Kennedy PE.	1991
283	Journal Am J Hosp Pharm 1994 ; 51: 394-396.	Stability of amphotericin B in 5% dextrose injection stored at 4 or 25°C for 120 hours. Lee MD, Hess MM, Boucher BA, Apple AM.	1994
2867	Journal Int J Pharm Compound 1999 ; 3, 4: 316-320.	Stability of Amphotericin B in 5% Dextrose Ophthalmic Solution. Peyron F, Elias R, Ibrahim E, Amirat-Combralier V, Bu?s-Charbit M, Balansard G.	1999
2940	Journal Am J Health-Syst Pharm 2001 ; 58: 1021-1024.	Stability of amphotericin B in an extemporaneously compounded oral suspension. Dentinger PJ, Swenson CF, Anaizi NH.	2001
435	Journal Am J Hosp Pharm 1991 ; 48: 2430-2433.	Stability of amphotericin B in four concentrations of dextrose injection. Wiest DB, Maish WA, Garner SS, El-Chaar GM.	1991
3069	Journal Eur Hosp Pharm 1997 ; 3: 59-60.	Stability of amphotericin B in water solution for inhalation. Juarez JC, ,Lopez RM, Hucto M et al.	1997
3777	Journal Am J Health-Syst Pharm 2015 ; 72:13-14	Stability of ampicillin and amoxicillin in peritoneal dialysis solutions Patel R.P, Li K, Shastri M, Wanandy T, Jose M.D.	2015
3880	Journal Int J Pharm Compound 2016 ; 20, 4 : 338-342	Stability of Ampicillin in Normal Saline and Buffered Normal Saline. Maher M, Jensen Kara J,Lee David, Nix David E	2016
4640	Journal Hosp Pharm 2021 ; 56, 5: 507–512.	Stability of Ampicillin in Normal Saline Following Refrigerated Storage and 24-Hour Pump Recirculation. Huskey M, Lewis P, Brown S.D.	2021
1705	Journal Int J Pharm Compound 2002 ; 6: 226-229.	Stability of ampicillin sodium, nafcillin sodium, and oxacillin sodium in autodose system bags. Zhang Y, Trissel LA.	2002
4063	Journal Int J Pharm Compound 2018 ;22,1:66-75	Stability of an Alcohol-free, Dye-free Hydrocortisone (2mg/mL) Compounded Oral Suspension. Manchanda A, Laracy M, Savji T, Bogner R.	2018
342	Journal Am J Hosp Pharm 1985 ; 42: 339-342.	Stability of an analgesic-sedative combination in glass and plastic single-dose syringes. Conklin CA, Kerege JF, Christensen JM.	1985
3780	Journal EJHP 2015 ;22:7-11	Stability of an epidural analgesic admixture containing butorphanol tartrate and ropivacaine hydrochloride Chen F, Peng L, Zhou B, Fang B, Yang Y.	2015
2306	Journal Anaesthesia 2004 ; 59, 10: 979-983.	Stability of an epidural analgesic admixture containing epinephrine, fentanyl and bupivacaine. Priston M.J, Hughes J.M, Santillo M, Christie I.W.	2004
3401	Journal J Clin Pharm Ther 2013 ;38, 2: 104-108	Stability of an epidural analgesic admixture of levobupivacaine, fentanyl and epinephrine. Helin-Tanninen, M., Lehtonen, M., Naaranlahti, T., Ven?l?inen, T., Pentik?inen, J., Laatikainen, A., Kokki, H.	2013
1875	Journal Acta Anaesthesiol Scand 2000 ; 44: 864-867.	Stability of an epidural analgesic solution containing adrenaline, bupivacaine and fentanyl. Kjonniksen I, Brustugun J, Breivik H, Anderssen E, Klem W.	2000
3187	Journal Am J Health-Syst Pharm 2011 ; 68:420-423.	Stability of an extemporaneous alcohol-free melatonin suspension. Johnson CE, Cober MP, Thome T, Rouse E.	2011
2773	Journal Support Care Cancer 2009 ; 17, 6: 701-706.	Stability of an extemporaneous oral liquid aprepitant formulation. Dupuis LL, Lingertat-Walsh K, Walker SE.	2009
2478	Journal Am J Hosp Pharm 1993 ; 50: 2353-2355.	Stability of an extemporaneously compounded baclofen oral liquid Johnson CE, Hart SM.	1993
2502	Journal Am J Hosp Pharm 1992 ; 49: 122-125.	Stability of an extemporaneously compounded clonidine hydrochloride oral liquid Levinson ML, Johnson CE.	1992
4075	Journal Am J Health-Syst Pharm 2018 ;75,5: 309-315	Stability of an extemporaneously compounded minoxidil oral suspension. Song Y, Whey Chin Z, Ellis D, Mon Phyo Lwin E, Turner S, Williams D, Garg S.	2018
3872	Journal Hosp Pharm 2016 ; 51: 389-395.	Stability of an Extemporaneously Compounded Oral Suspension of Bosentan. Malik A, Gorman G, Coward L ,. Arnold J.J.	2016
2851	Journal Int J Pharm Compound 2005 ; 9, 1: 82-86.	Stability of An Extemporaneously Compounded Propylthiouracil Suspension Alexander KS, Mitra P.	2005
2503	Journal Am J Hosp Pharm 1991 ; 48: 293-295.	Stability of an extemporaneously compounded terbutaline sulfate oral liquid Horner RK, Johnson CE.	1991
2657	Journal Int J Pharm Compound 1997 : 60-63.	Stability of an extemporaneously formulated levothyroxine sodium syrup compounded from commercial tablets. Alexander KS, Kothapalli MR, Dollimor D.	1997
2401	Journal Am J Health-Syst Pharm 2007 ; 64: 644-646.	Stability of an extemporaneously prepared alcohol-free phenobarbital suspension Cober MP, Johnson CE.	2007
3420	Journal J Oncol Pharm Practice 2014 ; 21, 3: 178-187.	Stability of an extemporaneously prepared bleomycin-lidocaine-epinephrine intradermal admixture used in dermatology El Kateb N, Chaussard M, Bellenger P, Petit A, Faure P.	2014
3298	Journal Am J Health-Syst Pharm 2012 ; 69: 592-594	Stability of an extemporaneously prepared tadalafil suspension Pettit R.S, Johnson C.E, Caruthers R.L.	2012
3269	Journal Am J Health-Syst Pharm 2012 ; 69:56-58.	Stability of an extemporaneously prepared thalidomide suspension. Kraft S, . Johnson C.E, Tyler R.P.	2012
1341	Journal Pharm J 1983 ; 230: 495-497.	Stability of an intrathecal morphine injection formulation. Deeks T, Davis S, Nash S.	1983
444	Journal Am J Hosp Pharm 1992 ; 49: 2756-2760.	Stability of an ofloxacin injection in various infusion fluids. Bornstein M, Kao SH, Mercorelli M, Verma S.	1992
4249	Journal PeerJ 2018	Stability of an ophtalmic formulation of polyhexamethylene biguanide in gamma-sterilized and ethylene oxide sterilized low density polyethylene multi dose eyedroppers. Bouattour Y, Chennell P, Wasiak M, Jouannet M, Sautou V.	2018
2833	Journal Int J Pharm Compound 2001 ; 5, 6: 480-481.	Stability of an Oral Liquid Dosage Form of Glycopyrrolate Prepared from Tablets Das Gupta V.	2001
3336	Journal EJHP 2013 ;20:46-49	Stability of an oral ranitidine suspension (15 mg/ml). Petit-Jean E, Perello L, Hernandez C, Gairard Dory A.C, Gourieux B, Ubeaud-Sequier G.	2013
2925	Journal Am J Health-Syst Pharm 2005 ; 62: 2518-2520.	Stability of anhydrous theophylline in extemporaneously prepared alcohol-free oral suspensions. Johnson CE, vanDe Koppel S, Myers E.	2005
632	Journal J Parenter Sci Technol 1985 ; 39: 220-222.	Stability of anthracycline antitumour agents in infusion fluids. Beijnen JH, Rosing H, De Vries PA, Underberg WJM.	1985
573	Journal Drug Intell Clin Pharm 1977 ; 11: 542-548.	Stability of antibiotic admixtures frozen in minibags. Dinel BA, Ayotte DL, Behme RJ, Black BL, Whitby JL.	1977
3888	Journal Perit Dial Int 2016 ; 36:421-426.	Stability of Antibiotics for Intraperitoneal Administration in Extraneal 7.5% Icodextrin Peritoneal Dialysis Bags (STAB Study). Ranganathan D, Naicker S,. Wallis S.C, Lipman J, . Ratanjee S.K, Roberts J.A	2016
574	Journal Am J Hosp Pharm 1980 ; 37: 1087-1088.	Stability of antibiotics frozen and stored in disposable hypodermic syringes. Kleinberg ML, Stauffer GL, Prior RB, Latiolais CJ.	1980
427	Journal Am J Hosp Pharm 1986 ; 43: 3027-3030.	Stability of aqueous solutions of amoxicillin sodium in the frozen and liquid states. Concannon J, Lovitt H, Ramage M, Tai LH, McDonald C, Sunderland VB.	1986
960	Journal Can J Hosp Pharm 1990 ; 43: 57-60.	Stability of aqueous solutions of deferoxamine. Koren G, Tesoro A, Leeder JS, Bentur Y, Olivieri N.	1990
2469	Journal Am J Hosp Pharm 1981 ; 38: 363-364.	Stability of aqueous suspensions of disulfiram Das Gupta V.	1981
2345	Journal Can J Hosp Pharm 2009 ; 62, 3: 226-231.	Stability of aseptically prepared Tazocin solutions in polyvinyl chloride bags. Donnelly R.F.	2009
3857	Journal Int J Pharm Compound 2016 ; 20, 2: 167-174.	Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Polonini H.C, Sharlene L, Claudio L,Ferreira A.O,Brand?o M.A.F.	2016
1093	Journal Anesthesiology 1984 ; 61: 347-348.	Stability of atracurium administered by infusion. Fisher DM, Canfell, Miller RD.	1984
1039	Journal Am J Hosp Pharm 1984 ; 41: 1156-1159.	Stability of azacitidine in infusion fluids. Cheung YW, Vishnuvajjala BR, Morris NL, Flora KP.	1984
414	Journal Am J Hosp Pharm 1989 ; 46: 2500-2505.	Stability of azacitidine in lactated Ringer’s injection frozen in polypropylene syringes. Den Hartigh J, Brandenburg HCR, Vermeij P.	1989
3351	Journal Can J Hosp Pharm 2012 ; 65, 5: 352-359	Stability of Azacitidine in Sterile Water for Injection. Walker S.E, Charbonneau L.F, Law S, Earle C.	2012
4227	Poster Prof Practice Conference - Canadian Society of PH 2019	Stability of Azacitidine Solutions In Sterile Water for Injection. Tyono I, Law S, Charbonneau L.F, Walker S.E.	2019
3204	Journal Ann Pharmacotherapy 2011 ;45, 4:546.	Stability of Azacitidine Suspensions. Duriez A, Vigneron J.H, Zenier H.A, May I, Demoré B.M.	2011
4301	Journal Oncotarget 2017 ;8, 63: 106249-106257.	Stability of azasetron-dexamethasone mixture for chemotherapyinduced nausea and vomiting administration. Fang B-X, Chen F-C, Zhu D, Guo J, Wang L-H.	2017
4408	Journal Int J Pharm Compound 2020 ;24,3:252-262	Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF PH4. Polonini H, Loures da Silva S, Neves Cunha C, de Oliveira Ferreira A, Anagnostou K, Dijkers E.	2020
258	Journal Am J Hosp Pharm 1994 ; 51: 901-904.	Stability of aztreonam and ampicillin sodium-sulbactam sodium in 0.9% sodium chloride injection. Belliveau PP, Nightingale CH, Quintiliani R.	1994
1064	Journal Pharm World Sci 1996 ; 18: 74-77.	Stability of aztreonam in a portable pump reservoir used for home intravenous antibiotic treatement (HIVAT). Vinks AATMM, Touw DJ, van Rossen RCJM, Heijeiman HGM, Bakker W.	1996
2263	Journal Il Farmaco 2005 ; 60: 599-603.	Stability of aztreonam in AZACTAM. Zajac M, Jelinska A, Cielecka-Piontek J, Osqczapowicz I.	2005
2433	Journal Am J Health-Syst Pharm 1996 ; 53: 2179-2184.	Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids Allen LV, Jr, Erickson MA,	1996
3342	Journal Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,1:13-21	Stability of Bendamustine Solutions: Influence of Sodium Chloride Concentration, Temperature and Container. Vigneron J, D'Huart E, Demoré B.	2018
2056	Journal J Antimicrob Chemother 2004 ; 53: 675-677.	Stability of benzylpenicillin during continuous home intravenous therapy. Vella-Brincat JWA, Begg EJ, Gallagher K, kirkpatrick CMJ, Zhang M, Frampton C, Chambers ST.	2004
3449	Journal Ann Pharmacotherapy 2013 ; 47: 1237-1238.	Stability of Betaxolol Suspensions in Oral Syringes and Glass Bottles. Auvity S, Chiadmi F.M, Cisternino S, Fontan J.E, Schlatter J.	2013
2421	Journal Am J Health-Syst Pharm 1998 ; 55: 1804-1809.	Stability of bethanechol chloride, pyrazinamide, quinidine sulfate, rifampin, and tetracycline hydrochloride in extemporaneously compounded oral liquids Allen LV, Jr, MA Erickson	1998
4383	Journal Crit Care Resusc 2020 ;22(1):83-85.	Stability of bicarbonate in normal saline: a technical report. Naorungroj T, Neto AS, Fujii T, Jude B, Udy A, Bellomo R.	2020
252	Journal Am J Hosp Pharm 1990 ; 47: 2528-2529.	Stability of bleomycin sulfate reconstituted in 5% dextrose injection or 0.9% sodium chloride injection stored in glass vials or polyvinyl chloride containers. Koberda M, Zieske PA, Raghavan NV, Payton RJ.	1990
2010	Journal Ann Pharmacotherapy 2005 ; 39: 1462-1466.	Stability of bortezomib 1 mg/ml solution in plastic syringe and glass vial. André P, Cisternino S, Chiadmi F, Toledano A, Schlatter J, Fain O, Fontan JE.	2005
3688	Journal Can J Hosp Pharm 2014 ; 67, 2: 102-107	Stability of bortezomib 2.5 mg/mL in vials and syringes stored at 4°C and room temperature (23°C). Walker S.E, Charbonneau L.F, Law S.	2014
3337	Journal EJHP 2012 ; 19: 428-431.	Stability of bortezomib reconstituted under clinical use conditions in original vials and polypropylene syringes at 4 °C and room temperature. Carati D, Masini C, Minguzzi M, Petocchi B, Romanazzi C, Rondoni C, Sangiorgi E, Sferra S, Simonetta S, Stancari A, Locchi F, Z	2012
2232	Journal Can J Hosp Pharm 2008 ; 61, 1: 14-20.	Stability of Bortezomib Reconstituted with 0.9% Sodium Chloride at 4°C and Room Temperature (23°C) Walker SE, Milliken D, Law S.	2008
4590	Journal J Pediatr Pharmacol Ther 2021 ; 51: 231-237.	Stability of buffered benzylpenicillin and flucloxacillin for a paediatric outpatient parenteral antibiotic therapy service. Smith E.K, McWhinney MPhil B.C.	2021
3702	Journal J Pharm Pract and Res 2014 ; 44, 1: 26-28.	Stability of buffered benzylpenicillin solutions for outpatient parenteral antimicrobial therapy. McDougall D.A.J, McWhinney.	2014
3263	Journal Can J Hosp Pharm 2011 ; 64, 4: 289-290.	Stability of buffered lidocaine in glass vials. Donnelly R.F.	2011
42	Journal Am J Health-Syst Pharm 1997 ; 54: 422-423.	Stability of bumetanide in 5% dextrose injection. Cornish LA, Montgomery PA, Johnson CE.	1997
306	Journal Am J Health-Syst Pharm 1996 ; 53: 170-173.	Stability of bupivacaine hydrochloride and hydromorphone hydrochloride during simulated epidural coadministration. Christen C, Johnson CE, Walters JR.	1996
293	Journal Am J Hosp Pharm 1993 ; 50: 2364-2365.	Stability of bupivacaine hydrochloride in polypropylene syringes. Jones JW, Davis AT.	1993
512	Journal Pharm World Sci 1995 ; 17: 87-92.	Stability of bupivacaine hydrochloride with diamorphine hydrochloride in an epidural infusion. Barnes AR, Nash S.	1995
217	Journal Am J Hosp Pharm 1993 ; 50: 714-715.	Stability of bupivacaine hydrochloride, epinephrine hydrochloride, and fentanyl citrate in portable infusion-pump reservoirs. Allen LV, Stiles ML, Wang DP, Tu YH.	1993
2113	Journal Pharm World Sci 1999 ; 21, 6: 272-274.	Stability of buprenorphine, haloperidol and glycopyrrolate mixture in a 0.9% sodium chloride solution. Jäppinen A, Kokki H, Naaranlahti TJ, Rasi AS.	1999
658	Journal J Oncol Pharm Practice 1996 ; 2: 101-105.	Stability of busulfan injection admixtures in 5% dextrose injection and 0.9% sodium chloride injection. Xu QA, Zhang YP, Trissel LA, Martinez JF.	1996
4033	Journal Am J Health-Syst Pharm 2017 ;74,22:1887-1894	Stability of busulfan solutions in polypropylene syringes and infusion bags as determined with an original assay. Guichard N, Bonnabry P, Rudaz S, Fleury-Souverain S.	2017
668	Journal Medicine 2015 ; 94(6):e432.	Stability of Butorphanol–Tropisetron Mixtures in 0.9% Sodium Chloride Injection for Patient-Controlled Analgesia Use. Chen, Fu-Chao; Shi, Xiao-Ya; Li, Peng; Yang, Jin-Guo; Zhou, Ben-Hong.	2015
691	Journal J Clin Pharm Ther 1989 ; 14: 53-55.	Stability of caffeine citrate injection in intravenous admixtures and parenteral nutrition solutions. Nahata MC, Zingarelli JR, Durell DE.	1989
43	Journal Am J Health-Syst Pharm 1997 ; 54: 1106-1108.	Stability of caffeine citrate injection in polypropylene syringes at room temperature. Fraser BD, Berod T, Whitney HAK.	1997
698	Journal Ann Pharmacotherapy 1989 ; 23: 466-467.	Stability of caffeine injection in intravenous admixtures and parenteral nutrition solutions. Nahata MC, Zingarelli JR, Durell DE.	1989
990	Journal Ann Pharmacotherapy 1989 ; 23: 1035.	Stability of caffeine injection stored in plastic and glass syringes. Nahata MC, Zingarelli JR, Hipple TF.	1989
2705	Journal J Clin Pharm Ther 1994 ; 19, 6: 391-396.	Stability of caffeine oral formulations for neonatal use. Barnes AR, Hebron BS, Smith J.	1994
2531	Journal J Oncol Pharm Practice 2021 ; 27, 2: 288-296.	Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/ polyamide infusion bags. Sanogo S, Silimbani P, Gaggeri R, Masini C.	2021
4189	Journal Am J Health-Syst Pharm 2022 ;79,12: 1011-1018	Stability of Captisol-enabled versus propylene glycol–based melphalan at room temperature and after refrigeration. Kawedia J, Ramchandran S, Liu X, Gulbis A, Titus M, Bashir Q, Qazilbash M, Champlin R, Ciur S,	2022
3802	Journal J Clin Pharm Ther 1998 ; 23: 451-456.	Stability of captopril in invert sugar solution Sam W.J, Ho P.C.	1998
2522	Journal Am J Hosp Pharm 1994 ; 51: 1707-1708.	Stability of captopril in liquid containing ascorbic acid or sodium ascorbate Nahata MC, Morosco RS, Hipple TF.	1994
2488	Journal Am J Hosp Pharm 1990 ; 47: 1799-1801.	Stability of captopril in powder papers under three storage conditions Taketomo CK, Chu SA, Cheng MH, Corpuz RP.	1990
3436	Journal Int J Pharm Compound 2013 ; 17, 4: 336-338.	Stability of Captopril in SyrSPend SF. Geiger C. M, Sorenson B, Whaley P. A.	2013
2245	Journal Int J Pharm 1996 ; 129: 275-277.	Stability of carboplatin in 5% glucose solution exposed to light. Torres F, Girona V, Puiol M, Prat J, de Bolos J.	1996
2244	Journal J Pharm Biomed Anal 1994 ; 12, 1: 81-84.	Stability of carboplatin in 5% glucose solution in glass, polyethylene and polypropylene containers. Prat J, Pujol M, Girona V, Munoz M, Sol? L-A.	1994
4205	Journal J Kor Soc Hosp Pharm 2006 ;23,3:219-224	Stability of Carboplatin in normal saline : dependence on initial dilution concentration and storage time. Choi S, O La H, Kim K, Kim S, Hwangbo S.	2006
486	Journal Am J Health-Syst Pharm 1998 ; 55: 602, 604.	Stability of carboplatin in polyvinyl chloride bags. Diaz Amador F, Sevilla Azzati E, Herreros de Tajeda y Lopez-Coterilla A.	1998
4120	Journal J Oncol Pharm Practice 2018 25,5:1076?1081	Stability of carboplatin infusion solutions used in desensitization protocol. Vazquez-Sanchez R, Sanchez-Rubio-Ferrandez J, Cordoba-Diaz D, Cordoba-Diaz M, Molina-Garcia T.	2018
3277	Journal Int J Pharm Compound 2012 ; 16, 1 : 82-85.	Stability of Carboplatin, Paclitaxel, and Docetaxel with Acetyl-L-carnitine During Simulated Y-site Administration. Yang Z, Cameron S, Paul H.	2012
837	Journal Acta Pharm Suec 1986 ; 23: 115-124.	Stability of carmustine - kinetics and compatibility during administration. Fredriksson K, Lundgren P, Landersjo L.	1986
1622	Journal Am J Health-Syst Pharm 2001 ; 58: 238-241.	Stability of carmustine in polyvinyl chloride bags and polyethylene-lined trilayer plastic containers. Favier M, De Casanove F, Coste A, Cherti N, Bressolle F.	2001
715	Journal Am J Hosp Pharm 1980 ; 37: 677-678.	Stability of carmustine in the presence of sodium bicarbonate. Colvin M, Hartner J, Summerfield M.	1980
2486	Journal Am J Hosp Pharm 1991 ; 48: 992-993.	Stability of cefadroxil in reconstituted suspension under refrigeration and at room temperature Nahata MC, Jackson DS.	1991
612	Journal Am J Hosp Pharm 1982 ; 39: 622-627.	Stability of cefamandole nafate injection with parenteral solutions and additives. Frable RA, Klink PR, Engel GL, Mundell EE.	1982
1979	Journal Am J Health-Syst Pharm 2002 ; 59: 1537-1538.	Stability of cefazolin in heparinized and nonheparinized peritoneal dialysis solutions. Wu CC, Wang DP, Wong CY, Lin YF.	2002
4247	Journal Clin Ther 2018 ;40,4:664-667	Stability of Cefazolin in Polyisoprene Elastomeric Infusion Devices. Patel R, Jacob J, Sedeeq M, Ming L.C, Wanandy T, Zaidi S.T.R, Peterson G.M.	2018
582	Journal Am J Hosp Pharm 1980 ; 37: 211-215.	Stability of cefazolin sodium admixtures in plastic bags after thawing by microwave radiation. Tomecko GW, Kleinberg ML, Latiolais CL, Proior RB, Pesko LJ, Jones BC.	1980
111	Journal Am J Health-Syst Pharm 1996 ; 53: 1608,1610.	Stability of cefazolin sodium and meperidine hydrochloride. Lee DKT, Wong CY, Wang DP.	1996
671	Journal J Parenter Sci Technol 1993 ; 47: 135-137.	Stability of cefazolin sodium and metronidazole at 8°C for use as an IV admixture. Rivers TE, McBride HA, Trang JM.	1993
2707	Journal J Clin Pharm Ther 1998 ; 23, 1: 41-47.	Stability of cefazolin sodium eye drops How TH, Loo WY, Yow KL, Lim LY, Chan EW, Ho PC, Chan SY.	1998
1805	Journal Am J Health-Syst Pharm 2002 ; 59: 2362-2364.	Stability of cefazolin sodium in icodextrin-containing peritoneal dialysis solution. Lin YF, Wu CC, Lin SH, Wang DP, Wang CN.	2002
2372	Journal Am J Hosp Pharm 1991 ; 48: 291 - 292.	Stability of cefazolin sodium in peritoneal dialysis solutions Nahata MC, Ahalt PA.	1991
3230	Journal Can J Hosp Pharm 2011 ; 64, 4: 241-245.	Stability of Cefazolin Sodium in Polypropylene Syringes and Polyvinylchloride Minibags Donnelly RF.	2011
2505	Journal Am J Hosp Pharm 1987 ; 44: 2287-2290	Stability of cefazolin sodium in various artificial tear solutions and aqueous vehicles Ahmed I, Day P.	1987
440	Journal Am J Hosp Pharm 1989 ; 46: 1408-1412.	Stability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in portable pump reservoirs. Stiles ML, Tu YH, Allen LV.	1989
1452	Journal Eur Hosp Pharm 2000 ; 6: 17-23.	Stability of cefazolin, cefotiam, cefuroxime, cefotaxime, ceftriaxone and ceftazidime in normal saline solutions, stored in a new IV container made of Biofine*. Muller HJ, Howe K, Frank C, Haker I.	2000
1626	Journal Int J Pharm Compound 2001 ; 5: 151-152.	Stability of cefepime hydrochloride after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use. Ling J, Das Gupta V.	2001
873	Journal Int J Pharm Compound 1997 ; 1: 435-436.	Stability of cefepime hydrochloride dextrose in 5% dextrose injection and 0.9% sodium chloride injection. Das Gupta V, Maswoswe J, Bailey RE.	1997
1834	Journal Ann Pharmacotherapy 2003 ; 37, 6: 804-807.	Stability of cefepime hydrochloride in autodose infusion system bags. Trissel LA, Xu QA.	2003
1068	Journal Am J Health-Syst Pharm 1999 ; 56: 457-459.	Stability of cefepime hydrochloride in polypropylene syringes at -20°C, 4°C and 22-24°C. Stewart JT, Warren FW, Maddox FC.	1999
1046	Journal Am J Health-Syst Pharm 1999 ; 56: 1134.	Stability of cefepime hydrochloride in polypropylene syringes. Stewart JT, Maddox FC, Warren FW.	1999
1605	Journal Hosp Pharm 2000 ; 35: 1057-1064.	Stability of cefepime hydrochloride injection and metronidazole in polyvinyl chloride bags at 4°C and 22-24°C. Stewart JT, Maddox FC, Warren FW.	2000
3182	Journal Pharmazie 2011 ; 66, 1: 17-23.	Stability of cefepime in eye drops. Kodym A, PawLowska M, Ruminski JK, Bartosinska A, Kieliba A.	2011
1945	Journal Ann Pharmacotherapy 2004 ; 38: 2041-2044.	Stability of cefepime in icodextrin peritoneal dialysis solution. Elwell RJ, Volino LR, Frye RF.	2004
1290	Journal Ann Pharmacotherapy 1999 ; 33: 906-909.	Stability of cefepime in peritoneal dialysis solution. Williamson JC, Volles DF, Lynch PLM, Rogers PD, Haverstick DM.	1999
237	Journal Am J Health-Syst Pharm 1996 ; 53: 432.	Stability of cefmetazole and famotidine. Lee DKT, Wong CY, Wang DP, Chang LC, Wu KH.	1996
652	Journal Int J Pharm Compound 1997 ; 1: 208-209.	Stability of cefmetazole sodium in 5% dextrose injection and 0.9% sodium chloride injection. Das Gupta V, Maswoswe J, Bailey R.E, County H.	1997
1664	Journal J Clin Pharm Ther 1994 ; 19: 317-325.	Stability of cefmetazole-doxycycline mixtures in sodium chloride and dextrose injections. King AD, Stewart JT, Warren FW.	1994
420	Journal Am J Hosp Pharm 1985 ; 42: 1980-1983.	Stability of cefonicid sodium in infusion fluids. Wong WW, Maderich AB, Polli GP, Ravin LJ.	1985
2374	Journal Am J Hosp Pharm 1990 ; 47: 147 - 150.	Stability of cefotaxime in two peritoneal dialysis solutions CM Paap CM, Nahata MC.	1990
1711	Journal Int J Pharm Compound 2002 ; 6: 234-236.	Stability of cefotaxime sodium after reconstitution in 0.9% sodium chloride injection and storage in polypropylene syringes for pediatric use. Das Gupta V.	2002
281	Journal Am J Health-Syst Pharm 1995 ; 52: 1561-1563.	Stability of cefotaxime sodium and metronidazole in 0.9% sodium chloride injection or in ready-to-use metronidazole bags. Belliveau PP, Nightingale CH, Quintiliani R.	1995
593	Journal J Pharm Sci 1984 ; 73: 565-567.	Stability of cefotaxime sodium as determined by High-Performance Liquid Chromatography. Das Gupta V.	1984
3840	Journal Acta Pol Pharm 2016 ; 73, 1: 23-27.	Stability of cefpirome sulfate in aqueous solutions. Zalewski P, Jelinska A, Paczkowska M, Garbacki P, Talaczynska A, Step-niak P, Cielecka- Piontek J.	2016
280	Journal Am J Health-Syst Pharm 1995 ; 52: 2427-2433.	Stability of cefpirome sulfate in the presence of commonly used intensive care drugs during simulated Y-site injection. Allen LV, Stiles ML, Prince SJ, Sylvestri MF.	1995
443	Journal Am J Hosp Pharm 1992 ; 49: 2761-2764.	Stability of ceftazidime (with arginine) and of cefuroxime sodium in infusion-pump reservoirs. Stiles ML, Allen LV, Fox JL.	1992
287	Journal Am J Health-Syst Pharm 1995 ; 52: 1912-1914.	Stability of ceftazidime (with arginine) in an elastomeric infusion device. Bednar DA, Klutman NE, Henry DW, Fox JL, Strayer AH.	1995
477	Journal Am J Hosp Pharm 1992 ; 49: 2954-2956.	Stability of ceftazidime (with arginine) stored in plastic syringes at three temperatures. Nahata MC, Morosco RS, Fox JL.	1992
4056	Journal Perit Dial Int 2017	Stability of ceftazidime and heparine in four different types of peritoneal dialysis solutions. Kandel S, Zaidi S, Wanandy T, Ming L, Castelino R, Sud K, Patel R.	2017
2369	Journal Am J Hosp Pharm 1992 ; 49: 1139 - 1142.	Stability of ceftazidime and tobramycin sulfate in peritoneal dialysis solution Mason NA, Johnson CE, O'Brien MA.	1992
3289	Journal Acta Pol Pharm 2011 ; 68, 1: 99-107.	Stability of ceftazidime in 1% and 5% buffered eye drops determined by HPLC method. Kodym A, Hapka-Zmich D, Golab M, Gwizdala M.	2011
2708	Journal J Clin Pharm Ther 1999 ; 24: 299-302	Stability of ceftazidime in a viscous eye drop formulation Barnes AR, Nash R.	1999
445	Journal Am J Hosp Pharm 1992 ; 49: 2765-2768.	Stability of ceftazidime in plastic syringes and glass vials under various storage conditions. Stewart JT, Warren FW, Johnson SM, Fox JL, Mullaney J.	1992
2450	Journal Am J Health-Syst Pharm 1996 ; 53: 2731 - 2734.	Stability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solution Manduru M, Fariello A, White RL, Fox JL, Bosso JA.	1996
591	Journal Can J Hosp Pharm 1993 ; 46: 13-16.	Stability of ceftizoxime in 5 percent dextrose and 0.9 percent sodium chloride. Knoppert DC, Freeman D, Webb D.	1993
282	Journal Am J Health-Syst Pharm 1995 ; 52: 2568-2570.	Stability of ceftizoxime sodium, ceftriaxone sodium, and ceftazidime with metronidazole in ready-to-use metronidazole bags. Rivers TE, Webster AA.	1995
4378	Journal Perit Dial Int 2020 ; 40, 5: 470-476.	Stability of ceftolozane and tazobactam in different peritoneal dialysis solutions. Harmanjeet H, Jani H, Zaidi S.T.R, Wanandy T, Castelino R.L, Sud K, Peterson G.M, Patel R.P.	2020
276	Journal Am J Hosp Pharm 1994 ; 51: 92-94.	Stability of ceftriaxone sodium and aminophylline or theophylline in intravenous admixtures. Parrish MA, Bailey LC, Medwick T.	1994
11	Journal Am J Health-Syst Pharm 1997 ; 54: 424-427.	Stability of ceftriaxone sodium and metronidazole hydrochloride. Bailey LC, Orosz ST.	1997
259	Journal Am J Hosp Pharm 1993 ; 50: 2092-2094.	Stability of ceftriaxone sodium in infusion-pump syringes. Bailey LC, Tang KT, Medwick T.	1993
279	Journal Am J Hosp Pharm 1994 ; 51: 2159-2161.	Stability of ceftriaxone sodium in injectable solutions stored frozen in syringes. Bailey LC, Cappel KM, Orosz ST.	1994
100	Journal Am J Health-Syst Pharm 1996 ; 43: 2320-2323.	Stability of ceftriaxone sodium in polypropylene syringes at -20, 4, and 20°C. Plumridge RJ, Rieck AM, Annus TP, Langton SR.	1996
649	Journal Int J Pharm Compound 1997 ; 1: 280-281.	Stability of ceftriaxone sodium when mixed with metronidazole injection. Das Gupta V.	1997
2491	Journal Am J Hosp Pharm 1989 ; 46: 256.	Stability of cefuroxime axetil in beverages St Claire RL, Caudill WL.	1989
2699	Journal J Clin Pharm Ther 1991 ; 16, 5: 341-345.	Stability of cefuroxime axetil in suspensions. Pramar Y, Das Gupta V, Bethea C, Zerai T.	1991
3290	Journal Acta Pol Pharm 2011 ; 68, 4: 555-564.	Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method. Kodym A, Wisniewski A, Kniola D, Olejniczak M.	2011
2095	Journal EJHP Science 2006 ; 12, 2: 32-34.	Stability of cefuroxime infusion: the brand-name drug versus a generic product. Rodenbach, MP, Hecq JD, Vanbeckbergen D, jamart J, Galanti L.	2006
96	Journal Am J Hosp Pharm 1994 ; 51: 809-811.	Stability of cefuroxime sodium and aminophylline or theophylline. Stewart JT, Warren FW, Johnson SM.	1994
636	Journal J Clin Hosp Pharm 1986 ; 11: 47-54.	Stability of cefuroxime sodium in some aqueous buffered solutions and intravenous admixtures. Das Gupta V, Stewart KR.	1986
3078	Journal Can J Hosp Pharm 2009 ; 62, 6: 464-468.	Stability of celecoxib oral suspensions. Donnelly RF, Pascuet E, Ma C, Vaillancourt R.	2009
3135	Journal Am J Health-Syst Pharm 2010 ; 67, 3: 223-226.	Stability of cetuximab and panitumumab in glass vials and polyvinyl chloride bags. Ikesue H, Vermeulen LC, Hoke R, Kolesar JM.	2010
2206	Journal Am J Health-Syst Pharm 2015 ; 72:1292-1297	Stability of chlorothiazide sodium in polypropylene syringes McCluskey S.V, Gardner B, . Graner K.K, Nicole Vu N.	2015
1	Journal Am J Health-Syst Pharm 1996 ; 53: 1939-1943.	Stability of cidofovir in 0.9% sodium chloride and in 5% dextrose injection. Yuan LC, Samuels GJ, Visor GC.	1996
71	Journal Am J Health-Syst Pharm 1997 ; 54: 2204-2206.	Stability of cidofovir in 0.9% sodium chloride injection for five days. Ennis RD, Dahl TC.	1997
1989	Journal Am J Health-Syst Pharm 2005 ; 62: 506-509.	Stability of cidofovir in extemporaneously prepared syringes. Hennere G, Havard L, Bonan B, Prognon P.	2005
3722	Journal Acta Pol Pharm 2014 ; 71, 4: 661-666.	Stability of cilazapril in pediatric oral suspensions prepared from commercially available tablet dosage forms. Beata J. Stanisz, Sylwia K. Paszun, Anna Zalewska.	2014
80	Journal Am J Hosp Pharm 1993 ; 50: 2559-2561.	Stability of cimetidine hydrochloride and of clindamycin phosphate in water for injection stored in glass vials at two temperatures. Nahata MC, Morosco RS, Hipple TF.	1993
362	Journal Am J Hosp Pharm 1985 ; 42: 2208-2210.	Stability of cimetidine hydrochloride in a total nutrient admixture. Baptista RJ, Palombo JD, Tahan SR, Valicenti AJ, Bistrian BR, Arkin CF, Blackburn GL.	1985
1503	Journal Am J Hosp Pharm 1983 ; 40: 1002-1006.	Stability of cimetidine hydrochloride in admixtures after microwave thawing Elliott GT, McKenzie MW, Curry SH, Pieper JA, Quinn SL.	1983
1614	Journal Hosp Pharm 2001 ; 36: 1170-1173.	Stability of ciprofloxacin and vancomycin hydrochloride in autodose infusion system bags. Trissel LA, Xu QA, Zhang Y, Saenz CA, Ingram DS.	2001
666	Journal J Clin Pharm Ther 1994 ; 19: 261-262.	Stability of ciprofloxacin in 5% dextrose and normal saline injections. Mathew M, Das Gupta V, Zerai T.	1994
1740	Journal Int J Pharm Compound 1998 ; 2, 4: 314-317.	Stability of ciprofloxacin in an extemporaneous oral liquid dosage form. Johnson CE, Wong D, Hoppe HL, Bhatt-Mehta V.	1998
2676	Journal Int J Pharm Compound 1998 ; 2: 314-317.	Stability of ciprofloxacin in an extemporaneous oral liquid dosage form. Johnson C.E, Wong D.V, Hoppe H.L, Bhatt-Mehta V.	1998
2368	Journal Am J Hosp Pharm 1992 ; 49: 2956 - 2959.	Stability of ciprofloxacin in peritoneal dialysis solution Mawhinney WM, Adair CG, Gorman SP, McClurg B.	1992
3231	Journal Can J Hosp Pharm 2011 ; 64, 4 : 252-256.	Stability of Ciprofloxacin in Polyvinylchloride Minibags. Donnelly RF.	2011
4263	Journal Am J Hosp Pharm 1994 ;51:373-377	Stability of ciprofloxacin injection in peritoneal dialysis solutions. Kane MP, Bailie GR, Moon DG, Siu I.	1994
533	Journal Am J Health-Syst Pharm 1998 ; 55: 1037-1041.	Stability of cisatracurium besylate in vials, syringes and infusion admixtures. Xu QA, Zhang YP, Trissel LA, Gilbert DL, Martinez JF, Fox JL.	1998
1080	Journal Am J Hosp Pharm 1985 ; 42: 2652.	Stability of cisplatin admixtures in polyvinyl chloride bags. La Folette JM, Arbus MH, Lauper RD.	1985
417	Journal Am J Hosp Pharm 1989 ; 46: 1400-1404.	Stability of cisplatin and etoposide in intravenous admixtures. Stewart CF, Hampton EM.	1989
53	Journal Am J Health-Syst Pharm 1995 ; 52: 2570-2573.	Stability of cisplatin and ondansetron hydrochloride in admixtures for continuous infusion. Henry DW, Marshall JL, Nazzar OD, Fox JL, Leff RD.	1995
1729	Journal Pharmazie 1998 ; 53: 490-492.	Stability of cisplatin containing infusion. Mittner A, Vincze Z, Jemnitz K.	1998
742	Journal Am J Hosp Pharm 1979 ; 36: 38-43.	Stability of cisplatin in aqueous solution. Greene RF, Chatterji DC, Hiranaka PK, Gallelli JF.	1979
149	Journal J Clin Pharm Ther 1992 ; 17: 315-318.	Stability of cisplatin in ethylene vinylacetate portable infusion-pump reservoirs. Rochard E, Barthes D, Courtois P.	1992
147	Journal Pharm World Sci 1993 ; 15: 34-36.	Stability of cisplatin in sodium chloride 0.9% intravenous solution related to the container’s material. Pujol Cubells M, Prat Aixela J, Girona Brumos V, Duran Pou S, Villaronga Flaque MV.	1993
409	Journal Am J Hosp Pharm 1987 ; 44: 124-130.	Stability of cisplatin, iproplatin, carboplatin, and tetraplatin in commonly used intravenous solutions. Cheung YW, Cradock JC, Vishnuvajjala BR, Flora KP.	1987
1604	Journal Eur Hosp Pharm 2001 ; 7: 11-14.	Stability of citalopram hydrochloride in polyvinyl chloride bag for I.V. solutions and compatibility in the presence of dipotassium clorazepate. Gury C, Dolizy I, Aymard N, Sellali Y, Rochet S.	2001
318	Journal Am J Hosp Pharm 1994 ; 51: 512-514.	Stability of citrated caffeine injectable solution in glass vials. Donnelly RF, Tirona RG.	1994
1354	Journal Am J Hosp Pharm 1984 ; 41: 2405-2406.	Stability of citrated caffeine solutions for injectable and enteral use. Eisenberg MG, Kang N.	1984
1505	Journal Eur Hosp Pharm 1997 3,4: 154-6	Stability of cladribine in either polyethylene containers or polyvinylchloride bags. Daouphars M, Vigneron J, Perrin A, Hoffman MA, Hoffman M.	1997
3901	Journal Int J Pharm Compound 2016 ; 20, 5 : 421-425.	Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt Pramar Yashoda V, Graves Richard A, Ledet Grace A, Phan Kelly V, Bostanian Levon A,Mandal Tarun K	2016
567	Journal Can J Hosp Pharm 1989 ; 42: 109-112.	Stability of clindamycin phophate in dextrose and saline solutions. Das Gupta V, Parasrampuria J, Bethea C, Wright W.	1989
418	Journal Am J Hosp Pharm 1985 ; 42: 2211-2214.	Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitine sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions. Bosso JA, Townsend RJ.	1985
1815	Journal Int J Pharm Compound 2003 ; 7, 2: 149-151.	Stability of clindamycin phosphate in autodose infusion system bags. Xu QA, Trissel LA.	2003
432	Journal Am J Hosp Pharm 1986 ; 43: 1732-1736.	Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutions. Marble DA, Bosso JA, Townsend RJ.	1986
4630	Journal J Pharm Health Care Sci 2021 ; 7:31	Stability of clonidine hydrochloride in an oral powder form compounded for pediatric patients in Japan. Saito J, Hanawa T, Matsumoto T, Yoshikawa N, Harada T, Iwahashi K, Nakamura H, Yamatani A.	2021
3649	Journal Am J Health-Syst Pharm 2014 ; 71:657-661.	Stability of clonidine suspension in oral plastic syringes. Ma C, Decarie D, Ensom M.H.H.	2014
2592	Journal Can J Hosp Pharm 2005 ; 58, 5: 279-284.	Stability of clozapine stored in oral suspension vehicles at room temperature. Walker SE, Baker D, Law S.	2005
2397	Journal Am J Health-Syst Pharm 2007 Dentinger PJ, Swenson CF	Stability of codeine phosphate in an extemporaneously compounded syrup Dentinger PJ, Swenson CF.	2007
2783	Journal Int J Pharm 2015 ; 486; 1-2: 367-369.	Stability of colistimethate sodium in a disposable elastomeric infusion device. Abdulla A,.van Leeuwen R.W.F, de Vries Schultink A.H.M,.Koch B.C.P.	2015
3360	Journal Antimicrob Agents Chemother 2012 ; 56:6432-6433.	Stability of Colistimethate Sodium in Aqueous Solution. Healan A. M, Gray W, Fuchs E.J, Griffiss J.M, Salata R.A, Blumer J.	2012
2285	Journal Antimicrob Agents Chemother 2008 ; 52, 9: 3047-3051.	Stability of colistin methanesulfonate in pharmaceutical products and solutions for administration to patients. Wallace SJ, Li J, Rayner CR, Coulthard K, Nation RL.	2008
4607	Journal Can J Hosp Pharm 2021 ;74(3):227-34	Stability of Compounded Clozapine 25 mg/mL and 50 mg/mL Suspensions in Plastic Bottles. Walker SE, Sachedina H, Bichar K.	2021
4690	Journal Hosp Pharm 2022 ; 57, 2: 294-299.	Stability of Compounded Digoxin Solution 0.05mg/mL for Injection. Friciu M, Marcelin R.B, Bédard P, Forest J.M, Leclair G.	2022
3202	Journal Am J Health-Syst Pharm 2011 ; 68: 900-908.	Stability of compounded thioguanine oral suspensions Montazeri Aliabadi H, Romanick M, Somayaji V, Mahdipoor P, Lavasanifar A	2011
4593	Journal Int J Pharm Compound 2021 ;78,4:344-351	Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases. Teimouri A, Yeung P, Agu R.	2021
4214	Journal Int J Pharm Compound 2019 ;23,1:70-76	Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt. Pramar Y.V, Mandal T.K, Bostanian L.A, Nguyen A.TQ, Miller V, Morris T.C, Graves R.A.	2019
4089	Journal Pharmaceutical Technology in Hospital Pharmacy 2018 ;3,1:23-30	Stability of Concentrated Solution of Vancomycin Hydrochloride in Syringes for Intensive Care Units. Godet M, Simar J, Closset M, Hecq J.D, Braibant M, Soumoy L, Gillet P, Jamart J, Bihin B, Galanti L.	2018
2162	Journal Perit Dial Int 1990 ; 10: 157-160.	Stability of cotrimoxazole in peritoneal dialysis fluid. Holmes SE, Aldous S.	1990
1833	Journal Ann Pharmacotherapy 2003 ; 37, 12: 1789-1792.	Stability of cyclophosphamide and mesna admixtures in polyethylene infusion bags. Menard C, Bourguignon C, Schlatter J, Vermerie N.	2003
1728	Journal Pharmazie 1999 ; 54: 224-225.	Stability of cyclophosphamide containing infusions. Mittner A, Vincze Z, Jemnitz.	1999
3096	Journal Ann Pharmacotherapy 2010 ;44:295-301.	Stability of Cyclophosphamide in Extemporaneous Oral Suspensions. Kennedy R, Groepper D, Tagen M, Christensen R, Navid F, Gajjar A, Stewart CF.	2010
3476	Journal Am J Health-Syst Pharm 2013 ;70:1970-1972.	Stability of cyclosporine diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in ethylene-vinyl acetate containers. Li M, Coursol C, Leclair G.	2013
471	Journal Am J Hosp Pharm 1989 ; 46: 2053-2055.	Stability of cyclosporine in 5% dextrose injection. Shea BF, Ptachcinski RJ, O'Neill S, Cersosimo RJ, Sesin GP, Souney PF.	1989
2444	Journal Am J Health-Syst Pharm 1995 ; 52: 2204-2207.	Stability of cyclosporine in an extemporaneously compounded paste Ghnassia LT, Yau DF, Kaye KI, Duggin GG.	1995
3229	Journal Am J Health-Syst Pharm 2011 ;68:1646-1650.	Stability of cyclosporine solutions stored in polypropylene–polyolefin bags and polypropylene syringes. Li M, Forest JM, Coursol C, Leclair G.	2011
291	Journal Am J Hosp Pharm 1993 ; 50: 470-472.	Stability of cyclosporine with magnesium sulfate in 5% dextrose injection. Nieforth KA, Shea BF, Souney PF, Scavone JM.	1993
1028	Journal Am J Hosp Pharm 1984 ; 41: 1802-1806.	Stability of cytarabine, methotrexate sodium, and hydrocortisone sodium succinate admixtures. Cheung YW, Vishnuvajjala BR, Flora KP.	1984
859	Journal Nor Pharm Acta 1983 ; 45: 61-67.	Stability of cytotoxic intravenous solutions subjected to freeze-thaw treatment. Karlsen J, Thonnesen HH, Olsen IR, Sollien AH, Skobba TJ.	1983
1635	Journal Am J Health-Syst Pharm 2002 ; 59: 1351-1356.	Stability of dacarbazine in amber glass vials and polyvinyl chloride bags. El Aatmani M, Poujol S, Astre C, Malosse F, Pinguet F.	2002
4031	Journal Int J Pharm Compound 2017 ;21 , 5 : 426-429	Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes. Kirkham K, Munson J, McCluskey S, Graner K.	2017
4106	Journal Can J Hosp Pharm 2018 ;71,2/152-154	Stability of Dapsone in Extemporaneously Compounded Oral Suspensions. Alarie H, Friciu M, Leclair G.	2018
2545	Journal Ann Pharmacotherapy 2000 ;34:848-850.	Stability of dapsone in two oral liquid dosage forms. Nahata MC, Morosco RC, Trowbridge JM.	2000
3665	Journal Am J Health-Syst Pharm 2014 ; 71:956-959	Stability of daptomycin 5 mg/mL and heparin sodium 100 units/mL combined in lactated Ringer’s injection and stored in polypropylene syringes at 4 and -20°C. Ortega R, Salmer?n-Garc?a A, Cabeza J, Capit?n-Vallvey L.F, Navas N.	2014
4074	Journal EJHP 2018 ; 25: 107-110.	Stability of daptomycin reconstituted vials and infusion solutions. Ferrandez J, Sanchez R, Diaz D, Diaz M, Estevan M, Garcia T.	2018
5	Journal Am J Health-Syst Pharm 1996 ; 53: 1583-1588.	Stability of deferoxamine mesylate, floxuridine, fluorouracil, hydromorphone hydrochloride, lorazepam, and midazolam hydrochloride in polypropylene infusion-pump syringes. Stiles ML, Allen LV Jr, Prince SJ.	1996
2156	Journal Perit Dial Int 1994 ; 14: 396-398.	Stability of deferoxamine peritoneal dialysate solutions. Kane MP, Bailie GR, Moon DG, Siu I.	1994
2961	Journal Can J Hosp Pharm 2001 ; 54: 96-101.	Stability of dexamethasone in extemporaneously prepared oral suspensions. Wen-Lin Chow J, Decarie D, Dumont RJ.	2001
24	Journal Am J Hosp Pharm 1994 ; 51: 514-517.	Stability of dexamethasone sodium phosphate, diphenhydramine hydrochloride, lorazepam, and metoclopramide hydrochloride in portable infusion-pump reservoirs. Stiles ML, Allen LV Jr, Prince SJ, Holland JS.	1994
3299	Journal Am J Health-Syst Pharm 2012 ; 69:595-597.	Stability of dexmedetomidine 4 µg/mL in polypropylene syringes. Anderson C.R, Mackay M.W, Holley M, Kay B.A	2012
4029	Journal Int J Pharm Compound 2017 ; 21, 5: 436-439	Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags. Marquis K, Hohlfelder B, Szumita Paul.	2017
3433	Journal Am J Health-Syst Pharm 2013 ; 70:1336-1341	Stability of dexmedetomidine in polyvinyl chloride bags containing 0.9% sodium chloride injection. Preslaski C.R, Mueller S.W, Wempe M.F, Robert MacLaren R.	2013
779	Journal J Pharm Pharmacol 1986 ; 38: 51P.	Stability of diamorphine hydrochloride with haloperidol in prefilled syringes for continuous subcutaneous administration. Collins AJ, Abethell JA, Holmes SG, Rain R.	1986
4533	Journal Int J Pharm Compound 2021 ;25,5:427-430	Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base. Lopalco A, Lopedota A, Aurelio F, La Forgia F, Fontana S, Franco M, Denora N.	2021
1199	Journal Am J Hosp Pharm 1982 ; 1687-1690.	Stability of diazepam injection repackaged in glass unit-dose syringes. Smith FM, Nuessle NO.	1982
4313	Journal PlosOne 2017	Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions. Friciu M, Zaraa S, Roullin G, Leclair G.	2017
2840	Journal Can J Hosp Pharm 2010 ; 63, 1 : 25-30.	Stability of Diclofenac Sodium Oral suspensions Packaged in Amber Polyvinyl Chloride Bottles. Donnell RF, Pascuet E, Ma C, Vaillancourt R.	2010
618	Journal Am J Hosp Pharm 1982 ; 39: 844-846.	Stability of digoxin in common large-volume injections. Shank WA, Coupal JJ.	1982
3426	Journal Journal of Addiction Medicine 2013 ; 7,2:113-115.	Stability of Dilute Oral Morphine Solution for Neonatal Abstinence Syndrome. Sauberan, Jason; Rossi, Steven; Kim, Jae H.	2013
3422	Journal Hosp Pharm 2013 ; 48, 6: 484-488.	Stability of Diluted Adenosine Solutions in Polyolefin Infusion Bags. Almagambetova E, Hutchinson D, Blais D.M, Zhao F.	2013
3223	Journal Am J Health-Syst Pharm 2011 ;68:1533-1536.	Stability of diluted adenosine solutions in polyvinyl chloride infusion bags Kaltenbach M, Hutchinson DJ, Bollinger JE, Zhao F.	2011
546	Journal Ann Pharmacotherapy 1994 ; 28: 1018-1019.	Stability of diluted dexamethasone sodium phosphate injection at two temperatures. Lugo RA, Nahata MC.	1994
3309	Journal EJHP 2012 ;19:378-380	Stability of diluted epinephrine in prefilled syringes for use in neonatology. Zenoni D, Priori G, Bellan C, Invernizzi R.W.	2012
1183	Journal Am J Hosp Pharm 1981 ; 38: 1001-1004.	Stability of diluted heparin sodium stored in plastic syringes. Tunbridge LJ, Lloyd JV, Penhall RK, Wise AL, Maloney T.	1981
3443	Journal J Pharm Pract and Res 2013 ; 43: 112-116.	Stability of Diluted Iron Polymaltose in PVC Infusion Bags. Patel R.P, Wanandy T, Loring S, Johns C, Hutchinson J, Shastri M.	2013
3435	Journal Can J Hosp Pharm 2013 ; 66, 3 : 198.	Stability of Diluted Ketamine Packaged in Glass Vials. Donnelly R.F.	2013
3243	Poster ECCO Congress Stockholm 2011	Stability of diluted L-asparaginase in normal saline solution. Nicolson O, d'Hayer B, Vieillard V, Dollet S, Astier A, Paul M.	2011
212	Journal Am J Hosp Pharm 1994 ; 51: 2157-2159.	Stability of diluted methylprednisolone sodium succinate injection at two temperatures. Nahata MC, Morosco RS, Hipple TF.	1994
2310	Journal EJHP Science 2008 ; 14, 6: 36-38.	Stability of diluted nadroparin for the treatment of paediatric thrombosis. Hunfeld N, Ypma P, Westerman E, Leebeck F, Touw D.	2008
2132	Journal Int J Pharm Compound 2015 ; 19, 4 : 344-347.	Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes. Anderson Collin R, Halford Zachery, MacKay Mark.	2015
2471	Journal Am J Hosp Pharm 1982 ; 39: 309-310.	Stability of disopyramide phosphate in cherry syrup Mathur LK, Lai PK, Shively CD.	1982
2765	Journal Pharm World Sci 1999 ; 21: 275-277.	Stability of dithranol in creams. Wuis EW, Burger DM, Beelen M.	1999
3293	Journal EJHP 2012 ; 19: 52-56.	Stability of dobutamine 500 mg in 50 ml syringes prepared using a Central Intravenous Additive Service Patel N, Taki M, Tunstell P, Forsey P, Forbes B.	2012
1753	Journal Int J Pharm Compound 1999 ; 3: 412-414.	Stability of dobutamine hydrochloride 4 mg/ml in 5% dextrose injection at 5 and 23°C. Webster AA, English BA, McGuire JM, Riggs RM, Lander V, Buckle T.	1999
1045	Journal Am J Hosp Pharm 1984 ; 41: 686-689.	Stability of dobutamine hydrochloride and verapamil hydrochloride in 0.9% sodium chloride and 5 % dextrose injections. Das Gupta V, Stewart KR.	1984
2371	Journal Am J Hosp Pharm 1991 ; 48: 1234 - 1237.	Stability of dobutamine hydrochloride in peritoneal dialysis solutions Gora ML, Seth S, Visconti JA, Shields B, Bay W.	1991
628	Journal Am J Hosp Pharm 1982 ; 39: 1923-1925.	Stability of dobutamine hydrochloride in selected large-volume parenterals. Kirschenbaum HL, Aronoff W, Perentesis GP, Piltz GW, Goldberg RJ, Cutie AJ.	1982
4141	Journal J Clin Pharm Ther 2018 : 530-535.	Stability of dobutamine in continuous ambulatory delivery devices. Al Madfai F, Valah B, Zaidi S.T.R, Wanandy T, Ming M.C, Peterson G.M, Patel R.P.	2018
2210	Journal Can J Hosp Pharm 2007 ; 60, 4: 231-237.	Stability of Docetaxel Solution after Dilution in Ethanol and Storage in Vials and after Dilution in Normal Saline and Storage in Bags. Walker S.E, Charbonneau F, Law S.	2007
1807	Journal Can J Hosp Pharm 2003 ; 56, 2: 87-92.	Stability of dolasetron mesylate in 0.9% sodium chloride and 5% dextrose in water. Chan J, Walker SE, Law S.	2003
3712	Journal Pediatr Crit Care Med 2001 ; 2, 4: 315-317.	Stability of dopamine and epinephrine solutions up to 84 hours. Ghanayem N.S, Lee L, Nelson T, Wong S, Gordon G.B, Markdante K et al.	2001
1820	Journal J Clin Pharm Ther 2003 ; 28: 471-474.	Stability of dopamine hydrochloride 0.5 mg/ml in polypropylene syringes. Braenden JU, Stendal TL, Fagernaes CB.	2003
206	Journal Am J Health-Syst Pharm 1996 ; 53: 186.	Stability of dopamine hydrochloride and of dobutamine hydrochloride in plastic syringes and administration sets. Sautou-Miranda V, Gremeau I, Chamard I, Cassagnes J, Chopineau J.	1996
1249	Journal Am J Hosp Pharm 1985 ; 42: 595-597.	Stability of dopamine hydrochloride exposed to blue-light phototherapy. Dandurand KR, Stennett DJ.	1985
3145	Journal Am J Health-Syst Pharm 2010 ; 67: 1539-1544.	Stability of doripenem in polyvinyl chloride bags and elastomeric pumps. Crandon JL, Sutherland C, Nicolau DP.	2010
2316	Journal Clin Ther 2008 ; 30, 11: 2075-2087.	Stability of doripenem in vitro in representative infusion solutions and infusion bags. Psathas P.A, Kuzmission A, Ikeda K, Yasuo S.	2008
2256	Manufacturer Ebewe Pharma 2007	Stability of doxorubicin "Ebewe" infusion solutions.	2007
32	Journal Am J Health-Syst Pharm 1996 ; 53: 1171-1173.	Stability of doxorubicin and vincristine sulfate in two portable infusion-pump reservoirs. Nyhammar EK, Johansson SG, Seiving BE.	1996
686	Journal J Clin Pharm Ther 1990 ; 15: 279-289.	Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags. Wood MJ, Irwin WJ, Scott DK.	1990
3207	Journal Int J Pharm Compound 2011 ; 15, 2: 170-173.	Stability of Droperidol 0.625 mg/mL Diluted with 0.9% Sodium Chloride Injection and Stored in Polypropylene Syringes. McCluskey Susan V, Lovely Jenna K .	2011
2425	Journal Am J Health-Syst Pharm 1998 ; 55: 1155-1157.	Stability of enalapril maleate in three extemporaneously prepared oral liquids Nahata MC, Morosco RS, Hipple TF.	1998
1720	Journal Int J Pharm Compound 2001 ; 5: 394-396.	Stability of ephedrine sulfate at ambient temperature and 4°C in polypropylene syringes. Storms ML, Stewart JT, Warren FW.	2001
1292	Journal Int J Pharm Pract 1995 ; 3: 174-177.	Stability of epidural opiate solutions in 0.9 per cent sodium chloride infusion bags. Grassby PF, Roberts DE.	1995
3704	Journal Can J Hosp Pharm 2014 ; 67, 3:179-202.	Stability of Epinephrine at Standard Concentrations Carr R.R, Decarie D, Ensom M.H.H	2014
2437	Journal Am J Health-Syst Pharm 1996 ; 53: 659-662.	Stability of epinephrine hydrochloride in an extemporaneously compounded topical anesthetic solution of lidocaine, racepinephrine, and tetracaine Larson TA, Uden DL, Schilling CG.	1996
2077	Journal Ann Emerg Med 1990 ; 19: 1242-1244.	Stability of epinephrine in alkalinized solutions. Bonhomme L, Benhamou D, Comoy E, Preaux N.	1990
2257	Manufacturer Ebewe Pharma 2007	Stability of epirubicin "Ebewe" infusion solutions.	2007
3891	Journal Can J Hosp Pharm 2015 ; 68, 2: 121-126.	Stability of Ertapenem 100 mg/mL in Manufacturer’s Glass Vials or Syringes at 4°C and 23°C Walker S.E, Law S, Perks W, Iazzetta J.	2015
3717	Journal Am J Health-Syst Pharm 2014 ; 71:1480-1484	Stability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and -20 °C. Jain J.G, Sutherland C, Nicolau D.P, Kuti J.L.	2014
3208	Journal Int J Pharm Compound 2011 ; 15, 3: 252-254.	Stability of Ertapenem in an Elastomeric Infusion Device. Phipps Stephen D, Peacock Gina F, Smith Douglas L .	2011
2178	Journal J Pharm Biomed Anal 2007 ; 43: 445-449.	Stability of ertapenem in aqueous solutions. Zajac M, Cielecka-Piontek J, J